UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 20-F
(Mark One)
¨ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
OR
þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2008 |
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to |
OR
¨ | SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Date of event requiring this shell company report |
Commission file numbers | Barclays PLC | 1-09246 | ||
Barclays Bank PLC | 1-10257 |
BARCLAYS PLC
BARCLAYS BANK PLC
(Exact Names of Registrants as Specified in their Charters)
ENGLAND
(Jurisdiction of Incorporation or Organization)
1 CHURCHILL PLACE, LONDON E14 5HP, ENGLAND
(Address of Principal Executive Offices)
PATRICK GONSALVES, +44 (0)20 7116 2901, PATRICK.GONSALVES@BARCLAYS.COM
1 CHURCHILL PLACE, LONDON E14 5HP, ENGLAND
*(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Barclays PLC
Title of Each Class |
Name of Each Exchange On Which Registered | |
25p ordinary shares | New York Stock Exchange* | |
American Depository Shares, each representing four 25p ordinary shares | New York Stock Exchange |
* | Not for trading, but in connection with the registration of American Depository Shares, pursuant to the requirements of the Securities and Exchange Commission. |
Barclays Bank PLC
Title of Each Class |
Name of Each Exchange On Which Registered | |
7.4% Subordinated Notes 2009 | New York Stock Exchange | |
Callable Floating Rate Notes 2035 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 2 | New York Stock Exchange* | |
American Depository Shares, Series 2, each representing one Non-Cumulative Callable Dollar Preference Share, Series 2 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 3 | New York Stock Exchange* | |
American Depository Shares, Series 3, each representing one Non-Cumulative Callable Dollar Preference Share, Series 3 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 4 | New York Stock Exchange* | |
American Depository Shares, Series 4, each representing one Non-Cumulative Callable Dollar Preference Share, Series 4 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 5 | New York Stock Exchange* | |
American Depository Shares, Series 5, each representing one Non-Cumulative Callable Dollar Preference Share, Series 5 | New York Stock Exchange | |
iPath® Dow Jones AIG Grains total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Livestock Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Nickel Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Copper Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Energy Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Agriculture Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Natural Gas total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones AIG Industrial Metals Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Softs Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Tin Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Coffee Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Cotton Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Sugar Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Precious Metals Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Platinum Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Cocoa Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Lead Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Dow Jones-AIG Aluminum Total Return Sub-IndexSM ETN | NYSE Arca | |
iPath® Global Carbon ETN | NYSE Arca | |
iPath® Dow Jones AIG Commodity Index Total ReturnSM ETN | NYSE Arca | |
iPath® S&P GSCITM Crude Oil Total Return Index ETN | NYSE Arca | |
iPath® S&P GSCITM Total Return Index ETN | NYSE Arca | |
iPath® MSCI India IndexSM ETN | NYSE Arca | |
iPath® EUR/USD Exchange Rate ETN | NYSE Arca | |
iPath® GBP/USD Exchange Rate ETN | NYSE Arca | |
iPath® JPY/USD Exchange Rate ETN | NYSE Arca | |
iPath® S&P 500 VIX Short-Term FuturesTM ETN | NYSE Arca | |
iPath® S&P 500 VIX Mid-Term FuturesTM ETN | NYSE Arca | |
iPath® CBOE S&P 500 BuyWrite IndexSM ETN | NYSE Arca | |
iPath® Optimized Currency Carry ETN | NYSE Arca | |
Barclays GEMS IndexTM ETN | NYSE Arca | |
Barclays GEMS Asia 8 ETN | NYSE Arca | |
Barclays Asian and Gulf Currency Revaluation ETN | NYSE Arca | |
Barclays GEMS IndexTM ETN | American Stock Exchange |
* | Not for trading, but in connection with the registration of American Depository Shares, pursuant to the requirements of the Securities and Exchange Commission. |
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report.
Barclays PLC | 25p ordinary shares | 8,371,830,617 | ||
Barclays Bank PLC | £1 ordinary shares | 2,338,170,515 | ||
£1 preference shares | 1,000 | |||
£100 preference shares | 75,000 | |||
€100 preference shares | 240,000 | |||
$0.25 preference shares | 237,000,000 | |||
$100 preference shares | 100,000 |
Indicate by check mark if each registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes þ No ¨
If this report is an annual or transition report, indicate by check mark if the registrants are not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934.
Yes ¨ No þ
NoteChecking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrants: (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.
Yes þ No ¨
Indicate by check mark whether each registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. (Check one):
Barclays PLC | ||||||||||||
Large Accelerated Filer þ | Accelerated Filer ¨ | Non-Accelerated Filer ¨ | ||||||||||
Barclays Bank PLC | ||||||||||||
Large Accelerated Filer ¨ | Accelerated Filer ¨ | Non-Accelerated Filer þ |
* | Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing: |
U.S. GAAP ¨
International Financial Reporting Standards as issued by the International Accounting Standards Board þ
Other ¨
* | If Other has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: |
Item 17 ¨ Item 18 ¨
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No þ
(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS.)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes ¨ No ¨
Certain non-IFRS measures
In this document certain non-IFRS (International Financial Reporting Standards) measures are reported. Barclays management believes that these non-IFRS measures provide valuable information to readers of its financial statements because they enable the reader to focus more directly on the underlying day-to-day performance of its businesses and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays management. However, any non-IFRS measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
Market and other data
This document contains information, including statistical data, about certain of Barclays markets and its competitive position. Except as otherwise indicated, this information is taken or derived from Datastream, Dealogic, Euroweek, Thompson Reuters, AMEX/NYSE weekly reports, European ETF reports and other external sources. Barclays cannot guarantee the accuracy of information taken from external sources, or that, in respect of internal estimates, a third party using different methods would obtain the same estimates as Barclays.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to certain of the Groups plans and its current goals and expectations relating to its future financial condition and performance. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as may, will, seek, continue, aim, anticipate, target, expect, estimate, intend, plan, goal, believe or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding the Groups future financial position, income growth, assets, impairment charges, business strategy, capital ratios, leverage, payment of dividends, projected levels of growth in the banking and financial markets, projected costs, estimates of capital expenditures, and plans and objectives for future operations and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances, including, but not limited to, UK domestic and global economic and business conditions, the effects of continued volatility in credit markets, market related risks such as changes in interest rates and exchange rates, effects of changes in valuation of credit market exposures, changes in valuation of issued notes, the policies and actions of governmental and regulatory authorities, changes in legislation, the further development of standards and interpretations under IFRS applicable to past, current and future periods, evolving practices with regard to the interpretation and application of standards under IFRS, progress in the integration of the Lehman Brothers North American businesses into the Groups business and the quantification of the benefits resulting from such acquisition, the outcome of pending and future litigation, the success of future acquisitions and other strategic transactions and the impact of competition a number of which factors are beyond the Groups control. As a result, the Groups actual future results may differ materially from the plans, goals, and expectations set forth in the Groups forward-looking statements.
Any forward-looking statements made herein speak only as of the date they are made. Except as required by the UK Financial Services Authority (FSA), the London Stock Exchange or applicable law, Barclays expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Barclays expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The reader should, however, consult any additional disclosures that Barclays has made or may make in documents it has filed or may file with the Securities and Exchange Commission (SEC).
SEC FORM 20-F CROSS REFERENCE INFORMATION
Form 20-F item number |
Page and caption references in this document* | |||
1 | Identity of Directors, Senior Management and Advisers | Not applicable | ||
2 | Offer Statistics and Expected Timetable | Not applicable | ||
3 | Key Information | |||
A. Selected financial data | 2, 12, 304 | |||
B. Capitalization and indebtedness | Not applicable | |||
C. Reason for the offer and use of proceeds | Not applicable | |||
D. Risk factors | 57-61 | |||
4 | Information on the Company | |||
A. History and development of the company | 176, 234(Note 38)-239(Note 42), 244(Events after balance sheet date), 305 | |||
B. Business overview | 30, 135-136, 202-204(Note 14), 232(Note 36), 279-284 (Note 53) | |||
C. Organizational structure | 238(Notes 40 and 41), 239(Note 42) | |||
D. Property, plants and equipment | 210(Note 23), 233-224(Note 37) | |||
4A | Unresolved staff comments | Not applicable | ||
5 | Operating and Financial Review and Prospects | |||
A. Operating results | 2-52, 135-136, 202-204(Note 14), 232(Note 36), 267(Note 48) | |||
B. Liquidity and capital resources | 17, 91-92, 111-116, 193, 202-204(Note 14), 214-218(Note 27), 219(Note 29), 226-228(Note 31), 230-231(Note 34), 268-272(Note 49), 278(Note 52) | |||
C. Research and development, patents and licenses, etc. | Not applicable | |||
D. Trend information | 11 | |||
E. Off-balance sheet arrangements | 25-26 | |||
F. Tabular disclosure of contractual obligations | 19 | |||
G. Safe harbor | Inside front cover (Forward-looking statements) | |||
6 | Directors, Senior Management and Employees | |||
A. Directors and senior management | 138-139 | |||
B. Compensation | 157-172, 220-226(Note 30), 240-243(Note 43) | |||
C. Board practices | 138-139, 141-156, 165-166 | |||
D. Employees | 9-10, 55 | |||
E. Share ownership | 157-172, 243(Note 43) | |||
7 | Major Shareholders and Related Party Transactions | |||
A. Major shareholders | 141, 176 | |||
B. Related party transactions | 240-243(Note 43) | |||
C. Interests of experts and counsel | Not applicable | |||
8 | Financial Information | |||
A. Consolidated statements and other financial information | 11, 140, 177-298, 305-306 | |||
B. Significant changes | 11, 189, 244(Note 44) | |||
9 | The Offer and Listing | |||
A. Offer and listing details | 303 | |||
B. Plan of distribution | Not applicable | |||
C. Markets | 302 | |||
D. Selling shareholders | Not applicable | |||
E. Dilution | Not applicable | |||
F. Expenses of the issue | Not applicable | |||
10 | Additional Information | |||
A. Share capital | Not applicable | |||
B. Memorandum and Articles of Association | 305-307 | |||
C. Material contracts | 142, 165-166, 227-228(Note 31) | |||
D. Exchange controls | 239(Note 42), 309 | |||
E. Taxation | 307-309 | |||
F. Dividends and paying agents | Not applicable | |||
G. Statement by experts | Not applicable | |||
H. Documents on display | 309 | |||
I. Subsidiary information | 238(Note 40) | |||
11 | Quantitative and Qualitative Disclosures about Market Risk | 56-134, 250(Note 46)-272(Note 49) | ||
12 | Description of Securities Other than Equity Securities | Not applicable | ||
13 | Defaults, Dividend Arrearages and Delinquencies | Not applicable | ||
14 | Material Modifications to the Rights of Security Holders and Use of Proceeds | Not applicable | ||
15 | Controls and Procedures | |||
A. Disclosure controls and procedures | 174 | |||
B. Managements annual report on internal control over financial reporting | 173 | |||
C. Attestation report of the registered public accounting firm | 177-178 | |||
D. Changes in internal control over financial reporting | 174 | |||
15T | Controls and Procedures | 173-174, 177 | ||
16A | Audit Committee Financial Expert | 149 | ||
16B | Code of Ethics | 155 | ||
16C | Principal Accountant Fees and Services | 142, 151(Non-Audit Services Policy), 198-199(Note 9) | ||
16D | Exemptions from the Listing Standards for Audit Committees | Not applicable | ||
16E | Purchases of Equity Securities by the Issuer and Affiliated Purchasers | 227(Share repurchase) | ||
16F | Change in Registrants Certifying Accountant | Not applicable | ||
16G | Corporate Governance | 143, 155 | ||
17 | Financial Statements | Not applicable | ||
18 | Financial Statements | 175-300 | ||
19 | Exhibits | Exhibit Index |
* | Captions have been included only in respect of pages with multiple sections on the same page in order to identify the relevant caption on that page covered by the corresponding Form 20-F item number. |
1 | ||
1 | ||
53 | ||
55 | ||
56 | ||
137 | ||
138 | ||
140 | ||
143 | ||
157 | ||
173 | ||
175 | ||
176 | ||
Independent Auditors report/Independent Registered Public Accounting Firms report |
177 | |
179 | ||
285 | ||
301 |
For the year ended 31st December | |||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004 £m a |
|||||||||||
Net interest income |
11,469 | 9,610 | 9,143 | 8,075 | 6,833 | ||||||||||
Net fee and commission income |
8,407 | 7,708 | 7,177 | 5,705 | 4,847 | ||||||||||
Principal transactions |
2,009 | 4,975 | 4,576 | 3,179 | 2,514 | ||||||||||
Net premiums from insurance contracts |
1,090 | 1,011 | 1,060 | 872 | 1,042 | ||||||||||
Other income |
377 | 188 | 214 | 147 | 131 | ||||||||||
Total income |
23,352 | 23,492 | 22,170 | 17,978 | 15,367 | ||||||||||
Net claims and benefits incurred on insurance contracts |
(237 | ) | (492 | ) | (575 | ) | (645 | ) | (1,259 | ) | |||||
Total income net of insurance claims |
23,115 | 23,000 | 21,595 | 17,333 | 14,108 | ||||||||||
Impairment charges and other credit provisions |
(5,419 | ) | (2,795 | ) | (2,154 | ) | (1,571 | ) | (1,093 | ) | |||||
Net income |
17,696 | 20,205 | 19,441 | 15,762 | 13,015 | ||||||||||
Operating expenses |
(14,366 | ) | (13,199 | ) | (12,674 | ) | (10,527 | ) | (8,536 | ) | |||||
Share of post-tax results of associates and joint ventures |
14 | 42 | 46 | 45 | 56 | ||||||||||
Profit before business acquisitions and disposals |
3,344 | 7,048 | 6,813 | 5,280 | 4,535 | ||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
327 | 28 | 323 | | 45 | ||||||||||
Gains on acquisitions |
2,406 | | | | | ||||||||||
Profit before tax |
6,077 | 7,076 | 7,136 | 5,280 | 4,580 | ||||||||||
Tax |
(790 | ) | (1,981 | ) | (1,941 | ) | (1,439 | ) | (1,279 | ) | |||||
Profit after tax |
5,287 | 5,095 | 5,195 | 3,841 | 3,301 | ||||||||||
Profit attributable to minority interests |
905 | 678 | 624 | 394 | 47 | ||||||||||
Profit attributable to equity holders of the parent |
4,382 | 4,417 | 4,571 | 3,447 | 3,254 | ||||||||||
5,287 | 5,095 | 5,195 | 3,841 | 3,301 | |||||||||||
Selected financial statistics
|
|||||||||||||||
Basic earnings per share |
59.3p | 68.9p | 71.9p | 54.4p | 51.0p | ||||||||||
Diluted earnings per share |
57.5p | 66.7p | 69.8p | 52.6p | 49.8p | ||||||||||
Dividends per ordinary share |
11.5p | 34.0p | 31.0p | 26.6p | 24.0p | ||||||||||
Dividend payout ratio |
19.4% | 49.3% | 43.1% | 48.9% | 47.1% | ||||||||||
Profit attributable to the equity holders of the parent as a percentage of: |
|||||||||||||||
average shareholders equity |
16.5% | 20.3% | 24.7% | 21.1% | 21.7% | ||||||||||
average total assets |
0.2% | 0.3% | 0.4% | 0.4% | 0.5% | ||||||||||
Cost: income ratio |
62% | 57% | 59% | 61% | 61% | ||||||||||
Average United States Dollar exchange rate used in preparing the accounts |
1.86 | 2.00 | 1.84 | 1.82 | 1.83 | ||||||||||
Average Euro exchange rate used in preparing the accounts |
1.26 | 1.46 | 1.47 | 1.46 | 1.47 | ||||||||||
Average Rand exchange rate used in preparing the accounts |
15.17 | 14.11 | 12.47 | 11.57 | 11.83 |
The financial information above is extracted from the published accounts for the last three years. This information should be read together with, and is qualified by reference to, the accounts and notes included in this report.
Note
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
2 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
3 |
Financial review
Income statement commentary
4 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
5 |
6 | Barclays Annual Report 2008 |
Impairment charges and other credit provisions | |||||||||
2008 £m |
2007 £m |
2006 £m |
|||||||
Impairment charges on loans and advances |
|||||||||
New and increased impairment allowances |
5,116 | 2,871 | 2,722 | ||||||
Releases |
(358 | ) | (338 | ) | (389 | ) | |||
Recoveries |
(174 | ) | (227 | ) | (259 | ) | |||
Impairment charges on loans and advances |
4,584 | 2,306 | 2,074 | ||||||
Charge/(release) in respect of provision for undrawn contractually committed facilities and guarantees provided |
329 | 476 | (6 | ) | |||||
Impairment charges on loans and advances and other credit provisions |
4,913 | 2,782 | 2,068 | ||||||
Impairment charges on reverse repurchase agreements |
124 | | | ||||||
Impairment on available for sale assets |
382 | 13 | 86 | ||||||
Impairment charges and other credit provisions |
5,419 | 2,795 | 2,154 | ||||||
Impairment charges and other credit provisions on ABS CDO Super Senior and other credit market exposures included above: |
|||||||||
Impairment charges on loans and advances |
1,218 | 300 | | ||||||
Charges in respect of undrawn facilities and guarantees |
299 | 469 | | ||||||
Impairment charges on loans and advances and other credit provisions on ABS CDO Super Senior and other credit market exposures |
1,517 | 769 | | ||||||
Impairment charges on reverse repurchase agreements |
54 | | | ||||||
Impairment charges on available for sale assets |
192 | 13 | | ||||||
Impairment charges and other credit provisions on ABS CDO Super Senior and other credit market exposures |
1,763 | 782 | |
Barclays Annual Report 2008 |
7 |
8 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
9 |
10 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
11 |
Financial review
As at 31st December
2008 | 2007 | 2006 | 2005 | 2004 | ||||||
£m | £m | £m | £m | £m a | ||||||
Assets | ||||||||||
Cash and other short-term funds |
31,714 | 7,637 | 9,753 | 5,807 | 3,525 | |||||
Treasury bills and other eligible bills |
n/a | n/a | n/a | n/a | 6,658 | |||||
Trading portfolio and financial assets designated at fair value |
306,836 | 341,171 | 292,464 | 251,820 | n/a | |||||
Derivative financial instruments |
984,802 | 248,088 | 138,353 | 136,823 | n/a | |||||
Debt securities and equity securities |
n/a | n/a | n/a | n/a | 141,710 | |||||
Loans and advances to banks |
47,707 | 40,120 | 30,926 | 31,105 | 80,632 | |||||
Loans and advances to customers |
461,815 | 345,398 | 282,300 | 268,896 | 262,409 | |||||
Available for sale financial investments |
64,976 | 43,072 | 51,703 | 53,497 | n/a | |||||
Reverse repurchase agreements and cash collateral on securities borrowed |
130,354 | 183,075 | 174,090 | 160,398 | n/a | |||||
Other assets |
24,776 | 18,800 | 17,198 | 16,011 | 43,247 | |||||
Total assets | 2,052,980 | 1,227,361 | 996,787 | 924,357 | 538,181 | |||||
Liabilities |
||||||||||
Deposits and items in the course of collection due to banks |
116,545 | 92,338 | 81,783 | 77,468 | 112,229 | |||||
Customer accounts |
335,505 | 294,987 | 256,754 | 238,684 | 217,492 | |||||
Trading portfolio and financial liabilities designated at fair value |
136,366 | 139,891 | 125,861 | 104,949 | n/a | |||||
Liabilities to customers under investment contracts |
69,183 | 92,639 | 84,637 | 85,201 | n/a | |||||
Derivative financial instruments |
968,072 | 248,288 | 140,697 | 137,971 | n/a | |||||
Debt securities in issue |
149,567 | 120,228 | 111,137 | 103,328 | 83,842 | |||||
Repurchase agreements and cash collateral on securities lent |
182,285 | 169,429 | 136,956 | 121,178 | n/a | |||||
Insurance contract liabilities, including unit-linked liabilities |
2,152 | 3,903 | 3,878 | 3,767 | 8,377 | |||||
Subordinated liabilities |
29,842 | 18,150 | 13,786 | 12,463 | 12,277 | |||||
Other liabilities |
16,052 | 15,032 | 13,908 | 14,918 | 87,200 | |||||
Total liabilities | 2,005,569 | 1,194,885 | 969,397 | 899,927 | 521,417 | |||||
Shareholders equity | ||||||||||
Shareholders equity excluding minority interests |
36,618 | 23,291 | 19,799 | 17,426 | 15,870 | |||||
Minority interests |
10,793 | 9,185 | 7,591 | 7,004 | 894 | |||||
Total shareholders equity | 47,411 | 32,476 | 27,390 | 24,430 | 16,764 | |||||
Total liabilities and shareholders equity | 2,052,980 | 1,227,361 | 996,787 | 924,357 | 538,181 | |||||
Risk weighted assets and capital ratios b | ||||||||||
Risk weighted assets |
433,302 | 353,878 | 297,833 | 269,148 | 218,601 | |||||
Tier 1 ratio |
8.6% | 7.6% | 7.7% | 7.0% | 7.6% | |||||
Risk asset ratio |
13.6% | 11.2% | 11.7% | 11.3% | 11.5% | |||||
Selected financial and other statistics | ||||||||||
Net asset value per ordinary share |
437p | 353p | 303p | 269p | 246p | |||||
Number of ordinary shares of Barclays PLC (in millions) |
8,372 | 6,601 | 6,535 | 6,490 | 6,454 | |||||
Year-end United States Dollar exchange rate used in preparing the accounts |
1.46 | 2.00 | 1.96 | 1.72 | 1.92 | |||||
Year-end Euro exchange rate used in preparing the accounts |
1.04 | 1.36 | 1.49 | 1.46 | 1.41 | |||||
Year-end Rand exchange rate used in preparing the accounts |
13.74 | 13.64 | 13.71 | 10.87 | 10.86 |
The financial information above is extracted from the published accounts for the last three years. This information should be read together with, and is qualified by reference to, the accounts and Notes included in this report.
12 | Barclays Annual Report 2008 |
Financial review
Barclays Annual Report 2008 |
13 |
Financial review
Balance sheet commentary
Notes
a | The 2008/07 commentary on risk weighted assets is on a Basel II basis. The 2007/06 commentary is on a Basel I basis. |
b | Under the Groups securitisation programme, certain portfolios subject to securitisation or similar risk transfer transaction are adjusted in calculating the Groups risk weighted assets. Previously, for pre-2008 transactions, regulatory capital adjustments were allocated to the business in proportion to their RWAs. From 1st January 2008, the regulatory capital adjustments for all transactions are allocated to the business undertaking the securitisation unless the transaction has been undertaken for the benefit of a cluster of businesses, in which case the regulatory capital adjustments are shared. |
14 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
15 |
Financial review
Balance sheet commentary
16 | Barclays Annual Report 2008 |
Financial review
Capital ratios
Basel II | Basel II | Basel I | Basel I | |||||||||||||||||||||
2008 | 2007 | 2007 | 2006 | |||||||||||||||||||||
Barclays PLC Group |
|
Barclays Bank PLC Group |
|
Barclays PLC Group |
|
Barclays Bank PLC Group |
|
Barclays PLC Group |
|
Barclays Bank PLC Group |
|
Barclays PLC Group |
|
Barclays Bank PLC Group |
| |||||||||
Capital ratios |
% | % | % | % | % | % | % | % | ||||||||||||||||
Tier 1 ratio |
8.6 | 8.6 | 7.6 | 7.3 | 7.8 | 7.5 | 7.7 | 7.5 | ||||||||||||||||
Risk asset ratio |
13.6 | 13.5 | 11.2 | 11.0 | 12.1 | 11.8 | 11.7 | 11.5 | ||||||||||||||||
Risk weighted assets |
£m | £m | £m | £m | £m | £m | £m | £m | ||||||||||||||||
Credit risk |
266,912 | 266,912 | 244,474 | 244,469 | 265,264 | 265,259 | 233,630 | 233,630 | ||||||||||||||||
Counterparty risk |
70,902 | 70,902 | 41,203 | 41,203 | 51,947 | 51,947 | 33,912 | 33,912 | ||||||||||||||||
Market risk |
65,372 | 65,372 | 39,812 | 39,812 | 36,265 | 36,265 | 30,291 | 30,291 | ||||||||||||||||
Operational risk |
30,116 | 30,116 | 28,389 | 28,389 | n/a | n/a | n/a | n/a | ||||||||||||||||
Total risk weighted assets |
433,302 | 433,302 | 353,878 | 353,873 | 353,476 | 353,471 | 297,833 | 297,833 | ||||||||||||||||
Total net capital resources
|
||||||||||||||||||||||||
Capital resources (as defined for regulatory purposes) |
||||||||||||||||||||||||
£m | £m | £m | £m | £m | £m | £m | £m | |||||||||||||||||
Tier 1 |
||||||||||||||||||||||||
Called up share capital |
2,093 | 2,338 | 1,651 | 2,382 | 1,651 | 2,382 | 1,634 | 2,363 | ||||||||||||||||
Eligible reserves |
31,156 | 36,639 | 22,939 | 26,028 | 22,526 | 25,615 | 19,608 | 21,700 | ||||||||||||||||
Minority interests |
13,915 | 8,038 | 10,551 | 5,857 | 10,551 | 5,857 | 7,899 | 4,528 | ||||||||||||||||
Tier One Notes |
1,086 | 1,086 | 899 | 899 | 899 | 899 | 909 | 909 | ||||||||||||||||
Less: Intangible assets |
(9,964 | ) | (9,964 | ) | (8,191 | ) | (8,191 | ) | (8,191 | ) | (8,191 | ) | (7,045 | ) | (7,045 | ) | ||||||||
Less: Deductions from Tier 1 capital |
(1,036 | ) | (1,036 | ) | (1,106 | ) | (1,106 | ) | (28 | ) | (28 | ) | | | ||||||||||
Total qualifying Tier 1 capital |
37,250 | 37,101 | 26,743 | 25,869 | 27,408 | 26,534 | 23,005 | 22,455 | ||||||||||||||||
Tier 2 |
||||||||||||||||||||||||
Revaluation reserves |
26 | 26 | 26 | 26 | 26 | 26 | 25 | 25 | ||||||||||||||||
Available for sale equity |
122 | 122 | 295 | 295 | 295 | 295 | 221 | 221 | ||||||||||||||||
Collectively assessed impairment allowances |
1,654 | 1,654 | 440 | 440 | 2,619 | 2,619 | 2,556 | 2,556 | ||||||||||||||||
Minority interests |
607 | 607 | 442 | 442 | 442 | 442 | 451 | 451 | ||||||||||||||||
Qualifying subordinated liabilities |
||||||||||||||||||||||||
Undated loan capital |
6,745 | 6,768 | 3,191 | 3,191 | 3,191 | 3,191 | 3,180 | 3,180 | ||||||||||||||||
Dated loan capital |
14,215 | 14,215 | 10,578 | 10,578 | 10,578 | 10,578 | 7,603 | 7,603 | ||||||||||||||||
Less: Deductions from Tier 2 capital |
(1,036 | ) | (1,036 | ) | (1,106 | ) | (1,106 | ) | (28 | ) | (28 | ) | | | ||||||||||
Total qualifying Tier 2 capital |
22,333 | 22,356 | 13,866 | 13,866 | 17,123 | 17,123 | 14,036 | 14,036 | ||||||||||||||||
Less: Regulatory deductions |
||||||||||||||||||||||||
Investments not consolidated for supervisory purposes |
(403 | ) | (403 | ) | (633 | ) | (633 | ) | (633 | ) | (633 | ) | (982 | ) | (982 | ) | ||||||||
Other deductions |
(453 | ) | (561 | ) | (193 | ) | (193 | ) | (1,256 | ) | (1,256 | ) | (1,348 | ) | (1,348 | ) | ||||||||
Total deductions |
(856 | ) | (964 | ) | (826 | ) | (826 | ) | (1,889 | ) | (1,889 | ) | (2,330 | ) | (2,330 | ) | ||||||||
Total net capital resources |
58,727 | 58,493 | 39,783 | 38,909 | 42,642 | 41,768 | 34,711 | 34,161 |
Barclays Annual Report 2008 |
17 |
Financial review
Additional financial disclosure
Deposits and short-term borrowings
18 | Barclays Annual Report 2008 |
Financial review
Additional financial disclosure
Commitments and contractual obligations
Commercial commitments include guarantees, contingent liabilities and standby facilities.
Commercial commitments
2008 Amount of commitment expiration per period | ||||||||||
Less than one year £m |
Between one to £m |
Between three to £m |
After £m |
Total £m | ||||||
Acceptances and endorsements |
576 | 6 | 3 | | 585 | |||||
Guarantees and letters of credit pledged as collateral security |
7,272 | 2,529 | 1,781 | 4,070 | 15,652 | |||||
Securities lending arrangements |
38,290 | | | | 38,290 | |||||
Other contingent liabilities |
7,989 | 1,604 | 372 | 1,818 | 11,783 | |||||
Documentary credits and other short-term trade related transactions |
770 | 88 | 1 | | 859 | |||||
Forward asset purchases and forward deposits placed |
50 | 241 | | | 291 | |||||
Standby facilities, credit lines and other |
195,035 | 29,666 | 26,150 | 8,815 | 259,666 | |||||
2007 Amount of commitment expiration per period | ||||||||||
Less than £m |
Between one to £m |
Between three to five years £m |
After five years £m |
Total £m | ||||||
Acceptances and endorsements |
365 | | | | 365 | |||||
Guarantees and letters of credit pledged as collateral security |
6,417 | 2,711 | 1,971 | 1,874 | 12,973 | |||||
Securities lending arrangements |
22,719 | | | | 22,719 | |||||
Other contingent liabilities |
6,594 | 1,556 | 416 | 1,151 | 9,717 | |||||
Documentary credits and other short-term trade related transactions |
401 | 121 | | | 522 | |||||
Forward asset purchases and forward deposits placed |
283 | | | | 283 | |||||
Standby facilities, credit lines and other |
136,457 | 17,039 | 28,127 | 10,211 | 191,834 | |||||
Contractual obligations include debt securities, operating lease and purchase obligations.
Contractual obligations | ||||||||||
2008 Payments due by period | ||||||||||
Less than £m |
Between one to three years £m |
Between five years £m |
After five years £m |
Total £m | ||||||
Long-term debt |
108,172 | 24,701 | 10,855 | 22,008 | 165,736 | |||||
Operating lease obligations |
280 | 690 | 785 | 2,745 | 4,500 | |||||
Purchase obligations |
214 | 225 | 61 | 20 | 520 | |||||
Total |
108,666 | 25,616 | 11,701 | 24,773 | 170,756 | |||||
2007 Payments due by period | ||||||||||
Less than one year £m |
Between one to three years £m |
Between three to five years £m |
After five years £m |
Total £m | ||||||
Long-term debt |
90,201 | 13,558 | 8,630 | 19,358 | 131,747 | |||||
Operating lease obligations |
197 | 755 | 610 | 2,225 | 3,787 | |||||
Purchase obligations |
141 | 186 | 27 | 6 | 360 | |||||
Total |
90,539 | 14,499 | 9,267 | 21,589 | 135,894 |
The long-term debt does not include undated loan capital of £13,673m (2007: £6,631m).
Further information on the contractual maturity of the Groups assets and liabilities is given in Note 49.
Barclays Annual Report 2008 |
19 |
Financial review
Additional financial disclosure
The following table analyses the book value of securities which are carried at fair value.
2008 | 2007 | 2006 | ||||||||||
Book value £m |
Amortised £m |
Book value £m |
Amortised £m |
Book value £m |
Amortised £m | |||||||
Investment securities available for sale |
||||||||||||
Debt securities: |
||||||||||||
United Kingdom government |
1,238 | 1,240 | 78 | 81 | 758 | 761 | ||||||
Other government |
11,456 | 11,338 | 7,383 | 7,434 | 12,587 | 12,735 | ||||||
Other public bodies |
2,373 | 2,379 | 634 | 632 | 280 | 277 | ||||||
Mortgage and asset backed securities |
3,510 | 4,126 | 1,367 | 1,429 | 1,706 | 1,706 | ||||||
Bank and building society certificates of deposit |
10,478 | 10,535 | 3,028 | 3,029 | 6,686 | 6,693 | ||||||
Corporate and other issuers |
29,776 | 30,363 | 26,183 | 26,219 | 25,895 | 25,857 | ||||||
Equity securities |
2,142 | 1,814 | 1,676 | 1,418 | 1,371 | 1,047 | ||||||
Investment securities available for sale |
60,973 | 61,795 | 40,349 | 40,242 | 49,283 | 49,076 | ||||||
Other securities held for trading |
||||||||||||
Debt securities: |
||||||||||||
United Kingdom government |
6,955 | n/a | 3,832 | n/a | 4,986 | n/a | ||||||
Other government |
50,727 | n/a | 51,104 | n/a | 46,845 | n/a | ||||||
Mortgage and asset backed securities |
30,748 | n/a | 37,038 | n/a | 29,606 | n/a | ||||||
Bank and building society certificates of deposit |
7,518 | n/a | 17,751 | n/a | 14,159 | n/a | ||||||
Corporate and other issuers |
52,738 | n/a | 43,053 | n/a | 44,980 | n/a | ||||||
Equity securities |
30,535 | n/a | 36,307 | n/a | 31,548 | n/a | ||||||
Other securities held for trading |
179,221 | n/a | 189,085 | n/a | 172,124 | n/a |
Investment debt securities include government securities held as part of the Groups treasury management portfolio for asset and liability, liquidity and regulatory purposes and are for use on a continuing basis in the activities of the Group. In addition, the Group holds as investments listed and unlisted corporate securities.
Bank and building society certificates of deposit are freely negotiable and have original maturities of up to five years, but are typically held for shorter periods.
In addition to UK government securities shown above, at 31st December 2008, 2007 and 2006, the Group held the following government securities which exceeded 10% of shareholders equity.
Government securities
2008 | 2007 | 2006 | ||||
Book value £m |
Book value £m |
Book value £m | ||||
United States |
17,165 | 15,156 | 18,343 | |||
Japan |
9,092 | 9,124 | 15,505 | |||
Germany |
5,832 | 5,136 | 4,741 | |||
France |
4,091 | 3,538 | 4,336 | |||
Italy |
6,091 | 5,090 | 3,419 | |||
Spain |
3,647 | 3,674 | 2,859 |
Maturities and yield of available for sale debt securities
Maturing within one year |
Maturing after one but within five years |
Maturing after five but within ten years |
Maturing after ten years |
Total | ||||||||||||||||
Amount £m |
Yield % |
Amount £m |
Yield % |
Amount £m |
Yield % |
Amount £m |
Yield % |
Amount £m |
Yield % | |||||||||||
Government |
3,096 | 6.0 | 5,410 | 5.1 | 1,694 | 1.1 | 2,493 | 0.9 | 12,693 | 4.0 | ||||||||||
Other public bodies |
832 | 1.9 | 1,526 | 0.9 | 1 | | 14 | 4.7 | 2,373 | 1.3 | ||||||||||
Other issuers |
21,749 | 4.3 | 9,692 | 3.8 | 7,702 | 4.4 | 4,622 | 5.7 | 43,765 | 4.3 | ||||||||||
Total book value |
25,677 | 4.4 | 16,628 | 3.9 | 9,397 | 3.8 | 7,129 | 4.0 | 58,831 | 4.1 |
The yield for each range of maturities is calculated by dividing the annualised interest income prevailing at 31st December 2008 by the fair value of securities held at that date.
20 | Barclays Annual Report 2008 |
Financial review
Additional financial disclosure
Average balance sheet and net interest income (year ended 31st December)
2008 | 2007 | 2006 | ||||||||||||||||||||||
Average balance a £m |
|
Interest £m |
|
Average rate % |
Average balance a £m |
|
Interest £m |
|
Average rate % |
Average balance a £m |
|
Interest £m |
|
Average rate % | ||||||||||
Assets |
||||||||||||||||||||||||
Loans and advances to banks b : |
||||||||||||||||||||||||
in offices in the United Kingdom |
38,913 | 1,453 | 3.7 | 29,431 | 1,074 | 3.6 | 18,401 | 647 | 3.5 | |||||||||||||||
in offices outside the United Kingdom |
14,379 | 419 | 2.9 | 12,262 | 779 | 6.4 | 12,278 | 488 | 4.0 | |||||||||||||||
Loans and advances to customers b : |
||||||||||||||||||||||||
in offices in the United Kingdom |
249,081 | 13,714 | 5.5 | 205,707 | 13,027 | 6.3 | 184,392 | 11,247 | 6.1 | |||||||||||||||
in offices outside the United Kingdom |
116,284 | 9,208 | 7.9 | 88,212 | 6,733 | 7.6 | 77,615 | 4,931 | 6.4 | |||||||||||||||
Lease receivables: |
||||||||||||||||||||||||
in offices in the United Kingdom |
4,827 | 281 | 5.8 | 4,822 | 283 | 5.9 | 5,266 | 300 | 5.7 | |||||||||||||||
in offices outside the United Kingdom |
6,543 | 752 | 11.5 | 5,861 | 691 | 11.8 | 6,162 | 595 | 9.7 | |||||||||||||||
Financial investments: |
||||||||||||||||||||||||
in offices in the United Kingdom |
35,844 | 1,654 | 4.6 | 37,803 | 2,039 | 5.4 | 41,125 | 1,936 | 4.7 | |||||||||||||||
in offices outside the United Kingdom |
10,450 | 697 | 6.7 | 14,750 | 452 | 3.1 | 14,191 | 830 | 5.8 | |||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed: |
||||||||||||||||||||||||
in offices in the United Kingdom |
207,521 | 8,768 | 4.2 | 211,709 | 9,644 | 4.6 | 166,713 | 6,136 | 3.7 | |||||||||||||||
in offices outside the United Kingdom |
128,250 | 4,450 | 3.5 | 109,012 | 5,454 | 5.0 | 100,416 | 5,040 | 5.0 | |||||||||||||||
Trading portfolio assets: |
||||||||||||||||||||||||
in offices in the United Kingdom |
107,626 | 4,948 | 4.6 | 120,691 | 5,926 | 4.9 | 106,148 | 4,166 | 3.9 | |||||||||||||||
in offices outside the United Kingdom |
128,287 | 5,577 | 4.3 | 57,535 | 3,489 | 6.1 | 61,370 | 2,608 | 4.2 | |||||||||||||||
Total average interest earning assets |
1,048,005 | 51,921 | 5.0 | 897,795 | 49,591 | 5.5 | 794,077 | 38,924 | 4.9 | |||||||||||||||
Impairment allowances/provisions |
(5,749 | ) | (4,435 | ) | (3,565 | ) | ||||||||||||||||||
Non-interest earning assets |
711,856 | 422,834 | 310,949 | |||||||||||||||||||||
Total average assets and interest income |
1,754,112 | 51,921 | 3.0 | 1,316,194 | 49,591 | 3.8 | 1,101,461 | 38,924 | 3.5 | |||||||||||||||
Percentage of total average interest earning assets in offices outside the United Kingdom |
38.6% | 32.0% | 34.3% | |||||||||||||||||||||
Total average interest earning assets related to: |
||||||||||||||||||||||||
Interest income |
51,921 | 5.0 | 49,591 | 5.5 | 38,924 | 4.9 | ||||||||||||||||||
Interest expense |
(38,181 | ) | 3.6 | (37,892 | ) | 4.2 | (30,385 | ) | 3.8 | |||||||||||||||
13,740 | 1.4 | 11,699 | 1.3 | 8,539 | 1.1 |
Notes
a | Average balances are based upon daily averages for most UK banking operations and monthly averages elsewhere. |
b | Loans and advances to customers and banks include all doubtful lendings, including non-accrual lendings. Interest receivable on such lendings has been included to the extent to which either cash payments have been received or interest has been accrued in accordance with the income recognition policy of the Group. |
Barclays Annual Report 2008 |
21 |
Financial review
Additional financial disclosure
Average balance sheet
Average balance sheet and net interest income (year ended 31st December)
2008 | 2007 | 2006 | ||||||||||||||||
Average balance a £m |
Interest £m |
Average rate % |
Average balance a £m |
Interest £m |
Average rate % |
Average balance a £m |
Interest £m |
Average rate % | ||||||||||
Liabilities and shareholders equity |
||||||||||||||||||
Deposits by banks: |
||||||||||||||||||
in offices in the United Kingdom |
70,272 | 2,780 | 4.0 | 63,902 | 2,511 | 3.9 | 62,236 | 2, 464 | 4.0 | |||||||||
in offices outside the United Kingdom |
32,172 | 956 | 3.0 | 27,596 | 1,225 | 4.4 | 23,438 | 1,137 | 4.9 | |||||||||
Customer accounts: |
||||||||||||||||||
demand deposits: |
||||||||||||||||||
in offices in the United Kingdom |
24,333 | 910 | 3.7 | 29,110 | 858 | 2.9 | 25,397 | 680 | 2.7 | |||||||||
in offices outside the United Kingdom |
14,902 | 572 | 3.8 | 13,799 | 404 | 2.9 | 10,351 | 254 | 2.5 | |||||||||
Customer accounts: |
||||||||||||||||||
savings deposits: |
||||||||||||||||||
in offices in the United Kingdom |
71,062 | 2,143 | 3.0 | 55,064 | 2,048 | 3.7 | 57,734 | 1,691 | 2.9 | |||||||||
in offices outside the United Kingdom |
7,033 | 413 | 5.9 | 4,848 | 128 | 2.6 | 3,124 | 74 | 2.4 | |||||||||
Customer accounts: |
||||||||||||||||||
other time deposits retail: |
||||||||||||||||||
in offices in the United Kingdom |
32,283 | 1,523 | 4.7 | 30,578 | 1,601 | 5.2 | 34,865 | 1,548 | 4.4 | |||||||||
in offices outside the United Kingdom |
20,055 | 1,350 | 6.7 | 12,425 | 724 | 5.8 | 8,946 | 482 | 5.4 | |||||||||
Customer accounts: |
||||||||||||||||||
other time deposits wholesale: |
||||||||||||||||||
in offices in the United Kingdom |
60,574 | 2,362 | 3.9 | 52,147 | 2,482 | 4.8 | 45,930 | 1,794 | 3.9 | |||||||||
in offices outside the United Kingdom |
31,300 | 2,094 | 6.7 | 24,298 | 1,661 | 6.8 | 23,442 | 1,191 | 5.1 | |||||||||
Debt securities in issue: |
||||||||||||||||||
in offices in the United Kingdom |
41,014 | 1,920 | 4.7 | 41,552 | 2,053 | 4.9 | 47,216 | 1,850 | 3.9 | |||||||||
in offices outside the United Kingdom |
80,768 | 3,734 | 4.6 | 94,271 | 5,055 | 5.4 | 74,125 | 3,686 | 5.0 | |||||||||
Dated and undated loan capital and other subordinated liabilities principally: |
||||||||||||||||||
in offices in the United Kingdom |
22,912 | 1,435 | 6.3 | 12,972 | 763 | 5.9 | 13,686 | 777 | 5.7 | |||||||||
Repurchase agreements and cash collateral on securities lent: |
||||||||||||||||||
in offices in the United Kingdom |
203,967 | 8,445 | 4.1 | 169,272 | 7,616 | 4.5 | 141,862 | 5,080 | 3.6 | |||||||||
in offices outside the United Kingdom |
177,883 | 2,800 | 1.6 | 118,050 | 5,051 | 4.3 | 86,693 | 4,311 | 5.0 | |||||||||
Trading portfolio liabilities: |
||||||||||||||||||
in offices in the United Kingdom |
56,675 | 2,657 | 4.7 | 47,971 | 2,277 | 4.7 | 49,892 | 2,014 | 4.0 | |||||||||
in offices outside the United Kingdom |
62,239 | 2,087 | 3.4 | 29,838 | 1,435 | 4.8 | 39,064 | 1,352 | 3.5 | |||||||||
Total average interest bearing liabilities |
1,009,444 | 38,181 | 3.8 | 827,693 | 37,892 | 4.6 | 748,001 | 30,385 | 4.1 | |||||||||
Interest free customer deposits: |
||||||||||||||||||
in offices in the United Kingdom |
40,439 | 34,109 | 27,549 | |||||||||||||||
in offices outside the United Kingdom |
3,089 | 3,092 | 2,228 | |||||||||||||||
Other non-interest bearing liabilities |
664,458 | 421,473 | 297,816 | |||||||||||||||
Minority and other interests and shareholders equity |
36,682 | 29,827 | 25,867 | |||||||||||||||
Total average liabilities, shareholders equity and interest expense |
1,754,112 | 38,181 | 2.2 | 1,316,194 | 37,892 | 2.9 | 1,101,461 | 30,385 | 2.8 | |||||||||
Percentage of total average interest bearing non-capital liabilities in offices outside the United Kingdom |
42.2% | 39.4% | 36.1% |
Note
a | Average balances are based upon daily averages for most UK banking operations and monthly averages elsewhere. |
22 | Barclays Annual Report 2008 |
2008/2007 Change due to increase/ (decrease) in: |
2007/2006 Change due to increase/ (decrease) in: |
2006/2005 Change due to increase/ (decrease) in: | ||||||||||||||||||||||||
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m | ||||||||||||||||||
Interest receivable |
||||||||||||||||||||||||||
Loans and advances to banks: |
||||||||||||||||||||||||||
in offices in the UK |
379 | 354 | 25 | 427 | 402 | 25 | 193 | 121 | 72 | |||||||||||||||||
in offices outside the UK |
(360 | ) | 117 | (477 | ) | 291 | (1 | ) | 292 | 85 | 46 | 39 | ||||||||||||||
19 | 471 | (452 | ) | 718 | 401 | 317 | 278 | 167 | 111 | |||||||||||||||||
Loans and advances to customers: |
||||||||||||||||||||||||||
in offices in the UK |
687 | 2,525 | (1,838 | ) | 1,780 | 1,337 | 443 | 1,018 | 726 | 292 | ||||||||||||||||
in offices outside the UK |
2,475 | 2,214 | 261 | 1,802 | 728 | 1,074 | 1,956 | 1,695 | 261 | |||||||||||||||||
3,162 | 4,739 | (1,577 | ) | 3,582 | 2,065 | 1,517 | 2,974 | 2,421 | 553 | |||||||||||||||||
Lease receivables: |
||||||||||||||||||||||||||
in offices in the UK |
(2 | ) | | (2 | ) | (17 | ) | (26 | ) | 9 | (48 | ) | (70 | ) | 22 | |||||||||||
in offices outside the UK |
61 | 79 | (18 | ) | 96 | (30 | ) | 126 | 478 | 413 | 65 | |||||||||||||||
59 | 79 | (20 | ) | 79 | (56 | ) | 135 | 430 | 343 | 87 | ||||||||||||||||
Financial investments: |
||||||||||||||||||||||||||
in offices in the UK |
(385 | ) | (102 | ) | (283 | ) | 103 | (165 | ) | 268 | 181 | (85 | ) | 266 | ||||||||||||
in offices outside the UK |
245 | (163 | ) | 408 | (378 | ) | 32 | (410 | ) | 363 | 202 | 161 | ||||||||||||||
(140 | ) | (265 | ) | 125 | (275 | ) | (133 | ) | (142 | ) | 544 | 117 | 427 | |||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed: |
||||||||||||||||||||||||||
in offices in the UK |
(876 | ) | (188 | ) | (688 | ) | 3,508 | 1,865 | 1,643 | 1,519 | 324 | 1,195 | ||||||||||||||
in offices outside the UK |
(1,004 | ) | 855 | (1,859 | ) | 414 | 430 | (16 | ) | 2,316 | 254 | 2,062 | ||||||||||||||
(1,880 | ) | 667 | (2,547 | ) | 3,922 | 2,295 | 1,627 | 3,835 | 578 | 3,257 | ||||||||||||||||
Trading portfolio assets: |
||||||||||||||||||||||||||
in offices in the UK |
(978 | ) | (616 | ) | (362 | ) | 1,760 | 621 | 1,139 | 1,456 | 907 | 549 | ||||||||||||||
in offices outside the UK |
2,088 | 3,303 | (1,215 | ) | 881 | (172 | ) | 1,053 | 492 | 151 | 341 | |||||||||||||||
1,110 | 2,687 | (1,577 | ) | 2,641 | 449 | 2,192 | 1,948 | 1,058 | 890 | |||||||||||||||||
Total interest receivable: |
||||||||||||||||||||||||||
in offices in the UK |
(1,175 | ) | 1,973 | (3,148 | ) | 7,561 | 4,034 | 3,527 | 4,319 | 1,923 | 2,396 | |||||||||||||||
in offices outside the UK |
3,505 | 6,405 | (2,900 | ) | 3,106 | 987 | 2,119 | 5,690 | 2,761 | 2,929 | ||||||||||||||||
2,330 | 8,378 | (6,048 | ) | 10,667 | 5,021 | 5,646 | 10,009 | 4,684 | 5,325 |
Barclays Annual Report 2008 |
23 |
Financial review
Additional financial disclosure
Average balance sheet
Changes in net interest income volume and rate analysis
2008/2007 Change due to increase/ (decrease) in: |
2007/2006 Change due to increase/ (decrease) in: |
2006/2005 Change due to increase/ (decrease) in: |
|||||||||||||||||||||||||
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
|||||||||||||||||||
Interest payable |
|||||||||||||||||||||||||||
Deposits by banks: |
|||||||||||||||||||||||||||
in offices in the UK |
269 | 252 | 17 | 47 | 66 | (19 | ) | 799 | 247 | 552 | |||||||||||||||||
in offices outside the UK |
(269 | ) | 181 | (450 | ) | 88 | 190 | (102 | ) | 432 | 52 | 380 | |||||||||||||||
| 433 | (433 | ) | 135 | 256 | (121 | ) | 1,231 | 299 | 932 | |||||||||||||||||
Customer accounts demand deposits: |
|||||||||||||||||||||||||||
in offices in the UK |
52 | (155 | ) | 207 | 178 | 105 | 73 | 170 | 68 | 102 | |||||||||||||||||
in offices outside the UK |
168 | 34 | 134 | 150 | 95 | 55 | 166 | 80 | 86 | ||||||||||||||||||
220 | (121 | ) | 341 | 328 | 200 | 128 | 336 | 148 | 188 | ||||||||||||||||||
Customer accounts savings deposits: |
|||||||||||||||||||||||||||
in offices in the UK |
95 | 527 | (432 | ) | 357 | (81 | ) | 438 | 121 | 152 | (31 | ) | |||||||||||||||
in offices outside the UK |
285 | 77 | 208 | 54 | 45 | 9 | 35 | 28 | 7 | ||||||||||||||||||
380 | 604 | (224 | ) | 411 | (36 | ) | 447 | 156 | 180 | (24 | ) | ||||||||||||||||
Customer accounts other time deposits retail: |
|||||||||||||||||||||||||||
in offices in the UK |
(78 | ) | 86 | (164 | ) | 53 | (204 | ) | 257 | 78 | 41 | 37 | |||||||||||||||
in offices outside the UK |
626 | 500 | 126 | 242 | 200 | 42 | 222 | 125 | 97 | ||||||||||||||||||
548 | 586 | (38 | ) | 295 | (4 | ) | 299 | 300 | 166 | 134 | |||||||||||||||||
Customer accounts other time deposits wholesale: |
|||||||||||||||||||||||||||
in offices in the UK |
(120 | ) | 367 | (487 | ) | 688 | 263 | 425 | 603 | 129 | 474 | ||||||||||||||||
in offices outside the UK |
433 | 469 | (36 | ) | 470 | 45 | 425 | 601 | 550 | 51 | |||||||||||||||||
313 | 836 | (523 | ) | 1,158 | 308 | 850 | 1,204 | 679 | 525 | ||||||||||||||||||
Debt securities in issue: |
|||||||||||||||||||||||||||
in offices in the UK |
(133 | ) | (26 | ) | (107 | ) | 203 | (240 | ) | 443 | 219 | 22 | 197 | ||||||||||||||
in offices outside the UK |
(1,321 | ) | (673 | ) | (648 | ) | 1,369 | 1,063 | 306 | 1,991 | 850 | 1,141 | |||||||||||||||
(1,454 | ) | (699 | ) | (755 | ) | 1,572 | 823 | 749 | 2,210 | 872 | 1,338 | ||||||||||||||||
Dated and undated loan capital and other subordinated liabilities principally in offices in the UK |
672 | 620 | 52 | (14 | ) | (41 | ) | 27 | 172 | 135 | 37 | ||||||||||||||||
Repurchase agreements and cash collateral on securities lent: |
|||||||||||||||||||||||||||
in offices in the UK |
829 | 1,471 | (642 | ) | 2,536 | 1,090 | 1,446 | 1,446 | 329 | 1,117 | |||||||||||||||||
in offices outside the UK |
(2,251 | ) | 1,840 | (4,091 | ) | 740 | 1,402 | (662 | ) | 1,932 | 200 | 1,732 | |||||||||||||||
(1,422 | ) | 3,311 | (4,733 | ) | 3,276 | 2,492 | 784 | 3,378 | 529 | 2,849 | |||||||||||||||||
Trading portfolio liabilities: |
|||||||||||||||||||||||||||
in offices in the UK |
380 | 408 | (28 | ) | 263 | (80 | ) | 343 | 277 | 222 | 55 | ||||||||||||||||
in offices outside the UK |
652 | 1,189 | (537 | ) | 83 | (366 | ) | 449 | 156 | 85 | 71 | ||||||||||||||||
1,032 | 1,597 | (565 | ) | 346 | (446 | ) | 792 | 433 | 307 | 126 | |||||||||||||||||
Total interest payable: |
|||||||||||||||||||||||||||
in offices in the UK |
1,966 | 3,550 | (1,584 | ) | 4,311 | 878 | 3,433 | 3,885 | 1,345 | 2,540 | |||||||||||||||||
in offices outside the UK |
(1,677 | ) | 3,617 | (5,294 | ) | 3,196 | 2,674 | 522 | 5,535 | 1,970 | 3,565 | ||||||||||||||||
289 | 7,167 | (6,878 | ) | 7,507 | 3,552 | 3,955 | 9,420 | 3,315 | 6,105 | ||||||||||||||||||
Movement in net interest income Increase/(decrease) in interest receivable |
2,330 | 8,378 | (6,048 | ) | 10,667 | 5,021 | 5,646 | 10,009 | 4,684 | 5,325 | |||||||||||||||||
(Increase)/decrease in interest payable |
(289 | ) | (7,167 | ) | 6,878 | (7,507 | ) | (3,552 | ) | (3,955 | ) | (9,420 | ) | (3,315 | ) | (6,105 | ) | ||||||||||
2,041 | 1,211 | 830 | 3,160 | 1,469 | 1,691 | 589 | 1,369 | (780 | ) |
24 | Barclays Annual Report 2008 |
Financial review
Additional financial disclosure
Off-balance sheet arrangements
Barclays Annual Report 2008 |
25 |
Financial review
Additional financial disclosure
Off-balance sheet arrangements
26 | Barclays Annual Report 2008 |
Financial review
Additional financial disclosure
Barclays Annual Report 2008 |
27 |
Financial review
Additional financial disclosure
Critical accounting estimates
28 | Barclays Annual Report 2008
|
Barclays Annual Report 2008 |
29 |
30 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Analysis of results by business
For the year ended 31st December 2008
UK £m |
Barclays Commercial £m |
Barclaycard £m |
GRCB Western Europe £m |
GRCB Emerging Markets £m |
GRCB Absa £m |
|||||||||||||
Net interest income | 2,996 | 1,757 | 1,786 | 856 | 616 | 1,104 | ||||||||||||
Net fee and commission income | 1,299 | 861 | 1,299 | 383 | 223 | 762 | ||||||||||||
Principal transactions | | 22 | 82 | 165 | 169 | 111 | ||||||||||||
Net premiums from insurance contracts | 205 | | 44 | 352 | | 234 | ||||||||||||
Other income | 17 | 105 | 19 | 39 | 11 | 113 | ||||||||||||
Total income | 4,517 | 2,745 | 3,230 | 1,795 | 1,019 | 2,324 | ||||||||||||
Net claims and benefits incurred on insurance contracts | (35 | ) | | (11 | ) | (365 | ) | | (126 | ) | ||||||||
Total income, net of insurance claims | 4,482 | 2,745 | 3,219 | 1,430 | 1,019 | 2,198 | ||||||||||||
Impairment charges and other credit provisions | (602 | ) | (414 | ) | (1,097 | ) | (296 | ) | (166 | ) | (347 | ) | ||||||
Net income | 3,880 | 2,331 | 2,122 | 1,134 | 853 | 1,851 | ||||||||||||
Operating expenses | (2,519 | ) | (1,063 | ) | (1,422 | ) | (929 | ) | (719 | ) | (1,305 | ) | ||||||
Share of post-tax results of associates and joint ventures | 8 | (2 | ) | (3 | ) | | | 5 | ||||||||||
Profit on disposal of subsidiaries | | | | | | 1 | ||||||||||||
Gains on acquisitions | | | 92 | 52 | | | ||||||||||||
Profit before tax | 1,369 | 1,266 | 789 | 257 | 134 | 552 | ||||||||||||
As at 31st December 2008 | ||||||||||||||||||
Total assets | 101,384 | 84,029 | 30,925 | 64,732 | 14,653 | 40,391 | ||||||||||||
Total liabilities | 104,640 | 64,997 | 3,004 | 37,250 | 10,517 | 20,720 |
Barclays Annual Report 2008 |
31 |
Analysis of results by business For the year ended 31st December 2008 |
|||||||||
Barclays £m |
Barclays £m |
Barclays Wealth £m |
|||||||
Net interest income | 1,724 | (38 | ) | 486 | |||||
Net fee and commission income | 1,429 | 1,917 | 720 | ||||||
Principal transactions | 2,065 | (43 | ) | (344 | ) | ||||
Net premiums from insurance contracts | | | 136 | ||||||
Other income | 13 | 8 | 26 | ||||||
Total income | 5,231 | 1,844 | 1,024 | ||||||
Net claims and benefits incurred on insurance contracts | | | 300 | ||||||
Total income, net of insurance claims | 5,231 | 1,844 | 1,324 | ||||||
Impairment charges and other credit provisions | (2,423 | ) | | (44 | ) | ||||
Net income | 2,808 | 1,844 | 1,280 | ||||||
Operating expenses | (3,774 | ) | (1,249 | ) | (935 | ) | |||
Share of post-tax results of associates and joint ventures | 6 | | | ||||||
Profit on disposal of subsidiaries | | | 326 | ||||||
Gain on acquisition | 2,262 | | | ||||||
Profit before tax | 1,302 | 595 | 671 | ||||||
As at 31st December 2008 | |||||||||
Total assets | 1,629,117 | 71,340 | 13,263 | ||||||
Total liabilities | 1,603,093 | 68,372 | 45,846 |
32 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Notes
a | Decrease in 2007 reflects the consolidation of Woolwich and Barclays current accounts. |
b | Excludes Housing Associations. |
Barclays Annual Report 2008 | 33 |
UK Retail Banking
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
2,996 | 2,858 | 2,765 | |||||||||||||
Net fee and commission income |
1,299 | 1,183 | 1,232 | |||||||||||||
Net premiums from insurance contracts |
205 | 252 | 342 | |||||||||||||
Other income |
17 | 47 | 42 | |||||||||||||
Total income |
4,517 | 4,340 | 4,381 | |||||||||||||
Net claims and benefits on insurance contracts |
(35 | ) | (43 | ) | (35 | ) | ||||||||||
Total income net of insurance claims |
4,482 | 4,297 | 4,346 | |||||||||||||
Impairment charges |
(602 | ) | (559 | ) | (635 | ) | ||||||||||
Net income |
3,880 | 3,738 | 3,711 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(2,499 | ) | (2,461 | ) | (2,531 | ) | ||||||||||
Amortisation of intangible assets |
(20 | ) | (9 | ) | (1 | ) | ||||||||||
Operating expenses |
(2,519 | ) | (2,470 | ) | (2,532 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
8 | 7 | 2 | |||||||||||||
Profit before tax |
1,369 | 1,275 | 1,181 | |||||||||||||
Balance sheet information |
||||||||||||||||
Loans and advances to customers |
£ | 94.4bn | £ | 82.0bn | £ | 74.7bn | ||||||||||
Customer accounts |
£ | 89.6bn | £ | 87.1bn | £ | 82.3bn | ||||||||||
Total assets |
£ | 101.4bn | £ | 88.5bn | £ | 81.7bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost:income ratio |
56% | 57% | 58% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk tendency |
£ | 520m | £ | 470m | £ | 500m | ||||||||||
Risk weighted assetsa |
£ | 30.5bn | £ | 31.5bn | £ | 43.0bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
34 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 | 35 |
Barclays Commercial Bank
2008 £m
|
2007 £m
|
2006 £m
|
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
1,757 | 1,747 | 1,710 | |||||||||||||
Net fee and commission income |
861 | 750 | 643 | |||||||||||||
Net trading income |
3 | 9 | 2 | |||||||||||||
Net investment income |
19 | 47 | 28 | |||||||||||||
Principal transactions |
22 | 56 | 30 | |||||||||||||
Other income |
105 | 11 | 21 | |||||||||||||
Total income |
2,745 | 2,564 | 2,404 | |||||||||||||
Impairment charges and other credit provisions |
(414 | ) | (292 | ) | (253 | ) | ||||||||||
Net income |
2,331 | 2,272 | 2,151 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(1,048 | ) | (924 | ) | (867 | ) | ||||||||||
Amortisation of intangible assets |
(15 | ) | (5 | ) | (1 | ) | ||||||||||
Operating expenses |
(1,063 | ) | (929 | ) | (868 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
(2 | ) | | 3 | ||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
| 14 | 76 | |||||||||||||
Profit before tax |
1,266 | 1,357 | 1,362 | |||||||||||||
Balance sheet information |
||||||||||||||||
Loans and advances to customers |
£ | 67.5bn | £ | 63.7bn | £ | 56.6bn | ||||||||||
Loans and advances to customers including those designated at fair value |
£ | 80.5bn | £ | 70.7bn | £ | 62.1bn | ||||||||||
Customer accounts |
£ | 60.6bn | £ | 60.8bn | £ | 57.4bn | ||||||||||
Total assets |
£ | 84.0bn | £ | 74.6bn | £ | 66.2bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost:income ratio |
39% | 36% | 36% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 400m | £ | 305m | £ | 300m | ||||||||||
Risk weighted assetsa |
£ | 63.1bn | £ | 57.0bn | £ | 50.3bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
36 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 | 37 |
Barclaycard
2008 | 2007 | 2006 | ||||||||||||||
£m | £m | £m | ||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
1,786 | 1,374 | 1,363 | |||||||||||||
Net fee and commission income |
1,299 | 1,143 | 1,183 | |||||||||||||
Net tracking income |
2 | | | |||||||||||||
Net investment income |
80 | 11 | 20 | |||||||||||||
Principal transactions |
82 | 11 | 20 | |||||||||||||
Net premiums from insurance contracts |
44 | 40 | 18 | |||||||||||||
Other income |
19 | (25 | ) | | ||||||||||||
Total income |
3,230 | 2,543 | 2,584 | |||||||||||||
Net claims and benefits incurred on insurance contracts |
(11 | ) | (13 | ) | (8 | ) | ||||||||||
Total income net of insurance claims |
3,219 | 2,530 | 2,576 | |||||||||||||
Impairment charges and other credit provisions |
(1,097 | ) | (827 | ) | (1,053 | ) | ||||||||||
Net income |
2,122 | 1,703 | 1,523 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(1,361 | ) | (1,057 | ) | (969 | ) | ||||||||||
Amortisation of intangible assets |
(61 | ) | (36 | ) | (24 | ) | ||||||||||
Operating expenses |
(1,422 | ) | (1,093 | ) | (993 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
(3 | ) | (7 | ) | (8 | ) | ||||||||||
Gain on acquisition |
92 | | | |||||||||||||
Profit before tax |
789 | 603 | 522 | |||||||||||||
Balance sheet information |
||||||||||||||||
Loans and advances to customers |
£ | 27.4bn | £ | 19.7bn | £ | 18.1bn | ||||||||||
Total assets |
£ | 30.9bn | £ | 22.1bn | £ | 20.0bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost: income ratio |
44% | 43% | 39% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 1,475m | £ | 955m | £ | 1,090m | ||||||||||
Risk weighted assets a |
£ | 27.3bn | £ | 20.2bn | £ | 16.9bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
38 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 |
39 |
GRCB Western Europe
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
856 | 527 | 436 | |||||||||||||
Net fee and commission income |
383 | 322 | 248 | |||||||||||||
Net trading income |
4 | 13 | 14 | |||||||||||||
Net investment income |
161 | 93 | 65 | |||||||||||||
Principal transactions |
165 | 106 | 79 | |||||||||||||
Net premiums from insurance contracts |
352 | 145 | 110 | |||||||||||||
Other income |
39 | 7 | 16 | |||||||||||||
Total income |
1,795 | 1,107 | 889 | |||||||||||||
Net claims and benefits incurred under insurance contracts |
(365 | ) | (170 | ) | (138 | ) | ||||||||||
Total income net of insurance claims |
1,430 | 937 | 751 | |||||||||||||
Impairment charges |
(296 | ) | (76 | ) | (38 | ) | ||||||||||
Net income |
1,134 | 861 | 713 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(915 | ) | (665 | ) | (542 | ) | ||||||||||
Amortisation of intangible assets |
(14 | ) | (8 | ) | (8 | ) | ||||||||||
Operating expenses |
(929 | ) | (673 | ) | (550 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
| | (1 | ) | ||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
| 8 | | |||||||||||||
Gain on acquisition |
52 | | | |||||||||||||
Profit before tax |
257 | 196 | 162 | |||||||||||||
Balance sheet information |
||||||||||||||||
Loans and advances to customers |
£ | 53.5bn | £ | 35.0bn | £ | 26.9bn | ||||||||||
Customer accounts |
£ | 15.3bn | £ | 9.4bn | £ | 6.8bn | ||||||||||
Total assets |
£ | 64.7bn | £ | 43.7bn | £ | 33.5bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost: income ratio |
65% | 72% | 73% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 270m | £ | 135m | £ | 90m | ||||||||||
Risk weighted assetsa |
£ | 36.5bn | £ | 25.0bn | £ | 17.6bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
40 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 | 41 |
GRCB Emerging Markets
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information | ||||||||||||||||
Net interest income | 616 | 319 | 246 | |||||||||||||
Net fee and commission income | 223 | 140 | 141 | |||||||||||||
Net trading income | 78 | 56 | 3 | |||||||||||||
Net investment income | 91 | 16 | 1 | |||||||||||||
Principal transactions | 169 | 72 | 4 | |||||||||||||
Net premiums from insurance contracts | | | 1 | |||||||||||||
Other income | 11 | 2 | 4 | |||||||||||||
Total income | 1,019 | 533 | 396 | |||||||||||||
Impairment charges | (166 | ) | (39 | ) | (30 | ) | ||||||||||
Net income | 853 | 494 | 366 | |||||||||||||
Operating expenses excluding amortisation of intangible assets | (711 | ) | (391 | ) | (269 | ) | ||||||||||
Amortisation of intangible assets | (8 | ) | (4 | ) | (1 | ) | ||||||||||
Operating expenses | (719 | ) | (395 | ) | (270 | ) | ||||||||||
Share of post-tax results of associates and joint ventures | | 1 | 41 | |||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures | | | 247 | |||||||||||||
Profit before tax | 134 | 100 | 384 | |||||||||||||
Balance sheet information | ||||||||||||||||
Loans and advances to customers | £ | 10.1bn | £ | 5.1bn | £ | 2.7bn | ||||||||||
Customer accounts | £ | 9.6bn | £ | 6.2bn | £ | 4.2bn | ||||||||||
Total assets | £ | 14.7bn | £ | 9.2bn | £ | 5.2bn | ||||||||||
Performance ratios | ||||||||||||||||
Cost: income ratio | 71% | 74% | 68% | |||||||||||||
Other financial measures | ||||||||||||||||
Risk Tendency | £ | 350m | £ | 140m | £ | 35m | ||||||||||
Risk weighted assets a | £ | 15.1bn | £ | 10.5bn | £ | 3.3bn |
Note |
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
42 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 | 43 |
GRCB Absa
|
||||||||||||||||
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
1,104 | 1,055 | 983 | |||||||||||||
Net fee and commission income |
762 | 684 | 754 | |||||||||||||
Net trading income/(expense) |
6 | | (11 | ) | ||||||||||||
Net investment income |
105 | 70 | 117 | |||||||||||||
Principal transactions |
111 | 70 | 106 | |||||||||||||
Net premiums from insurance contracts |
234 | 227 | 240 | |||||||||||||
Other income |
113 | 77 | 54 | |||||||||||||
Total income |
2,324 | 2,113 | 2,137 | |||||||||||||
Net claims and benefits incurred under insurance contracts |
(126 | ) | (114 | ) | (106 | ) | ||||||||||
Total income net of insurance claims |
2,198 | 1,999 | 2,031 | |||||||||||||
Impairment charges |
(347 | ) | (146 | ) | (112 | ) | ||||||||||
Net income |
1,851 | 1,853 | 1,919 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(1,255 | ) | (1,212 | ) | (1,250 | ) | ||||||||||
Amortisation of intangible assets |
(50 | ) | (55 | ) | (69 | ) | ||||||||||
Operating expenses |
(1,305 | ) | (1,267 | ) | (1,319 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
5 | 6 | 9 | |||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
1 | 5 | | |||||||||||||
Profit before tax |
552 | 597 | 609 | |||||||||||||
Balance sheet information |
||||||||||||||||
Loans and advances to customers |
£ | 32.7bn | £ | 29.9bn | £ | 23.5bn | ||||||||||
Customer accounts |
£ | 17.0bn | £ | 13.0bn | £ | 10.9bn | ||||||||||
Total assets |
£ | 40.4bn | £ | 36.4bn | £ | 29.6bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost:income ratio |
59% | 63% | 65% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 255m | £ | 190m | £ | 130m | ||||||||||
Risk weighted assetsa |
£ | 18.8bn | £ | 17.8bn | £ | 19.8bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
44 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 | 45 |
Barclays Capital
|
||||||||||||||||
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
1,724 | 1,179 | 1,158 | |||||||||||||
Net fee and commission income |
1,429 | 1,235 | 952 | |||||||||||||
Net trading income |
1,506 | 3,739 | 3,562 | |||||||||||||
Net investment income |
559 | 953 | 573 | |||||||||||||
Principal transactions |
2,065 | 4,692 | 4,135 | |||||||||||||
Other income |
13 | 13 | 22 | |||||||||||||
Total income |
5,231 | 7,119 | 6,267 | |||||||||||||
Impairment charges and other credit provisions |
(2,423 | ) | (846 | ) | (42 | ) | ||||||||||
Net income |
2,808 | 6,273 | 6,225 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(3,682 | ) | (3,919 | ) | (3,996 | ) | ||||||||||
Amortisation of intangible assets |
(92 | ) | (54 | ) | (13 | ) | ||||||||||
Operating expenses |
(3,774 | ) | (3,973 | ) | (4,009 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
6 | 35 | | |||||||||||||
Gain on acquisition |
2,262 | | | |||||||||||||
Profit before tax |
1,302 | 2,335 | 2,216 | |||||||||||||
Balance sheet information |
||||||||||||||||
Total assets |
£ | 1,629.1bn | £ | 839.9bn | £ | 657.9bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost:income ratio |
72% | 56% | 64% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 415m | £ | 140m | £ | 95m | ||||||||||
Risk weighted assetsa |
£ | 227.4bn | £ | 178.2bn | £ | 137.6bn | ||||||||||
Average DVaR (95%)b |
£ | 53.4m | £ | 32.5m | £ | 37.1m |
Notes
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
b | Average DVaR for 2007 and 2006 are calculated with a 98% confidence level. |
46 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 |
47 |
Barclays Global Investors
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information | ||||||||||||||||
Net interest (expense)/income | (38 | ) | (8 | ) | 10 | |||||||||||
Net fee and commission income | 1,917 | 1,936 | 1,651 | |||||||||||||
Net trading income | (14 | ) | 5 | 2 | ||||||||||||
Net investment (expense)/income | (29 | ) | (9 | ) | 2 | |||||||||||
Principal transactions | (43 | ) | (4 | ) | 4 | |||||||||||
Other income | 8 | 2 | | |||||||||||||
Total income | 1,844 | 1,926 | 1,665 | |||||||||||||
Operating expenses excluding amortisation of intangible assets | (1,234 | ) | (1,184 | ) | (946 | ) | ||||||||||
Amortisation of intangible assets | (15 | ) | (8 | ) | (5 | ) | ||||||||||
Operating expenses | (1,249 | ) | (1,192 | ) | (951 | ) | ||||||||||
Profit before tax | 595 | 734 | 714 | |||||||||||||
Balance sheet information | ||||||||||||||||
Total assets | £ | 71.3bn | £ | 89.2bn | £ | 80.5bn | ||||||||||
Performance ratios | ||||||||||||||||
Cost:income ratio | 68% | 62% | 57% | |||||||||||||
Other financial measures | ||||||||||||||||
Risk weighted assetsa | £ | 3.9bn | £ | 4.4bn | £ | 1.4bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
48 | Barclays Annual Report 2008 |
Financial review
Analysis of results by business
Barclays Annual Report 2008 | 49 |
Barclays Wealth
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
486 | 431 | 392 | |||||||||||||
Net fee and commission income |
720 | 739 | 674 | |||||||||||||
Net trading income |
(11 | ) | 3 | 2 | ||||||||||||
Net investment income |
(333 | ) | 52 | 154 | ||||||||||||
Principal transactions |
(344 | ) | 55 | 156 | ||||||||||||
Net premiums from insurance contracts |
136 | 195 | 210 | |||||||||||||
Other income |
26 | 19 | 16 | |||||||||||||
Total income |
1,024 | 1,439 | 1,448 | |||||||||||||
Net claims and benefits incurred on insurance contracts |
300 | (152 | ) | (288 | ) | |||||||||||
Total income net of insurance claims |
1,324 | 1,287 | 1,160 | |||||||||||||
Impairment charges |
(44 | ) | (7 | ) | (2 | ) | ||||||||||
Net income |
1,280 | 1,280 | 1,158 | |||||||||||||
Operating expenses excluding amortisation of intangible assets |
(919 | ) | (967 | ) | (909 | ) | ||||||||||
Amortisation of intangible assets |
(16 | ) | (6 | ) | (4 | ) | ||||||||||
Operating expenses |
(935 | ) | (973 | ) | (913 | ) | ||||||||||
Profit on disposal of associates and joint ventures |
326 | | | |||||||||||||
Profit before tax |
671 | 307 | 245 | |||||||||||||
Balance sheet information |
||||||||||||||||
Loans and advances to customers |
£ | 11.4bn | £ | 9.0bn | £ | 6.2bn | ||||||||||
Customer accounts |
£ | 42.4bn | £ | 34.4bn | £ | 28.3bn | ||||||||||
Total assets |
£ | 13.3bn | £ | 18.2bn | £ | 15.0bn | ||||||||||
Performance ratios |
||||||||||||||||
Cost:income ratio |
71% | 76% | 79% | |||||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 20m | £ | 10m | £ | 10m | ||||||||||
Risk weighted assets a |
£ | 10.3bn | £ | 8.2bn | £ | 6.1bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
50 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
51 |
Head office functions and other operations
2008 £m |
2007 £m |
2006 £m |
||||||||||||||
Income statement information |
||||||||||||||||
Net interest income |
182 | 128 | 80 | |||||||||||||
Net fee and commission income |
(486 | ) | (424 | ) | (301 | ) | ||||||||||
Net trading (loss)/income |
(245 | ) | (66 | ) | 40 | |||||||||||
Net investment income/(expense) |
27 | (17 | ) | 2 | ||||||||||||
Principal transactions |
(218 | ) | (83 | ) | 42 | |||||||||||
Net premiums from insurance contracts |
119 | 152 | 139 | |||||||||||||
Other income |
26 | 35 | 39 | |||||||||||||
Total income |
(377 | ) | (192 | ) | (1 | ) | ||||||||||
Impairment (charges)/releases |
(30 | ) | (3 | ) | 11 | |||||||||||
Net income |
(407 | ) | (195 | ) | 10 | |||||||||||
Operating expenses excluding amortisation of intangible assets |
(451 | ) | (233 | ) | (259 | ) | ||||||||||
Amortisation of intangible assets |
| (1 | ) | (10 | ) | |||||||||||
Operating expenses |
(451 | ) | (234 | ) | (269 | ) | ||||||||||
Profit on disposal of associates and joint ventures |
| 1 | | |||||||||||||
Loss before tax |
(858 | ) | (428 | ) | (259 | ) | ||||||||||
Balance sheet information |
||||||||||||||||
Total assets |
£ | 3.1bn | £ | 5.7bn | £ | 7.1bn | ||||||||||
Other financial measures |
||||||||||||||||
Risk Tendency |
£ | 5m | £ | 10m | £ | 10m | ||||||||||
Risk weighted assets a |
£ | 0.4bn | £ | 1.1bn | £ | 1.9bn |
Note
a | Risk weighted assets for 2008 and 2007 are calculated under Basel II. 2006 is calculated under Basel I. |
52 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
53 |
54 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
55 |
56 | Barclays Annual Report 2008 |
Risk management
Barclays Annual Report 2008 |
57 |
58 | Barclays Annual Report 2008 |
Risk management
Risk factors
Barclays Annual Report 2008 |
59 |
60 | Barclays Annual Report 2008 |
Risk management
Risk factors
Barclays Annual Report 2008 |
61 |
Risk management
Barclays approach to risk management
62 | Barclays Annual Report 2008 |
Risk management
Barclays approach to risk management
Governance structure at Group level
Barclays Annual Report 2008 |
63 |
64 | Barclays Annual Report 2008 |
Risk management
Barclays approach to risk management
Barclays Annual Report 2008 |
65 |
66 | Barclays Annual Report 2008 |
Risk management
Barclays Annual Report 2008 |
67 |
Risk management
Credit risk management
68 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Measurement, reporting and internal ratings
Barclays Annual Report 2008 |
69 |
70 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Measurement, reporting and internal ratings
Barclays Annual Report 2008 |
71 |
72 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Annual Report 2008 |
73 |
74 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Analysis of total assets and credit risk exposures
Analysis of total assets |
Sub analysis | |||||||||||||||||
Assets | Loans and advancesa £m |
Debt £m |
Derivatives c £m |
Reverse repurchase agreements d £m |
Other £m |
Assets £m |
Assets not £m |
Total assets £m |
Credit market exposures e £m | |||||||||
Cash and balances at central banks |
30,019 | 30,019 | 30,019 | |||||||||||||||
Items in the course of collection from other banks |
1,695 | 1,695 | 1,695 | |||||||||||||||
Treasury and other eligible bills |
4,544 | 4,544 | 4,544 | |||||||||||||||
Debt securities |
148,686 | 148,686 | 148,686 | 4,745 | ||||||||||||||
Equity securities f |
30,535 | 30,535 | ||||||||||||||||
Traded loans |
1,070 | 1,070 | 1,070 | |||||||||||||||
Commodities g |
802 | 802 | ||||||||||||||||
Total Trading portfolio assets |
1,070 | 153,230 | 154,300 | 31,337 | 185,637 | |||||||||||||
Financial assets designated at fair value |
||||||||||||||||||
Loans and advances |
30,057 | 130 | 30,187 | 30,187 | 14,429 | |||||||||||||
Debt securities |
8,628 | 8,628 | 8,628 | |||||||||||||||
Equity securities f |
6,496 | 6,496 | ||||||||||||||||
Other financial assets h |
1,469 | 7,283 | 479 | 9,231 | 9,231 | |||||||||||||
Held on own account |
31,526 | 8,628 | | 7,283 | 609 | 48,046 | 6,496 | 54,542 | ||||||||||
Held in respect of linked liabilities under investment contracts i |
66,657 | 66,657 | ||||||||||||||||
Derivative financial instruments |
984,802 | 984,802 | 984,802 | 9,234 | ||||||||||||||
Loans and advances to banks |
47,707 | 47,707 | 47,707 | |||||||||||||||
Loans and advances to customers |
461,815 | 461,815 | 461,815 | 12,808 | ||||||||||||||
Debt securities |
58,831 | 58,831 | 58,831 | 727 | ||||||||||||||
Equity securities f |
2,142 | 2,142 | ||||||||||||||||
Treasury and other eligible bills |
4,003 | 4,003 | 4,003 | |||||||||||||||
Available for sale financial instruments |
62,834 | 62,834 | 2,142 | 64,976 | ||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed |
130,354 | 130,354 | 130,354 | |||||||||||||||
Other assets |
3,096 | 3,096 | 3,206 | 6,302 | 109 | |||||||||||||
Current tax assets |
389 | 389 | ||||||||||||||||
Investments in associates and joint ventures |
341 | 341 | ||||||||||||||||
Goodwill |
7,625 | 7,625 | ||||||||||||||||
Intangible assets |
2,777 | 2,777 | ||||||||||||||||
Property, plant and equipment |
4,674 | 4,674 | ||||||||||||||||
Deferred tax assets |
2,668 | 2,668 | ||||||||||||||||
Total on-balance sheet |
542,118 | 224,692 | 984,802 | 137,637 | 35,419 | 1,924,668 | 128,312 | 2,052,980 | ||||||||||
Off-balance sheet: |
||||||||||||||||||
Acceptances and endorsements |
585 | |||||||||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements |
53,942 | |||||||||||||||||
Commitments |
260,816 | 1,030 | ||||||||||||||||
Total off-balance sheet |
315,343 | |||||||||||||||||
Total maximum exposure to credit risk |
2,240,011 |
Notes
a | Further analysis of loans and advances is on pages 76 to 89 |
b | Further analysis of debt securities and other bills is on page 90 |
c | Further analysis of derivatives is on pages 91 to 92. |
d | Reverse repurchase agreements comprise primarily short-term cash lending with assets pledged by counterparties securing the loan. |
e | Further analysis of Barclays Capital credit market exposures is on pages 93 to 105. |
f | Equity securities comprise primarily equity securities determined by available quoted prices in active markets. |
g | Commodities primarily consists of physical inventory positions. |
h | These instruments consist primarily of loans with embedded derivatives and reverse repurchase agreements designated at fair value. |
i | Financial assets designated at fair value in respect of linked liabilities to customers under investment contracts have not been further analysed as the Group is not exposed to the risks inherent in these assets. |
Barclays Annual Report 2008 |
75 |
Risk management
Credit risk management
Table 1: Loans and advances at amortised cost
|
||||||||||||||||
As at 31st December 2008 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk Loans £m |
CRLs % of gross loans and advances % |
Impairment £m |
Loan loss rates basis points |
|||||||||
Wholesale customers | 266,750 | 2,784 | 263,966 | 8,144 | 3.1 | 2,540 | 95 | |||||||||
Wholesale banks | 47,758 | 51 | 47,707 | 48 | 0.1 | 40 | 8 | |||||||||
Total wholesale |
314,508 | 2,835 | 311,673 | 8,192 | 2.6 | 2,580 | 82 | |||||||||
Retail customers | 201,588 | 3,739 | 197,849 | 7,508 | 3.7 | 2,333 | 116 | |||||||||
Total retail |
201,588 | 3,739 | 197,849 | 7,508 | 3.7 | 2,333 | 116 | |||||||||
Total |
516,096 | 6,574 | 509,522 | 15,700 | 3.0 | 4,913 | 95 | |||||||||
As at 31st December 2007 | ||||||||||||||||
Wholesale customers |
187,086 | 1,309 | 185,777 | 5,157 | 2.8 | 1,190 | 64 | |||||||||
Wholesale banks |
40,123 | 3 | 40,120 | | | (13 | ) | (3 | ) | |||||||
Total wholesale |
227,209 | 1,312 | 225,897 | 5,157 | 2.3 | 1,177 | 52 | |||||||||
Retail customers |
162,081 | 2,460 | 159,621 | 4,484 | 2.8 | 1,605 | 99 | |||||||||
Total retail |
162,081 | 2,460 | 159,621 | 4,484 | 2.8 | 1,605 | 99 | |||||||||
Total |
389,290 | 3,772 | 385,518 | 9,641 | 2.5 | 2,782 | 71 |
76 | Barclays Annual Report 2008 |
Risk Management
Credit Risk Management
Loans and advances
Table 2: Wholesale loans and advances to customers and banks
|
||||||||||||||
As at 31st December 2008 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk £m |
CRLs % of gross loans and advances % |
Impairment £m |
Loan loss rates basis points | |||||||
Barclays Commercial Bank |
68,904 | 504 | 68,400 | 1,181 | 1.70 | 414 | 60 | |||||||
Barclaycard |
301 | 2 | 299 | 20 | 6.60 | 11 | 365 | |||||||
GRCB Western Europe |
15,432 | 232 | 15,200 | 578 | 3.70 | 125 | 81 | |||||||
GRCB Emerging Markets |
7,551 | 122 | 7,429 | 191 | 2.50 | 36 | 48 | |||||||
GRCB Absa |
8,648 | 140 | 8,508 | 304 | 3.50 | 19 | 22 | |||||||
Barclays Capital |
208,596 | 1,796 | 206,800 | 5,743 | 2.80 | 1,936 | 93 | |||||||
Barclays Global Investors |
834 | | 834 | | | | | |||||||
Barclays Wealth |
3,282 | 28 | 3,254 | 174 | 5.30 | 28 | 85 | |||||||
Head office |
960 | 11 | 949 | 1 | 0.10 | 11 | 115 | |||||||
Total |
314,508 | 2,835 | 311,673 | 8,192 | 2.60 | 2,580 | 82 | |||||||
As at 31st December 2007 | ||||||||||||||
Barclays Commercial Bank |
65,535 | 483 | 65,052 | 956 | 1.50 | 292 | 45 | |||||||
Barclaycard |
295 | 3 | 292 | 17 | 5.80 | 9 | 305 | |||||||
GRCB Western Europe |
10,927 | 63 | 10,864 | 93 | 0.90 | 19 | 17 | |||||||
GRCB Emerging Markets |
4,833 | 79 | 4,754 | 119 | 2.50 | 10 | 21 | |||||||
GRCB Absa |
5,321 | 112 | 5,209 | 97 | 1.80 | 11 | 21 | |||||||
Barclays Capital |
136,082 | 514 | 135,568 | 3,791 | 2.80 | 833 | 61 | |||||||
Barclays Global Investors |
211 | | 211 | | | | | |||||||
Barclays Wealth |
2,745 | 7 | 2,738 | 47 | 1.70 | | | |||||||
Head office |
1,260 | 51 | 1,209 | 37 | 2.90 | 3 | 24 | |||||||
Total |
227,209 | 1,312 | 225,897 | 5,157 | 2.30 | 1,177 | 52 |
Barclays Annual Report 2008 | 77 |
Table 3: Analysis of wholesale loans and advances net of impairment allowances
|
||||||||||||||||||||
Corporate | Government | Settlement balance and cash collateral |
Other wholesale | Total wholesale | ||||||||||||||||
Wholesale | 2008 £m |
2007 £m |
2008 £m |
2007 £m |
2008 £m |
2007 £m |
2008 £m |
2007 £m |
2008 £m |
20 07 £m | ||||||||||
BCB |
67,741 | 64,773 | 659 | 279 | | | | | 68,400 | 65,052 | ||||||||||
Barclaycard |
299 | 292 | | | | | | | 299 | 292 | ||||||||||
GRCB Western Europe |
15,017 | 10,721 | 32 | 4 | | | 151 | 139 | 15,200 | 10,864 | ||||||||||
GRCB Emerging Markets |
5,283 | 3,276 | 1,709 | 1,193 | | | 437 | 285 | 7,429 | 4,754 | ||||||||||
GRCB Absa |
8,480 | 5,204 | 28 | 5 | | | | | 8,508 | 5,209 | ||||||||||
Barclays Capital |
72,796 | 51,038 | 3,760 | 1,220 | 79,418 | 46,639 | 50,826 | 36,671 | 206,800 | 135,568 | ||||||||||
BGI |
834 | 211 | | | | | | | 834 | 211 | ||||||||||
Barclays Wealth |
3,254 | 2,738 | | | | | | | 3,254 | 2,738 | ||||||||||
Head office |
949 | 1,209 | | | | | | | 949 | 1,209 | ||||||||||
Total |
174,653 | 139,462 | 6,188 | 2,701 | 79,418 | 46,639 | 51,414 | 37,095 | 311,673 | 225,897 |
Table 4: Analysis of Barclays Capitals loans and advances at amortised cost
|
||||||||||||||
As at 31st December 2008 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk £m |
CRLs % of gross loans and advances % |
Impairment £m |
Loan loss rates basis points | |||||||
Loans and advances bank |
||||||||||||||
Cash collateral and settlement balances |
19,264 | | 19,264 | | | | | |||||||
Interbank lending |
24,086 | 51 | 24,035 | 48 | 0.2 | 40 | 17 | |||||||
Loans and advances to customers |
||||||||||||||
Corporate lending |
77,042 | 486 | 76,556 | 1,100 | 1.4 | 305 | 40 | |||||||
ABS CDO Super Senior |
4,117 | 1,013 | 3,104 | 4,117 | 100.0 | 1,383 | 3,359 | |||||||
Other wholesale lending |
23,933 | 246 | 23,687 | 478 | 2.0 | 208 | 87 | |||||||
Cash collateral and settlement balances |
60,154 | | 60,154 | | | | | |||||||
Total |
208,596 | 1,796 | 206,800 | 5,743 | 2.8 | 1,936 | 93 |
78 | Barclays Annual Report 2008 |
Risk Management
Credit Risk Management
Loans and advances
Table 5: Analysis of Barclays Commercial Bank loans and advances
Loans and advances to banks at amortised cost
| ||
Total £m | ||
Financial institutions and services |
867 | |
Total |
867 | |
Loans and advances to customers at amortised cost
|
||
Total £m | ||
Business and other services |
16,611 | |
Construction |
3,974 | |
Energy and water |
1,112 | |
Financial institutions and services |
6,427 | |
Finance Lease receivables |
6,644 | |
Manufacturing |
8,378 | |
Postal and communications |
1,303 | |
Property |
8,985 | |
Transport |
2,014 | |
Wholesale and retail distribution and leisure |
11,426 | |
Government |
659 | |
Total |
67,533 | |
Loans and advances held at fair value
|
||
Total £m | ||
Business and other services |
535 | |
Construction |
39 | |
Financial institutions and services |
32 | |
Property |
7,366 | |
Government |
4,994 | |
Total |
12,966 |
Barclays Annual Report 2008 |
79 |
Table 6: Barclays Commercial Bank financial sponsor leveraged finance
Leveraged finance exposure by region
|
||
As at 31st December 2008 |
£m | |
UK |
2,111 | |
Europe |
323 | |
Other |
11 | |
Total lending and commitments |
2,445 | |
Underwriting |
28 | |
Total exposure |
2,473 | |
The industry classification of the exposure was as follows: |
||
Leveraged finance exposure by industry |
As at 31st December 2008 | Drawn £m |
Undrawn £m |
Total £m | |||
Business and other services |
1,083 | 288 | 1,371 | |||
Construction |
12 | 5 | 17 | |||
Energy and water |
43 | 17 | 60 | |||
Financial institutions and services |
58 | 10 | 68 | |||
Manufacturing |
307 | 130 | 437 | |||
Postal and communications |
35 | 2 | 37 | |||
Property |
26 | 5 | 31 | |||
Transport |
14 | 43 | 57 | |||
Wholesale and retail distribution and leisure |
297 | 70 | 367 | |||
Total exposure |
1,875 | 570 | 2,445 |
80 | Barclays Annual Report 2008 |
Risk Management
Credit Risk Management
Loans and advances
Table 7: Retail loans and advances net of impairment allowances
As at 31st December 2008 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk £m |
CRLs % of gross loans and advances % |
Impairment £m |
Loan loss rates basis points | |||||||
UK Retail Banking |
96,083 | 1,134 | 94,949 | 2,403 | 2.50 | 602 | 63 | |||||||
Barclaycard |
29,390 | 1,677 | 27,713 | 2,566 | 8.70 | 1,086 | 370 | |||||||
GRCB Western Europe |
38,918 | 302 | 38,616 | 794 | 2.00 | 171 | 44 | |||||||
GRCB Emerging Markets |
4,083 | 191 | 3,892 | 179 | 4.40 | 130 | 318 | |||||||
GRCB Absa |
24,677 | 411 | 24,266 | 1,518 | 6.20 | 328 | 133 | |||||||
Barclays Wealth |
8,437 | 24 | 8,413 | 48 | 0.60 | 16 | 19 | |||||||
Total |
201,588 | 3,739 | 197,849 | 7,508 | 3.70 | 2,333 | 116 | |||||||
As at 31st December 2007 |
||||||||||||||
UK Retail Banking |
83,764 | 1,005 | 82,759 | 2,063 | 2.50 | 559 | 67 | |||||||
Barclaycard |
20,524 | 1,093 | 19,431 | 1,601 | 7.80 | 818 | 399 | |||||||
GRCB Western Europe |
24,482 | 81 | 24,401 | 250 | 1.00 | 57 | 23 | |||||||
GRCB Emerging Markets |
1,881 | 44 | 1,837 | 67 | 3.60 | 29 | 154 | |||||||
GRCB Absa |
24,994 | 235 | 24,759 | 499 | 2.00 | 135 | 54 | |||||||
Barclays Wealth |
6,436 | 2 | 6,434 | 4 | 0.10 | 7 | 11 | |||||||
Total |
162,081 | 2,460 | 159,621 | 4,484 | 2.80 | 1,605 | 99 |
Table 8: Analysis of retail loans and advances net of impairment allowances
Home loans | Cards and unsecured loans | Other retail | Total retail | |||||||||||||
2008 £m |
2007 £m |
2008 £m |
2007 £m |
2008 £m |
2007 £m |
2008 £m |
2007 £m | |||||||||
UK Retail Banking |
82,303 | 69,805 | 8,294 | 8,297 | 4,352 | 4,657 | 94,949 | 82,759 | ||||||||
Barclaycard |
| | 23,224 | 14,930 | 4,489 | 4,501 | 27,713 | 19,431 | ||||||||
GRCB Western Europe |
33,760 | 21,393 | 4,395 | 2,660 | 461 | 348 | 38,616 | 24,401 | ||||||||
GRCB Emerging Markets |
603 | 285 | 2,900 | 1,369 | 389 | 183 | 3,892 | 1,837 | ||||||||
GRCB Absa |
18,411 | 15,136 | 43 | | 5,812 | 9,623 | 24,266 | 24,759 | ||||||||
Barclays Wealth |
| | | | 8,413 | 6,434 | 8,413 | 6,434 | ||||||||
Total |
135,077 | 106,619 | 38,856 | 27,256 | 23,916 | 25,746 | 197,849 | 159,621 |
Barclays Annual Report 2008 |
81 |
Table 9: Home loans distribution of balances by loan to value (mark to market)a
UK | Spain | South Africa | ||||||||||
2008 % |
2007 % |
2008 % |
2007 % |
2008 % |
2007 % | |||||||
<= 75% |
78.2 | 90.1 | 86.7 | 92.2 | 60.5 | 68.6 | ||||||
> 75% and <= 80% |
6.1 | 4.7 | 4.8 | 4.2 | 7.5 | 7.2 | ||||||
> 80% and <= 85% |
5.5 | 2.5 | 3.7 | 1.6 | 7.2 | 7.1 | ||||||
> 85% and <= 90% |
4.5 | 1.5 | 1.6 | 0.7 | 7.6 | 5.9 | ||||||
> 90% and <= 95% |
2.5 | 0.9 | 1.3 | 0.6 | 6.7 | 6.1 | ||||||
> 95% |
3.1 | 0.3 | 1.9 | 0.7 | 10.5 | 5.1 | ||||||
Portfolio loan-to-value (mark to market) |
40 | 34 | 48 | 45 | 41 | 38 | ||||||
Average loan-to-value on new mortgages during the year |
47 | 49 | 63 | 63 | 58 | 59 |
82 | Barclays Annual Report 2008 |
Risk Management
Credit Risk Management
Loans and advances
CRLs and PPLs balances by UK and non-UK
Barclays Annual Report 2008 |
83 |
CRLs and PPLs as a percentage of Loans and Advances
Notes
84 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Loans and advances
Table 12: Potential credit risk loans and coverage ratios |
||||||||||||
CRLs | PPLs | PCRLs | ||||||||||
31.12.08 | 31.12.07 | 31.12.08 | 31.12.07 | 31.12.08 | 31.12.07 | |||||||
Retail Secured |
2,783 | 1,474 | 280 | 317 | 3,063 | 1,791 | ||||||
Retail Unsecured and other |
4,725 | 3,010 | 217 | 183 | 4,942 | 3,193 | ||||||
Retail |
7,508 | 4,484 | 497 | 500 | 8,005 | 4,984 | ||||||
Corporate/Wholesale (excl ABS) |
4,075 | 1,813 | 1,959 | 496 | 6,034 | 2,309 | ||||||
Group (excl ABS) |
11,583 | 6,297 | 2,456 | 996 | 14,039 | 7,293 | ||||||
ABS CDO Super Senior |
4,117 | 3,344 | | 801 | 4,117 | 4,145 | ||||||
Group |
15,700 | 9,641 | 2,456 | 1,797 | 18,156 | 11,438 | ||||||
Impairment allowance | CRL coverage | PCRL cove rage | ||||||||||
31.12.08 | 31.12.07 | 31.12.08 | 31.12.07 | 31.12.08 | 31.12.07 | |||||||
Retail Secured |
561 | 320 | 20.2% | 21.7% | 18.3% | 17.9% | ||||||
Retail Unsecured and other |
3,178 | 2,140 | 67.3% | 71.1% | 64.3% | 67.0% | ||||||
Retail |
3,739 | 2,460 | 49.8% | 54.9% | 46.7% | 49.4% | ||||||
Corporate/Wholesale (excl ABS) |
1,822 | 1,022 | 44.7% | 56.4% | 30.2% | 44.3% | ||||||
Group (excl ABS) |
5,561 | 3,482 | 48.0% | 55.3% | 39.6% | 47.7% | ||||||
ABS CDO Super Senior |
1,013 | 290 | 24.6% | 8.7% | 24.6% | 7.0% | ||||||
Group |
6,574 | 3,772 | 41.9% | 39.1% | 36.2% | 33.0% |
Barclays Annual Report 2008 |
85 |
86 | Barclays Annual Report 2008 |
Risk Management
Credit Risk Management
Loans and advances
Barclays Annual Report 2008 | 87 |
88 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Loans and advances
Barclays Annual Report 2008 |
89 |
Risk management
Credit risk management
Debt securities and other bills
The following table presents an analysis of the credit quality of debt and similar securities, other than loans held within the Group. Securities rated as investment grade amounted to 91.6% of the portfolio (2007: 88.0%).
As at 31.12.08 | Treasury and other eligible bills £m |
Debt securities £m |
Total £m |
% | ||||
AAA to BBB (investment grade) | 7,314 | 198,493 | 205,807 | 91.6 | ||||
BB+ to B | 1,233 | 15,309 | 16,542 | 7.4 | ||||
B or lower | | 2,343 | 2,343 | 1.0 | ||||
Total | 8,547 | 216,145 | 224,692 | 100.0 | ||||
Of which issued by: | ||||||||
governments and other public bodies | 8,547 | 73,881 | 82,428 | 36.7 | ||||
US agency | | 34,180 | 34,180 | 15.3 | ||||
mortgage and asset-backed securities | | 34,844 | 34,844 | 15.5 | ||||
corporate and other issuers | | 55,244 | 55,244 | 24.6 | ||||
bank and building society certificates of deposit | | 17,996 | 17,996 | 7.9 | ||||
Total | 8,547 | 216,145 | 224,692 | 100.0 | ||||
Of which classified as: | ||||||||
trading portfolio assets | 4,544 | 148,686 | 153,230 | 68.2 | ||||
financial instruments designated at fair value | | 8,628 | 8,628 | 3.8 | ||||
available-for-sale securities | 4,003 | 58,831 | 62,834 | 28.0 | ||||
Total | 8,547 | 216,145 | 224,692 | 100.0 | ||||
As at 31.12.07 | Treasury and other eligible bills £m |
Debt securities £m |
Total £m |
% | ||||
AAA to BBB (investment grade) | 4,114 | 189,794 | 193,908 | 88.0 | ||||
BB+ to B | 703 | 24,693 | 25,396 | 11.5 | ||||
B or lower | | 1,181 | 1,181 | 0.5 | ||||
Total | 4,817 | 215,668 | 220,485 | 100.0 | ||||
Of which issued by: | ||||||||
governments and other public bodies | 4,817 | 63,798 | 68,615 | 31.1 | ||||
US agency | | 13,956 | 13,956 | 6.3 | ||||
mortgage and asset-backed securities | | 28,928 | 28,928 | 13.1 | ||||
corporate and other issuers | | 88,207 | 88,207 | 40.0 | ||||
bank and building society certificates of deposit | | 20,779 | 20,779 | 9.5 | ||||
Total | 4,817 | 215,668 | 220,485 | 100.0 | ||||
Of which classified as: | ||||||||
trading portfolio assets | 2,094 | 152,778 | 154,872 | 70.2 | ||||
financial instruments designated at fair value | | 24,217 | 24,217 | 11.0 | ||||
available-for-sale securities | 2,723 | 38,673 | 41,396 | 18.8 | ||||
Total | 4,817 | 215,668 | 220,485 | 100.0 |
90 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Annual Report 2008 |
91 |
The tables below set out the fair values of the derivative assets together with the value of those assets subject to enforceable counterparty netting arrangements for which the Group holds offsetting liabilities and eligible collateral.
Derivative assets As at 31.12.08 | Gross assets £m |
Counterparty £m |
Net exposure £m | |||
Foreign exchange | 107,730 | 91,572 | 16,158 | |||
Interest rate | 615,321 | 558,985 | 56,336 | |||
Credit derivatives | 184,072 | 155,599 | 28,473 | |||
Equity and stock index | 28,684 | 20,110 | 8,574 | |||
Commodity derivatives | 48,995 | 35,903 | 13,092 | |||
984,802 | 862,169 | 122,633 | ||||
Total collateral held | 54,905 | |||||
Net exposure less collateral | 67,728 | |||||
Derivative assets As at 31.12.07 | Gross assets £m |
Counterparty £m |
Net exposure | |||
Foreign exchange | 30,824 | 22,066 | 8,758 | |||
Interest rate | 140,504 | 117,292 | 23,212 | |||
Credit derivatives | 38,696 | 31,307 | 7,389 | |||
Equity and stock index | 13,296 | 12,151 | 1,145 | |||
Commodity derivatives | 24,768 | 15,969 | 8,799 | |||
248,088 | 198,785 | 49,303 | ||||
Total collateral held | 16,700 | |||||
Net exposure less collateral | 32,603 |
Gross derivative assets of £985bn (2007: £248bn) cannot be netted down under IFRS. Derivative assets would be £917bn (2007: £215bn) lower than reported under IFRS if counterparty or collateral netting were allowed.
Exposure relating to derivatives, repurchase agreements, reverse repurchase agreements, stock borrowing and loan transactions is calculated using internal, FSA approved models. These are used as the basis to assess both regulatory capital and capital appetite and are managed on a daily basis. The methodology encompasses all relevant factors to enable the current value to be calculated and the future value to be estimated, for example: current market rates, market volatility and legal documentation (including collateral rights).
92 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Capital credit market exposures
Barclays Capitals credit market exposures primarily relate to US residential mortgages, commercial mortgages and leveraged finance businesses that have been significantly impacted by the continued deterioration in the global credit markets. The exposures include both significant positions subject to fair value movements in the profit and loss account and positions that are classified as loans and advances and available for sale. None of the exposure disclosed below has been reclassified to loans and advances under the amendments to IAS 39.
The exposures are set out by asset class in US Dollars and Sterling below:
$ma | £ma | |||||||||
US Residential Mortgages | Notes | As at 31.12.08 |
As at 31.12.07 |
As at 31.12 .08 |
As at 31.12.07 | |||||
ABS CDO Super Senior | A1 | 4,526 | 9,356 | 3,104 | 4,671 | |||||
Other US sub- prime | A2 | 5,017 | 10,089 | 3,441 | 5,037 | |||||
Alt-A | A3 | 6,252 | 9,847 | 4,288 | 4,916 | |||||
US RMBS exposure wrapped by monoline insurers | A4 | 2,389 | 1,462 | 1,639 | 730 | |||||
Commercial mortgages | ||||||||||
Commercial real estate | B1 | 16,882 | 22,239 | 11,578 | 11,103 | |||||
Commercial mortgage-backed securities | B1 | 1,072 | 2,596 | 735 | 1,296 | |||||
CMBS exposure wrapped by monoline insurers | B2 | 2,703 | 395 | 1,854 | 197 | |||||
Other Credit Market Exposures | ||||||||||
Leveraged financeb | C1 | 15,152 | 18,081 | 10,391 | 9,027 | |||||
SIVs and SIV-Lites | C2 | 1,404 | 1,570 | 963 | 784 | |||||
CDPCs | C3 | 218 | 39 | 150 | 19 | |||||
CLO and other exposure wrapped by monoline insurers | C4 | 7,202 | 817 | 4,939 | 408 |
These exposures have been actively managed during the year in an exceptionally challenging market environment and have been reduced by net sales and paydowns of £6,311m, offset by the 37% appreciation of the US Dollar against Sterling. In January 2009, there was an additional sale of £3,056m of leveraged finance exposure which was repaid at par. Exposures at 31st December 2008 included £1,060m of securities from the acquisition of Lehman Brothers North American businesses. Exposures wrapped by monolines have increased during the course of 2008 as a result of declines in the fair value of the underlying assets.
Analysis of Barclays Capital credit market exposures by asset class
ABS CDO Super Senior £m |
Other US sub -prime £m |
Alt-A £m |
RMBS £m |
Commercial £m |
Commercial mortgage backed securities £m |
CMBS wrapped by monoline insurers £m |
Leveraged finance £m |
SIVs and SIV-Lites £m |
CDPCs £m |
CLO and other exposure wrapped by monoline insurers £m |
As at 31.12.08 £m | ||||||||||||||
Debt securities | 782 | 2,532 | 1,420 | 11 | 4,745 | ||||||||||||||||||||
Trading portfolio assets | 782 | 2,532 | 1,420 | 11 | 4,745 | ||||||||||||||||||||
Loans and advances | 1,565 | 778 | 11,555 | 531 | 14,429 | ||||||||||||||||||||
Financial assets designated at fair value | 1,565 | 778 | 11,555 | 531 | 14,429 | ||||||||||||||||||||
Derivative financial instruments | 643 | 398 | 1,639 | 23 | (685 | ) | 1,854 | 273 | 150 | 4,939 | 9,234 | ||||||||||||||
Loans and advances to customers | 3,104 | 195 | 9,361 | 148 | 12,808 | ||||||||||||||||||||
Debt securities | 147 | 580 | 727 | ||||||||||||||||||||||
Available for sale financial instruments | 147 | 580 | 727 | ||||||||||||||||||||||
Other assets | 109 | 109 | |||||||||||||||||||||||
Exposure on balance sheet | 3,104 | 3,441 | 4,288 | 1,639 | 11,578 | 735 | 1,854 | 9,361 | 963 | 150 | 4,939 |
Barclays Annual Report 2008 |
93 |
There were gross losses of £8,053m (2007: £2,999m) in the year to 31st December 2008. These losses were partially offset by related income and hedges of £1,433m (2007: £706m), and gains of £1,663m (2007: £658m) from the general widening of credit spreads on issued notes measured at fair value through the profit and loss account.
The gross losses, which included £1,763m (2007: £782m) in impairment charges, comprised: £5,584m (2007: £2,811m) against US RMBS exposures; £1,488m (2007: £14m) against commercial mortgage exposures; and £981m (2007: £174m) against other credit market exposures.
Fair Value |
Impairment £m |
Gross |
|||||||
ABS CDO super senior |
(78 | ) | (1,383 | ) | (1,461 | ) | |||
Other US sub-prime |
(1,560 | ) | (168 | ) | (1,728 | ) | |||
Alt-A |
(1,858 | ) | (125 | ) | (1,983 | ) | |||
US RMBS wrapped by monoline insurers |
(412 | ) | | (412 | ) | ||||
Total US residential mortgages |
(3,908 | ) | (1,676 | ) | (5,584 | ) | |||
US |
(671 | ) | | (671 | ) | ||||
Europe |
(350 | ) | | (350 | ) | ||||
Total commercial real estate |
(1,021 | ) | | (1,021 | ) | ||||
Commercial mortgage-backed securities |
(127 | ) | | (127 | ) | ||||
CMBS wrapped by monoline insurers |
(340 | ) | | (340 | ) | ||||
Total commercial mortgages |
(1,488 | ) | | (1,488 | ) | ||||
SIVs and SIV-Lites |
(143 | ) | (87 | ) | (230 | ) | |||
CDPCs |
(14 | ) | | (14 | ) | ||||
CLO and other assets wrapped by monoline insurers |
(737 | ) | | (737 | ) | ||||
Total other credit market |
(894 | ) | (87 | ) | (981 | ) | |||
Total |
(6,290 | ) | (1,763 | ) | (8,053 | ) |
94 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Capital credit market exposures
A. US Residential Mortgages
US residential mortgage exposures have reduced by 41% in US Dollar terms, and 19% in Sterling terms, since 31st December 2007.
A1. ABS CDO Super Senior
During the year ABS CDO Super Senior exposures reduced by £1,567m to £3,104m (31st December 2007: £4,671m). Net exposures are stated after write-downs and charges of £1,461m incurred in 2008 (2007: £1,816m) and hedges of £nil (31st December 2007: £1,347m). There were no hedges in place at 31st December 2008 as the corresponding liquidity facilities had been terminated. There were liquidations and paydowns of £2,318m in the year; weaker Sterling and a reduction in hedges increased exposure by £865m and £1,347m respectively.
The remaining ABS CDO Super Senior exposure at 31st December 2008 comprised five high grade liquidity facilities which were fully drawn and classified within loans and receivables, and no remaining mezzanine exposure. At 31st December 2007 there were 15 facilities of which nine were high grade and six mezzanine.
The impairment assessment of remaining super senior positions is based on cash flow methodology using standard market assumptions such as default curves and remittance data to calculate the net present value of the future losses for the collateral pool over time. As a result, future potential impairment charges depend on changes in these assumptions.
We have included all ABS CDO Super Senior exposure in the US residential mortgages section as nearly 90% of the underlying collateral relates to US RMBS. The impairment applied to the notional collateral is set out in the table below.
As at 31.12.08 |
As at 31.12.07 |
As at |
As at | ||||||||||||||||
High Grade £m |
Total £m |
High Grade £m |
Mezzanine £m |
Total £m |
Marks a | Marks a | |||||||||||||
2005 and earlier |
1,226 | 1,226 | 1,458 | 1,152 | 2,610 | 90% | 69% | ||||||||||||
2006 |
471 | 471 | 1,654 | 314 | 1,968 | 37% | 47% | ||||||||||||
2007 and 2008 |
25 | 25 | 176 | 87 | 263 | 69% | 53% | ||||||||||||
Sub-prime |
1,722 | 1,722 | 3,288 | 1,553 | 4,841 | 75% | 60% | ||||||||||||
2005 and earlier |
891 | 891 | 714 | 102 | 816 | 77% | 96% | ||||||||||||
2006 |
269 | 269 | 594 | 68 | 662 | 75% | 90% | ||||||||||||
2007 and 2008 |
62 | 62 | 163 | 13 | 176 | 37% | 80% | ||||||||||||
Alt-A |
1,222 | 1,222 | 1,471 | 183 | 1,654 | 74% | 92% | ||||||||||||
Prime |
520 | 520 | 662 | 123 | 785 | 100% | 100% | ||||||||||||
RMBS CDO |
402 | 402 | 842 | 445 | 1,287 | | 19% | ||||||||||||
Sub-prime second lien |
127 | 127 | 158 | | 158 | | 32% | ||||||||||||
Total RMBS |
3,993 | 3,993 | 6,421 | 2,304 | 8,725 | 68% | 63% | ||||||||||||
CMBS |
44 | 44 | 189 | 110 | 299 | 100% | 96% | ||||||||||||
Non-RMBS CDO |
453 | 453 | 429 | 80 | 509 | 56% | 49% | ||||||||||||
CLOs |
35 | 35 | 26 | | 26 | 100% | 100% | ||||||||||||
Other ABS |
51 | 51 | 136 | 4 | 140 | 100% | 100% | ||||||||||||
Total other ABS |
583 | 583 | 780 | 194 | 974 | 66% | 72% | ||||||||||||
Total notional collateral |
4,576 | 4,576 | 7,201 | 2,498 | 9,699 | 68% | 64% | ||||||||||||
Subordination |
(459 | ) | (459 | ) | (1,001 | ) | (864 | ) | (1,865 | ) | |||||||||
Gross exposure pre impairment |
4,117 | 4,117 | 6,200 | 1,634 | 7,834 | ||||||||||||||
Impairment allowances |
(1,013 | ) | (1,013 | ) | (290 | ) | (432 | ) | (722 | ) | |||||||||
Trading losses gross of Hedges |
| | (1,041 | ) | (53 | ) | (1,094 | ) | |||||||||||
Hedges |
| | (960 | ) | (387 | ) | (1,347 | ) | |||||||||||
Net exposure |
3,104 | 3,104 | 3,909 | 762 | 4,671 | ||||||||||||||
Collateral marks including liquidated structures |
32% | 62% |
Note
a | Marks above reflect the gross exposure after the impairment and subordination and do not include the benefit of hedges. The change in marks since 31st December 2007 primarily results from the liquidation during 2008 of the most impaired structures. |
Barclays Annual Report 2008 |
95 |
Consolidated collateral of £8.4bn relating to the ten CDOs that were liquidated in 2008 has been sold or are stated at fair value net of hedges within Other US sub-prime, Alt-A and CMBS exposures. The notional collateral remaining at 31st December 2008 is marked at approximately 12%. The collateral valuation for all ABS CDO Super Senior deals, including those liquidated and consolidated in 2008, is approximately 32% (31st December 2007: 62%).
The collateral for the outstanding ABS CDO Super Senior exposures primarily comprises residential mortgage backed securities (RMBS). At 31st December 2008 the residual exposure contains a higher proportion of collateral originated in 2005 and earlier than at 31st December 2007. There is minimal exposure to collateral originated in 2007 or later. The vintages of the sub-prime, Alt-A and US RMBS collateral are set out in the table below.
As at |
As at | |||
Sub-prime Collateral by Vintage |
||||
2005 and earlier |
71% | 54% | ||
2006 |
27% | 41% | ||
2007 and 2008 |
2% | 5% | ||
Alt-A Collateral by Vintage |
||||
2005 and earlier |
73% | 49% | ||
2006 |
22% | 40% | ||
2007 and 2008 |
5% | 11% | ||
US RMBS Collateral by Vintage |
||||
2005 and earlier |
72% | 53% | ||
2006 |
25% | 40% | ||
2007 and 2008 |
3% | 7% |
RMBS collateral for the ABS CDO Super Senior exposures is subject to public ratings. The ratings of sub-prime, Alt-A and total US RMBS CDO collateral are set out in the table below.
31.12.08 |
31.12.07 |
31.12.07 |
31.12.07 | |||||
Sub-prime US RMBS Ratings |
||||||||
AAA/AA |
42% | 43% | 2% | 30% | ||||
A/BBB |
21% | 51% | 82% | 60% | ||||
Non-investment Grade |
37% | 6% | 16% | 10% | ||||
Alt-A RMBS Ratings |
||||||||
AAA/AA |
66% | 89% | 47% | 85% | ||||
A/BBB |
7% | 8% | 45% | 12% | ||||
Non-investment Grade |
27% | 3% | 8% | 3% | ||||
Total US RMBS Ratings |
||||||||
AAA/AA |
50% | 63% | 14% | 50% | ||||
A/BBB |
13% | 31% | 70% | 41% | ||||
Non-investment Grade |
37% | 6% | 16% | 9% |
96 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Capital credit market exposures
A2. Other US Sub-Prime
As
at |
As
at |
Marks at 31.12.08 |
Marks at | ||||||
Whole loans performing |
1,290 | 2,805 | 80% | 100% | |||||
Whole loans more than 60 days past due |
275 | 372 | 48% | 65% | |||||
Total whole loans |
1,565 | 3,177 | 72% | 94% | |||||
AAA securities |
111 | 735 | 40% | 92% | |||||
Other sub-prime securities |
818 | 525 | 23% | 61% | |||||
Total securities gross of hedges |
929 | 1,260 | 25% | 76% | |||||
Hedges |
| (369 | ) | ||||||
Securities (net of hedges) |
929 | 891 | |||||||
Residuals |
| 233 | | 24% | |||||
Other exposures with underlying sub-prime collateral: |
|||||||||
Derivatives |
643 | 333 | 87% | 100% | |||||
Loans |
195 | 346 | 70% | 100% | |||||
Real Estate |
109 | 57 | 46% | 68% | |||||
Total other direct and indirect exposure |
1,876 | 1,860 | |||||||
Total |
3,441 | 5,037 |
The majority of Other US sub-prime exposures are measured at fair value through profit and loss. US sub-prime securities held in conduits and a collateralised debt obligation (CDO) are categorised as available for sale and are recognised in equity.
Exposure declined from £5,037m to £3,441m driven by gross losses of £1,728m and net sales, paydowns and other movements of £1,649m. Weaker Sterling resulted in an increase in exposure of £1,086m. Exposures at 31st December 2008 included assets acquired from Lehman Brothers North American businesses of £83m in AAA securities and £124m in other US sub-prime securities.
At 31st December 2008, 82% of the whole loan exposure was performing. Whole loans included £1,422m (31st December 2007: £2,843m) acquired on or originated since the acquisition of EquiFirst in March 2007. Of this balance, £281m of new sub-prime loans were originated in 2008. At 31st December 2008, the average loan to value at origination of all the sub-prime whole loans was 79%. Loans guaranteed by Federal Housing Administration (FHA) are not included in the exposure above. An FHA loan is a mortgage loan fully insured by the US Federal Housing Administration and therefore not considered to be a credit sensitive product. EquiFirst has only originated FHA eligible loans since April 2008, and held £132m of these loans at 31st December 2008.
Securities included £37m held by consolidated conduits and £110m held in a CDO on which impairment charges of £16m and £53m respectively have been recorded.
Other exposures with underlying sub-prime collateral include counterparty derivative exposures to vehicles which hold sub-prime collateral. Derivatives of £643m (31st December 2007: £333m) relate to US Dollar denominated interest rate swaps. The increase in the balance principally relates to the decline in interest rates globally and the 37% depreciation of Sterling relative to the US Dollar, especially in the second half of 2008. The majority of all other exposures with underlying sub-prime collateral was the most senior obligation of the vehicle.
Barclays Annual Report 2008 |
97 |
A3. Alt-A
As at |
As at |
Marks at |
Marks at | |||||
AAA securities |
1,847 | 3,553 | 43% | 87% | ||||
Other Alt-A securities |
1,265 | 208 | 9% | 75% | ||||
Whole Loans |
776 | 909 | 67% | 97% | ||||
Residuals |
2 | 25 | 6% | 66% | ||||
Derivative exposure with underlying Alt-A collateral |
398 | 221 | 100% | 100% | ||||
Total |
4,288 | 4,916 |
Alt-A securities, whole loans and residuals are measured at fair value through profit and loss. Alt-A securities held in conduits and a collateralised debt obligation (CDO) are categorised as available for sale and are recognised in equity.
Net exposure to the Alt-A market was £4,288m (31st December 2007: £4,916m), through a combination of whole loans, securities and residuals, including those held in consolidated conduits. There were gross losses of £1,983m in the year and net sales, paydowns and other movements of £181m. Weaker Sterling resulted in an increase in exposure of £1,190m. Exposures at 31st December 2008 included assets acquired from Lehman Brothers North American businesses of £300m in AAA securities and £324m in other Alt-A securities.
Securities included £491m held by consolidated conduits and £89m held in a CDO on which impairment charges of £65m and £58m respectively have been recorded.
At 31st December 2008, 75% of the Alt-A whole loan exposure was performing, and the average loan to value ratio at origination was 81%.
Other exposures with underlying Alt-A collateral include counterparty derivative exposures to vehicles which hold Alt-A collateral. Derivative exposures with underlying Alt-A collateral of £398m (31st December 2007: £221m) relate to US Dollar denominated interest rate swaps. The increase in the balance principally relates to the decline in interest rates globally and the 37% depreciation of Sterling relative to the US Dollar, especially in the second half of 2008. The majority of this exposure was the most senior obligation of the vehicle.
A4. US Residential Mortgage Backed Securities Exposure Wrapped by Monoline Insurers
The deterioration in the US residential mortgage market has resulted in exposure to monoline insurers and other financial guarantors that provide credit protection.
The table below shows RMBS assets where we held protection from monoline insurers at 31st December 2008. These are measured at fair value through profit and loss. Declines in fair value of the underlying assets are reflected in increases in the value of potential claims against monoline insurers. Such declines have resulted in net exposure to monoline insurers under these contracts increasing to £1,639m by 31st December 2008 (2007: £730m).
Claims would become due in the event of default of the underlying assets and losses would only be realised if both the underlying asset and monoline defaulted. At 31st December 2008 while 81% of the underlying assets were non-investment grade, 97% are wrapped by monolines with investment grade ratings.
There is some uncertainty whether all of the monoline insurers would be able to meet all liabilities if such claims were to arise: certain monoline insurers have been subject to downgrades in 2008. Consequently, a fair value loss of £412m has been recognised in the year. There have been no claims due under these contracts as none of the underlying assets were in default at 31st December 2008.
The fair value is determined by a credit valuation adjustment calculation which incorporates stressed cash flow shortfall projections, current market valuations, stressed Probability of Default (PDs) and a range of Loss Given Default (LGD) assumptions. The cash flow shortfall projections are stressed to ensure that we consider the potential for further market deterioration and resultant additional cash flow shortfall in underlying collateral. Monoline ratings are based on external ratings analysis and where appropriate significant internal analysis conducted by the independent Credit Risk function. In addition, we reflect the potential for further deterioration of monolines by using stressed PDs which results in all monolines having an implied sub-investment grade rating. LGDs range from 45% to 100% depending on the monoline.
Exposure by Credit Rating of Monoline Insurer
As at 31.12.08 | |||||||||||
Notional £m |
Fair Value £m |
Fair Value Exposure £m |
Credit Valuation Adjustment £m |
Net Exposure £m | |||||||
AAA/AA |
| | | | | ||||||
A/BBB |
2,567 | 492 | 2,075 | (473 | ) | 1,602 | |||||
Non-investment grade |
74 | 8 | 66 | (29 | ) | 37 | |||||
Total |
2,641 | 500 | 2,141 | (502 | ) | 1,639 | |||||
As at 31.12.07 | |||||||||||
AAA/AA |
2,807 | 2,036 | 771 | (41 | ) | 730 |
98 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Capital credit market exposures
The notional value of the assets, split by the current rating of the monoline insurer, is shown below.
Rating of Monoline Insurers As at 31.12.08 | ||||||||
AAA/AA £m |
A/BBB £m |
Non- £m |
Total £m | |||||
2005 and earlier |
| 143 | | 143 | ||||
2006 |
| 1,240 | | 1,240 | ||||
2007 and 2008 |
| 510 | | 510 | ||||
High Grade |
| 1,893 | | 1,893 | ||||
Mezzanine 2005 and earlier |
| 625 | 74 | 699 | ||||
CDO 2 2005 and earlier |
| 49 | | 49 | ||||
US RMBS |
| 2,567 | 74 | 2,641 | ||||
The notional value of the assets, split by the current rating of the underlying asset, is shown below.
| ||||||||
Rating of Underlying Asset As at 31.12.08 | ||||||||
AAA/AA £m |
A/BBB £m |
Non- £m |
Total £m | |||||
2005 and earlier |
143 | | | 143 | ||||
2006 |
| | 1,240 | 1,240 | ||||
2007 and 2008 |
| | 510 | 510 | ||||
High Grade |
143 | | 1,750 | 1,893 | ||||
Mezzanine 2005 and earlier |
31 | 330 | 338 | 699 | ||||
CDO 2 2005 and earlier |
| | 49 | 49 | ||||
US RMBS |
174 | 330 | 2,137 | 2,641 |
Barclays Annual Report 2008 |
99 |
B. Commercial Mortgages
Commercial mortgages reduced 18% in US Dollar terms. In Sterling terms these increased by 12%.
B1. Commercial Mortgages
Exposures in Barclays Capitals commercial mortgages portfolio, all of which are measured at fair value, comprised commercial real estate loan exposure of £11,578m (31st December 2007: £11,103m) and commercial mortgage-backed securities (CMBS) of £735m (31st December 2007: £1,296m). During the year there were gross losses of £1,148m. Gross sales and paydowns of £1,034m in the UK and Continental Europe and £2,167m in the US were partially offset by additional drawdowns. Weaker Sterling increased exposure by £3,058m.
The commercial real estate loan exposure comprised 55% US, 41% UK and Europe and 4% Asia. 5% of the total relates to land or property under construction.
The US exposure included two large transactions which comprised 42% of the total US exposure and have paid down approximately £789m in the year. The remaining 58% of the US exposure comprised 76 transactions. The remaining weighted average number of years to initial maturity of the US portfolio is 1.4 years.
The UK and Europe portfolio is well diversified with 64 transactions in place as at 31st December 2008. In Europe protection is provided by loan covenants and periodic LTV retests, which cover 90% of the portfolio. 47% of the German exposure relates to one transaction secured on multifamily residential assets. Exposure to the Spanish market represents less than 1% of global exposure at 31st December 2008.
Commercial Real Estate Exposure by Region
| ||||||||
As at 31.12.08 £m |
As at 31.12.07 £m |
Marks at 31.12.08 |
Marks at 31.12.07 | |||||
US |
6,329 | 5,947 | 88% | 99% | ||||
Germany |
2,467 | 1,783 | 95% | 100% | ||||
Sweden |
265 | 250 | 96% | 100% | ||||
France |
270 | 289 | 94% | 100% | ||||
Switzerland |
176 | 127 | 97% | 100% | ||||
Spain |
106 | 89 | 92% | 100% | ||||
Other Continental Europe |
677 | 779 | 90% | 100% | ||||
UK |
831 | 1,422 | 89% | 100% | ||||
Asia |
457 | 417 | 97% | 100% | ||||
Total |
11,578 | 11,103 |
Commercial Real Estate Exposure Metrics
| ||||||
WALTVa | WAMb | WALAc | ||||
US |
79.5% | 1.4 yrs | 1.6 yrs | |||
Germany |
79.4% | 4.6 yrs | 1.5 yrs | |||
Other Europe |
82.2% | 4.5 yrs | 1.7 yrs | |||
UK |
77.8% | 5.8 yrs | 1.8 yrs | |||
Asia |
93.3% | 4.7 yrs | 1.3 yrs |
Commercial Real Estate Exposure by Industry
| ||||||||||||
As at 31.12.08 | ||||||||||||
US £m |
Germany £m |
Other Europe £m |
UK £m |
Asia £m |
Total £m | |||||||
Office |
2,081 | 436 | 802 | 192 | 145 | 3,656 | ||||||
Residential |
1,957 | 1,268 | | 229 | 128 | 3,582 | ||||||
Retail |
66 | 567 | 96 | 110 | 118 | 957 | ||||||
Hotels |
1,145 | | 441 | 29 | 18 | 1,633 | ||||||
Leisure |
| | | 233 | | 233 | ||||||
Land |
232 | | | | | 232 | ||||||
Industrial |
582 | 126 | 131 | 38 | 10 | 887 | ||||||
Mixed/Others |
243 | 70 | 24 | | 38 | 375 | ||||||
Hedges |
23 | | | | | 23 | ||||||
Total |
6,329 | 2,467 | 1,494 | 831 | 457 | 11,578 |
Notes
a | Weighted-average loan- to-value based on the most recent valuation. |
b | Weighted-average number of years to initial maturity. |
c | Weighted-average loan age. |
100 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Capital credit market exposures
B1. Commercial Mortgages (continued)
Commercial Mortgage Backed Securities (net of hedges)
| ||||||||
As at 31.12.08 £m |
As at £m |
Marksa at 31.12.08 |
Marksa at 31.12.07 | |||||
AAA securities |
588 | 1,008 | ||||||
Other securities |
147 | 288 | ||||||
Total |
735 | 1,296 | 21% | 98% |
Exposure is stated net of hedges traded in the liquid index swap market with market counterparties. The counterparty exposure is managed through a standard derivative collateralisation process and none of the hedge counterparties are monoline insurers.
Exposures at 31st December 2008 included assets acquired from Lehman Brothers North American businesses of £143m in AAA securities and £86m in other securities.
B2. CMBS Exposure Wrapped by Monoline Insurers
The deterioration in the commercial mortgage market has resulted in exposure to monoline insurers and other financial guarantors that provide credit protection.
The table below shows Commercial Mortgage Backed Security (CMBS) assets where we held protection from monoline insurers at 31st December 2008. These are measured at fair value through profit and loss. Declines in fair value of the underlying assets are reflected in increases in the value of potential claims against monoline insurers. Such declines have resulted in net exposure to monoline insurers under these contracts increasing to £1,854m by 31st December 2008 (31st December 2007: £197m).
Claims would become due in the event of default of the underlying assets and losses would only be realised if both the underlying asset and monoline defaulted. At 31st December 2008 all underlying assets were rated AAA/AA and 89% are wrapped by monolines with investment grade ratings.
There is some uncertainty whether all of the monoline insurers would be able to meet all liabilities if such claims were to arise: certain monoline insurers have been subject to downgrades in 2008. Consequently, a fair value loss of £340m has been recognised in the year. There have been no claims due under these contracts as none of the underlying assets were in default at 31st December 2008.
The fair value is determined by a credit valuation adjustment calculation which incorporates stressed cash flow shortfall projections, current market valuations, stressed Probability of Default (PDs) and a range of Loss Given Default (LGD) assumptions. The cash flow shortfall projections are stressed to ensure that we consider the potential for further market deterioration and resultant additional cash flow shortfall in underlying collateral. Monoline ratings are based on external ratings analysis and where appropriate significant internal analysis conducted by the independent Credit Risk function. In addition, we reflect the potential for further deterioration of monolines by using stressed PDs which results in all monolines having an implied sub-investment grade rating. LGDs range from 45% to 100% depending on the monoline.
Exposure by credit rating of monoline insurer
| |||||||||||
As at 31.12.08 | |||||||||||
Notional £m |
Fair value £m |
Fair value exposure £m |
Credit valuation adjustment £m |
Net exposure £m | |||||||
AAA/AA |
69 | 27 | 42 | (4 | ) | 38 | |||||
A/BBB |
3,258 | 1,301 | 1,957 | (320 | ) | 1,637 | |||||
Non-investment grade |
425 | 181 | 244 | (65 | ) | 179 | |||||
Total |
3,752 | 1,509 | 2,243 | (389 | ) | 1,854 | |||||
As at 31.12.07 | |||||||||||
AAA/AA |
3,614 | 3,408 | 206 | (9 | ) | 197 |
The notional value of the assets, split by the current rating of the monoline insurer, is shown below.
Rating of monoline insurers As at 31.12.08 | ||||||||
AAA/AA £m |
A/BBB £m |
Non- £m |
Total £m | |||||
2005 and earlier |
| 437 | | 437 | ||||
2006 |
69 | 544 | | 613 | ||||
2007 and 2008 |
| 2,277 | 425 | 2,702 | ||||
CMBS |
69 | 3,258 | 425 | 3,752 |
Note
a | Marks are based on gross collateral. |
Barclays Annual Report 2008 |
101 |
The notional value of the assets split by the current rating of the underlying asset, is shown below. All CMBS assets were rated AAA/AA at 31st December 2008.
Rating of Underlying Asset As at 31.12.08 | ||||||||
AAA/AA £m |
A/BBB £m |
Non- Investment £m |
Total £m | |||||
2005 and earlier |
437 | | | 437 | ||||
2006 |
613 | | | 613 | ||||
2007 and 2008 |
2,702 | | | 2,702 | ||||
CMBS |
3,752 | | | 3,752 |
C . Other credit market exposures
In the year ended 31st December 2008 these exposures increased by 17% in US Dollar terms, and 61% in Sterling terms.
C1. Leveraged Finance
Leveraged loans are classified within loans and advances and are stated at amortised cost less impairment. The overall credit performance of the assets remains satisfactory.
At 31st December 2008, the gross exposure relating to leveraged finance loans was £10,506m (31st December 2007: £9,217m). Barclays Capital expects to hold these leveraged finance positions until redemption. Material movements since 31st December 2007 reflect exchange rate changes rather than changes in loan positions.
The net exposure relating to leverage finance loans of £10,391m (31st December 2007: £9,027m) was reduced to £7,335m following a repayment of £3,056m at par in January 2009.
Leveraged Finance Exposure by Region
|
||||||
As at 31.12.08 £m |
As at 31.12.07 £m |
|||||
UK |
4,810 | 4,401 | ||||
US |
3,830 | 3,037 | ||||
Europe |
1,640 | 1,568 | ||||
Asia |
226 | 211 | ||||
Total lending and commitments |
10,506 | 9,217 | ||||
Identified and unidentified impairmenta |
(115 | ) | (190 | ) | ||
Net lending and commitments |
10,391 | 9,027 |
Leveraged finance exposure by industry
|
||||||||||||
As at 31.12.08 | As at 31.12.07 | |||||||||||
Drawn £m |
Undrawn £m |
Total £m |
Drawn £m |
Undrawn £m |
Total £m | |||||||
Insurance |
2,546 | 31 | 2,577 | 2,456 | 78 | 2,534 | ||||||
Telecoms |
2,998 | 211 | 3,209 | 2,259 | 240 | 2,499 | ||||||
Retail |
904 | 128 | 1,032 | 828 | 132 | 960 | ||||||
Health care |
659 | 144 | 803 | 577 | 141 | 718 | ||||||
Media |
655 | 89 | 744 | 469 | 127 | 596 | ||||||
Services |
568 | 131 | 699 | 388 | 134 | 522 | ||||||
Manufacturing |
500 | 102 | 602 | 371 | 125 | 496 | ||||||
Chemicals |
317 | 26 | 343 | 46 | 286 | 332 | ||||||
Other |
329 | 168 | 497 | 233 | 327 | 560 | ||||||
Total |
9,476 | 1,030 | 10,506 | 7,627 | 1,590 | 9,217 |
New leveraged finance commitments originated after 30th June 2007 comprised £573m (31st December 2007: £1,148m).
Note
a | The movement in impairment during the period is primarily due to the release of the provision on the post year end repayment, for which there was a binding commitment as at 31st December 2008. |
102 | Barclays Annual Report 2008 |
Risk management
Credit risk management
Barclays Capital credit market exposures
C2. SIVs and SIV-Lites
SIVs/SIV-Lites
|
||||||||
As at 31.12.08 £m |
As at 31.12.07 £m |
Marks at 31.12.08 |
Marks at 31.12.07 | |||||
Liquidity facilities |
679 | 466 | 62% | 100% | ||||
Bond inventory |
11 | 52 | 7% | 37% | ||||
Derivatives |
273 | 266 | ||||||
Total |
963 | 784 |
SIV exposure increased from £784m to £963m during the year. There were £230m of gross losses against SIVs and SIV lites in the year. Weaker Sterling resulted in an increase in exposure of £281m.
At 31st December 2008 liquidity facilities of £679m (31st December 2007: £466m) include £531m designated at fair value through profit and loss relating to a SIV-lite which had previously been hedged with Lehman Brothers. Following the Lehman Brothers bankruptcy this facility was reflected as a new exposure to the underlying assets. The remaining £148m represented drawn liquidity facilities in respect of SIV-lites and other structured investment vehicles classified as loans and advances stated at cost less impairment.
Bond inventory and derivatives are fair valued through profit and loss.
Movement in derivative exposure primarily related to CDS exposure due to general spread widening. At 31st December 2008 exposure was broadly in line with the prior year.
C3. CDPC exposure
Credit derivative product companies (CDPCs) are specialist providers of credit protection principally on corporate exposures in the form of credit derivatives. The Group has purchased protection from CDPCs against a number of securities with a notional value of £1,772m. The fair value of the exposure to CDPCs at 31st December 2008 was £150m. A fair value loss of £14m has been recognised in the year.
Of the notional exposure, 45% related to AAA/AA rated counterparties, with the remainder rated A/BBB.
Exposure by credit rating of CDPC
| |||||||||
As at 31.12.08 | |||||||||
Notional £m |
Gross exposure £m |
Credit valuation adjustment £m |
Net exposure £m | ||||||
AAA/AA |
796 | 77 | (14 | ) | 63 | ||||
A/BBB |
976 | 87 | | 87 | |||||
Total |
1,772 | 164 | (14 | ) | 150 | ||||
As at 31.12.07 | |||||||||
AAA/AA |
1,262 | 19 | | 19 |
Barclays Annual Report 2008 |
103 |
C4. CLO and other exposure wrapped by monoline insurers
The table below shows Collateralised Loan Obligations (CLOs) and other assets where we held protection from monoline insurers at 31st December 2008. The deterioration in markets for these assets has resulted in exposure to monoline insurers and other financial guarantors that provide credit protection. These are measured at fair value through profit and loss. Declines in fair value of the underlying assets are reflected in increases in the value of potential claims against monoline insurers. Such declines have resulted in net exposure to monoline insurers under these contracts increasing to £4,939m by 31st December 2008 (31st December 2007: £408m).
Claims would become due in the event of default of the underlying assets and losses would only be realised if both the underlying asset and monoline defaulted. At 31st December 2008 all of the underlying assets have investment grade ratings and 39% are wrapped by monolines rated AAA/AA. 87% of the underlying assets were CLOs, all of which were rated AAA/AA.
There is some uncertainty whether all of the monoline insurers would be able to meet all liabilities if such claims were to arise: certain monoline insurers have been subject to downgrades in 2008. Consequently, a fair value loss of £737m, has been recognised in the year. There have been no claims due under these contracts as none of the underlying assets were in default at 31st December 2008.
The fair value is determined by a credit valuation adjustment calculation which incorporates stressed cash flow shortfall projections, current market valuations, stressed Probability of Default (PDs) and a range of Loss Given Default (LGD) assumptions. The cash flow shortfall projections are stressed to ensure that we consider the potential for further market deterioration and resultant additional cash flow shortfall in underlying collateral. Monoline ratings are based on external ratings analysis and where appropriate significant internal analysis conducted by the independent Credit Risk function. In addition, we reflect the potential for further deterioration of monolines by using stressed PDs for non-AAA rated monolines, which results in all other monolines having an implied sub-investment grade rating. LGDs range from 45% to 100% depending on the monoline.
Exposure by credit rating of monoline in surer | |||||||||||
As at 31.12.08 | |||||||||||
Notional £m |
Fair value £m |
Fair value exposure £m |
Credit valuation adjustment £m |
Net exposure £m | |||||||
AAA/AA |
8,281 | 5,854 | 2,427 | (55 | ) | 2,372 | |||||
A/BBB |
6,446 | 4,808 | 1,638 | (204 | ) | 1,434 | |||||
Non-investment grade |
6,148 | 4,441 | 1,707 | (574 | ) | 1,133 | |||||
Total |
20,875 | 15,103 | 5,772 | (833 | ) | 4,939 | |||||
As at 31.12.07 | |||||||||||
AAA/AA |
15,152 | 14,735 | 417 | (9 | ) | 408 | |||||
The notional value of the assets, split by the current rating of the monoline insurer, is shown below.
| |||||||||||
Rating of monoline insurers As at 31.12.08 | |||||||||||
AAA/AA £m |
A/BBB £m |
Non- grade £m |
Total £m | ||||||||
2005 and earlier |
2,064 | 1,647 | 2,326 | 6,037 | |||||||
2006 |
1,803 | 2,173 | 1,918 | 5,894 | |||||||
2007 and 2008 |
3,324 | 1,369 | 1,602 | 6,295 | |||||||
CLOs |
7,191 | 5,189 | 5,846 | 18,226 | |||||||
2005 and earlier |
131 | 661 | 70 | 862 | |||||||
2006 |
145 | 158 | 232 | 535 | |||||||
2007 and 2008 |
814 | 438 | | 1,252 | |||||||
Other |
1,090 | 1,257 | 302 | 2,649 | |||||||
Total |
8,281 | 6,446 | 6,148 | 20,875 |
104 | Barclays Annual Report 2008 |
Risk Management
Credit risk management
Barclays Capital credit market exposures
The notional value of the assets split by the current rating of the underlying asset is shown below. All of the underlying assets had investment grade ratings as at 31st December 2008.
Rating of Underlying Asset As at 31.12. 08 | ||||||||
AAA/AA £m |
A/BBB £m |
Non- Investment £m |
Total £m | |||||
2005 and earlier |
6,037 | | | 6,037 | ||||
2006 |
5,894 | | | 5,894 | ||||
2007 and 2008 |
6,295 | | | 6,295 | ||||
CLOs |
18,226 | | | 18,226 | ||||
2005 and earlier |
862 | | | 862 | ||||
2006 |
535 | | | 535 | ||||
2007 and 2008 |
785 | 467 | | 1,252 | ||||
Other |
2,182 | 467 | | 2,649 | ||||
Total |
20,408 | 467 | | 20,875 |
Own credit
The carrying amount of issued notes that are designated under the IAS 39 fair value option is adjusted to reflect the effect of changes in own credit spreads. The resulting gain or loss is recognised in the income statement.
At 31st December 2008, the own credit adjustment arose from the fair valuation of £54.5bn of Barclays Capital structured notes (31st December 2007: £40.7bn). The widening of Barclays credit spreads in the year affected the fair value of these notes and as a result revaluation gains of £1,663m were recognised in trading income (2007: £658m).
Barclays Annual Report 2008 |
105 |
Risk management
106 | Barclays Annual Report 2008 |
Risk management
Traded market risk
The daily average, maximum and minimum values of DVaR, 95% and 98%, were calculated as below.
DVaR (95%) |
||||||||||||||
12 months to 31st December 2008 |
12 months to 31st December 2007 | |||||||||||||
Average £m |
High £m |
Low £m |
Average £m |
High £m |
Low £m | |||||||||
Interest rate risk |
28.9 | 47.8 | 15.1 | 15.3 | 26.5 | 10.0 | ||||||||
Credit spread risk |
31.1 | 71.7 | 15.4 | 17.3 | 28.0 | 10.8 | ||||||||
Commodity risk |
18.1 | 25.4 | 12.5 | 15.3 | 19.0 | 10.7 | ||||||||
Equity risk |
9.1 | 21.0 | 4.8 | 8.0 | 12.1 | 4.5 | ||||||||
Foreign exchange risk |
5.9 | 13.0 | 2.1 | 3.8 | 7.2 | 2.1 | ||||||||
Diversification effect a |
(39.7 | ) | n/a | n/a | (27.2 | ) | n/a | n/a | ||||||
Total DVaR |
53.4 | 95.2 | 35.5 | 32.5 | 40.9 | 25.2 | ||||||||
DVaR (98%) |
||||||||||||||
12 months to 31st December 2008 |
12 months to 31st December 2007 | |||||||||||||
Average £m |
High £m |
Low £m |
Average £m |
High £m |
Low £m | |||||||||
Interest rate risk |
45.0 | 80.9 | 21.0 | 20.0 | 33.3 | 12.6 | ||||||||
Credit spread risk |
54.0 | 143.4 | 30.1 | 24.9 | 43.3 | 14.6 | ||||||||
Commodity risk |
23.9 | 39.6 | 16.5 | 20.2 | 27.2 | 14.8 | ||||||||
Equity risk |
12.8 | 28.9 | 6.7 | 11.2 | 17.6 | 7.3 | ||||||||
Foreign exchange risk |
8.1 | 21.0 | 2.9 | 4.9 | 9.6 | 2.9 | ||||||||
Diversification effect a |
(67.3 | ) | n/a | n/a | (39.2 | ) | n/a | n/a | ||||||
Total DVaR |
76.5 | 158.8 | 47.5 | 42.0 | 59.3 | 33.1 |
Barclays Annual Report 2008 |
107 |
108 | Barclays Annual Report 2008 |
Risk management
Market risk management
Barclays Annual Report 2008 |
109 |
Risk management
Market risk management
Disclosures about certain trading activities
110 | Barclays Annual Report 2008 |
Risk management
Barclays Annual Report 2008 |
111 |
Risk management
Liquidity risk management
112 | Barclays Annual Report 2008 |
Risk management
Liquidity risk management
Key elements
Barclays Annual Report 2008 |
113 |
Risk management
114 | Barclays Annual Report 2008 |
Risk management
Capital risk management
Internal targets
Barclays Annual Report 2008 |
115 |
Risk management
Capital risk management
2008 £m |
|
2007 £m |
| |||
The average supply of capital to support the economic capital framework a | ||||||
Shareholders equity excluding minority interests less goodwill b | 17,650 | 14,150 | ||||
Retirement benefits liability | 1,050 | 1,150 | ||||
Cash flow hedging reserve | 100 | 250 | ||||
Available for sale reserve | 400 | (150 | ) | |||
Gains on own credit | (1,250 | ) | (100 | ) | ||
Preference shares | 5,500 | 3,700 | ||||
Available funds for economic capital excluding goodwill | 23,450 | 19,000 | ||||
Average historic goodwill and intangible assets b | 9,450 | 8,400 | ||||
Available funds for economic capital including goodwill c | 32,900 | 27,400 |
Notes
116 | Barclays Annual Report 2008 |
Risk management
Barclays Annual Report 2008 |
117 |
Risk management
Operational risk management
Measurement and capital modelling
118 | Barclays Annual Report 2008 |
Risk management
Operational risk management
Barclays Annual Report 2008 |
119 |
Risk management
Financial crime risk management
Anti-money laundering and sanctions risk
120 | Barclays Annual Report 2008 |
Risk management
Financial crime risk management
Fraud risk and security risk
Barclays Annual Report 2008 |
121 |
Risk management
Statistical and other risk information
This section of the report contains supplementary information that is more detailed or contains longer histories than the data presented in the discussion. For commentary on this information, please refer to the preceding text (pages 67 to 105).
Credit risk management
Table 1: Risk Tendency by business | ||||
2008 £m |
2007 £m | |||
UK Retail Banking | 520 | 470 | ||
Barclays Commercial Bank | 400 | 305 | ||
Barclaycard | 1,475 | 955 | ||
GRCB Western Europe | 270 | 135 | ||
GRCB Emerging Markets | 350 | 140 | ||
GRCB Absa | 255 | 190 | ||
Barclays Capital | 415 | 140 | ||
Barclays Wealth | 20 | 10 | ||
Head office functions and other operations a | 5 | 10 | ||
Risk Tendency by business | 3,710 | 2,355 |
Table 2: Loans and advances | ||||
2008 £m |
2007 £m | |||
Retail businesses | ||||
Customers |
201,588 | 162,081 | ||
Total retail businesses | 201,588 | 162,081 | ||
Wholesale businesses | ||||
Banks |
47,758 | 40,123 | ||
Customers |
266,750 | 187,086 | ||
Total wholesale businesses | 314,508 | 227,209 | ||
Loans and advances | 516,096 | 389,290 |
Note
a | Head office functions and other operations comprises discontinued business in transition. |
122 | Barclays Annual Report 2008 |
Risk management
Statistical information
Table 3: Maturity analysis of loans and advances to banks | ||||||||||||||||||
At 31st December 2008 | On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six not more than one year £m |
Over one but not |
Over three but not |
Over five years but not more than ten years £m |
Over ten years £m |
Total £m | |||||||||
United Kingdom | 127 | 6,474 | 193 | 163 | 232 | | | 343 | 7,532 | |||||||||
Other European Union | 1,210 | 10,458 | 54 | 415 | 407 | 50 | 5 | 1 | 12,600 | |||||||||
United States | 1,310 | 11,215 | 7 | 676 | 324 | | | 84 | 13,616 | |||||||||
Africa | 584 | 595 | 51 | 1 | 51 | 861 | 8 | 38 | 2,189 | |||||||||
Rest of the World | 1,652 | 6,957 | 201 | 666 | 884 | 943 | 39 | 479 | 11,821 | |||||||||
4,883 | 35,699 | 506 | 1,921 | 1,898 | 1,854 | 52 | 945 | 47,758 |
At 31st December 2007 |
On demand £m |
Not more £m |
Over three more than £m |
Over six £m |
Over one but not £m |
Over three but not £m |
Over five £m |
Over £m |
Total £m | |||||||||
United Kingdom | 796 | 4,069 | 56 | 92 | 114 | 20 | 1 | 370 | 5,518 | |||||||||
Other European Union | 2,977 | 7,745 | 74 | 88 | 95 | 116 | 7 | | 11,102 | |||||||||
United States | 321 | 5,736 | 95 | 1,255 | 343 | 98 | 5,498 | 97 | 13,443 | |||||||||
Africa | 283 | 1,260 | 131 | 114 | 196 | 439 | 158 | | 2,581 | |||||||||
Rest of the World | 1,505 | 3,336 | 90 | 1,640 | 512 | 362 | 15 | 19 | 7,479 | |||||||||
Loans and advances to banks | 5,882 | 22,146 | 446 | 3,189 | 1,260 | 1,035 | 5,679 | 486 | 40,123 |
Table 4: Interest rate sensitivity of loans and advances | ||||||||||||
2008 | 2007 | |||||||||||
At 31st December | Fixed rate £m |
Variable rate £m |
Total £m |
Fixed rate £m |
Variable rate £m |
Total £m | ||||||
Banks | 12,101 | 35,657 | 47,758 | 16,447 | 23,676 | 40,123 | ||||||
Customers | 98,404 | 369,934 | 468,338 | 77,861 | 271,306 | 349,167 |
Table 5: Loans and advances to customers by industry | ||||||||||
At 31st December | 2008 £m |
2007 7£m |
2006 £m |
2005 £m |
2004 a £m | |||||
Financial services | 114,069 | 71,160 | 45,954 | 43,102 | 25,132 | |||||
Agriculture, forestry and fishing | 3,281 | 3,319 | 3,997 | 3,785 | 2,345 | |||||
Manufacturing | 26,374 | 16,974 | 15,451 | 13,779 | 9,044 | |||||
Construction | 8,239 | 5,423 | 4,056 | 5,020 | 3,278 | |||||
Property | 22,155 | 17,018 | 16,528 | 16,325 | 8,992 | |||||
Government | 5,301 | 2,036 | 2,426 | 1,718 | | |||||
Energy and water | 14,101 | 8,632 | 6,810 | 6,891 | 3,709 | |||||
Wholesale and retail, distribution and leisure | 20,208 | 18,216 | 15,490 | 17,760 | 11,099 | |||||
Transport | 8,612 | 6,258 | 5,586 | 5,960 | 3,742 | |||||
Postal and communication | 7,268 | 5,404 | 2,180 | 1,313 | 834 | |||||
Business and other services | 37,373 | 30,363 | 26,999 | 22,529 | 23,223 | |||||
Home loans b | 135,384 | 106,751 | 92,477 | 85,206 | 79,164 | |||||
Other personal | 53,087 | 46,423 | 37,535 | 39,866 | 29,293 | |||||
Finance lease receivables | 12,886 | 11,190 | 10,142 | 9,088 | 6,938 | |||||
Loans and advances to customers excluding reverse repurchase agreements | 468,338 | 349,167 | 285,631 | 272,342 | 206,793 | |||||
Reverse repurchase agreements | n/a | n/a | n/a | n/a | 58,304 | |||||
Loans and advances to customers | 468,338 | 349,167 | 285,631 | 272,342 | 265,097 |
Notes
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
b | Excludes commercial property mortgages. |
Barclays Annual Report 2008 |
123 |
Table 6: Loans and advances to customers in the UK | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||
Financial services | 26,091 | 21,131 | 14,011 | 11,958 | 8,774 | |||||
Agriculture, forestry and fishing | 2,245 | 2,220 | 2,307 | 2,409 | 1,963 | |||||
Manufacturing | 11,340 | 9,388 | 9,047 | 8,469 | 5,684 | |||||
Construction | 4,278 | 3,542 | 2,761 | 3,090 | 2,285 | |||||
Property | 12,091 | 10,203 | 10,010 | 10,547 | 7,912 | |||||
Government | 20 | 201 | 6 | 6 | | |||||
Energy and water | 3,040 | 2,203 | 2,360 | 2,701 | 802 | |||||
Wholesale and re tail distribution and leisure | 14,421 | 13,800 | 12,951 | 12,747 | 9,356 | |||||
Transport | 3,467 | 3,185 | 2,745 | 2,797 | 1,822 | |||||
Postal and communication | 1,491 | 1,416 | 899 | 455 | 440 | |||||
Business and other services | 19,589 | 20,485 | 19,260 | 15,397 | 13,439 | |||||
Home loansb | 82,544 | 69,874 | 62,621 | 57,382 | 61,348 | |||||
Other personal | 31,490 | 28,691 | 27,617 | 30,598 | 26,872 | |||||
Finance lease receivables | 3,911 | 4,008 | 3,923 | 5,203 | 5,551 | |||||
Loans and advances to customers in the UK | 216,018 | 190,347 | 170,518 | 163,759 | 146,248 |
Loans and advances included in the above table for the years 2004 to 2007 have been reanalysed between wholesale and retail distribution and leisure, Home loans, and Other personal to reflect changes in classification of assets.
The industry classifications in Tables 7-9 have been prepared at the level of the borrowing entity. This means that a loan to the subsidiary of a major corporation is classified by the industry in which the subsidiary operates, even though the parents predominant business may be in a different industry.
Table 7: Loans and advances to customers in other European Union countries | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||
Financial services | 14,218 | 7,585 | 5,629 | 3,982 | 2,419 | |||||
Agriculture, forestry and fishing | 216 | 141 | 786 | 155 | 280 | |||||
Manufacturing | 8,700 | 4,175 | 3,147 | 2,254 | 2,021 | |||||
Construction | 1,786 | 1,159 | 639 | 803 | 716 | |||||
Property | 4,814 | 2,510 | 2,162 | 3,299 | 344 | |||||
Government | 1,089 | | 6 | | | |||||
Energy and water | 5,313 | 2,425 | 2,050 | 1,490 | 940 | |||||
Wholesale and retail distribution and leisure | 2,653 | 1,719 | 776 | 952 | 810 | |||||
Transport | 2,603 | 1,933 | 1,465 | 1,695 | 640 | |||||
Postal and communication | 962 | 662 | 580 | 432 | 111 | |||||
Business and other services | 5,490 | 3,801 | 2,343 | 3,594 | 3,795 | |||||
Home loansb | 33,644 | 21,405 | 18,202 | 16,114 | 11,828 | |||||
Other personal | 7,247 | 6,615 | 4,086 | 2,283 | 1,369 | |||||
Finance lease receivables | 3,328 | 2,403 | 1,559 | 1,870 | 937 | |||||
Loans and advances to customers in other European Union countries | 92,063 | 56,533 | 43,430 | 38,923 | 26,210 |
See note under Table 6.
Notes
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. The 2004 analysis excludes reverse repurchase agreements. |
b | Excludes commercial property mortgages. |
124 | Barclays Annual Report 2008 |
Risk management
Statistical information
Table 8: Loans and advances to customers in the United States | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||
Financial services | 56,006 | 29,342 | 17,516 | 16,229 | 9,942 | |||||
Agriculture, forestry and fishing | | 2 | 2 | 1 | | |||||
Manufacturing | 2,171 | 818 | 519 | 937 | 388 | |||||
Construction | 21 | 18 | 13 | 32 | 139 | |||||
Property | 549 | 568 | 1,714 | 329 | 394 | |||||
Government | 336 | 221 | 153 | 300 | | |||||
Energy and water | 3,085 | 1,279 | 1,078 | 1,261 | 891 | |||||
Wholesale and retail distribution and leisure | 1,165 | 846 | 403 | 794 | 466 | |||||
Transport | 415 | 137 | 128 | 148 | 186 | |||||
Postal and communication | 3,343 | 2,446 | 36 | 236 | 63 | |||||
Business and other services | 2,279 | 1,053 | 1,432 | 885 | 1,565 | |||||
Home loansb | 17 | 10 | 349 | 2 | 5,768 | |||||
Other personal | 7,702 | 3,256 | 2,022 | 1,443 | 845 | |||||
Finance lease receivables | 298 | 304 | 312 | 328 | 335 | |||||
Loans and advances to customers in the United States | 77,387 | 40,300 | 25,677 | 22,925 | 20,982 |
See note under Table 6.
Table 9: Loans and advances to customers in Africa | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||
Financial services |
1,956 | 3,472 | 2,821 | 4,350 | 186 | |||||
Agriculture, forestry and fishing |
817 | 956 | 889 | 1,193 | 102 | |||||
Manufacturing |
1,082 | 1,351 | 1,747 | 1,501 | 313 | |||||
Construction |
2,053 | 637 | 591 | 1,068 | 76 | |||||
Property |
3,485 | 2,433 | 1,987 | 1,673 | 87 | |||||
Government |
1,741 | 967 | 785 | 625 | | |||||
Energy and water |
118 | 356 | 156 | 193 | 184 | |||||
Wholesale and re tail distribution and leisure |
1,012 | 1,326 | 1,050 | 2,774 | 165 | |||||
Transport |
739 | 116 | 354 | 394 | 137 | |||||
Postal and communication |
293 | 231 | 241 | 27 | 52 | |||||
Business and other services |
4,699 | 1,285 | 2,631 | 1,258 | 1,012 | |||||
Home loansb |
19,018 | 15,393 | 11,223 | 11,630 | 214 | |||||
Other personal |
3,087 | 6,287 | 2,976 | 4,955 | 190 | |||||
Finance lease receivables |
5,130 | 4,357 | 4,240 | 1,580 | 41 | |||||
Loans and advances to customers in Africa |
45,230 | 39,167 | 31,691 | 33,221 | 2,759 |
See note under Table 6.
Table 10: Loans and advances to customers in the Rest of the World | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||
Loans and advances | 37,421 | 22,702 | 14,207 | 13,407 | 10,520 | |||||
Finance lease receivables | 219 | 118 | 108 | 107 | 74 | |||||
Loans and advances to customers in the Rest of the World | 37,640 | 22,820 | 14,315 | 13,514 | 10,594 |
Notes
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. The 2004 analysis excludes reverse re purchase agreements. |
b | Excludes commercial property mortgages. |
Barclays Annual Report 2008 |
125 |
Table 11: Maturity analysis of loans and advances to customers | ||||||||||||||||||
At 31st December 2008 | On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six £m |
Over one £m |
Over three but not |
Over five but not |
Over £m |
Total £m | |||||||||
United Kingdom | ||||||||||||||||||
Corporate lending | 24,790 | 14,715 | 1,574 | 3,259 | 10,585 | 12,372 | 10,495 | 15,876 | 93,666 | |||||||||
Other lending to customers in the | ||||||||||||||||||
United Kingdom | 4,560 | 6,264 | 2,495 | 4,477 | 16,604 | 10,541 | 21,913 | 55,498 | 122,352 | |||||||||
Total United Kingdom | 29,350 | 20,979 | 4,069 | 7,736 | 27,189 | 22,913 | 32,408 | 71,374 | 216,018 | |||||||||
Other European Union | 5,254 | 17,618 | 2,707 | 5,681 | 11,808 | 10,272 | 10,138 | 28,585 | 92,063 | |||||||||
United States | 6,298 | 39,754 | 2,737 | 5,413 | 8,767 | 3,447 | 4,238 | 6,733 | 77,387 | |||||||||
Africa | 8,428 | 2,247 | 1,143 | 1,852 | 4,560 | 4,557 | 5,674 | 16,769 | 45,230 | |||||||||
Rest of the World | 3,832 | 8,150 | 2,167 | 1,545 | 9,267 | 4,008 | 5,666 | 3,005 | 37,640 | |||||||||
Total | 53,162 | 88,748 | 12,823 | 22,227 | 61,591 | 45,197 | 58,124 | 126,466 | 468,338 |
At 31st December 2007 | On demand £m |
Not more than three months £m |
Over three more than |
Over six not more £m |
Over one £m |
Over three but not |
Over five but not |
Over ten years £m |
Total £m | |||||||||
United Kingdom | ||||||||||||||||||
Corporate lending | 26,557 | 15,737 | 2,453 | 3,834 | 8,474 | 8,358 | 10,718 | 11,643 | 87,774 | |||||||||
Other lending to customers in the | ||||||||||||||||||
United Kingdom | 4,384 | 4,717 | 2,106 | 3,597 | 11,517 | 8,699 | 19,325 | 48,228 | 102,573 | |||||||||
Total United Kingdom | 30,941 | 20,454 | 4,559 | 7,431 | 19,991 | 17,057 | 30,043 | 59,871 | 190,347 | |||||||||
Other European Union | 4,016 | 7,665 | 2,229 | 3,284 | 5,842 | 4,883 | 8,842 | 19,772 | 56,533 | |||||||||
United States | 3,053 | 20,205 | 3,430 | 5,938 | 1,904 | 2,498 | 2,658 | 614 | 40,300 | |||||||||
Africa | 6,806 | 4,243 | 881 | 1,969 | 5,568 | 4,124 | 2,285 | 13,291 | 39,167 | |||||||||
Rest of the World | 1,085 | 9,733 | 1,695 | 859 | 2,223 | 2,586 | 3,685 | 954 | 22,820 | |||||||||
Loans and advances to customers | 45,901 | 62,300 | 12,794 | 19,481 | 35,528 | 31,148 | 47,513 | 94,502 | 349,167 |
Table 12: Foreign outstandings in currencies other than the local currency of the borrower for countries where this exceeds 1% of total Group assets | ||||||||||
As % of assets |
Total £m |
Banks and other financial institutions £m |
Governments and official institutions £m |
Commercial £m | ||||||
At 31st December 2008 | ||||||||||
United States | 3.1 | 63,614 | 16,724 | 2 | 46,888 | |||||
Cayman Islands | 1.2 | 23,765 | 271 | | 23,494 | |||||
At 31st December 2007 | ||||||||||
United States | 2.1 | 26,249 | 7,151 | 6 | 19,092 | |||||
At 31st December 2006 | ||||||||||
United States | 1.7 | 16,579 | 7,307 | 89 | 9,183 |
At 31st December 2008, 2007 and 2006, there were no countries where Barclays had cross-currency loans to borrowers between 0.75% and 1% of total Group assets.
126 | Barclays Annual Report 2008 |
Risk management
Statistical information
Table 13: Off-balance sheet and other credit exposures as at 31st December | ||||||
2008 £m |
2007 £m |
2006 £m | ||||
Off-balance sheet exposures | ||||||
Contingent liabilities | 66,310 | 45,774 | 39,419 | |||
Commitments | 260,816 | 192,639 | 205,504 | |||
On-balance sheet exposures | ||||||
Trading portfolio assets | 185,637 | 193,691 | 177,867 | |||
Financial assets designated at fair value held on own account | 54,542 | 56,629 | 31,799 | |||
Derivative financial instruments | 984,802 | 248,088 | 138,353 | |||
Available for sale financial investments | 64,976 | 43,072 | 51,703 |
Table 14: Notional principal amounts of credit derivatives as at 31st December | ||||||
2008 £m |
2007 £m |
2006 £m | ||||
Credit derivatives held or issued for trading purposesa | 4,129,244 | 2,472,249 | 1,224,548 |
Table 15: Credit risk loans summary | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004b £m | |||||
Impaired loansc | 12,264 | 8,574 | 4,444 | 4,550 | n/a | |||||
Non-accruing loans | n/a | n/a | n/a | n/a | 2,115 | |||||
Accruing loans where interest is being suspended with or without provisions | n/a | n/a | n/a | n/a | 492 | |||||
Other accruing loans against which provisions have been made | n/a | n/a | n/a | n/a | 943 | |||||
Subtotal | 12,264 | 8,574 | 4,444 | 4,550 | 3,550 | |||||
Accruing loans which are contractually overdue 90 days or more as to principal or interest | 2,953 | 794 | 598 | 609 | 550 | |||||
Impaired and restructured loans | 483 | 273 | 46 | 51 | 15 | |||||
Credit risk loans | 15,700 | 9,641 | 5,088 | 5,210 | 4,115 |
Notes
a | Includes credit derivatives held as economic hedges which are not designated as hedges for accounting purposes. |
b | 2004 does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
c | Includes £4,117m (2007: £3,344m) of ABS CDO Super Senior exposures. |
Barclays Annual Report 2008 |
127 |
Table 16: Credit risk loans | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004 a £m | |||||
Impaired loans: b |
||||||||||
United Kingdom |
3,793 | 3,605 | 3,340 | 2,965 | n/a | |||||
Other European Union |
1,713 | 472 | 410 | 345 | n/a | |||||
United States |
4,397 | 3,703 | 129 | 230 | n/a | |||||
Africa |
1,996 | 757 | 535 | 831 | n/a | |||||
Rest of the World |
365 | 37 | 30 | 179 | n/a | |||||
Total |
12,264 | 8,574 | 4,444 | 4,550 | n/a | |||||
Non-accrual loans: |
||||||||||
United Kingdom |
n/a | n/a | n/a | n/a | 1,509 | |||||
Other European Union |
n/a | n/a | n/a | n/a | 243 | |||||
United States |
n/a | n/a | n/a | n/a | 258 | |||||
Africa |
n/a | n/a | n/a | n/a | 74 | |||||
Rest of the World |
n/a | n/a | n/a | n/a | 31 | |||||
Total |
n/a | n/a | n/a | n/a | 2,115 | |||||
Accruing loans where interest is being suspended with or without provisions: |
||||||||||
United Kingdom |
n/a | n/a | n/a | n/a | 323 | |||||
Other European Union |
n/a | n/a | n/a | n/a | 31 | |||||
Africa |
n/a | n/a | n/a | n/a | 21 | |||||
Rest of the World |
n/a | n/a | n/a | n/a | 117 | |||||
Total |
n/a | n/a | n/a | n/a | 492 | |||||
Other accruing loans against which provisions have been made: |
||||||||||
United Kingdom |
n/a | n/a | n/a | n/a | 865 | |||||
Other European Union |
n/a | n/a | n/a | n/a | 27 | |||||
United States |
n/a | n/a | n/a | n/a | 26 | |||||
Africa |
n/a | n/a | n/a | n/a | 21 | |||||
Rest of the World |
n/a | n/a | n/a | n/a | 4 | |||||
Total |
n/a | n/a | n/a | n/a | 943 | |||||
Accruing loans which are contractually overdue 90 days or more as to principal or interest: |
||||||||||
United Kingdom |
1,656 | 676 | 516 | 539 | 513 | |||||
Other European Union |
562 | 79 | 58 | 53 | 34 | |||||
United States |
433 | 10 | 3 | | 1 | |||||
Africa |
172 | 29 | 21 | 17 | 1 | |||||
Rest of the World |
130 | | | | 1 | |||||
Total |
2,953 | 794 | 598 | 609 | 550 | |||||
Impaired and restructured loans: |
||||||||||
United Kingdom |
367 | 179 | | 5 | 2 | |||||
Other European Union |
29 | 14 | 10 | 7 | | |||||
United States |
82 | 38 | 22 | 16 | 13 | |||||
Africa |
| 42 | 14 | 23 | | |||||
Rest of the World |
5 | | | | | |||||
Total |
483 | 273 | 46 | 51 | 15 | |||||
Total credit risk loans: |
||||||||||
United Kingdom |
5,816 | 4,460 | 3,856 | 3,509 | 3,212 | |||||
Other European Union |
2,304 | 565 | 478 | 405 | 335 | |||||
United States |
4,912 | 3,751 | 154 | 246 | 298 | |||||
Africa |
2,168 | 828 | 570 | 871 | 117 | |||||
Rest of the World |
500 | 37 | 30 | 179 | 153 | |||||
Credit risk loans |
15,700 | 9,641 | 5,088 | 5,210 | 4,115 |
Notes
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
b | Includes £4,117m (2007: £3,344m) of ABS CDO Super Senior Exposures. |
128 | Barclays Annual Report 2008 |
Risk management
Statistical information
Table 17: Potential problem loans | ||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||
United Kingdom |
883 | 419 | 465 | 640 | 658 | |||||
Other European Union |
963 | 59 | 32 | 26 | 32 | |||||
United States |
431 | 964 | 21 | 12 | 27 | |||||
Africa |
140 | 355 | 240 | 248 | 67 | |||||
Rest of the World |
39 | | 3 | 3 | 14 | |||||
Potential problem loans b |
2,456 | 1,797 | 761 | 929 | 798 |
Table 18: Interest foregone on credit risk loans | ||||||
2008 £m |
2007 £m |
2006 £m | ||||
Interest in come that would have been recognised under the original contractual terms |
||||||
United Kingdom |
244 | 340 | 357 | |||
Rest of the World |
235 | 91 | 70 | |||
Total |
479 | 431 | 427 |
Interest income of approximately £195m (2007: £48m, 2006: £72m) from such loans was included in profit, of which £72m (2007: £26m, 2006: £49m) related to domestic lending and the remainder related to foreign lending.
In addition, a further £159m (2007: £113m, 2006: £98m) was recognised arising from impaired loans. Following impairment, interest income is recognised using the original effective rate of interest which was used to discount the expected future cash flows for the purpose of measuring the impairment loss. £54m (2007: £93m, 2006: £88m) of this related to domestic impaired loans and the remainder related to foreign impaired loans.
Table 19: Analysis of impairment/provision charges | |||||||||||||
At 31st December | 2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m |
||||||||
Impairment charge/net specific provisions charge |
|||||||||||||
United Kingdom |
1,817 | 1,593 | 1,880 | 1,382 | 1,021 | ||||||||
Other European Union |
587 | 123 | 92 | 75 | 102 | ||||||||
United States |
1,519 | 374 | 12 | 76 | 57 | ||||||||
Africa |
454 | 214 | 143 | 37 | 27 | ||||||||
Rest of the World |
207 | 2 | (53 | ) | 4 | 103 | |||||||
Impairment on loans and advances |
4,584 | 2,306 | 2,074 | 1,574 | 1,310 | ||||||||
Impairment on available for sale assets |
382 | 13 | 86 | 4 | n/a | ||||||||
Impairment on reverse repurchase agreements |
124 | | | | | ||||||||
Impairment charge |
5,090 | 2,319 | 2,160 | 1,578 | 1,310 | ||||||||
Total net specific provisions charge |
n/a | n/a | n/a | n/a | n/a | ||||||||
General provisions (release)/charge |
n/a | n/a | n/a | n/a | (206 | ) | |||||||
Other credit provisions charge/(release) |
329 | 476 | (6 | ) | (7 | ) | (11 | ) | |||||
Impairment/provision charges |
5,419 | 2,795 | 2,154 | 1,571 | 1,093 |
Notes
a | Does not reflect the application of IA S 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
b | Includes £nil (2007: £951m) of ABS CDO Super Senior and SIV-lites exposures. |
Barclays Annual Report 2008 |
129 |
Table 20: Impairment/provisions charges ratios (Loan loss ratios) | |||||||||||
2008 % |
2007 % |
2006 % |
2005 % |
2004a % |
|||||||
Impairment/provisions charges as a percentage of average loans and advances for the year: |
|||||||||||
Specific provisions charge |
n/a | n/a | n/a | n/a | 0.40 | ||||||
General provisions charge |
n/a | n/a | n/a | n/a | (0.07 | ) | |||||
Impairment charge |
1.01 | 0.64 | 0.66 | 0.58 | n/a | ||||||
Total |
1.01 | 0.64 | 0.66 | 0.58 | 0.33 | ||||||
Amounts written off (net of recoveries) |
0.61 | 0.49 | 0.61 | 0.50 | 0.40 |
Table 21: Analysis of allowance for impairment/provision for bad and doubtful debts | ||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | ||||||
Impairment allowance/Specific provisions |
||||||||||
United Kingdom |
2,947 | 2,526 | 2,477 | 2,266 | 1,683 | |||||
Other European Union |
963 | 344 | 311 | 284 | 149 | |||||
United States |
1,561 | 356 | 100 | 130 | 155 | |||||
Africa |
857 | 514 | 417 | 647 | 70 | |||||
Rest of the World |
246 | 32 | 30 | 123 | 90 | |||||
Specific provision balances |
n/a | n/a | n/a | n/a | 2,147 | |||||
General provision balances |
n/a | n/a | n/a | n/a | 564 | |||||
Allowance for impairment provision balances |
6,574 | 3,772 | 3,335 | 3,450 | 2,711 | |||||
Average loans and advances for the year |
453,413 | 357,853 | 313,614 | 271,421 | 328,134 |
Table 22: Allowance for impairment/provision balance ratios | ||||||||||
2008 % |
2007 % |
2006 % |
2005 % |
2004a % | ||||||
Allowance for impairment/provision balance at end of year as a percentage of loans and advances at end of year: |
||||||||||
Specific provision balances |
n/a | n/a | n/a | n/a | 0.62 | |||||
General provision balances |
n/a | n/a | n/a | n/a | 0.16 | |||||
Impairment balance |
1.27 | 0.97 | 1.05 | 1.14 | n/a | |||||
Total |
1.27 | 0.97 | 1.05 | 1.14 | 0.78 |
Note
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
130 | Barclays Annual Report 2008 |
Risk management
Statistical information
Table 23: Movements in allowance for impairment/provisions charge for bad and doubtful debts | |||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m |
|||||||||||
Allowance for impairment/provision balance at beginning of year |
3,772 | 3,335 | 3,450 | 2,637 | 2,946 | ||||||||||
Acquisitions and disposals |
307 | (73 | ) | (23 | ) | 555 | 21 | ||||||||
Unwind of discount |
(135 | ) | (113 | ) | (98 | ) | (76 | ) | n/a | ||||||
Exchange and other adjustments |
791 | 53 | (153 | ) | 125 | (33 | ) | ||||||||
Amounts written off |
(2,919 | ) | (1,963 | ) | (2,174 | ) | (1,587 | ) | (1,582 | ) | |||||
Recoveries |
174 | 227 | 259 | 222 | 255 | ||||||||||
Impairment/provision charged against profit b |
4,584 | 2,306 | 2,074 | 1,574 | 1,104 | ||||||||||
Allowance for impairment/provision balance at end of year |
6,574 | 3,772 | 3,335 | 3,450 | 2,711 |
Table 24: Amounts written off | |||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m |
|||||||||||
United Kingdom |
(1,514 | ) | (1,530 | ) | (1,746 | ) | (1,302 | ) | (1,280 | ) | |||||
Other European Union |
(162 | ) | (143 | ) | (74 | ) | (56 | ) | (63 | ) | |||||
United States |
(1,044 | ) | (145 | ) | (46 | ) | (143 | ) | (50 | ) | |||||
Africa |
(187 | ) | (145 | ) | (264 | ) | (81 | ) | (15 | ) | |||||
Rest of the World |
(12 | ) | | (44 | ) | (5 | ) | (174 | ) | ||||||
Amounts written off |
(2,919 | ) | (1,963 | ) | (2,174 | ) | (1,587 | ) | (1,582 | ) |
Table 25: Recoveries | ||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | ||||||
United Kingdom |
131 | 154 | 178 | 160 | 217 | |||||
Other European Union |
4 | 32 | 18 | 13 | 9 | |||||
United States |
1 | 7 | 22 | 15 | 14 | |||||
Africa |
36 | 34 | 33 | 16 | 4 | |||||
Rest of the World |
2 | | 8 | 18 | 11 | |||||
Recoveries |
174 | 227 | 259 | 222 | 255 |
Notes
a | Does not reflect the application of IA S 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
b | Does not reflect the impairment of available for sale assets or other credit risk provisions. |
Barclays Annual Report 2008 |
131 |
Table 26: Impairment allowances/provision charged against profit | |||||||||||||||
2008 £m |
|
2007 £m |
|
2006 £m |
|
2005 £m |
|
2004a £m |
| ||||||
New and in creased impairment allowance/specific provision charge: | |||||||||||||||
United Kingdom | 2,160 | 1,960 | 2,253 | 1,763 | 1,358 | ||||||||||
Other European Union | 659 | 192 | 182 | 113 | 131 | ||||||||||
United States | 1,529 | 431 | 60 | 105 | 85 | ||||||||||
Africa |
526 | 268 | 209 | 109 | 47 | ||||||||||
Rest of the World | 242 | 20 | 18 | 39 | 134 | ||||||||||
5,116 | 2,871 | 2,722 | 2,129 | 1,755 | |||||||||||
Reversals of impairment allowance/specific provision charge: | |||||||||||||||
United Kingdom | (212 | ) | (213 | ) | (195 | ) | (221 | ) | (120 | ) | |||||
Other European Union | (68 | ) | (37 | ) | (72 | ) | (25 | ) | (20 | ) | |||||
United States | (9 | ) | (50 | ) | (26 | ) | (14 | ) | (14 | ) | |||||
Africa | (36 | ) | (20 | ) | (33 | ) | (56 | ) | (16 | ) | |||||
Rest of the World | (33 | ) | (18 | ) | (63 | ) | (17 | ) | (20 | ) | |||||
(358 | ) | (338 | ) | (389 | ) | (333 | ) | (190 | ) | ||||||
Recoveries |
(174 | ) | (227 | ) | (259 | ) | (222 | ) | (255 | ) | |||||
Net impairment allowance/specific provision charge b |
4,584 | 2,306 | 2,074 | 1,574 | 1,310 | ||||||||||
General provision (release)/charge |
n/a | n/a | n/a | n/a | (206 | ) | |||||||||
Net charge to profit |
4,584 | 2,306 | 2,074 | 1,574 | 1,104 |
Table 27: Total impairment/specific provision charges for bad and doubtful debts by industry | |||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m |
|||||||||
United Kingdom: |
|||||||||||||
Financial services |
76 | 32 | 64 | 22 | (1 | ) | |||||||
Agriculture, forestry and fishing |
4 | | 5 | 9 | | ||||||||
Manufacturing |
118 | 72 | 1 | 120 | 28 | ||||||||
Construction |
15 | 14 | 17 | 14 | 10 | ||||||||
Property |
80 | 36 | 15 | 18 | (42 | ) | |||||||
Energy and water |
1 | 1 | (7 | ) | 1 | 3 | |||||||
Wholesale and retail distribution and leisure |
59 | 118 | 88 | 39 | 66 | ||||||||
Transport |
3 | 3 | 19 | (27 | ) | (19 | ) | ||||||
Postal and communication |
| 15 | 15 | 3 | (1 | ) | |||||||
Business and other services |
234 | 81 | 133 | 45 | 64 | ||||||||
Home loans |
28 | 1 | 4 | (7 | ) | 17 | |||||||
Other personal |
1,178 | 1,187 | 1,526 | 1,142 | 894 | ||||||||
Finance lease receivables |
21 | 33 | | 3 | 2 | ||||||||
1,817 | 1,593 | 1,880 | 1,382 | 1,021 | |||||||||
Overseas |
2,767 | 713 | 194 | 192 | 289 | ||||||||
Impairment/specific provision charges |
4,584 | 2,306 | 2,074 | 1,574 | 1,310 |
Notes
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
b | Does not reflect the impairment of available for sale assets , reverse repurchase agreements or other credit risk provisions. |
132 | Barclays Annual Report 2008 |
Risk management
Statistical information
Table 28: Allowance for impairment/specific provision for bad and doubtful debts by industry | ||||||||||||||||||||
2008 | 2007 | 2006 | 2005 | 2004a | ||||||||||||||||
£m | % | £m | % | £m | % | £m | % | £m | % | |||||||||||
United Kingdom: |
||||||||||||||||||||
Financial services |
81 | 1.2 | 103 | 2.7 | 67 | 2.0 | 26 | 0.8 | 7 | 0.3 | ||||||||||
Agriculture, forestry and fishing |
1 | 0.0 | 5 | 0.1 | 17 | 0.5 | 12 | 0.3 | 4 | 0.2 | ||||||||||
Manufacturing |
185 | 2.8 | 65 | 1.7 | 85 | 2.5 | 181 | 5.2 | 37 | 1.7 | ||||||||||
Construction |
18 | 0.3 | 16 | 0.4 | 16 | 0.5 | 13 | 0.4 | 6 | 0.3 | ||||||||||
Property |
114 | 1.7 | 54 | 1.4 | 26 | 0.8 | 24 | 0.7 | 26 | 1.2 | ||||||||||
Energy and water |
1 | 0.0 | 1 | | | | 18 | 0.5 | 23 | 1.0 | ||||||||||
Wholesale and retail distribution and leisure |
43 | 0.7 | 102 | 2.7 | 81 | 2.4 | 99 | 2.9 | 70 | 3.3 | ||||||||||
Transport |
| 0.0 | 11 | 0.3 | 24 | 0.7 | 32 | 0.9 | 55 | 2.6 | ||||||||||
Postal and communication |
33 | 0.5 | 25 | 0.7 | 12 | 0.4 | 2 | 0.1 | 13 | 0.6 | ||||||||||
Business and other services |
236 | 3.6 | 158 | 4.2 | 186 | 5.6 | 102 | 3.0 | 105 | 4.9 | ||||||||||
Home loans |
46 | 0.7 | 15 | 0.4 | 10 | 0.3 | 50 | 1.4 | 58 | 2.7 | ||||||||||
Other personal |
2,160 | 32.9 | 1,915 | 50.8 | 1,953 | 58.6 | 1,696 | 49.2 | 1,265 | 58.9 | ||||||||||
Finance lease receivables |
29 | 0.4 | 56 | 1.5 | | | 11 | 0.3 | 14 | 0.7 | ||||||||||
2,947 | 44.8 | 2,526 | 67.0 | 2,477 | 74.3 | 2,266 | 65.7 | 1,683 | 78.4 | |||||||||||
Overseas |
3,627 | 55.2 | 1,246 | 33.0 | 858 | 25.7 | 1,184 | 34.3 | 464 | 21.6 | ||||||||||
Total |
6,574 | 100.0 | 3,772 | 100.0 | 3,335 | 100.0 | 3,450 | 100.0 | 2,147 | 100.0 |
See note under Table 27.
Table 29: Analysis of amounts written off and recovered by industry
Amounts written off for the year | Recoveries of amounts previously written off | |||||||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004a £m | |||||||||||
United Kingdom: |
||||||||||||||||||||
Financial services |
88 | 6 | 13 | 2 | 7 | 4 | 1 | | 1 | 3 | ||||||||||
Agriculture, forestry and fishing |
6 | 5 | 8 | 3 | 2 | | 2 | 1 | | 1 | ||||||||||
Manufacturing |
53 | 83 | 73 | 47 | 79 | 8 | 7 | 21 | 11 | 30 | ||||||||||
Construction |
19 | 23 | 17 | 15 | 13 | 2 | 3 | 2 | 1 | 2 | ||||||||||
Property |
27 | 16 | 23 | 4 | 2 | 2 | 10 | 6 | 1 | 69 | ||||||||||
Energy and water |
1 | | 1 | 22 | 9 | | | 2 | | 2 | ||||||||||
Wholesale and retail distribution and leisure |
137 | 109 | 120 | 85 | 55 | 7 | 12 | 14 | 25 | 7 | ||||||||||
Transport |
10 | 13 | 11 | 29 | 44 | 1 | 1 | 10 | 15 | |||||||||||
Postal and communication |
3 | 3 | 5 | 15 | 2 | | | | | 1 | ||||||||||
Business and other services |
153 | 83 | 124 | 83 | 96 | 10 | 22 | 17 | 14 | 16 | ||||||||||
Home loans |
4 | 1 | | 2 | 19 | 1 | 1 | 7 | 4 | 5 | ||||||||||
Other personal |
960 | 1,164 | 1,351 | 992 | 948 | 88 | 96 | 107 | 92 | 65 | ||||||||||
Finance lease receivables |
53 | 24 | | 3 | 4 | 8 | | | 1 | 1 | ||||||||||
1,514 | 1,530 | 1,746 | 1,302 | 1,280 | 131 | 154 | 178 | 160 | 217 | |||||||||||
Overseas |
1,405 | 433 | 428 | 285 | 302 | 43 | 73 | 81 | 62 | 38 | ||||||||||
Total |
2,919 | 1,963 | 2,174 | 1,587 | 1,582 | 174 | 227 | 259 | 222 | 255 |
See note under Table 27.
Note
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
Barclays Annual Report 2008 |
133 |
Table 30: Total impairment allowance/(provision) coverage of credit risk loans | ||||||||||
2008 % |
2007 % |
2006 % |
2005 % |
2004a % | ||||||
United Kingdom |
50.7 | 56.6 | 64.2 | 64.6 | 68.1 | |||||
Other European Union |
41.8 | 60.9 | 65.1 | 70.1 | 60.9 | |||||
United States |
31.8 | 9.5 | 64.9 | 52.8 | 57.0 | |||||
Africa |
39.5 | 62.1 | 73.2 | 74.3 | 68.4 | |||||
Rest of the World |
49.2 | 86.5 | 100.0 | 68.7 | 71.9 | |||||
Total coverage of credit risk loans |
41.9 | 39.1 | 65.6 | 66.2 | 66.9 | |||||
Total coverage of credit risk loans excluding ABS CDO Super Senior exposure |
48.0 | 55.3 | 65.6 | 66.2 | 66.9 |
Table 31: Total impairment allowance/(provision) coverage of potential credit risk lending (CRLs and PPLs) | ||||||||||
2008 % |
2007 % |
2006 % |
2005 % |
2004a % | ||||||
United Kingdom |
44.0 | 51.8 | 57.3 | 54.6 | 56.5 | |||||
Other European Union |
29.5 | 55.1 | 61.0 | 65.9 | 55.6 | |||||
United States |
29.2 | 7.6 | 57.1 | 50.4 | 52.3 | |||||
Africa |
37.1 | 43.4 | 51.5 | 57.8 | 43.5 | |||||
Rest of the World |
45.5 | 86.5 | 91.0 | 67.6 | 65.9 | |||||
Total coverage of potential credit risk lending |
36.2 | 33.0 | 57.0 | 56.2 | 56.0 | |||||
Total coverage of potential credit risk lenders excluding ABS CDO Super Senior exposure |
39.6 | 47.7 | 57.0 | 56.2 | 56.0 |
Allowance coverage of credit risk loans and potential credit risk loans excluding the drawn ABS CDO Super Senior exposure decreased to 48.0% (31st December 2007: 55.3%) and 39.6% (31st December 2007: 47.7%), respectively. The decrease in these ratios reflected a change in the mix of credit risk loans and potential credit risk loans: unsecured retail exposures, where the recovery outlook is relatively low, decreased as a proportion of the total as the collections and underwriting processes were improved. Secured retail and wholesale and corporate exposures, where the recovery outlook is relatively high, increased as a proportion of credit risk loans and potential credit risk loans.
Note
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
134 | Barclays Annual Report 2008 |
Risk management
Barclays Annual Report 2008 |
135 |
136 | Barclays Annual Report 2008 |
138 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
139 |
140 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 | 141 |
142 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
143 |
Corporate governance report
144 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
145 |
Corporate governance
Corporate governance report
146 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 | 147 |
Corporate governance
Corporate governance report
148 | Barclays Annual Report 2008 |
Board and Committee Membership and Attendance
The table below sets out attendance of Directors at Board and Committee meetings in 2008.
Independent | Scheduled Board |
Additional Board |
Board Audit Committee |
Board HR & Remuneration Committee |
Board Corporate Governance & Nominations Committee |
Board Risk Committee | ||||||||
Number of meetings held |
7 | 23 | 10 | 5 | 2 | 4 | ||||||||
Group Chairman |
||||||||||||||
Marcus Agius |
OA | 7 | 23 | | 5 | 2 | | |||||||
Executive Directors |
||||||||||||||
John Varley (Group Chief Executive) |
ED | 7 | 23 | | | | | |||||||
Bob Diamond |
ED | 7 | 22 | | | | | |||||||
Gary Hoffman (left the Board 31st August 2008) |
ED | 5 | 7 | | | | | |||||||
Chris Lucas |
ED | 7 | 23 | | | | | |||||||
Frits Seegers |
ED | 6 | 20 | | | | | |||||||
Non-executive Directors |
||||||||||||||
David Booth |
I | 7 | 22 | | | | 4 | |||||||
Sir Richard Broadbent (Senior Independent Director) |
I | 7 | 21 | | 5 | 2 | 4 | |||||||
Leigh Clifford |
I | 7 | 13 | | 4 | | | |||||||
Fulvio Conti |
I | 7 | 17 | 9 | | | | |||||||
Dr Danie Cronjé (left the Board 24th April 2008) |
I | 2 | | | | | 1 | |||||||
Professor Dame Sandra Dawson |
I | 7 | 21 | 10 | | | | |||||||
Sir Andrew Likierman |
I | 7 | 18 | 8 | | | 4 | |||||||
Sir Michael Rake |
I | 6 | 21 | 7 | | | | |||||||
Sir Nigel Rudd (Deputy Chairman) |
I | 7 | 20 | | | 2 | | |||||||
Stephen Russell |
I | 6 | 13 | 10 | | 2 | 3 | |||||||
Sir John Sunderland |
I | 7 | 20 | | 4 | 1 | | |||||||
Patience Wheatcroft |
I | 7 | 22 | | | | |
Key
OA | Independent on appointment | |
ED | Executive Director | |
I | Independent non-executive Director |
Barclays Annual Report 2008 |
149 |
Corporate governance
Corporate governance report
Board Audit Committee Chairmans Statement
We held ten meetings in 2008 and an overview of how we used our meetings is set out below.
Our areas of focus in 2008 were dominated by the continuing disruption to the credit markets and financial services sector as a whole. In early 2008, we held a separate session of the Committee on accounting for and valuation of derivatives and complex financial instruments and also reviewed the Groups valuation methodology for these instruments. The latter comprises trading desk evaluation supported by independent price testing and benchmarking, followed by a review by Finance and Risk and by the external auditor.
When considering the Groups preliminary and half-year results and interim management statements, we spent a significant amount of time reviewing the disclosures around and the fair value of Barclays Capitals credit markets exposures, including asset backed securities and leveraged credit positions. As part of the approval of each results statement, we reviewed the fair value of the credit market exposures and the form and content of the disclosures. The review of the credit market exposure valuations included a review of marks by key asset categories, movements in exposures (including sales/paydowns) and a review of underlying collateral by vintage and rating. The Committee received at both the half-year and year-end and before each Interim Management Statement a specific presentation from Barclays Capitals Chief Operating Officer and discussed the valuations with the Group Finance Director, Group Risk Director and, importantly, the Groups external auditors. Reassurance was sought from independent Group control functions such as Risk and Finance, and the external auditors, that the individual marks were appropriate. The Committee was reassured that there were no significant variations between the prices at which assets were sold and the underlying marks. The Committee was content that the markets and models to which the valuations are marked are sufficiently robust to enable reliable and relevant valuations to be determined.
We also reviewed the controls around Barclays Capitals complex financial instruments, as well as reviewing the overall control environment at Barclays Capital. The Committee has sought to learn lessons from events at our peers, receiving reports on the circumstances surrounding losses experienced at Société Générale and UBS. We discussed the overall impact of market conditions and the challenging financial markets on the remit of the Committee and this will help shape our agenda for 2009.
In the second half of the year, as the financial crisis started to evolve into a global economic downturn, the Committee directed increasing attention at the deepening economic downturn, reviewing the key controls by which consequent risk can be managed. As a result, impairment measurement, fraud controls, collections activities and day-to-day credit controls and security documentation are receiving increased scrutiny from the Committee. During the year we also received additional presentations and reports on the impact of the acquisition of the Lehman Brothers North
|
American businesses in September 2008, including an initial assessment of the risks and controls in that business and a report on the impact of the acquisition on financial reporting. In reviewing the Internal Audit Plan for 2009, we also challenged management to make sure that the Internal Audit function is appropriately resourced for the challenges ahead and is directing its attention on areas likely to come under pressure in the expected downturn.
Impairment numbers continue to be closely reviewed by the Committee. It reviews a paper prepared by the Risk function, which examines impairment on a business-by-business basis. It examines closely any amendments or overrides to models, compares trends and impairment levels with peers and seeks independent reassurance from the external auditor.
Our reviews of the control environment in each of our businesses in 2008 continued to focus on those areas where the Groups business is expanding or which are deemed to be higher risk, including Emerging Markets. We also reviewed the controls around our key regulatory programmes, in particular, Sarbanes-Oxley and Basel II, and received regular reports on Sanctions compliance and Know Your Customer and Anti-Money Laundering controls.
The internal and external auditors are evaluated annually. Feedback on both is sought from key stakeholders in the Group via questionnaires with the results being presented to and discussed by the Committee. The Committee is satisfied with the performance of both auditors. During 2009, an external assessment of the internal audit function will be undertaken. The Committee has recommended to the Board and to shareholders that PwC should be re-appointed as the Groups auditors at the AGM on 23rd April 2009. We are fully satisfied that PwC provides effective, independent challenge to management, which has been crucial in the current difficult environment, and has provided valued support to the Committee in the advice given and the clarity of their briefings and reports. The feedback received from other stakeholders through the annual evaluation exercise has been positive.
As Chairman of the Committee, I have liaised as appropriate with the Chairman of the Board HR and Remuneration Committee, particularly to draw attention to any specific aspects of the Groups results which I feel he ought to be aware of when determining appropriate levels of compensation.
The Committee can confirm that it received sufficient, reliable and timely information from management to enable it to fulfil its responsibilities.
Stephen Russell Chairman of the Board Audit Committee 5th March 2009 |
150 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
151 |
Corporate governance
Corporate governance report
152 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
153 |
Corporate governance
Corporate governance report
154 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
155 |
Corporate governance
Corporate governance report
156 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
157 |
Remuneration Report
158 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
159 |
Corporate governance
Remuneration Report
Executive Directors Pay
Table 1a: Executive Directors annual remuneration | ||||||||
Element | Purpose | Delivery | Programme summary | When normally received/ awarded | ||||
Salary | To reflect the market value of the individual and their role | Cash Monthly Pensionable |
Reviewed annually, with any increases typically effective on 1st April |
Paid in year | ||||
Annual performance bonus (cash) | To incentivise the delivery of annual goals at the Group, business division and individual levels | No more than 75% of annual performance bonus paid in cash At least 25% recommended as deferred share awards under ESAS Non-pensionable |
Based on annual business unit performance, performance of the Group as a whole and individual contribution |
Normally paid in the following financial year | ||||
Total cash | Sub-total of the above | |||||||
Deferred share award (ESAS) | To align annual performance with shareholder value and increase retention | At least 25% of annual performance bonus recommended as deferred share awards under ESAS Non-pensionable |
Discretionary awards of shares to be deferred for three to five years. No performance condition on release, as a deferred share award 20% bonus shares releasable after three years, a further 10% after five years Dividends normally accumulated during deferral period |
Normally awarded in the following financial year | ||||
Long-term incentive (PSP) | To reward the creation of above median, sustained growth in shareholder value and Economic Profit (EP) performance | Annual awards of shares that vest after three years, subject to performance conditions Non-pensionable |
Discretionary awards Participation reviewed annually Barclays performance over three years determines the performance shares eligible for release to each individual |
Normally awarded in the following financial year | ||||
Total direct remuneration | Total of the above | |||||||
Pension (or cash allowance) | To provide a market competitive post-retirement benefit | Deferred cash or cash allowance Monthly |
Non-contributory, defined benefit scheme and/or defined contribution scheme, or cash allowance in lieu of pension contributions |
Paid or accrued during year | ||||
Other benefits | To provide market competitive benefits | Benefit in kind, or cash allowance Non-pensionable |
Benefits include private medical, insurance life and disability cover, accommodation overseas when required for business purposes, use of company owned vehicle or cash equivalent and tax advice |
Received during year | ||||
Sub-total in accordance with Companies Act 1985 | Total of Salary, Annual Cash Bonus, Other Benefits and Pension Cash Allowance |
160 | Barclays Annual Report 2008 |
Table 1b: Executive Directors annual remuneration | ||||||||||||||||
John Varley | Robert E Diamond Jr | Chris Lucas | Frits Seegers | |||||||||||||
2008 £000 |
2007 £000 |
2008 £000 |
2007 £000 |
2008 £000 |
2007 £000 |
2008 £000 |
2007 £000 | |||||||||
Salary |
1,075 | 975 | 250 | 250 | 638 | 450 | 700 | 700 | ||||||||
Annual performance bonus (cash) |
0 | 1,425 | 0 | 6,500 | 0 | 450 | 0 | 1,313 | ||||||||
Total cash |
1,075 | 2,400 | 250 | 6,750 | 638 | 900 | 700 | 2,013 | ||||||||
Deferred share award (ESAS) |
0 | 618 | 0 | 11,375 | 0 | 195 | 0 | 569 | ||||||||
Fair value of long- term incentive (PSP) award |
0 | 1,200 | 0 | 3,000 | 800 | 800 | 1,600 | 1,600 | ||||||||
Total direct remuneration |
1,075 | 4,218 | 250 | 21,125 | 1,438 | 1,895 | 2,300 | 4,182 | ||||||||
Pension (or cash allowance) |
Member of pension scheme. See page 164 |
Member of pension scheme. See page 164 |
Member of pension scheme. See page 164 |
Member of pension scheme. See page 164 |
159 | 113 | 175 | 175 | ||||||||
Other benefits |
23 | 18 | 66 | 14 | 18 | 22 | 27 | 24 | ||||||||
Sub-total in accordance with Companies Act 1985 |
1,098 | 2,418 | 316 | 6,764 | 815 | 1,035 | 902 | 2,212 |
Barclays Annual Report 2008 |
161 |
Corporate governance
Remuneration Report
Share Plans
Table 3: Long-term plans and deferred share plans | |||||||||||||
Number of shares under award/option 1st January 2008 (maximum) |
Awarded in year (maximum) |
Market price on award date |
Adjusted weighted average exercise price |
Number released/ exercised |
|||||||||
John Varley |
|||||||||||||
PSP 2005-2007 |
426,135 | | £ | 5.30 | | | |||||||
PSP 2006-2008 |
461,244 | | £ | 6.75 | | | |||||||
PSP 2007-2009 |
491,130 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
| 791,208 | £ | 4.25 | | | |||||||
ISOP |
920,000 | | | £ | 4.29 | | |||||||
Sharesave |
3,638 | | | £ | 4.70 | | |||||||
ESAS |
344,711 | 135,715 | £ | 4.25 | | (23,214 | ) | ||||||
Robert E Diamond Jr |
|||||||||||||
PSP 2005-2007 |
156,249 | | £ | 5.30 | | | |||||||
PSP 2006-2008 |
2,306,208 | | £ | 6.75 | | | |||||||
PSP 2007-2009 |
2,803,548 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
| 1,978,020 | £ | 4.25 | | | |||||||
ISOP |
560,000 | | | £ | 4.42 | | |||||||
ESOS |
100,000 | | | £ | 3.97 | | |||||||
RIO cash release |
| | | | | ||||||||
BGI EOP |
100,000 | | | £ | 20.11 | | |||||||
ESAS |
4,863,749 | 4,131,868 | £ | 4.25 | | (2,131,463 | ) | ||||||
Chris Lucas |
|||||||||||||
PSP 2007-2009 |
248,730 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
| 527,472 | £ | 4.25 | | | |||||||
Sharesave |
3,638 | | | £ | 4.70 | | |||||||
ESAS |
69,091 | 42,857 | £ | 4.25 | | (34,546 | ) | ||||||
Frits Seegers |
|||||||||||||
PSP 2006-2008 |
473,184 | | £ | 6.30 | | | |||||||
PSP 2007-2009 |
409,278 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
| 1,054,944 | £ | 4.25 | | | |||||||
Sharesave |
3,390 | | | £ | 4.70 | | |||||||
ESAS |
231,383 | 125,000 | £ | 4.25 | | (80,221 | ) |
Table 4: Performance conditions attaching to the share plans in which the executive Directors participate | ||||||
Scheme |
Performance period |
Performance measure |
Target | |||
PSP |
2008 -2010 | 50% of award calibrated against TSR | 33% of maximum award released for above median performance (6th place) with 100% released in 1st place and a scaled basis in between | |||
50% of award calibrated against Cumulative EP over the three year performance period | 33% of maximum award released for £6,921m scaled to 100% of maximum award at £8,350m | |||||
2007-2009 | 50% of award calibrated against TSR | As above | ||||
50% of award calibrated against Cumulative EP over the three year performance period | 33% of maximum award released for £7,618m scaled to 100% of maximum award at £8,668m | |||||
2006-2008 | 50% of award calibrated against TSR | As above | ||||
50% of award calibrated against Cumulative EP over the three year performance period | 33% of maximum award released for £5,661m scaled to 100% of maximum award at £7,073m | |||||
2005-2007 | 100% of award calibrated against TSR | As above |
162 | Barclays Annual Report 2008 |
Cash released |
Market price |
Number lapsed in 2008 |
Adjustment due to open offer |
Adjusted number of shares under award/option at 31st December 2008 (maximum) |
Vested number of shares under option |
Value of release/ exercise |
End of three year PSP performance period, or first exercise/ scheduled release date |
Last exercise/ scheduled release date | |||||||||||
|
| (426,135 | ) | | | | | 31/12/07 | 16/06/08 | ||||||||||
|
| | 12,360 | 473,604 | | | 31/12/08 | 21/03/09 | |||||||||||
|
| | 13,164 | 504,294 | | | 31/12/09 | 22/03/10 | |||||||||||
|
| | 21,204 | 812,412 | | | 31/12/10 | 20/03/11 | |||||||||||
|
| | 24,655 | 944,655 | 944,655 | | 18/05/03 | 22/03/14 | |||||||||||
|
| | 97 | 3,735 | | | 01/11/14 | 01/05/15 | |||||||||||
|
£ | 4.56 | | 12,255 | 469,467 | | £ | 0.1m | 13/03/06 | 20/03/13 | |||||||||
|
| (156,249 | ) | | | | | 31/12/07 | 16/06/08 | ||||||||||
|
| | 61,806 | 2,368,014 | | | 31/12/08 | 21/03/09 | |||||||||||
|
| | 75,138 | 2,878,686 | | | 31/12/09 | 22/03/10 | |||||||||||
|
| | 53,010 | 2,031,030 | | | 31/12/10 | 20/03/11 | |||||||||||
|
| | 15,008 | 575,008 | 575,008 | | 12/03/04 | 22/03/14 | |||||||||||
|
| (100,000 | ) | | | | | 14/08/01 | 13/08/08 | ||||||||||
£7.425m |
| | | | | £ | 7.42m | 06/02/08 | 15/03/08 | ||||||||||
|
| | | 100,000 | 100,000 | | 26/03/07 | 26/03/14 | |||||||||||
|
£ | 4.56/£4.57 | | 183,958 | 7,048,112 | | £ | 9.74m | 28/02/06 | 20/03/13 | |||||||||
|
| | 6,666 | 255,396 | | | 31/12/09 | 22/03/10 | |||||||||||
|
| | 14,136 | 541,608 | | | 31/12/10 | 20/03/11 | |||||||||||
|
| | 97 | 3,735 | | | 01/11/14 | 01/05/15 | |||||||||||
|
£ | 4.45 | | 2,075 | 79,477 | | £ | 0.16m | 31/03/08 | 20/03/13 | |||||||||
|
| | 12,684 | 485,868 | | | 31/12/08 | 04/08/09 | |||||||||||
|
| | 10,968 | 420,246 | | | 31/12/09 | 22/03/10 | |||||||||||
|
| | 28,272 | 1,083,216 | | | 31/12/10 | 20/03/11 | |||||||||||
|
| | 90 | 3,480 | | | 01/11/12 | 01/05/13 | |||||||||||
|
£ | 2.91 | | 9,550 | 285,712 | | £ | 0.23m | 29/06/07 | 20/03/13 |
TSR Peer group constituents |
||||||||
UK | Mainland Europe | US | Underpin | Actual performance | ||||
HBOS, HSBC, Lloyds TSB, Royal Bank of Scotland |
Banco Santander, BBVA, BNP Paribas, Deutsche Bank, UBS |
Citigroup, JP Morgan Chase |
Cumulative EP over performance period must exceed cumulative EP over previous three years | To be determined at vesting in March 2011 | ||||
|
||||||||
As above |
As above | To be determined | ||||||
|
at vesting in March 2010 | |||||||
As above |
As above | Performance condition | ||||||
partially met | ||||||||
|
||||||||
As above |
As above | TSR performance condition not met |
Barclays Annual Report 2008 |
163 |
Corporate governance
Remuneration Report
Table 5: Pension provision
| ||||||||||||||||||||
Age at 31st December |
Completed years of service |
Accrued £000 |
Pension accrued during 2008 (including increase for inflation) £000 |
Pension accrued during 2008 (excluding inflation) £000 |
Accrued December £000 |
Transfer value of December £000 |
Transfer December £000 |
Increase in transfer value during the year £000 |
Annual cash in lieu of pension £000 | |||||||||||
John Varley |
52 | 26 | 489 | 83 | 59 | 572 | 9,463 | 12,328 | 2,865 | | ||||||||||
Robert E Diamon Jr |
57 | 12 | 38 | 7 | 5 | 45 | 214 | 280 | 66 | | ||||||||||
Chris Lucas |
48 | 1 | | | | | | | | 159 | ||||||||||
Frits Seegers |
50 | 2 | | | | | |
| | 175 |
164 | Barclays Annual Report 2008 |
Table 9: Contract terms | ||||||
Effective date of contract |
Notice period from the Company |
Potential compensation for loss of office | ||||
Executive Directors |
||||||
John Varley |
1st September 2004 | 12 months | 12 months base salary, bonus and continuation of medical and pension benefits whilst an employee | |||
Robert E Diamond Jr |
1st June 2005 | 12 months | 12 months base salary, bonus and continuation of medical and pension benefits whilst an employee | |||
Chris Lucas |
1st April 2007 | 12 months | 12 months base salary, bonus equivalent to the average of the previous three years up to 100% of base salary and continuation of medical and pension benefits whilst an employee | |||
Frits Seegers |
7th June 2006 | 12 months | 12 months base salary, bonus and continuation of medical and pension benefits whilst an employee |
Table 10: Other directorships held by the executive Directors and fees retained
2008 | 2007 | |||||||||||||
Director | Organisation | Fees | Fees retained |
Fees | Fees retained | |||||||||
John Varley |
British Grolux Investments Limited | £ | 7,788 | £ | 7,788 | £ | 7,613 | £ | 7,613 | |||||
AstraZeneca plc | £ | 83,333 | £ | 83,333 | £ | 56,486 | £ | 56,486 | ||||||
International Advisory Panel of the Monetary Authority of Singapore | US$ | 0 | US$ | 0 | US$ | 10,000 | US$ | 10,000 | ||||||
Robert E Diamond Jr |
Old Vic Productions plc | £ | 0 | £ | 0 | £ | 0 | £ | 0 | |||||
Frits Seegers |
Absa Group Limited and Absa Bank Limited | £ | 26,807 | £ | 0 | £ | 33,363 | £ | 0 | |||||
Chris Lucas |
| | | | |
Barclays Annual Report 2008 |
165 |
Corporate governance
Remuneration Report
Table 11: Fees | ||||||||||||||||||||||
Chairman £000 |
Deputy Chairman £000 |
Board Member £000 |
Senior Independent Director £000 |
Audit Committee £000 |
Board HR and Remuneration Committee £000 |
Board Corporate Governance and Nominations Committee £000 |
Board Risk Committee £000 |
Benefits £000 |
Total 2008 £000 |
Total 2007 £000 | ||||||||||||
Full-year fee |
||||||||||||||||||||||
(at 31st Dec 08) |
750 | 200 | 70 | 30 | | | | | | | | |||||||||||
Full-year fee Committee Chair |
||||||||||||||||||||||
(at 31st Dec 08) |
| | | | 60 | 40 | | 40 | | | | |||||||||||
Full-year fee Committee Member |
||||||||||||||||||||||
(at 31st Dec 08) |
| | | | 25 | 15 | 15 | 15 | | | | |||||||||||
Fees to 31st December 2008 | ||||||||||||||||||||||
Group Chairman |
||||||||||||||||||||||
Marcus Agius |
750 | | | | | M. | Ch. | | 1 | 751 | 751 | |||||||||||
Non-executive Directors |
||||||||||||||||||||||
David Booth |
| | M. | | | | | M. | | 83 | 43 | |||||||||||
Sir Richard Broadbent |
| | M. | Snr. Ind. | | Ch. | M. | Ch. | | 188 | 180 | |||||||||||
Leigh Clifford AO |
| | M. | | | M. | | | | 115 | 97 | |||||||||||
Fulvio Conti |
|
| M. |
| M. | | | | | 90 | 85 | |||||||||||
Professor Dame Sandra Dawson | | | M. | | M. | | | | | 90 | 85 | |||||||||||
Sir Andrew Likierman |
| | M. | | M. | | | M. | | 105 | 100 | |||||||||||
Sir Michael Rake |
| | M. | | M. | | | | | 90 | | |||||||||||
Sir Nigel Rudd DL |
| D. Ch. | | | | | M. | | | 200 | 200 | |||||||||||
Stephen Russell |
| | M. | | Ch. | | M. | M. | | 153 | 145 | |||||||||||
Sir John Sunderland |
| | M. | | | M. | M. | | | 98 | 95 | |||||||||||
Patience Wheatcroft |
| | M. | | | | | | | 78 | |
Patience Wheatcroft was a member of the Brand and Reputation Committee for which the full year fee is £15,000. Leigh Clifford was also a member of the Asia Pacific Advisory Committee and received fees of US$60,000 (2007: US$35,000). These fees are included in those shown above.
Table 12: Shareholdings | ||||||
At 1st January total |
At 31st total |
At 27th total | ||||
Group Chairman |
||||||
Marcus Agius |
86,136 | 113,148 | 113,148 | |||
Non-executive Directors |
||||||
David Booth |
50,374 | 64,248 | 64,248 | |||
Sir Richard Broadbent |
14,026 | 24,625 | 24,625 | |||
Leigh Clifford AO |
18,872 | 26,236 | 26,236 | |||
Fulvio Conti |
10,067 | 30,482 | 30,482 | |||
Professor Dame |
||||||
Sandra Dawson |
12,040 | 18,859 | 18,859 | |||
Sir Andrew Likierman |
8,137 | 13,297 | 13,297 | |||
Sir Michael Rake |
2,700 | 6,399 | 6,399 | |||
Sir Nigel Rudd DL |
84,843 | 107,569 | 107,569 | |||
Stephen Russell |
21,054 | 30,459 | 30,459 | |||
Sir John Sunderland |
31,658 | 71,463 | 71,463 | |||
Patience Wheatcroft |
828 | 4,144 | 4,144 |
Table 13: Terms of Letters of Appointment | ||||||
Effective date |
Notice period from the Company |
Potential compensation for loss of office | ||||
Group Chairman |
||||||
Marcus Agius |
1st Jan 2007 |
12 months |
12 months contractual remuneration | |||
Non-executive Directors |
||||||
David Booth |
1st May 2007 | 6 months | 6 months fees | |||
Sir Richard Broadbent |
1st Sep 2003 | 6 months | 6 months fees | |||
Leigh Clifford AO |
1st Oct 2004 | 6 months | 6 months fees | |||
Fulvio Conti |
1st Apr 2006 | 6 months | 6 months fees | |||
Professor Dame |
||||||
Sandra Dawson |
1st Mar 2003 | 6 months | 6 months fees | |||
Sir Andrew Likierman |
1st Sep 2004 | 6 months | 6 months fees | |||
Sir Michael Rake |
1st Jan 2008 | 6 months | 6 months fees | |||
Sir Nigel Rudd DL |
1st Feb 1996 | 6 months | 6 months fees | |||
Stephen Russell |
25th Oct 2000 | 6 months | 6 months fees | |||
Sir John Sunderland |
1st Jun 2005 | 6 months | 6 months fees | |||
Patience Wheatcroft |
1st Jan 2008 | 6 months | 6 months fees |
166 | Barclays Annual Report 2008 |
Former Directors
Gary Hoffman and Dr Danie Cronjé ceased to be Directors during the year.
Mr Hoffman resigned as a Director on 23rd July 2008 and ceased to be an executive Director on 31st August 2008. His employment ceased on 30th September 2008. On cessation of his directorship and employment, Mr Hoffman received no termination payments and it was mutually agreed that his full notice period would be waived without payment in lieu, to allow him to take up his appointment at Northern Rock. Dr Cronjé did not put himself forward for re-election at the 2008 AGM and received no termination payments. Their remuneration received during the year was as follows:
Table 14: Annual remuneration | ||||||||||||||
Received for 2008 | ||||||||||||||
Salary £000 |
Annual £000 |
Deferred £000 |
Long term £000 |
Benefits £000 |
Total £000 |
Total 2007 £000 | ||||||||
Gary Hoffman |
417 | 298 | | | 9 | 724 | 1,146 | |||||||
Dr Danie Cronjé |
25 | | | | | 25 | 217 |
Mr Hoffman received his normal monthly salary benefits and pro-rated annual cash bonus, total of £90,477 for the period between the cessation of his directorship and 30th September 2008.
The former Directors beneficial shareholdings were as follows:
Table 15: Shareholdings at date of cessation as Director | ||||
At 1st January 2008 total beneficial holdings |
At date of cessation as Director total beneficial holdings | |||
Gary Hoffman |
431,761 | 542,979 | ||
Dr Danie Cronjé |
5,146 | 6,416 |
Dr Cronjé also held 11,700 preference shares in Absa Bank Limited and 101,577 ordinary shares in Absa Bank Limited at 31st January 2008 and 24th April 2008.
Mr Hoffman participates in the UK closed defined benefit pension scheme providing a pension at the normal retirement age of 60 at an accrual rate of 1/60th of pensionable salary for each year of pensionable service.
Table 16: Pension provision | ||||||||||||||||||||
Age at 31st August 2008 |
Completed years of service |
Accrued at 31st |
Pension accrued during 2008 (including increase for inflation) £000 |
Pension accrued during 2008 (excluding inflation) £000 |
Accrued at 31st |
Transfer at 31st |
Transfer at 31st |
Increase in transfer value during the year £000 | ||||||||||||
Gary Hoffman |
47 | 25 | 273 | (1 | ) | (15 | ) | 272 | 2,598 | 2,824 | 226 |
In addition to the value of the accrued pension at 31st August 2008, Mr Hoffman also had defined contribution benefits in respect of Special Company Contributions (bonus sacrifice). The fund value of this arrangement was £626,412 as at 31st August 2008. The scheme also provided, whilst in employment, a death in service dependants pension of 50% of the pension that would have been payable if employment had continued until normal pension age.
The terms of Mr Hoffmans contract and Dr Cronjés letter of appointment were:
Table 17: Terms of contract or letter of appointment | ||||||
Effective date | Notice period from the Company |
Potential compensation for loss of office | ||||
Gary Hoffman |
1st January 2004 | 12 months | 12 months base salary, bonus equivalent to the average of the previous three years up to 100% of base salary, and continuation of medical and pension benefits whilst an employee | |||
Dr Danie Cronjé |
1st September 2005 | 6 months | 6 months fees |
Mr Hoffmans other Directorships and fees retained were:
Table 18: Other Directorships held by Gary Hoffman | ||||||||||||
2008 | 2007 | |||||||||||
Organisation | Fees £000 |
Fees retained £000 |
Fees £000 |
Fees retained £000 | ||||||||
Visa (Europe) Limited |
£ | 0 | £ | 0 | £ | 0 | £ | 0 | ||||
Trinity Mirror plc |
£ | 46,666 | £ | 46,666 | £ | 62,754 | £ | 62,754 | ||||
Barclays Pension Fund Trustees Limited |
£ | 12,500 | £ | 12,500 | | |
Mr Hoffman was retained as a Director of Barclays Pension Fund Trustees Limited following cessation of his employment on 30th September 2008. The fees disclosed represent those paid to him for the remainder of 2008.
Barclays Annual Report 2008 |
167 |
Corporate governance
Remuneration Report
Table 19: Executive Share Award Scheme (ESAS)
Scheme | Number at beginning of year (maximum) |
Awarded (maximum) |
Market price on award date |
Number released |
Market price on release date |
Number lapsed |
Adjustment due to open offer |
Adjusted number at 31/08/08 (maximum) |
Value of release |
First release date |
Last release date | |||||||||||||||
Gary Hoffman |
||||||||||||||||||||||||||
ESAS |
177,314 | 48,215 | £ | 4.25 | (19,273 | ) | £ | 4.56 | | 5,527 | 211,783 | £ | 0.1m | 13/03/06 | 20/03/11 |
Table 20: Voluntary Executive Share Award Scheme (VESAS)
Scheme | Number at beginning of year (maximum) |
Awarded (maximum) |
Adjusted exercise price |
Number vested in year |
Number exercised |
Market date |
Number lapsed |
Adjustment due to open offer |
Adjusted number 31/08/08 (maximum) |
Vested number of share options |
Value of exercise |
First exercise date |
Last exercise date | |||||||||||||
Gary Hoffman |
||||||||||||||||||||||||||
VESAS |
97,088 | | nil | | | | | 2,602 | 99,690 | 92,022 | | 05/03/07 | 29/09/09 |
Table 21: Performance Share Plan (PSP)
Maximum number of shares at beginning of year |
Maximum of shares the year |
Market price on award date |
Number released |
Market price on release/ lapse date |
Number lapsed |
Adjustment due to open offer |
Adjusted maximum number of shares at 31/08/08 |
Value of release |
End of three year performance period |
Scheduled release date | ||||||||||||||
Gary Hoffman |
||||||||||||||||||||||||
2005 |
227,274 | | £ | 5.30 | | | (227,274 | ) | | | | 31/12/07 | 16/06/08 | |||||||||||
2006 |
288,276 | | £ | 6.75 | | | | 7,728 | 296,004 | | 31/12/08 | 21/03/09 | ||||||||||||
2007 |
255,798 | | £ | 7.08 | | | | 6,858 | 262,656 | | 31/12/09 | 22/03/10 | ||||||||||||
2008 |
| 412,086 | £ | 4.25 | | | | 11,046 | 423,132 | | 31/12/10 | 20/03/11 |
Table 22: Incentive Share Option Plan (ISOP)
Scheme | Number at beginning of year (maximum) |
Awarded in year (maximum) |
Adjusted weighted exercise price |
Number vested in year |
Number exercised |
Market price on exercise/ lapse date |
Number lapsed |
Adjustment due to open offer |
Adjusted number at 31/08/08 (maximum) |
Vested number of share options |
Value of exercise |
First exercise date |
Last exercise date | ||||||||||||||
Gary Hoffman |
|||||||||||||||||||||||||||
ISOP |
540,000 | | £ | 4.39 | | | | | 14,472 | 554,472 | 554,472 | | 12/03/04 | 29/09/09 |
Table 23: Sharesave
Number at beginning of year (maximum) |
Awarded in year (maximum) |
Adjusted weighted exercise price |
Number vested in year |
Number exercised |
Market price on exercise date |
Adjusted number |
Adjustment due to open offer |
Adjusted number at 31/08/08 (maximum) |
Vested number of share options |
Value of exercise |
First exercise date |
Last exercise date | |||||||||||||||||
Gary Hoffman |
|||||||||||||||||||||||||||||
Total |
6,150 | | £ | 4.24 | | | | | 163 | 6,313 | | | n/a | n/a |
168 | Barclays Annual Report 2008 |
Share and Long Term Incentive Plans
Barclays operates a number of Group-wide plans. Summaries of the principal plans are set out below. Barclays has a number of employee benefit trusts which operate with these plans. In some cases, the trustees grant awards and purchase shares in the market to satisfy awards as required, in others, new issue or treasury shares may be used to satisfy awards where the appropriate shareholder approval has been obtained. The number of shares held by the trustees is set out in Note 32 on page 229. The limits on the issue of new shares comply with the guidelines issued by the Association of British Insurers.
Table 24: Plans under which awards made in 2008
Plan name
|
Executive
|
Description
| ||
Performance Share Plan (PSP) |
Yes | PSP is a performance related share plan under which awards of Barclays shares may be made to selected employees (including executive Directors), subject to trustee discretion. | ||
The PSP trustee may select any employee of the Group to participate in the plan. | ||||
Awards are granted by the PSP trustee, in consultation with the Remuneration Committee and are communicated as provisional allocations to participants. No right to the shares arises until the PSP trustee releases the shares. | ||||
Participants do not pay for a grant or release of an award. | ||||
Awards are normally releasable on or after the third anniversary of grant, to the extent that applicable performance conditions are satisfied, subject to trustee discretion. | ||||
Any awards released may also include an additional number of shares equivalent to any dividends that would have been paid on the shares between the date of grant and release. | ||||
Normally, the maximum expected value of an award made to an employee at the date of grant is the higher of 150% of base salary, or 75% of base salary and target bonus. Maximum awards reflect the relevant market for each executive Director. Awards are communicated on grant as an expected value, this is a single value for the award at grant, which takes into account the sum of the various possible performance and vesting outcomes. | ||||
On cessation of employment, eligible leavers (as defined) normally receive an award pro rated for time and performance subject to trustee discretion. For other leavers, awards will normally lapse. | ||||
On a change of control awards may vest at the PSP trustees discretion and may be pro rated for time and performance to the date of change of control. | ||||
PSP is not an HMRC approved plan. | ||||
The plan was approved for a ten year period by shareholders in April 2005.
| ||||
Executive Share Award Scheme (ESAS) |
Yes |
ESAS is a deferred share award plan operated in conjunction with various Barclays Group bonus plans for selected employees (including executive Directors), subject to trustee discretion. | ||
Awards are granted by the ESAS trustee having first consulted with the Remuneration Committee. | ||||
For certain eligible employees a proportion of discretionary annual bonus is delivered in cash and a proportion is as a recommended mandatory provisional allocation of Barclays shares under ESAS. Normally, for executive Directors, a minimum of 25% of bonus is delivered as a recommended mandatory award under ESAS with 75% delivered as cash. | ||||
The mandatory provisional allocation will normally include bonus shares equal to 30% of the value of the deferred bonus amount awarded in shares. Bonus shares are awarded to recognise the interest that a participant forgoes on the deferred part of the discretionary bonus. | ||||
Under mandatory ESAS awards, nil cost options are typically granted three years from award, subject to the discretion of the ESAS trustee. Participants may then call for the shares plus two thirds of the bonus shares and any associated dividend shares. If the nil cost option is not exercised by the end of the two year period, the ESAS trustee may release all shares, bonus shares and any dividend shares to the participant. | ||||
In addition to mandatory ESAS, participants may also request to waive any bonus (or part of a bonus) to which they may become entitled and request that a voluntary ESAS award be made to them in the form of a nil cost option. Voluntary ESAS awards are typically fully exercisable after five years, and include bonus shares equal to 30% of the waived bonus amount. Dividend shares may be awarded, as per mandatory ESAS awards. | ||||
On cessation of employment, a participant may forfeit an award depending on the reason for leaving. Special provisions apply on a change of control. | ||||
ESAS is also used to make certain awards to facilitate the retention and recruitment of new joiners to the Group who have forfeited share awards on leaving previous employment. Typically bonus shares are not awarded, though dividend shares may be awarded, as per mandatory ESAS awards. | ||||
ESAS is not an HMRC approved plan.
| ||||
Incentive shares |
No |
Incentive shares are discretionary share awards that may be made to selected employees (excluding executive Directors), subject to trustee discretion. | ||
Shares are normally released after three years, subject to continued employment and the discretion of the trustee. Dividends received are normally awarded as additional shares and released at the same time. | ||||
On cessation of employment eligible leavers (as defined) normally receive an award pro rated for time in employment, subject to the discretion of the trustee; for other leavers, awards will normally lapse. | ||||
On a change of control awards may vest, pro rated for time to the date of change of control, subject to the discretion of the trustee. | ||||
Incentive shares is not an HMRC approved plan.
|
Barclays Annual Report 2008 |
169 |
Corporate governance
Remuneration Report
Share and Long Term Incentive Plans (continued)
Table 24: Plans under which awards made in 2008 (continued) | ||||
Plan name | Executive Directors Eligible? |
Description | ||
Sharesave | Yes | Sharesave is a share option plan under which all eligible employees in the UK, Ireland and Spain (including executive Directors) are invited to participate. It is HMRC approved in the UK and approved by the Revenue Commissioners in Ireland. | ||
Participants are granted options over Barclays shares which may be at a discount to the market value at the date of award (currently 20%). | ||||
At the expiry of a fixed term (three, five or seven years) participants may use savings to acquire the shares by exercising their option within 6 months of the date of vesting. Participants may save up to £250 per month (500 in Ireland, 135 in Spain) for this purpose. | ||||
On cessation of employment eligible leavers (as defined) may exercise their option to acquire shares to the extent of their savings for a period of 6 months. | ||||
On a change of control, participants may be able to exercise their options to acquire shares to the extent of their savings for a period of 6 months (or a shorter period in certain circumstances). | ||||
The plan was approved for a ten year period by shareholders in April 2000.
| ||||
Sharepurchase |
Yes |
Sharepurchase is an HMRC approved share incentive plan under which all employees in the UK (including executive Directors) are invited to participate. | ||
Participants may purchase up to £1,500 shares each tax year. To encourage employee share ownership, Barclays matches the first £600 of shares purchased by participants on a one-for-one basis. Dividends are also earned in the form of additional shares. | ||||
Purchased shares may be withdrawn from the plan any time. Matching and dividend shares must be held in trust for three years before release, but may be kept in trust for five years. | ||||
On cessation of employment participants must withdraw all shares and depending on the reason for and timing of cessation, the matching shares may be forfeited. | ||||
On a change of control, participants are able to instruct the Sharepurchase trustee how to act or vote on their behalf. | ||||
The plan was approved for a ten year period by shareholders in April 2000.
|
Table 25: New Plans under which awards are to be made 2009 | ||||
Plan name | Executive Directors Eligible? |
Description | ||
BGI Equity Participation Plan | No | The BGI Equity Participation Plan is a share plan under which awards linked to the value of BGI shares may be made to selected BGI employees (excluding executive Directors) in the form of either stock appreciation rights settled in shares or restricted share awards. | ||
Awards normally vest in three equal tranches following the first, second and third anniversary of grant provided there has been no significant deterioration in the performance of Barclays, with delivery in Barclays shares. | ||||
On cessation of employment awards normally vest for eligible leavers (as defined) provided there has been no significant deterioration in the performance of Barclays; for other leavers, awards will normally lapse. | ||||
On a change of control awards may vest provided there has been no significant deterioration in the performance of Barclays.
| ||||
Long Term Cash Plan (LTCP) |
No |
LTCP is a new forward looking plan introduced initially for 2009, under which conditional awards of cash are made to eligible employees, (excluding executive Directors). | ||
Awards are released in portions over a period of time (two years for 2009 awards), subject to continued employment. At the time of the final release, for 2009 awards, a service credit (10% of the initial value of the award) is added. | ||||
Participants must normally be in employment at the time of release in order to receive each portion of the payment. | ||||
Participants who leave employment before the release date of any portion of the award will normally forfeit any outstanding amounts. For categories of eligible leavers an award will vest, pro rated for time in service. | ||||
On a change of control awards may vest at the discretion of the Committee.
|
170 | Barclays Annual Report 2008 |
Share and Long Term Incentive Plans (continued)
Table 26: Plans under which awards not made in 2008
Plan name | Executive Directors Eligible? |
Description | ||
ISOP (Incentive Share Option Plan) |
Yes | The Incentive Share Option Plan is a share option plan under which share options were granted to selected employees (including executive Directors). No options have been granted since 2004. | ||
ISOP contains HMRC approved and unapproved parts. | ||||
Options were awarded at the market price at the date of grant calculated in accordance with the rules of the plan. | ||||
Options granted had an EP threshold and a TSR performance condition associated with them. Options were normally exercisable between three and ten years of the grant date. | ||||
All options granted which met these performance criteria have now vested and are exercisable. | ||||
On cessation of employment eligible leavers (as defined) normally are able to exercise their options; for other leavers, options normally lapse. | ||||
On a change of control options would remain exercisable for a specified period. | ||||
The plan was approved for a ten year period by shareholders in April 2000.
| ||||
ESOS (Executive Share Option Scheme) |
n/a | The Executive Share Option Scheme is a share option plan under which share options were granted to selected employees (including executive Directors). No options have been granted since 2000. | ||
Options were awarded at the market price at the date of grant calculated in accordance with the rules of the plan. | ||||
Options were normally exercisable between three and ten years of the grant date. All options are now vested. | ||||
On cessation of employment eligible leavers (as defined) normally are able to exercise their option pro-rated for performance; for other leavers, options normally lapse. | ||||
On a change of control options remain exercisable for a specified period. | ||||
The plan was adopted for a ten year period by shareholders in 1990.
| ||||
BGI EOP (BGI Equity Ownership Plan) |
No | BGI is Barclays asset management business headquartered in San Francisco. The BGI Equity Ownership Plan (BGI EOP) was approved by shareholders at Barclays 2000 AGM to provide the employee share incentive arrangements required to recruit and retain the quality of senior management and investment talent appropriate for building a global investment management business. | ||
The BGI EOP was designed to provide participants with a long-term equity interest in BGI to meet the expectations of, in particular, BGIs key investment talent in the United States, who could expect to participate in the equity of their employer. Under the terms of the BGI EOP, options were granted at fair value to key BGI employees over shares in Barclays Global Investors UK Holdings Limited (BGI Holdings) within an overall cap of 20% of the issued ordinary share capital of BGI Holdings. | ||||
No options were granted under the BGI EOP in 2008 and no further options will be granted. The plan will not be renewed in 2010 when it comes to the end of its life. | ||||
All grants of options were approved by the Committee. The Committee is also advised of option exercises and share sales by employees. Employees who were executive Directors of Barclays PLC at the date of grant were not eligible to receive options under the BGI EOP. | ||||
In summary the BGI EOP operated as follows: | ||||
certain key BGI employees were granted options over shares in BGI Holdings; | ||||
the option exercise price was based on the fair value of a BGI Holdings share at the date of grant determined by an independent appraiser; | ||||
the options generally vest evenly over a three-year period and can be exercised during the exercise windows which generally occur twice annually; | ||||
option holders are required to fund the exercise without any financial support from any member of the Barclays Group. | ||||
Once employees become shareholders, they are subject to the Articles of BGI Holdings under which: | ||||
shareholders are required to hold the shares for a minimum of 355 days. As shareholders, employees derive the full risks and rewards of ownership, including voting rights and entitlement to any ordinary dividends paid by BGI Holdings; | ||||
on expiry of the minimum holding period, shareholders may, but are not obliged to, offer their shares for sale to Barclays Bank PLC during the sales windows which generally occur twice annually; | ||||
Barclays Bank PLC, at its discretion, has a right to purchase shares so offered, but is not obliged to do so. | ||||
The table below contains information on the number of shares in BGI Holdings over which options were granted, outstanding and exercised in 2007 and 2008: |
Year |
Number (000s) |
Number (000s) |
Number (000s) |
|||||||||||||||
2007 | 2,599 | 7,502 | 1,632 | |||||||||||||||
2008 | | 6,584 | 550 |
In 2008 BGI employees exercised options over 0.5m (2007: 1.6m) shares for consideration of £19m (2007: £57m); Barclays Bank PLC purchased 1.8m (2007: 4.9m) shares offered for sale by shareholders for consideration of £157m (2007: £488m). As at 31st December 2008, employees owned 4.5% of BGI Holdings (2007: 5.9%). |
Barclays Annual Report 2008 |
171 |
Corporate governance
Remuneration Report
Share and Long Term Incentive Plans (continued)
Table 26: Plans under which awards not made in 2008 (continued)
Plan name |
Executive Directors Eligible? | Description | ||
BGI EOP Accounting and disclosure | ||||
The BGI EOP is accounted for as an equity settled share-based payment in accordance with IFRS 2 Share-based Payment. The fair value of the services received from the employees is measured by reference to the fair value of the share options granted on the date of the grant. The cost of the employee services received in respect of the share options granted is recognised in the income statement over the period that the services are received. | ||||
The cost for 2008 of £30.9m (2007: £54.8m, 2006: £37.4m) is included in staff costs in Note 8 to the accounts. In accordance with IFRS 2, details of share options granted and exercised, together with weighted average fair values at grant date and weighted average exercise prices are set out in Note 45 to the accounts. In accordance with IAS 33 Earnings per Share, unexercised options are taken into account in the calculation of diluted earnings per share as set out in Note 11 to the accounts. | ||||
For Group reporting, the exercise of options by employees is treated as a deemed disposal of interests in a subsidiary, as its holding in the subsidiary has been reduced for the consideration represented by the exercise price. Any subsequent purchase of shares offered for sale by employees is treated as a purchase of an additional investment in a subsidiary entity. The cash flows relating to these capital transactions are included in the consolidated cash flow statement and disclosed, along with other disposals and acquisitions, in Note 38 to the accounts and related movements in goodwill and minority interests are included in Notes 21 and 33 to the accounts respectively. |
172 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 | 173 |
Accountability and audit
174 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
175 |
176 | Barclays Annual Report 2008 |
Independent Registered Public Accounting Firms report
Barclays Annual Report 2008 |
177 |
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Barclays Bank PLC:
In our opinion, the accompanying Consolidated income statements and the related Consolidated balance sheets, Consolidated statements of recognised income and expense and Consolidated statements of cash flows present fairly, in all material respects, the financial position of Barclays Bank PLC and its subsidiaries at 31st December 2008 and 31st December 2007, and the results of their operations and cash flows for each of the three years in the period ended 31st December 2008 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. These financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
PricewaterhouseCoopers LLP
London
United Kingdom
5th March 2009
178 | Barclays Annual Report 2008 |
Consolidated accounts Barclays PLC
Barclays Annual Report 2008 |
179 |
Consolidated accounts Barclays PLC
Accounting policies
180 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
181 |
Consolidated accounts Barclays PLC
Accounting policies
182 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
183 |
Consolidated accounts Barclays PLC
Accounting policies
Note
a Where leasehold property has a remaining useful life of less than 15 years, costs of adaptation and installed equipment are depreciated over the remaining life of the lease. |
184 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
185 |
Consolidated accounts Barclays PLC
Accounting policies
186 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
187 |
Consolidated accounts Barclays PLC
188 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
189 |
Consolidated accounts Barclays PLC
For the year ended 31st December
Notes | 2008 £m |
2007 £m |
2006 £m |
||||||||
Continuing operations |
|||||||||||
Interest income |
2 | 28,010 | 25,308 | 21,805 | |||||||
Interest expense |
2 | (16,541 | ) | (15,698 | ) | (12,662 | ) | ||||
Net interest income |
11,469 | 9,610 | 9,143 | ||||||||
Fee and commission income |
3 | 9,489 | 8,678 | 8,005 | |||||||
Fee and commission expense |
3 | (1,082 | ) | (970 | ) | (828 | ) | ||||
Net fee and commission income |
8,407 | 7,708 | 7,177 | ||||||||
Net trading income |
4 | 1,329 | 3,759 | 3,614 | |||||||
Net investment income |
4 | 680 | 1,216 | 962 | |||||||
Principal transactions |
2,009 | 4,975 | 4,576 | ||||||||
Net premiums from insurance contracts |
5 | 1,090 | 1,011 | 1,060 | |||||||
Other income |
6 | 377 | 188 | 214 | |||||||
Total income |
23,352 | 23,492 | 22,170 | ||||||||
Net claims and benefits incurred on insurance contracts |
5 | (237 | ) | (492 | ) | (575 | ) | ||||
Total income net of insurance claims |
23,115 | 23,000 | 21,595 | ||||||||
Impairment charges and other credit provisions |
7 | (5,419 | ) | (2,795 | ) | (2,154 | ) | ||||
Net income |
17,696 | 20,205 | 19,441 | ||||||||
Staff costs |
8 | (7,779 | ) | (8,405 | ) | (8,169 | ) | ||||
Administration and general expenses |
9 | (5,666 | ) | (4,141 | ) | (3,914 | ) | ||||
Depreciation of property, plant and equipment |
23 | (630 | ) | (467 | ) | (455 | ) | ||||
Amortisation of intangible assets |
22 | (291 | ) | (186 | ) | (136 | ) | ||||
Operating expenses |
(14,366 | ) | (13,199 | ) | (12,674 | ) | |||||
Share of post-tax results of associates and joint ventures |
20 | 14 | 42 | 46 | |||||||
Profit on disposal of subsidiaries, associates and joint ventures |
38 | 327 | 28 | 323 | |||||||
Gains on acquisitions |
39 | 2,406 | | | |||||||
Profit before tax |
6,077 | 7,076 | 7,136 | ||||||||
Tax |
10 | (790 | ) | (1,981 | ) | (1,941 | ) | ||||
Profit after tax |
5,287 | 5,095 | 5,195 | ||||||||
Profit attributable to minority interests |
33 | 905 | 678 | 624 | |||||||
Profit attributable to equity holders of the parent |
4,382 | 4,417 | 4,571 | ||||||||
5,287 | 5,095 | 5,195 | |||||||||
p | p | p | |||||||||
Earnings per share |
|||||||||||
Basic earnings per share |
11 | 59.3 | 68.9 | 71.9 | |||||||
Diluted earnings per share |
11 | 57.5 | 66.7 | 69.8 | |||||||
Interim dividend per ordinary share |
11.5 | 11.50 | 10.50 | ||||||||
Proposed final dividend per ordinary share |
1 | | 22.50 | 20.50 | |||||||
£m | £m | £m | |||||||||
Interim dividend paid |
906 | 768 | 666 | ||||||||
Proposed final dividend |
1 | | 1,485 | 1,307 |
The Board of Directors approved the accounts set out on pages 179 to 284 on 5th March 2009.
The accompanying notes form an integral part of the Consolidated accounts.
190 | Barclays Annual Report 2008 |
As at 31st December
Notes | 2008 £m |
2007 £m |
||||||
Assets |
||||||||
Cash and balances at central banks |
30,019 | 5,801 | ||||||
Items in the course of collection from other banks |
1,695 | 1,836 | ||||||
Trading portfolio assets |
12 | 185,637 | 193,691 | |||||
Financial assets designated at fair value: |
||||||||
held on own account |
13 | 54,542 | 56,629 | |||||
held in respect of linked liabilities to customers under investment contracts |
13 | 66,657 | 90,851 | |||||
Derivative financial instruments |
14 | 984,802 | 248,088 | |||||
Loans and advances to banks |
15 | 47,707 | 40,120 | |||||
Loans and advances to customers |
15 | 461,815 | 345,398 | |||||
Available for sale financial investments |
16 | 64,976 | 43,072 | |||||
Reverse repurchase agreements and cash collateral on securities borrowed |
17 | 130,354 | 183,075 | |||||
Other assets |
18 | 6,302 | 5,150 | |||||
Current tax assets |
389 | 518 | ||||||
Investments in associates and joint ventures |
20 | 341 | 377 | |||||
Goodwill |
21 | 7,625 | 7,014 | |||||
Intangible assets |
22 | 2,777 | 1,282 | |||||
Property, plant and equipment |
23 | 4,674 | 2,996 | |||||
Deferred tax assets |
19 | 2,668 | 1,463 | |||||
Total assets |
2,052,980 | 1,227,361 | ||||||
Liabilities |
||||||||
Deposits from banks |
114,910 | 90,546 | ||||||
Items in the course of collection due to other banks |
1,635 | 1,792 | ||||||
Customer accounts |
335,505 | 294,987 | ||||||
Trading portfolio liabilities |
12 | 59,474 | 65,402 | |||||
Financial liabilities designated at fair value |
24 | 76,892 | 74,489 | |||||
Liabilities to customers under investment contracts |
13 | 69,183 | 92,639 | |||||
Derivative financial instruments |
14 | 968,072 | 248,288 | |||||
Debt securities in issue |
149,567 | 120,228 | ||||||
Repurchase agreements and cash collateral on securities lent |
17 | 182,285 | 169,429 | |||||
Other liabilities |
25 | 12,640 | 10,499 | |||||
Current tax liabilities |
1,216 | 1,311 | ||||||
Insurance contract liabilities, including unit-linked liabilities |
26 | 2,152 | 3,903 | |||||
Subordinated liabilities |
27 | 29,842 | 18,150 | |||||
Deferred tax liabilities |
19 | 304 | 855 | |||||
Provisions |
28 | 535 | 830 | |||||
Retirement benefit liabilities |
30 | 1,357 | 1,537 | |||||
Total liabilities |
2,005,569 | 1,194,885 | ||||||
Shareholders equity |
||||||||
Called up share capital |
31 | 2,093 | 1,651 | |||||
Share premium account |
31 | 4,045 | 56 | |||||
Other equity |
31 | 3,652 | | |||||
Other reserves |
32 | 2,793 | 874 | |||||
Retained earnings |
32 | 24,208 | 20,970 | |||||
Less: treasury shares |
32 | (173 | ) | (260 | ) | |||
Shareholders equity excluding minority interests |
36,618 | 23,291 | ||||||
Minority interests |
33 | 10,793 | 9,185 | |||||
Total shareholders equity |
47,411 | 32,476 | ||||||
Total liabilities and shareholders equity |
2,052,980 | 1,227,361 |
The accompanying notes form an integral part of the Consolidated accounts.
Marcus Agius
Group Chairman
John Varley
Group Chief Executive
Christopher Lucas
Group Finance Director
Barclays Annual Report 2008 |
191 |
Consolidated accounts Barclays PLC
Consolidated statement of recognised income and expense
For the year ended 31st December
2008 £m |
2007 £m |
2006 £m |
|||||||
Available for sale reserve: |
|||||||||
Net (losses)/gains from changes in fair value |
(1,741 | ) | 484 | 87 | |||||
Losses transferred to net profit due to impairment |
382 | 13 | 86 | ||||||
Net gains transferred to net profit on disposal |
(209 | ) | (563 | ) | (327 | ) | |||
Net (gains)/losses transferred to net profit due to fair value hedging |
(2 | ) | 68 | 14 | |||||
Cash flow hedging reserve: |
|||||||||
Net gains/(losses) from changes in fair value |
305 | 106 | (437 | ) | |||||
Net losses/(gains) transferred to net profit |
71 | 253 | (50 | ) | |||||
Currency translation differences |
2,407 | 54 | (781 | ) | |||||
Tax |
841 | 54 | 253 | ||||||
Other |
(5 | ) | 22 | 25 | |||||
Amounts included directly in equity |
2,049 | 491 | (1,130 | ) | |||||
Profit after tax |
5,287 | 5,095 | 5,195 | ||||||
Total recognised income and expense for the year |
7,336 | 5,586 | 4,065 | ||||||
Attributable to: |
|||||||||
Equity holders of the parent |
6,213 | 4,854 | 3,682 | ||||||
Minority interests |
1,123 | 732 | 383 | ||||||
7,336 | 5,586 | 4, 065 |
192 | Barclays Annual Report 2008 |
Consolidated cash flow statement
For the year ended 31st December
2008 £m |
2007 £m |
2006 £m |
|||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: |
|||||||||||||
Profit before tax |
6,077 | 7,076 | 7,136 | ||||||||||
Adjustment for non-cash items: |
|||||||||||||
Allowance for impairment |
5,419 | 2,795 | 2,154 | ||||||||||
Depreciation, amortisation and impairment of property, plant, equipment and intangibles |
951 | 669 | 612 | ||||||||||
Other provisions, including pensions |
804 | 753 | 558 | ||||||||||
Net profit from associates and joint ventures |
(14 | ) | (42 | ) | (46 | ) | |||||||
Net profit on disposal of investments and property, plant and equipment |
(371 | ) | (862 | ) | (778 | ) | |||||||
Net profit from disposal of associates and joint ventures |
| (26 | ) | (263 | ) | ||||||||
Net profit from disposal of subsidiaries |
(327 | ) | (2 | ) | (60 | ) | |||||||
Net gains on acquisitions |
(2,406 | ) | | | |||||||||
Other non-cash movements |
796 | (1,133 | ) | 1,702 | |||||||||
Changes in operating assets and liabilities: |
|||||||||||||
Net increase in loans and advances to banks and customers |
(58,431 | ) | (77,987 | ) | (27,385 | ) | |||||||
Net increase in deposits and debt securities in issue |
77,743 | 90,589 | 46,944 | ||||||||||
Net (increase)/decrease in derivative financial instruments |
(17,529 | ) | (2,144 | ) | 1,196 | ||||||||
Net decrease/(increase) in trading portfolio assets |
26,919 | (18,227 | ) | (18,323 | ) | ||||||||
Net (decrease)/increase in trading liabilities |
(5,928 | ) | (6,472 | ) | 310 | ||||||||
Net decrease/(increase) in financial investments |
5,229 | (4,379 | ) | 1,538 | |||||||||
Net (increase)/decrease in other assets |
(3,008 | ) | 1,299 | (1,527 | ) | ||||||||
Net decrease in other liabilities |
(477 | ) | (1,071 | ) | (1,580 | ) | |||||||
Tax paid |
(1,731 | ) | (1,583 | ) | (2,141 | ) | |||||||
Net cash from operating activities |
33,716 | (10,747 | ) | 10,047 | |||||||||
Purchase of available for sale financial investments |
(57,756 | ) | (26,899 | ) | (47,086 | ) | |||||||
Proceeds from sale or redemption of available for sale financial investments |
51,429 | 38,423 | 46,069 | ||||||||||
Purchase of intangible assets |
(687 | ) | (263 | ) | (212 | ) | |||||||
Purchase of property, plant and equipment |
(1,720 | ) | (1,241 | ) | (654 | ) | |||||||
Proceeds from sale of property, plant and equipment |
799 | 617 | 786 | ||||||||||
Acquisitions of subsidiaries, net of cash acquired |
(961 | ) | (270 | ) | (248 | ) | |||||||
Disposal of subsidiaries, net of cash disposed |
238 | 383 | (15 | ) | |||||||||
Increase in investment in subsidiaries |
(157 | ) | (668 | ) | (432 | ) | |||||||
Decrease in investment in subsidiaries |
19 | 57 | 44 | ||||||||||
Acquisition of associates and joint ventures |
(96 | ) | (220 | ) | (162 | ) | |||||||
Disposal of associates and joint ventures |
137 | 145 | 739 | ||||||||||
Other cash flows associated with investing activities |
| | 17 | ||||||||||
Net cash from investing activities |
(8,755 | ) | 10,064 | (1,154 | ) | ||||||||
Dividends paid |
(3,047 | ) | (2,559 | ) | (2,215 | ) | |||||||
Proceeds of borrowings and issuance of debt securities |
5,763 | 4,625 | 2,493 | ||||||||||
Repayments of borrowings and redemption of debt securities |
(1,207 | ) | (683 | ) | (366 | ) | |||||||
Net issue of shares and other equity instruments |
9,493 | 2,494 | 179 | ||||||||||
Repurchase of shares and other equity instruments |
(173 | ) | (1,802 | ) | | ||||||||
Net disposal/(purchase) of treasury shares |
87 | (48 | ) | (31 | ) | ||||||||
Net issue of shares to minority interests |
1,356 | 1,331 | 632 | ||||||||||
Net cash from financing activities |
12,272 | 3,358 | 692 | ||||||||||
Effect of exchange rates on cash and cash equivalents |
(5,801 | ) | (550 | ) | 562 | ||||||||
Net increase in cash and cash equivalents |
31,432 | 2,125 | 10,147 | ||||||||||
Cash and cash equivalents at beginning of year |
33,077 | 30,952 | 20,805 | ||||||||||
Cash and cash equivalents at end of year |
64,509 | 33,077 | 30,952 | ||||||||||
Cash and cash equivalents comprise: |
|||||||||||||
Cash and balances at central banks |
30,019 | 5,801 | 7,345 | ||||||||||
Loans and advances to banks |
47,707 | 40,120 | 30,926 | ||||||||||
Less: non-cash amounts and amounts with original maturity greater than three months |
(15,428 | ) | (19,377 | ) | (15,892 | ) | |||||||
32,279 | 20,743 | 15,034 | |||||||||||
Available for sale treasury and other eligible bills |
64,976 | 43,072 | 51,703 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(62,876 | ) | (41,688 | ) | (50,684 | ) | |||||||
2,100 | 1,384 | 1,019 | |||||||||||
Trading portfolio assets |
185,637 | 193,691 | 177,867 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(185,526 | ) | (188,556 | ) | (170,329 | ) | |||||||
111 | 5,135 | 7,538 | |||||||||||
Other |
| 14 | 16 | ||||||||||
64,509 | 33,077 | 30,952 |
Interest received in 2008 was £41,017m (2007: £49,441m, 2006: £38,544m) and interest paid in 2008 was £38,975m (2007: £37,821m, 2006: £29,372m).
The Group is required to maintain balances with central banks and other regulatory authorities and these amounted to £1,050m at 31st December 2008 (2007: £1,037m).
Barclays Annual Report 2008 |
193 |
Accounts of Barclays PLC
Income statement For the year ended 31st December
|
2008 £m |
2007 £m |
2006 £m |
||||||
Dividends received from subsidiary |
1,173 | 3,287 | 1,964 | ||||||
Interest income |
7 | 4 | 4 | ||||||
Trading gain/(loss) |
18 | (13 | ) | | |||||
Other income |
| 15 | | ||||||
Management charge from subsidiary |
(4 | ) | (4 | ) | (4 | ) | |||
Profit before tax |
1,194 | 3,289 | 1,964 | ||||||
Tax |
(1 | ) | | | |||||
Profit after tax |
1,193 | 3,289 | 1,964 |
The Company had no staff during the year (2007: nil, 2006: nil).
Balance sheet As at 31st December
|
Notes | 2008 £m |
2007 £m | |||
Assets |
||||||
Non-current assets |
||||||
Investment in subsidiaries |
40 | 15,340 | 10,391 | |||
Current assets |
||||||
Cash and balances at central banks |
| 671 | ||||
Other assets |
3,851 | 20 | ||||
Total assets |
19,191 | 11,082 | ||||
Liabilities |
||||||
Current liabilities |
||||||
Amounts payable within one year |
1 | 1 | ||||
Shareholders equity |
||||||
Called up share capital |
31 | 2,093 | 1,651 | |||
Share premium account |
31 | 4,045 | 56 | |||
Other equity |
31 | 3,652 | | |||
Capital redemption reserve |
32 | 394 | 384 | |||
Retained earnings |
32 | 9,006 | 8,990 | |||
Total shareholders equity |
19,190 | 11,081 | ||||
Total liabilities and shareholders equity |
19,191 | 11,082 |
The accompanying notes form an integral part of the accounts.
Marcus Agius
Group Chairman
John Varley
Group Chief Executive
Christopher Lucas
Group Finance Director
194 | Barclays Annual Report 2008 |
Statement of recognised income and expense For the year ended 31st December
|
2008 £m |
2007 £m |
2006 £m | |||
Profit after tax |
1,193 | 3,289 | 1,964 | |||
Total recognised income and expense for the year |
1,193 | 3,289 | 1,964 |
Cash flow statement For the year ended 31st December
|
2008 £m |
2007 £m |
2006 £m |
||||||
Reconciliation of profit before tax to net cash flows from operating activities: |
|||||||||
Profit before tax |
1,194 | 3,289 | 1,964 | ||||||
Changes in operating assets and liabilities: |
|||||||||
Net increase in other assets |
(16 | ) | (3 | ) | (13 | ) | |||
Net decrease in other liabilities |
| (3 | ) | | |||||
Net cash from operating activities |
1,178 | 3,283 | 1,951 | ||||||
Capital contribution to subsidiaries |
(4,362 | ) | (1,434 | ) | | ||||
Purchase of shares in subsidiaries |
(16 | ) | (316 | ) | (179 | ) | |||
Liquidation of subsidiary |
205 | | | ||||||
Net cash used in investing activities |
(4,173 | ) | (1,750 | ) | (179 | ) | |||
Issue of shares and other equity instruments |
4,911 | 2,494 | 179 | ||||||
Dividends paid |
(2,414 | ) | (2,129 | ) | (1,814 | ) | |||
Repurchase of ordinary shares |
(173 | ) | (1,802 | ) | | ||||
Net cash from financing activities |
2,324 | (1,437 | ) | (1,635 | ) | ||||
Net (decrease)/increase in cash and cash equivalents |
(671 | ) | 96 | 137 | |||||
Cash and cash equivalents at beginning of year |
671 | 575 | 438 | ||||||
Cash and cash equivalents at end of year |
| 671 | 575 | ||||||
Cash and cash equivalents comprise: |
|||||||||
Cash and balances at central banks |
| 671 | 575 | ||||||
Net cash from operating activities includes: |
|||||||||
Dividends received |
1,173 | 3,287 | 1,964 | ||||||
Interest received |
7 | 4 | 4 |
The parent companys main activity is to hold the investment in its wholly-owned subsidiary, Barclays Bank PLC.
The Company was not exposed at 31st December 2008 or 2007 to significant risks arising from the financial instruments it holds; which comprised cash, balances with central banks, and other assets which had no credit or market risk.
Dividends received are treated as operating income.
Non-cash transactions
During the year Barclays Bank PLC issued £4,050m of Mandatorily Convertible Notes, which mandatorily convert into ordinary shares of Barclays PLC on or before 30th June 2009. Barclays PLC has the right to receive the Notes in the future; the fair value of which has been included in other assets, with a corresponding increase net of issue costs in other equity.
The accompanying notes form an integral part of the accounts.
Barclays Annual Report 2008 |
195 |
For the year ended 31st December 2008
1 Dividends per share
As announced on 13th October 2008, the Board of Barclays has concluded that it would not be appropriate to recommend the payment of a final dividend for 2008. The final dividend for 2007 of £1,485m is accounted for in shareholders equity as an appropriation of retained profits in the year ending 31st December 2008.
2 Net interest income
2008 £m |
|
2007 £m |
|
2006 £m |
| ||||
Cash and balances with central banks |
174 | 145 | 91 | ||||||
Available for sale investments |
2,355 | 2,580 | 2,811 | ||||||
Loans and advances to banks |
1,267 | 1,416 | 903 | ||||||
Loans and advances to customers |
23,754 | 19,559 | 16,290 | ||||||
Other |
460 | 1,608 | 1,710 | ||||||
Interest income |
28,010 | 25,308 | 21,805 | ||||||
Deposits from banks |
(2,189 | ) | (2,720 | ) | (2,819 | ) | |||
Customer accounts |
(6,697 | ) | (4,110 | ) | (3,076 | ) | |||
Debt securities in issue |
(5,910 | ) | (6,651 | ) | (5,282 | ) | |||
Subordinated liabilities |
(1,349 | ) | (878 | ) | (777 | ) | |||
Other |
(396 | ) | (1,339 | ) | (708 | ) | |||
Interest expense |
(16,541 | ) | (15,698 | ) | (12,662 | ) | |||
Net interest income |
11,469 | 9,610 | 9,143 |
Interest income includes £135m (2007: £113m, 2006: £98m) accrued on impaired loans.
Other interest income principally includes interest income relating to reverse repurchase agreements. Similarly, other interest expense principally includes interest expense relating to repurchase agreements and hedging activity.
Included in net interest income is hedge ineffectiveness as detailed in Note 14.
3 Net fee and commission income
2008 £m |
|
2007 £m |
|
2006 £m |
| ||||
Fee and commission income |
|||||||||
Brokerage fees |
87 | 109 | 70 | ||||||
Investment management fees |
1,616 | 1,787 | 1,535 | ||||||
Securities lending |
389 | 241 | 185 | ||||||
Banking and credit related fees and commissions |
7,208 | 6,363 | 6,031 | ||||||
Foreign exchange commissions |
189 | 178 | 184 | ||||||
Fee and commission income |
9,489 | 8,678 | 8,005 | ||||||
Fee and commission expense |
(1,082 | ) | (970 | ) | (828 | ) | |||
Net fee and commission income |
8,407 | 7,708 | 7,177 |
196 | Barclays Annual Report 2008 |
4 Principal transactions
2008 £m |
2007 £m |
2006 £m | ||||||
Rates related business |
4,751 | 4,162 | 2,848 | |||||
Credit related business |
(3,422 | ) | (403 | ) | 766 | |||
Net trading income |
1,329 | 3,759 | 3,614 | |||||
Net gain from disposal of available for sale assets |
212 | 560 | 307 | |||||
Dividend income |
196 | 26 | 15 | |||||
Net gain from financial instruments designated at fair value |
33 | 293 | 447 | |||||
Other investment income |
239 | 337 | 193 | |||||
Net investment income |
680 | 1,216 | 962 | |||||
Principal transactions |
2,009 | 4,975 | 4,576 |
Net trading income includes the profits and losses arising both on the purchase and sale of trading instruments and from the revaluation to fair value, together with the interest income earned from these instruments and the related funding cost.
Of the total net trading income, a £2,096m net loss (2007: £116m loss, 2006: £1,427m gain) was made on the purchase and sale of securities and the revaluation of both securities and derivatives. This included a £1,272m gain (2007: £640m, 2006: £480m) that was earned in foreign exchange dealings.
The net loss on financial assets designated at fair value included within principal transactions was £6,602m (2007: £78m gain, 2006: £489m gain) of which losses of £6,635m (2007: £215m loss, 2006: £42m gain) were included in net trading income and gains of £33m (2007: £293m, 2006: £447m) were included in net investment income.
The net gain on financial liabilities designated at fair value included within principal transactions was £3,328m (2007: £231m loss, 2006: £920m loss) all of which was included within net trading income.
Net trading income includes the net gain from widening of credit spreads relating to Barclays Capital issued structured notes held at fair value was £1,663m (2007: £658m, 2006: £nil).
5 Insurance premiums and insurance claims and benefits
2008 £m |
2007 £m |
2006 £m |
|||||||
Gross premiums from insurance contracts |
1,138 | 1,062 | 1,108 | ||||||
Premiums ceded to reinsurers |
(48 | ) | (51 | ) | (48 | ) | |||
Net premiums from insurance contracts |
1,090 | 1,011 | 1,060 | ||||||
2008 £m |
|
2007 £m |
|
2006 £m |
| ||||
Gross claims and benefits incurred on insurance contracts |
263 | 520 | 588 | ||||||
Reinsurers share of claims incurred |
(26 | ) | (28 | ) | (13 | ) | |||
Net claims and benefits incurred on insurance contracts |
237 | 492 | 575 |
6 Other income
2008 £m |
2007 £m |
2006 £m |
|||||||
(Decrease)/increase in fair value of assets held in respect of linked liabilities to customers under investment contracts |
(10,422 | ) | 5,592 | 7,417 | |||||
Decrease/(increase) in liabilities to customers under investment contracts |
10,422 | (5,592 | ) | (7,417 | ) | ||||
Property rentals |
73 | 53 | 55 | ||||||
Other income |
304 | 135 | 159 | ||||||
Other income |
377 | 188 | 214 |
Included in other income are sub-lease rentals of £18m (2007: £18m, 2006: £18m), and in 2008 only is a £47m gain from the Visa IPO.
Barclays Annual Report 2008 |
197 |
Notes to the accounts
For the year ended 31st December 2008
7 Impairment charges and other credit provisions
2008 £m |
2007 £m |
2006 £m |
|||||||
Impairment charges on loans and advances |
|||||||||
New and increased impairment allowances |
5,116 | 2,871 | 2,722 | ||||||
Releases |
(358 | ) | (338 | ) | (389 | ) | |||
Recoveries |
(174) | (227) | (259) | ||||||
Impairment charges on loans and advances |
4,584 | 2,306 | 2,074 | ||||||
Charge/(release) in respect of provision for undrawn contractually committed facilities and guarantees provided |
329 | 476 | (6) | ||||||
Impairment charges on loans and advances and other credit provisions |
4,913 | 2,782 | 2,068 | ||||||
Impairment charges on re verse repurchase agreements |
124 | | | ||||||
Impairment on available for sale assets |
382 | 13 | 86 | ||||||
Impairment charges and other credit provisions |
5,419 | 2,795 | 2,154 |
An analysis of the impairment charges by class of financial instrument is included in Note 47.
8 Staff costs
2008 £m |
2007 £m |
2006 £m | ||||
Salaries and accrued incentive payments |
6,273 | 6,993 | 6,635 | |||
Social security costs |
464 | 508 | 502 | |||
Pension costs defined contribution plans |
237 | 141 | 128 | |||
Pension costs defined benefit plans (Note 30) |
89 | 150 | 282 | |||
Other post-retirement benefits (Note 30) |
1 | 10 | 30 | |||
Other |
715 | 603 | 592 | |||
Staff costs |
7,779 | 8,405 | 8,169 |
Included in salaries and incentive payments is £257m (2007: £551m, 2006: £640m) arising from equity settled share-based payments, of which £23m (2007: £60m, 2006: £78m) is a charge related to options-based schemes. Also included is £3m (2007: £8m, 2006: £6m) arising from cash settled share-based payments.
The average number of persons employed by the Group worldwide during the year was 151,500 (2007: 128,900, 2006: 118,600).
9 Administration and general expenses
2008 £m |
2007 £m |
2006 £m | |||||
Administrative expenses |
5,153 | 3,978 | 3,980 | ||||
Impairment charges/(releases) |
|||||||
property and equipment (Note 23) |
33 | 2 | 14 | ||||
intangible assets (Note 22) |
(3 | ) | 14 | 7 | |||
goodwill (Note 21) |
111 | | | ||||
Operating lease rentals |
520 | 414 | 345 | ||||
Gain on property disposals |
(148) | (267) | (432) | ||||
Administration and general expenses |
5,666 | 4,141 | 3,914 |
Auditors remuneration
2008 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
12 | | | | 12 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Companys associates pursuant to legislation |
20 | | | | 20 | |||||
Other services supplied pursuant to such legislation |
| 2 | 2 | |||||||
Other services relating to taxation |
| | 10 | | 10 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Company or any of its associates |
| | | 3 | 3 | |||||
Other |
| 4 | | 1 | 5 | |||||
Total auditors remuneration |
32 | 6 | 10 | 4 | 52 |
198 | Barclays Annual Report 2008 |
9 Administration and general expenses (continued)
2007 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
7 | | | | 7 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Companys associates pursuant to legislation |
12 | | | | 12 | |||||
Other services supplied pursuant to such legislation |
6 | 2 | | | 8 | |||||
Other services relating to taxation |
| | 8 | | 8 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Company or any of its associates |
| | | 5 | 5 | |||||
Other |
| 2 | | 2 | 4 | |||||
Total auditors remuneration |
25 | 4 | 8 | 7 | 44 | |||||
2006 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
7 | | | | 7 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Companys associates pursuant to legislation |
11 | | | | 11 | |||||
Other services supplied pursuant to such legislation |
10 | 1 | | | 11 | |||||
Other services relating to taxation |
| | 6 | | 6 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Company or any of its associates |
| | | 4 | 4 | |||||
Other |
| 4 | | 1 | 5 | |||||
Total auditors remuneration |
28 | 5 | 6 | 5 | 44 |
The figures shown in the above table relate to fees paid to PricewaterhouseCoopers LLP and its associates. Fees paid to other auditors not associated with PricewaterhouseCoopers LLP in respect of the audit of the Companys subsidiaries were £3m (2007: £2m, 2006: £2m).
Fees payable for the audit of the Companys associates pursuant to legislation comprise the fees for the statutory audit of the subsidiaries and associated pension schemes both inside and outside Great Britain and fees for the work performed by the associates of PricewaterhouseCoopers LLP in respect of the consolidated financial statements of the Company. The fees relating to the audit of the associated pension schemes were £0.2m (2007: £0.3m, 2006: £0.3m).
Other services supplied pursuant to such legislation comprise services in relation to statutory and regulatory filings. These include audit services for the review of the interim financial information under the Listing Rules of the UK listing authority and fees paid for reporting under Section 404 of the US Sarbanes-Oxley Act (Section 404). In 2008 fees paid for reporting under section 404 are not separately identifiable from the fees of the audit of the Groups annual accounts and the Companys associates. In addition, other services include Section 404 advisory, reporting accountant work for capital raising, securitisations and services relating to acquisition activities.
Taxation services include compliance services such as tax return preparation and advisory services such as consultation on tax matters, tax advice relating to transactions and other tax planning and advice.
Services relating to corporate finance transactions comprise due diligence related to transactions and other work in connection with such transactions.
10 Tax
The charge for tax is based upon the UK corporation tax rate of 28.5% (2007: 30%, 2006: 30%) and comprises:
2008 £m |
|
2007 £m |
|
2006 £m |
| ||||
Current tax charge/(credit) |
|||||||||
Current year |
1,563 | 2,385 | 1,929 | ||||||
Adjustment for prior years |
97 | (11 | ) | 8 | |||||
1,660 | 2,374 | 1,937 | |||||||
Deferred tax (credit)/charge |
|||||||||
Current year |
(597 | ) | (367 | ) | (16 | ) | |||
Adjustment for prior years |
(273 | ) | (26 | ) | 20 | ||||
(870 | ) | (393 | ) | 4 | |||||
Total charge/(credit) |
790 | 1,981 | 1,941 |
Barclays Annual Report 2008 |
199 |
Notes to the accounts
For the year ended 31st December 2008
10 Tax (continued)
The effective tax rate for the years 2008, 2007 and 2006 is lower than the standard rate of corporation tax in the UK of 28.5% (2007: 30%, 2006: 30%). The differences are set out below:
2008 £m |
2007 £m |
2006 £m |
|||||||
Profit before tax |
6,077 | 7,076 | 7,136 | ||||||
Tax charge at standard UK corporation tax rate of 28.5% (2007: 30%, 2006: 30%) |
1,732 | 2,123 | 2,141 | ||||||
Adjustment for prior years |
(176 | ) | (37 | ) | 24 | ||||
Differing overseas tax rates |
215 | (77 | ) | (17 | ) | ||||
Non-taxable gains and income (including amounts offset by unrecognised tax losses) |
(833 | ) | (136 | ) | (393 | ) | |||
Share-based payments |
229 | 72 | 27 | ||||||
Deferred tax assets not previously recognised |
(514 | ) | (158 | ) | (4 | ) | |||
Change in tax rates |
(1 | ) | 24 | 4 | |||||
Other non-allowable expenses |
138 | 170 | 159 | ||||||
Overall tax charge |
790 | 1,981 | 1,941 | ||||||
Effective tax rate |
13% | 28% | 27% |
The effective rate of tax for 2008, based on profit before tax, was 13% (2007: 28%). The effective tax rate differs from the 2007 effective rate and the UK corporation tax rate of 28.5% principally due to the Lehman Brothers North American businesses acquisition. Under IFRS the gain on acquisition of £2,262m is calculated net of deferred tax liabilities included in the acquisition balance sheet and is thus not subject to further tax in calculating the tax charge for the year. Furthermore, Barclays has tax losses previously unrecognised as a deferred tax asset but capable of sheltering part of this deferred tax liability. This gives rise to a tax benefit of £492m which, in accordance with IAS 12, is included as a credit within the tax charge for the year. The effective rate has been adversely impacted by the effect of the fall in the Barclays share price on the deferred tax asset recognised on share awards. In common with prior years there have been offsetting adjustments relating to different overseas tax rates, disallowable expenditure and non taxable gains and income.
11 Earnings per share
2008 £m |
2007 £m |
2006 £m |
|||||||
Profit attributable to equity holders of parent |
4,382 | 4,417 | 4,571 | ||||||
Dilutive impact of convertible options |
(24 | ) | (25 | ) | (30 | ) | |||
Profit attributable to equity holders of parent including dilutive impact of convertible options |
4,358 | 4,392 | 4,541 | ||||||
2008 million |
2007 million |
2006 million |
|||||||
Basic weighted average number of shares in issue |
7,389 | 6,410 | 6,357 | ||||||
Number of potential ordinary shares |
188 | 177 | 150 | ||||||
Diluted weighted average number of shares |
7,577 | 6,587 | 6,507 | ||||||
p | p | p | |||||||
Basic earnings per share |
59.3 | 68.9 | 71.9 | ||||||
Diluted earnings per share |
57.5 | 66.7 | 69.8 |
The calculation of basic earnings per share is based on the profit attributable to equity holders of the parent and the number of basic weighted average number of shares excluding own shares held in employee benefits trusts and shares held for trading.
The basic and diluted weighted average number of shares in issue in the year ended 31st December 2008 reflects 1,802 million shares issued during the year and the 2,642 million shares that will be issued following conversion in full of the Mandatorily Convertible Notes, included from the date of issue and the date the contract was entered into respectively. As a result, the weighted average number of shares in issue in the year ended 31st December 2008 was increased by 1,034 million shares as a result of this increase.
When calculating the diluted earnings per share, the profit attributable to equity holders of the parent is adjusted for the conversion of outstanding options into shares within Absa Group Limited and Barclays Global Investors UK Holdings Limited. The weighted average number of ordinary shares excluding own shares held in employee benefit trusts and shares held for trading, is adjusted for the effects of all dilutive potential ordinary shares, totalling 188 million (2007: 177 million, 2006: 150 million).
Of the total number of employee share options and share awards at 31st December 2008, 64 million were anti-dilutive (2007: nil, 2006: 5 million).
Subsequent to the balance sheet date, the Group continued to make on-market purchases of treasury shares under its various employee share schemes. No adjustment has been made to earnings per share in respect of these purchases.
200 | Barclays Annual Report 2008 |
12 Trading portfolio
2008 £m |
2007 £m |
|||||
Trading portfolio assets |
||||||
Treasury and other eligible bills |
4,544 | 2,094 | ||||
Debt securities |
148,686 | 152,778 | ||||
Equity securities |
30,535 | 36,307 | ||||
Traded loans |
1,070 | 1,780 | ||||
Commodities |
802 | 732 | ||||
Trading portfolio assets |
185,637 | 193,691 | ||||
Trading portfolio liabilities |
||||||
Treasury and other eligible bills |
(79 | ) | (486 | ) | ||
Debt securities |
(44,309 | ) | (50,506 | ) | ||
Equity securities |
(14,919 | ) | (13,702 | ) | ||
Commodities |
(167 | ) | (708 | ) | ||
Trading portfolio liabilities |
(59,474 | ) | (65,402 | ) |
13 Financial assets designated at fair value
Held on own account
2008 £m |
2007 £m | |||
Loans and advances |
30,187 | 23,491 | ||
Debt securities |
8,628 | 24,217 | ||
Equity securities |
6,496 | 5,376 | ||
Other financial assets |
9,231 | 3,545 | ||
Financial assets designated at fair value held on own account |
54,542 | 56,629 |
The maximum exposure to credit risk on loans and advances designated at fair value at 31st December 2008 was £30,187m (2007: £23,491m). The amount by which related credit derivatives and similar instruments mitigate the exposure to credit risk at 31st December was £2,084m (2007: £2,605m).
The net loss attributable to changes in credit risk for loans and advances designated at fair value was £2,550m in 2008 (2007: £401m). The gains on related credit derivatives was £519m for the year (2007: £4m loss).
The cumulative net loss attributable to changes in credit risk for loans and advances designated at fair value since initial recognition is £2,149m at 31st December 2008 (2007: £401m). The cumulative change in fair value of related credit derivatives at 31st December 2008 is £523m (2007: £4m).
Held in respect of linked liabilities to customers under investment contracts/liabilities arising from investment contracts
2008 £m |
2007 £m |
|||||
Financial assets designated at fair value held in respect of linked liabilities to customers under investment contracts |
66,657 | 90,851 | ||||
Cash and bank balances within the portfolio |
2,526 | 1,788 | ||||
Assets held in respect of linked liabilities to customers under investment contracts |
69,183 | 92,639 | ||||
Liabilities to customers under investment contracts |
(69,183 | ) | (92,639 | ) |
A portion of the Groups fund management business takes the legal form of investment contracts, under which legal title to the underlying investment is held by the Group, but the inherent risks and rewards in the investments are borne by the investors. In the normal course of business, the Groups financial interest in such investments is restricted to fees for investment management services.
Due to the nature of these contracts, the carrying value of the assets is always the same as the value of the liabilities and any change in the value of the assets results in an equal but opposite change in the value of the amounts due to the policyholders.
The Group is therefore not exposed to the financial risks market risk, credit risk and liquidity risk inherent in the investments and they are omitted from the disclosures on financial risks in Notes 47 to 49.
In the balance sheet, the assets are included as Financial assets designated at fair value held in respect of linked liabilities to customers under investment contracts. Cash balances within the portfolio have been included in the Groups cash balances. The associated obligation to deliver the value of the investments to customers at their fair value on balance sheet date is included as Liabilities to customers under investment contracts.
The increase/decrease in the value arising from the return on the investments and the corresponding increase/decrease in linked liabilities to customers is included in the Other income note in Note 6.
Barclays Annual Report 2008 |
201 |
Notes to the accounts
For the year ended 31st December 2008
14 Derivative financial instruments
The Groups objectives and policies on managing the risks that arise in connection with derivatives, including the policies for hedging, are included in Note 46 to Note 49.
The fair values and notional amounts of derivative instruments held for trading are set out in the following table:
2008 | 2007 | |||||||||||||
Notional £m |
Fair value | Notional £m |
Fair value | |||||||||||
Year ended 31st December Derivatives held for trading |
Assets £m |
Liabilities £m |
Assets £m |
Liabilities £m |
||||||||||
Foreign exchange derivatives |
||||||||||||||
Forward foreign exchange |
1,374,108 | 44,631 | (46,371 | ) | 1,041,781 | 11,381 | (11,629 | ) | ||||||
Currency swaps |
828,983 | 47,077 | (53,116 | ) | 562,682 | 15,617 | (14,676 | ) | ||||||
OTC options bought and sold |
426,739 | 15,405 | (14,331 | ) | 464,575 | 3,350 | (3,995 | ) | ||||||
OTC derivatives |
2,629,830 | 107,113 | (113,818 | ) | 2,069,038 | 30,348 | (30,300 | ) | ||||||
Exchange traded futures bought and sold |
8,008 | | | 139,199 | | | ||||||||
Exchange traded options bought and sold |
1,295 | | | 132 | | | ||||||||
Foreign exchange derivatives |
2,639,133 | 107,113 | (113,818 | ) | 2,208,369 | 30,348 | (30,300 | ) | ||||||
Interest rate derivatives |
||||||||||||||
Interest rate swaps |
17,624,591 | 498,661 | (496,292 | ) | 11,758,215 | 111,746 | (110,680 | ) | ||||||
Forward rate agreements |
4,377,619 | 8,853 | (8,224 | ) | 1,960,106 | 755 | (738 | ) | ||||||
OTC options bought and sold |
5,598,960 | 105,743 | (101,005 | ) | 3,776,600 | 27,337 | (26,944 | ) | ||||||
OTC derivatives |
27,601,170 | 613,257 | (605,521 | ) | 17,494,921 | 139,838 | (138,362 | ) | ||||||
Exchange traded futures bought and sold |
586,312 | | | 903,516 | | | ||||||||
Exchange traded options bought and sold |
276,752 | | | 269,095 | 102 | (64 | ) | |||||||
Exchange traded swaps |
9,411,001 | | | 4,941,417 | | | ||||||||
Interest rate derivatives |
37,875,235 | 613,257 | (605,521 | ) | 23,608,949 | 139,940 | (138,426 | ) | ||||||
Credit derivatives |
||||||||||||||
Swaps |
4,129,244 | 184,072 | (170,011 | ) | 2,472,249 | 38,696 | (35,814 | ) | ||||||
Equity and stock index derivatives |
||||||||||||||
OTC options bought and sold |
180,157 | 19,576 | (19,998 | ) | 145,399 | 11,293 | (15,743 | ) | ||||||
Equity swaps and forwards |
51,267 | 3,432 | (2,819 | ) | 36,149 | 1,057 | (1,193 | ) | ||||||
OTC derivatives |
231,424 | 23,008 | (22,817 | ) | 181,548 | 12,350 | (16,936 | ) | ||||||
Exchange traded futures bought and sold |
38,340 | | | 31,519 | | | ||||||||
Exchange traded options bought and sold |
121,712 | 5,551 | (3,109 | ) | 30,930 | 848 | (2,200 | ) | ||||||
Equity and stock index derivatives |
391,476 | 28,559 | (25,926 | ) | 243,997 | 13,198 | (19,136 | ) | ||||||
Commodity derivatives |
||||||||||||||
OTC options bought and sold |
78,680 | 6,565 | (10,261 | ) | 95,032 | 4,496 | (4,720 | ) | ||||||
Commodity swaps and forwards |
407,015 | 38,316 | (35,556 | ) | 276,102 | 19,075 | (18,039 | ) | ||||||
OTC derivatives |
485,695 | 44,881 | (45,817 | ) | 371,134 | 23,571 | (22,759 | ) | ||||||
Exchange traded futures bought and sold |
165,564 | 3,953 | (2,745 | ) | 228,465 | | | |||||||
Exchange traded options bought and sold |
54,435 | 161 | (233 | ) | 66,732 | 1,197 | (943 | ) | ||||||
Commodity derivatives |
705,694 | 48,995 | (48,795 | ) | 666,331 | 24,768 | (23,702 | ) | ||||||
Derivative assets/(liabilities) held for trading |
45,740,782 | 981,996 | (964,071 | ) | 29,199,895 | 246,950 | (247,378 | ) |
202 | Barclays Annual Report 2008 |
14 Derivative financial instruments (continued)
The fair values and notional amounts of derivative instruments held for risk management are set out in the following table:
2008 | 2007 | |||||||||||||
Notional | Fair value | Notional | Fair value | |||||||||||
Year ended 31st December Derivatives held for risk management |
contract amount £m |
Assets £m |
Liabilities £m |
contract amount £m |
Assets £m |
Liabilities £m |
||||||||
Derivatives designated as cash flow hedges |
||||||||||||||
Currency swaps |
586 | | (271 | ) | | | | |||||||
Interest rate swaps |
60,669 | 1,013 | (1,011 | ) | 38,453 | 239 | (437 | ) | ||||||
Equity options |
400 | | (154 | ) | 54 | 41 | | |||||||
Forward foreign exchange |
1,871 | 309 | (354 | ) | 2,256 | 178 | | |||||||
Exchange traded interest rate swaps |
20,028 | | | 14,529 | | | ||||||||
Derivatives designated as cash flow hedges |
83,554 | 1,322 | (1,790 | ) | 55,292 | 458 | (437 | ) | ||||||
Derivatives designated as fair value hedges |
||||||||||||||
Currency swaps |
2,666 | 283 | (105 | ) | 4,299 | 81 | (75 | ) | ||||||
Interest rate swaps |
14,010 | 1,052 | (357 | ) | 18,450 | 323 | (195 | ) | ||||||
Equity options |
259 | 124 | (110 | ) | 1,203 | 58 | (58 | ) | ||||||
Exchange traded interest rate swaps |
18,767 | | | | | | ||||||||
Derivatives designated as fair value hedges |
35,702 | 1,459 | (572 | ) | 23,952 | 462 | (328 | ) | ||||||
Derivatives designated as hedges of net investments |
||||||||||||||
Forward foreign exchange |
2,019 | 4 | (76 | ) | 4,223 | 31 | (57 | ) | ||||||
Currency swaps |
3,675 | 21 | (1,563 | ) | 8,397 | 187 | (88 | ) | ||||||
Derivatives designated as hedges of net investment |
5,694 | 25 | (1,639 | ) | 12,620 | 218 | (145 | ) | ||||||
Derivative assets/(liabilities) held for risk management |
124,950 | 2,806 | (4,001 | ) | 91,864 | 1,138 | (910 | ) |
Interest rate derivatives, designated as cash flow hedges, primarily hedge the exposure to cash flow variability from interest rates of variable rate loans to banks and customers, variable rate debt securities held and highly probable forecast financing transactions and reinvestments.
Interest rate derivatives designated as fair value hedges primarily hedge the interest rate risk of fixed rate borrowings in issue, fixed rate loans to banks and customers and investments in fixed rate debt securities held.
Currency derivatives are primarily designated as hedges of the foreign currency risk of net investments in foreign operations.
The Groups total derivative asset and liability position as reported on the balance sheet is as follows:
2008 | 2007 | |||||||||||||
Year ended 31st December | Notional | Fair value | Notional | Fair value | ||||||||||
contract £m |
Assets £m |
Liabilities £m |
contract £m |
Assets £m |
Liabilities £m |
|||||||||
Total derivative assets/(liabilities) held for trading |
45,740,782 | 981,996 | (964,071 | ) | 29,199,895 | 246,950 | (247,378 | ) | ||||||
Total derivative assets/(liabilities) held for risk management |
124,950 | 2,806 | (4,001 | ) | 91,864 | 1,138 | (910 | ) | ||||||
Derivative assets/(liabilities) |
45,865,732 | 984,802 | (968,072 | ) | 29,291,759 | 248,088 | (248,288 | ) |
Derivative assets and liabilities subject to counterparty netting agreements amounted to £862bn (2007: £199bn). Additionally, the Group held £55bn (2007: £17bn) of collateral against the net derivative assets exposure.
Barclays Annual Report 2008 |
203 |
Notes to the accounts
For the year ended 31st December 2008
14 Derivative financial instruments (continued)
The Group has hedged the following forecast cash flows, which primarily vary with interest rates. These cash flows are expected to impact the income statement in the following periods, excluding any hedge adjustments that may be applied:
2008 | ||||||||||||||
Total £m |
Up to one year £m |
Between one to two years £m |
Between two to three years £m |
Between three to four years £m |
Between four to five years £m |
More than five years £m | ||||||||
Forecast receivable cash flows |
2,569 | 875 | 586 | 596 | 347 | 127 | 38 | |||||||
Forecast payable cash flows |
974 | 275 | 166 | 175 | 145 | 123 | 90 | |||||||
2007 | ||||||||||||||
Total £m |
Up to one year £m |
Between one to two years £m |
Between two to three years £m |
Between three to four years £m |
Between four to five years £m |
More than five years £m | ||||||||
Forecast receivable cash flows |
4,329 | 1,593 | 987 | 903 | 535 | 254 | 57 | |||||||
Forecast payable cash flows |
2,121 | 394 | 369 | 335 | 283 | 244 | 496 |
The maximum length of time over which the Group hedges exposure to the variability in future cash flows for forecast transactions, excluding those forecast transactions related to the payment of variable interest on existing financial instruments, is seven years (2007: ten years).
All gains or losses on hedging derivatives relating to forecast transactions, which are no longer expected to occur, have been recycled to the income statement.
A gain of £2,439m on hedging instruments was recognised in relation to fair value hedges in net interest income (2007: £66m loss). A loss of £2,423m on the hedged items was recognised in relation to fair value hedges in net interest income (2007: £70m gain).
Ineffectiveness recognised in relation to cash flow hedges in net interest income was a gain of £14m (2007: £21m). Ineffectiveness recognised in relation to hedges of net investment was a gain of £2m (2007: £4m).
15 Loans and advances to banks and customers
2008 £m |
2007 £m | |||
Gross loans and advances to banks |
47,758 | 40,123 | ||
Less: Allowance for impairment |
(51) | (3) | ||
Loans and advances to banks |
47,707 | 40,120 | ||
Gross loans and advances to customers |
468,338 | 349,167 | ||
Less: Allowance for impairment |
(6,523) | (3,769) | ||
Loans and advances to customers |
461,815 | 345,398 |
204 | Barclays Annual Report 2008 |
16 Available for sale financial investments
2008 £m |
2007 £m |
|||||
Debt securities |
58,831 | 38,673 | ||||
Treasury bills and other eligible bills |
4,003 | 2,723 | ||||
Equity securities |
2,142 | 1,676 | ||||
Available for sale financial investments |
64,976 | 43,072 | ||||
Movement in available for sale financial investments |
2008 £m |
|
2007 £m |
| ||
At beginning of year |
43,072 | 51,703 | ||||
Exchange and other adjustments |
14,275 | 1,499 | ||||
Acquisitions and transfers |
59,703 | 26,920 | ||||
Disposals (through sale and redemption) |
(50,501 | ) | (37,498 | ) | ||
(Losses)/gains from changes in fair value recognised in equity |
(1,174 | ) | 486 | |||
Impairment |
(382 | ) | (13 | ) | ||
Amortisation of discounts/premium |
(17 | ) | (25 | ) | ||
At end of year |
64,976 | 43,072 |
17 Securities borrowing, securities lending, repurchase and reverse repurchase agreements
Amounts included in the balance sheet and reported on a net basis where the Group has the intention and the legal ability to settle net or realise simultaneously were as follows:
(a) | Reverse repurchase agreements and cash collateral on securities borrowed |
Amounts advanced to counterparties under reverse repurchase agreements and cash collateral provided under stock borrowing agreements are treated as collateralised loans receivable. The related securities purchased or borrowed subject to an agreement with the counterparty to repurchase them are not recognised on balance sheet where the risks and rewards of ownership remain with the counterparty.
2008 £m |
2007 £m | |||
Banks |
55,471 | 86,710 | ||
Customers |
74,883 | 96,365 | ||
Reverse repurchase agreements and cash collateral held on securities borrowed |
130,354 | 183,075 |
(b) | Repurchase agreements and cash collateral on securities lent |
Securities that are not recorded on the balance sheet (for example, securities that have been obtained as a result of reverse repurchase and stock borrow transactions) may also be lent or sold subject to a commitment to repurchase such securities remain off-balance sheet. In both instances, amounts received from counterparty are treated as liabilities, which at 31st December were as follows:
2008 £m |
2007 £m | |||
Banks |
87,403 | 97,297 | ||
Customers |
94,882 | 72,132 | ||
Repurchase agreements and cash collateral on securities lent |
182,285 | 169,429 |
18 Other assets
2008 £m |
2007 £m | |||
Sundry debtors |
4,814 | 4,042 | ||
Prepayments |
882 | 551 | ||
Accrued income |
483 | 400 | ||
Reinsurance assets |
123 | 157 | ||
Other assets |
6,302 | 5,150 |
Included in the above are balances of £4,704m (2007: £3,859m) expected to be recovered within no more than 12 months after the balance sheet date; and balances of £1,598m (2007: £1,291m) expected to be recovered more than 12 months after the balance sheet date.
Other assets include £3,096m (2007: £3,966m) of receivables which meet the definition of financial assets.
Barclays Annual Report 2008 |
205 |
Notes to the accounts
For the year ended 31st December 2008
19 Deferred tax
The components of deferred taxes disclosed on the balance sheet are as follows:
2008 £m |
2007 £m | |||
Deferred tax liability |
304 | 855 | ||
Deferred tax asset |
2,668 | 1,463 | ||
Net deferred tax |
2,364 | 608 |
Deferred taxes are calculated on all temporary differences under the liability method. The movement on the deferred tax account is as follows:
Fixed asset timing differences £m |
Available for sale investments £m |
Cash flow hedges £m |
Pensions and other retirement benefits £m |
Allowance for impairment on loans £m |
Other provisions £m |
Tax losses carried forward £m |
Share based payments £m |
Other £m |
Total £m |
|||||||||||||||||||
Liabilities |
(803 | ) | (101 | ) | (51 | ) | | | | | | (771 | ) | (1,726 | ) | |||||||||||||
Assets |
| | 44 | 491 | 108 | 377 | 215 | 428 | 671 | 2,334 | ||||||||||||||||||
At 1st January 2008 |
(803 | ) | (101 | ) | (7 | ) | 491 | 108 | 377 | 215 | 428 | (100 | ) | 608 | ||||||||||||||
Income statement |
124 | 8 | 5 | (90 | ) | 223 | (10 | ) | 598 | (215 | ) | 227 | 870 | |||||||||||||||
Equity |
| 103 | (161 | ) | | | | 750 | (33 | ) | (13 | ) | 646 | |||||||||||||||
Acquisitions and disposals |
(195 | ) | | | | | 56 | | 75 | (211 | ) | (275 | ) | |||||||||||||||
Exchange and other adjustments |
16 | 1 | 41 | 2 | 25 | 109 | 96 | 87 | 138 | 515 | ||||||||||||||||||
(858 | ) | 11 | (122 | ) | 403 | 356 | 532 | 1,659 | 342 | 41 | 2,364 | |||||||||||||||||
Liabilities |
(945 | ) | (46 | ) | (368 | ) | | | | | | (1,075 | ) | (2,434 | ) | |||||||||||||
Assets |
87 | 57 | 246 | 403 | 356 | 532 | 1,659 | 342 | 1,116 | 4,798 | ||||||||||||||||||
At 31st December 2008 |
(858 | ) | 11 | (122 | ) | 403 | 356 | 532 | 1,659 | 342 | 41 | 2,364 | ||||||||||||||||
Liabilities |
(705 | ) | (116 | ) | | | | | | | (702 | ) | (1,523 | ) | ||||||||||||||
Assets |
| | 91 | 622 | 69 | 436 | 1 | 380 | 406 | 2,005 | ||||||||||||||||||
At 1st January 2007 |
(705 | ) | (116 | ) | 91 | 622 | 69 | 436 | 1 | 380 | (296 | ) | 482 | |||||||||||||||
Income statement |
(118 | ) | 1 | (96 | ) | 28 | 165 | 214 | 100 | 99 | 393 | |||||||||||||||||
Equity |
| 13 | (132 | ) | | | | | (63 | ) | (125 | ) | (307 | ) | ||||||||||||||
Acquisitions and disposals |
| | | | | 45 | | | (12 | ) | 33 | |||||||||||||||||
Exchange and other adjustments |
20 | 1 | 34 | (35 | ) | 11 | (269 | ) | | 11 | 234 | 7 | ||||||||||||||||
(803 | ) | (101 | ) | (7 | ) | 491 | 108 | 377 | 215 | 428 | (100 | ) | 608 | |||||||||||||||
Liabilities |
(803 | ) | (101 | ) | (51 | ) | | | | | | (771 | ) | (1,726 | ) | |||||||||||||
Assets |
| | 44 | 491 | 108 | 377 | 215 | 428 | 671 | 2,334 | ||||||||||||||||||
At 31st December 2007 |
(803 | ) | (101 | ) | (7 | ) | 491 | 108 | 377 | 215 | 428 | (100 | ) | 608 |
The amount of deferred tax liability expected to be settled after more than 12 months is £1,949m (2007: £1,468m).
The amount of deferred tax asset expected to be recovered after more than 12 months is £4,593m (2007: £1,950m).
The deferred tax assets balance includes £2,139m (2007: £450m) which is the excess deferred tax assets over deferred tax liabilities in entities which have suffered a loss in either the current or prior year. This is based on management assessment that it is probable that the relevant entities will have taxable profits against which the temporary differences can be utilised.
Deferred tax assets have not been recognised in respect of deductible temporary differences (gross) £9m (2007: £247m), unused tax losses (gross) of £4,083m (2007: £1,683m) and unused tax credits of £46m (2007: £126m). The following tax losses expire: £3,854m in 2028. The other tax losses, tax credits and temporary differences do not expire under current tax legislation. Deferred tax assets have not been recognised in respect of these items because it is not probable that future taxable profit will be available against which the Group can utilise benefits. The unused tax losses include amounts relating to non-UK branches of Barclays Bank PLC where the future tax benefit might be restricted to the amount in excess of the UK rate.
The amount of temporary differences associated with investments in subsidiaries, branches, associates and joint ventures for which deferred tax liabilities have not been recognised is £8,429m (2007: £5,722m).
206 | Barclays Annual Report 2008 |
20 Investments in associates and joint ventures
Share of net assets
Associates | Joint ventures | Total | ||||||||||||||||
2008 £m |
|
2007 £m |
|
2008 £m |
|
2007 £m |
|
2008 £m |
|
2007 £m |
| |||||||
At beginning of year |
90 | 74 | 287 | 154 | 377 | 228 | ||||||||||||
Share of results before tax |
25 | 35 | (6 | ) | 10 | 19 | 45 | |||||||||||
Share of tax |
(3 | ) | (2 | ) | (2 | ) | (1 | ) | (5 | ) | (3 | ) | ||||||
Share of post-tax results |
22 | 33 | (8 | ) | 9 | 14 | 42 | |||||||||||
New investments |
6 | 7 | 27 | 8 | 33 | 15 | ||||||||||||
Acquisitions |
62 | 56 | 1 | 150 | 63 | 206 | ||||||||||||
Disposals |
(20 | ) | (47 | ) | (117 | ) | (72 | ) | (137 | ) | (119 | ) | ||||||
Exchange and other adjustments |
15 | (33 | ) | (24 | ) | 38 | (9 | ) | 5 | |||||||||
At end of year |
175 | 90 | 166 | 287 | 341 | 377 | ||||||||||||
Goodwill included above: |
||||||||||||||||||
Associates | Joint ventures | Total | ||||||||||||||||
2008 £m |
|
2007 £m |
|
2008 £m |
|
2007 £m |
|
2008 £m |
|
2007 £m |
| |||||||
Cost |
||||||||||||||||||
At beginning of year |
| 1 | 27 | 40 | 27 | 41 | ||||||||||||
Disposals |
| (1 | ) | | (16 | ) | | (17 | ) | |||||||||
Exchange and other adjustments |
| | 4 | 3 | 4 | 3 | ||||||||||||
At end of year |
| | 31 | 27 | 31 | 27 |
The Group has investments in two associates listed on the Johannesburg Stock Exchange. The fair value of the Groups investment in Ambit Properties Limited is £51m (2007: £42m) and in Pinnacle Point Group Limited, acquired during 2008, is £60m.
Acquisitions of joint ventures and associates
During the year the Group made additional investments in associates and joint ventures for aggregate cash consideration of £96m (2007: £221m), including new associates and joint ventures amounting to £63m (2007: £206m) primarily relating to Pinnacle Point Group Limited.
Summarised financial information for the Groups associates and joint ventures is set out below:
2008 | 2007 | |||||||||||
Associates £m |
|
Joint ventures |
|
Associates £m |
|
Joint ventures £m |
| |||||
Property, plant and equipment |
788 | 104 | 588 | 632 | ||||||||
Financial investments |
124 | | 239 | 8 | ||||||||
Loans to banks and customers |
271 | 2,883 | 516 | 2,372 | ||||||||
Other assets |
1,343 | 418 | 1,387 | 314 | ||||||||
Total assets |
2,526 | 3,405 | 2,730 | 3,326 | ||||||||
Deposits from banks and customers |
1,376 | 2,207 | 1,515 | 2,189 | ||||||||
Other liabilities |
985 | 890 | 902 | 458 | ||||||||
Shareholders equity |
165 | 308 | 313 | 679 | ||||||||
Total liabilities |
2,526 | 3,405 | 2,730 | 3,326 | ||||||||
Net income |
859 | 357 | 528 | 340 | ||||||||
Operating expenses |
(732 | ) | (364 | ) | (404 | ) | (292 | ) | ||||
Profit/(loss) before tax |
127 | (7 | ) | 124 | 48 | |||||||
Profit/(loss) after tax |
52 | (11 | ) | 104 | 40 |
The amounts included above, which include the entire assets, liabilities and net income of the investees, not just the Groups share, are based on accounts made up to 31st December 2008 with the exception of certain undertakings for which the amounts are based on accounts made up to dates not earlier than three months before the balance sheet date.
Associates and joint ventures in 2008 includes £1,651m (2007: £1,728m) of assets, £1,525m (2007: £1,537m) of liabilities and £9m (2007: £18m) of profit after tax in associates and joint ventures within the Absa Group.
The Groups share of commitments and contingencies of its associates and joint ventures is £nil (2007: £6m).
Barclays Annual Report 2008 |
207 |
Notes to the accounts
For the year ended 31st December 2008
21 Goodwill
2008 £m |
2007 £m |
|||||
Net book value |
||||||
At beginning of year |
7,014 | 6,092 | ||||
Acquisitions |
400 | 879 | ||||
Disposals |
(10 | ) | (17 | ) | ||
Impairment charge |
(111 | ) | | |||
Exchange and other adjustments |
332 | 60 | ||||
At end of year |
7,625 | 7,014 |
Goodwill is allocated to business operations according to business segments identified by the Group under IFRS 8, as follows:
2008 £m |
2007 £m | |||
UK Retail Banking |
3,139 | 3,138 | ||
Barclays Commercial Bank |
10 | 9 | ||
Barclaycard |
413 | 408 | ||
GRCB Western Europe |
705 | 551 | ||
GRCB Emerging Markets |
292 | 45 | ||
GRCB Absa |
1,084 | 1,062 | ||
Barclays Capital |
95 | 147 | ||
Barclays Global Investors |
1,496 | 1,261 | ||
Barclays Wealth |
391 | 393 | ||
Goodwill |
7,625 | 7,014 |
Goodwill is reviewed annually for impairment, or more frequently when there are indicators that impairment may have occurred, by comparing the carrying value to its recoverable amount.
Impairment testing of goodwill
The recoverable amount of each operations goodwill is based on value-in-use or fair value less costs to sell calculations. The calculations are based upon discounting expected pre-tax cash flows at a risk adjusted interest rate appropriate to the cash generating unit, the determination of both of which requires the exercise of judgement. The estimation of pre-tax cash flows is sensitive to the periods for which forecasts are available and to assumptions regarding the long-term sustainable cash flows. While forecasts are compared with actual performance and external economic data, expected cash flows naturally reflect managements view of future performance.
At 31st December 2008, the goodwill allocated to UK Retail Banking was £3,139m (2007: £3,138m) including £3,130m (2007: £3,130m) relating to Woolwich, the goodwill allocated to GRCB Absa was £1,084m (2007: £1,062m) and the goodwill allocated to Barclays Global Investors was £1,496m (2007: £1,261m). The remaining aggregate of goodwill of £1,915m (2007: £1,561m) consists of balances relating to multiple business operations which are not considered individually significant.
Goodwill impairment of £111m (2007: £nil) reflects the full write-down of £74m relating to EquiFirst, a US non-prime mortgage originator and a partial write-down of £37m relating to FirstPlus following its closure to new business in August 2008.
Key assumptions used in impairment testing for significant goodwill
UK Retail Banking
The recoverable amount of UK Retail Banking has been determined based on a value in use calculation. The calculation uses cash flow projections based on financial budgets approved by management covering a three year period, and a discount rate of 17.48%. For the purposes of the calculations, cash flows beyond that period have been extrapolated using a steady 3% growth rate. The growth rate does not exceed the long-term average growth rate for the market in which UK Retail Banking operates. Management believes that any reasonable possible change in the key assumptions on which UK Retail Bankings recoverable amount is based would not cause its carrying amount to exceed its recoverable amount.
Global Retail and Commercial Banking Absa
The recoverable amount of GRCB Absa has been determined based on a value in use calculation. The calculation uses cash flow projections based on financial budgets approved by management covering a three year period, and a discount rate of 14.10%. For the purposes of the calculations, cash flows beyond that period have been extrapolated using a growth rate of 8% to cash flows for the two years 2012 to 2013, and a rate of 6% for the ten years 2014 to 2023. The growth rate does not exceed the long-term average growth rate for the market in which GRCB Absa operates. Management believes that any reasonable possible change in the key assumptions on which GRCB Absas recoverable amount is based would not cause its carrying amount to exceed its recoverable amount.
Barclays Global Investors
The recoverable amount of BGI has been determined based on a fair value methodology approach which includes both a discounted cash flow valuation and comparable company valuation multiples based on revenue, EBITDA and assets under management. The calculation uses earnings projections based on financial budgets approved by management covering a three year period and a discount rate of 11.5%. For the purposes of the calculations, cash flows beyond that period have been extrapolated using growth rates of between 2% and 11% for cash flows from 2012 to 2017, and a terminal growth factor of 4% for 2018 and beyond. The growth rate does not exceed the long-term average growth rate for the market in which BGI operates. Management believes that any reasonable possible change in the key assumptions on which BGIs recoverable amount is based would not cause its carrying amount to exceed its recoverable amount.
208 | Barclays Annual Report 2008 |
22 Intangible assets
2008 | ||||||||||||||||||||||||
Internally generated software £m |
Other software £m |
Core deposit intangibles £m |
Brands £m |
Customer £m |
Mortgage £m |
Licences £m |
Total £m |
|||||||||||||||||
Cost |
||||||||||||||||||||||||
At 1st January 2008 |
388 | 188 | 244 | 149 | 524 | 126 | 161 | 1,780 | ||||||||||||||||
Acquisitions |
| 127 | 17 | 6 | 992 | | 210 | 1,352 | ||||||||||||||||
Additions/disposals |
274 | 5 | | | | | 3 | 282 | ||||||||||||||||
Exchange and other adjustments |
59 | 8 | | | 49 | 47 | 52 | 215 | ||||||||||||||||
At 31st December 2008 |
721 | 328 | 261 | 155 | 1,565 | 173 | 426 | 3,629 | ||||||||||||||||
Accumulated amortisation and impairment |
||||||||||||||||||||||||
At 1st January 2008 |
(163 | ) | (57 | ) | (37 | ) | (38 | ) | (101 | ) | (64 | ) | (38 | ) | (498 | ) | ||||||||
Disposals |
11 | 7 | | | | | | 18 | ||||||||||||||||
Amortisation charge |
(86 | ) | (33 | ) | (14 | ) | (15 | ) | (62 | ) | (22 | ) | (59 | ) | (291 | ) | ||||||||
Impairment release |
3 | | | | | | | 3 | ||||||||||||||||
Exchange and other adjustments |
(49 | ) | 14 | (1 | ) | (2 | ) | (9 | ) | (30 | ) | (7 | ) | (84 | ) | |||||||||
At 31st December 2008 |
(284 | ) | (69 | ) | (52 | ) | (55 | ) | (172 | ) | (116 | ) | (104 | ) | (852 | ) | ||||||||
Net book value |
437 | 259 | 209 | 100 | 1,393 | 57 | 322 | 2,777 | ||||||||||||||||
2007 | ||||||||||||||||||||||||
Internally generated software £m |
Other software £m |
Core deposit intangibles £m |
Brands £m |
Customer £m |
Mortgage £m |
Licences and other £m |
Total £m |
|||||||||||||||||
Cost |
||||||||||||||||||||||||
At 1st January 2007 |
267 | 123 | 242 | 145 | 467 | 122 | 140 | 1,506 | ||||||||||||||||
Acquisitions |
| | | | 54 | | 23 | 77 | ||||||||||||||||
Additions |
118 | 56 | | 3 | | 4 | | 181 | ||||||||||||||||
Exchange and other adjustments |
3 | 9 | 2 | 1 | 3 | | (2) | 16 | ||||||||||||||||
At 31st December 2007 |
388 | 188 | 244 | 149 | 524 | 126 | 161 | 1,780 | ||||||||||||||||
Accumulated amortisation and impairment |
||||||||||||||||||||||||
At 1st January 2007 |
(116 | ) | (29 | ) | (24 | ) | (22 | ) | (64 | ) | (10 | ) | (26 | ) | (291 | ) | ||||||||
Amortisation charge |
(45 | ) | (13 | ) | (11 | ) | (15 | ) | (36 | ) | (54 | ) | (12 | ) | (186 | ) | ||||||||
Impairment charge |
| (14 | ) | | | | | | (14 | ) | ||||||||||||||
Exchange and other adjustments |
(2 | ) | (1 | ) | (2 | ) | (1 | ) | (1 | ) | | | (7 | ) | ||||||||||
At 31st December 2007 |
(163 | ) | (57 | ) | (37 | ) | (38 | ) | (101 | ) | (64 | ) | (38 | ) | (498 | ) | ||||||||
Net book value |
225 | 131 | 207 | 111 | 423 | 62 | 123 | 1,282 |
The impairment release detailed above has been included within other operating expenses.
Barclays Annual Report 2008 |
209 |
Notes to the accounts
For the year ended 31st December 2008
23 Property, plant and equipment
2008 | 2007 | |||||||||||||||||||||||
Property £m |
Equipment £m |
Operating leased assets £m |
Total £m |
Property £m |
Equipment £m |
Operating leased assets £m |
Total £m |
|||||||||||||||||
Cost |
||||||||||||||||||||||||
At 1st January |
2,451 | 2,995 | 413 | 5,859 | 2,154 | 2,429 | 365 | 4,948 | ||||||||||||||||
Acquisitions and disposals |
992 | 218 | | 1,210 | 5 | 13 | | 18 | ||||||||||||||||
Additions |
493 | 846 | 126 | 1,465 | 506 | 638 | 105 | 1,249 | ||||||||||||||||
Disposals |
(485 | ) | (276 | ) | (235 | ) | (996 | ) | (241 | ) | (112 | ) | (57 | ) | (410 | ) | ||||||||
Fully depreciated assets written off |
(15 | ) | (7 | ) | | (22 | ) | (1 | ) | (8 | ) | | (9 | ) | ||||||||||
Exchange and other adjustments |
188 | 168 | | 356 | 28 | 35 | | 63 | ||||||||||||||||
At 31st December |
3,624 | 3,944 | 304 | 7,872 | 2,451 | 2,995 | 413 | 5,859 | ||||||||||||||||
Accumulated depreciation and impairment |
||||||||||||||||||||||||
At 1st January |
(1,044 | ) | (1,804 | ) | (15 | ) | (2,863 | ) | (993 | ) | (1,454 | ) | (9 | ) | (2,456 | ) | ||||||||
Acquisitions and disposals |
(8 | ) | (12 | ) | | (20 | ) | (1 | ) | (7 | ) | | (8 | ) | ||||||||||
Depreciation charge |
(124 | ) | (475 | ) | (31 | ) | (630 | ) | (91 | ) | (370 | ) | (6 | ) | (467 | ) | ||||||||
Impairment charge |
| (33 | ) | | (33 | ) | (2 | ) | | | (2 | ) | ||||||||||||
Disposals |
168 | 185 | 3 | 356 | 58 | 37 | | 95 | ||||||||||||||||
Fully depreciated assets written off |
15 | 7 | | 22 | 1 | 8 | | 9 | ||||||||||||||||
Exchange and other adjustments |
(18 | ) | (12 | ) | | (30 | ) | (16 | ) | (18 | ) | | (34 | ) | ||||||||||
At 31st December |
(1,011 | ) | (2,144 | ) | (43 | ) | (3,198 | ) | (1,044 | ) | (1,804 | ) | (15 | ) | (2,863 | ) | ||||||||
Net book value |
2,613 | 1,800 | 261 | 4,674 | 1,407 | 1,191 | 398 | 2,996 |
Operating leased assets represent assets such as plant and equipment leased to customers under operating leases.
Certain of the Groups equipment is held on finance leases. See Note 37.
210 | Barclays Annual Report 2008 |
24 Financial liabilities designated at fair value
2008 | 2007 | |||||||
Fair value £m |
Contractual amount due on maturity £m |
Fair value £m |
Contractual amount due on maturity £m | |||||
Debt securities |
61,297 | 69,197 | 52,320 | 62,167 | ||||
Deposits |
10,518 | 10,109 | 17,319 | 18,140 | ||||
Other |
5,077 | 6,761 | 4,850 | 6,239 | ||||
Financial liabilities designated at fair value |
76,892 | 86,067 | 74,489 | 86,546 |
At 31st December 2008, the own credit adjustment arose from the fair valuation of £54.5bn of Barclays Capital structured notes (2007: £40.7bn). The widening of Barclays credit spreads in the year affected the fair value of these notes and as a result revaluation gains of £1,663m were recognised in trading income (2007: £658m).
25 Other liabilities
2008 £m |
2007 £m | |||
Accruals and deferred income |
6,495 | 6,075 | ||
Sundry creditors |
6,049 | 4,341 | ||
Obligations under finance leases (Note 37) |
96 | 83 | ||
Other liabilities |
12,640 | 10,499 |
Included in the above are balances of £11,068m (2007: £9,043m) expected to be settled within no more than 12 months after the balance sheet date; and balances of £1,572m (2007: £1,456m) expected to be settled more than 12 months after the balance sheet date.
Accruals and deferred income included £nil (2007: £102m) in relation to deferred income from investment contracts and £nil (2007: £677m) in relation to deferred income from insurance contracts.
Barclays Annual Report 2008 |
211 |
Notes to the accounts
For the year ended 31st December 2008
26 Insurance assets and liabilities
Insurance assets
Reinsurance assets are £123m (2007: £157m) and relate principally to the Groups long-term business. Reinsurers share of provisions relating to the Groups short-term business are £32m (2007: £94m). The reinsurance assets expected to be recovered after more than one year are £91m (2007: £63m).
Insurance contract liabilities including unit-linked liabilities
Insurance liabilities comprise the following:
2008 £m |
2007 £m | |||
Insurance contract liabilities: |
||||
linked liabilities |
125 | 1,398 | ||
non-linked liabilities |
1,908 | 2,347 | ||
Provision for claims |
119 | 158 | ||
Insurance contract liabilities including unit-linked liabilities |
2,152 | 3,903 |
Insurance contract liabilities relate principally to the Groups long-term business. Insurance contract liabilities associated with the Groups short-term non-life business are £73m (2007: £174m).
Movements in insurance liabilities and reinsurance assets
Movements in insurance assets and insurance contract liabilities were as follows:
2008 | 2007 | |||||||||||||||
Gross £m |
Reinsurance £m |
Net £m |
Gross £m |
Reinsurance £m |
Net £m | |||||||||||
At beginning of year |
3,903 | (157 | ) | 3,746 | 3,878 | (172 | ) | 3,706 | ||||||||
Change in year |
(1,751 | ) | 34 | (1,717 | ) | 25 | 15 | 40 | ||||||||
At end of year |
2,152 | (123 | ) | 2,029 | 3,903 | (157 | ) | 3,746 |
Assumptions used to measure insurance liabilities
The assumptions that have the greatest effect on the measurement of the amounts recognised above, and the processes used to determine them were as follows:
Long-term business linked and non-linked
Mortality mortality estimates are based on standard industry and national mortality tables, adjusted where appropriate to reflect the Groups own experience. A margin is added to ensure prudence for example, future mortality improvements for annuity business.
Renewal expenses level and inflation expense reserves are a small part of overall insurance liabilities, however, increases in expenses caused by unanticipated inflation or other unforeseen factors could lead to expense reserve increases. Expenses are therefore set using prudent assumptions. Initial renewal expense levels are set by considering expense forecasts for the business and, where appropriate, building in a margin to allow for the increasing burden of fixed costs on the UK closed life book of business. The inflation assumption is set by adding a margin to the market rate of inflation implied by index-linked gilt yields.
Short-term business
Short-term business for single premium policies the proportion of unearned premiums is calculated based on estimates of the frequency and severity of incidents.
Changes in assumptions
There have been no changes in assumptions in 2008 that have had a material effect on the financial statements.
Uncertainties associated with cash flows related to insurance contracts and risk management activities
Long-term insurance contracts (linked and non-linked)
For long-term insurance contracts where death is the insured risk, the most significant factors that could detrimentally affect the frequency and severity of claims are the incidence of disease, such as AIDS, or general changes in lifestyle, such as in eating, exercise and smoking. Where survival is the insured risk, advances in medical care and social conditions are the key factors that increase longevity.
The Group manages its exposure to risk by operating in part as a unit-linked business, prudent product design, applying strict underwriting criteria, transferring risk to reinsurers, managing claims and establishing prudent reserves.
Short-term insurance contracts
For payment protection contracts where inability to make payments under a loan contract is the insured risk, the most significant factors are the health of the policyholder and the possibility of unemployment which depends upon, among other things, long-term and short-term economic factors. The Group manages its exposure to such risks through prudent product design, efficient claims management, prudent reserving methodologies and bases, regular product, economic and market reviews and regular adequacy tests on the size of the reserves.
Absa insures property and motor vehicles, for which the most significant factors that could effect the frequency and severity of claims are climatic change and crime. Absa manages its exposure to risk by diversifying insurance risks accepted and transferring risk to reinsurers.
212 | Barclays Annual Report 2008 |
26 Insurance assets and liabilities (continued)
Sensitivity analysis
The following table presents the sensitivity of the level of insurance contract liabilities disclosed in this note to movements in the actuarial assumptions used to calculate them. The percentage change in variable is applied to a range of existing actuarial modelling assumptions to derive the possible impact on net profit after tax. The disclosure is not intended to explain the impact of a percentage change in the insurance assets and liabilities disclosed above.
2008 | 2007 | |||||||
Change in variable % |
Net profit after tax impact £m |
Change in variable % |
Net profit after tax impact £m | |||||
Long-term insurance contracts: |
||||||||
Improving mortality (annuitants only) |
10 | 1 | 10 | 21 | ||||
Worsening of mortality (assured lives only) |
10 | 20 | 10 | 29 | ||||
Worsening of base renewal expense level |
20 | 19 | 20 | 43 | ||||
Worsening of expense inflation rate |
10 | 1 | 10 | 10 | ||||
Short-term insurance contracts: |
||||||||
Worsening of claim expense assumptions |
10 | 3 | 10 | 3 |
Any change in net profit after tax would result in a corresponding increase or decrease in shareholders equity.
The above analyses are based on a change in a single assumption while holding all other assumptions constant. In practice this is unlikely to occur.
Options and guarantees
The Groups contracts do not contain options or guarantees that could confer material risk.
Concentration of insurance risk
The Group considers that the concentration of insurance risk that is most relevant to the Group financial statements is according to the type of cover offered and the location of insured risk. The following table shows the maximum amounts payable under all of the Groups insurance products. It ignores the probability of insured events occurring and the contribution from investments backing the insurance policies. The table shows the broad product types and the location of the insured risk, before and after the impact of reinsurance that represents the risk that is passed to other insurers.
2008 | 2007 | |||||||||||||
Before Reinsurance £m |
Reinsurance £m |
After Reinsurance £m |
Before Reinsurance £m |
Reinsurance £m |
After Reinsurance £m | |||||||||
Total benefits insured by product type |
||||||||||||||
Long-term insurance contracts |
19,193 | (3,591 | ) | 15,602 | 31,205 | (10,497 | ) | 20,708 | ||||||
Short-term insurance contracts |
36,228 | (2,735 | ) | 33,493 | 31,464 | (1,139 | ) | 30,325 | ||||||
Total benefits insured |
55,421 | (6,326 | ) | 49,095 | 62,669 | (11,636 | ) | 51,033 | ||||||
2008 | 2007 | |||||||||||||
Before Reinsurance £m |
Reinsurance £m |
After Reinsurance £m |
Before Reinsurance £m |
Reinsurance £m |
After Reinsurance | |||||||||
Total benefits insured by geographic location |
||||||||||||||
United Kingdom |
8,120 | (525 | ) | 7,595 | 22,538 | (7,473 | ) | 15,065 | ||||||
Other European Union |
6,519 | (2,305 | ) | 4,214 | 4,304 | (2,479 | ) | 1,825 | ||||||
Africa |
40,782 | (3,496 | ) | 37,286 | 35,827 | (1,684 | ) | 34,143 | ||||||
Total benefits insured |
55,421 | (6,326 | ) | 49,095 | 62,669 | (11,636 | ) | 51,033 |
Reinsurer credit risk
For the long-term business, reinsurance programmes are in place to restrict the amount of cover on any single life. The reinsurance cover is spread across highly rated companies to diversify the risk of reinsurer solvency. Net insurance reserves include a margin to reflect reinsurer credit risk.
Barclays Annual Report 2008 |
213 |
Notes to the accounts
For the year ended 31st December 2008
27 Subordinated liabilities
Subordinated liabilities comprise dated and undated loan capital as follows:
2008 £m |
2007 £m | |||||
Undated lo an capital |
(a) | 13,673 | 6,631 | |||
Dated loan capital |
(b) | 16,169 | 11,519 | |||
29,842 | 18,150 | |||||
(a) Undated loan capital
|
||||||
Notes | 2008 £m |
2007 £m | ||||
Non-convertible |
||||||
The Bank |
||||||
6% Callable Perpetual Core Tier One Notes |
a,q | 487 | 392 | |||
6.86% Callable Perpetual Core Tier One Notes (US$1,000m) |
a,q | 1,118 | 624 | |||
5.3304% Step-up Callable Perpetual Reserve Capital Instruments |
b,r | 652 | 520 | |||
5.926% Step-up Callable Perpetual Reserve Capital Instruments (US$1,350m) |
c,s | 1,109 | 708 | |||
6.3688% Step-up Callable Perpetual Reserve Capital Instruments |
n,ae | 600 | 526 | |||
7.434% Step-up Callable Perpetual Reserve Capital Instruments (US$1,250m) |
o,af | 1,055 | 660 | |||
14% Step-up Callable Perpetual Reserve Capital Instruments |
e,t | 2,514 | | |||
Junior Undated Floating Rate Notes (US$121m) |
d,u | 83 | 61 | |||
7.7% Undated Subordinated Notes (US$2,000m) |
p,ah | 1,644 | | |||
Undated Floating Rate Primary Capital Notes Series 3 |
d,v | 147 | 147 | |||
9.875% Undated Subordinated Notes |
| 319 | ||||
9.25% Perpetual Subordinated Bonds (ex-Woolwich plc) |
f, w | 232 | 171 | |||
9% Permanent Interest Bearing Capital Bonds |
g,x | 120 | 102 | |||
8.25% Undated Subordinated Notes |
p,ag | 1,092 | | |||
7.125% Undated Subordinated Notes |
h,y | 620 | 535 | |||
6.875% Undated Subordinated Notes |
i, z | 729 | 657 | |||
6.375% Undated Subordinated Notes |
j, aa | 526 | 482 | |||
6.125% Undated Subordinated Notes |
k,ab | 666 | 560 | |||
6.5% Undated Subordinated Notes (FFr1,000m) |
l,ac | 151 | 115 | |||
5.03% Reverse Dual Currency Undated Subordinated Loan (Yen 8,000m) |
m,ad | 51 | 21 | |||
5% Reverse Dual Currency Undated Subordinated Loan (Yen12,000m) |
m,ad | 77 | 31 | |||
Undated lo an capital non-convertible |
13,673 | 6,631 |
Security and subordination
None of the undated loan capital of the Bank is secured.
The Junior Undated Floating Rate Notes (the Junior Notes) rank behind the claims against the Bank of depositors and other unsecured unsubordinated creditors and holders of dated loan capital.
All other issues of the Banks undated loan capital rank pari passu with each other and behind the claims of the holders of the Junior Notes, except for the 6% and 6.86% Callable Perpetual Core Tier One Notes (the TONs) and the 5.3304%, 5.926%, 6.3688%, 7.434% and 14% Step-up Callable Perpetual Reserve Capital Instruments (the RCIs) (such issues, excluding the TONs and the RCIs, being the Undated Notes and Loans).
The TONs and the RCIs rank pari passu with each other and behind the claims of the holders of the Undated Notes and Loans.
Interest
Notes
a | These TONs bear a fixed rate of interest until 2032. After that date, in the event that the TONs are not redeemed, the TONs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
b | These RCIs bear a fixed rate of interest until 2036. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
c | These RCIs bear a fixed rate of interest until 2016. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
d | These Notes bear interest at rates fixed periodically in advance, based on London interbank rates. |
e | These RCIs bear a fixed rate of interest until 2019. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
f | These Bonds bear a fixed rate of interest until 2021. After that date, in the event that the Bonds are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
g | The interest rate on these Bonds is fixed for the life of this issue. |
h | These Notes bear a fixed rate of interest until 2020. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
i | These Notes bear a fixed rate of interest until 2015. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
214 | Barclays Annual Report 2008 |
27 Subordinated liabilities (continued)
j | These Notes bear a fixed rate of interest until 2017. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
k | These Notes bear a fixed rate of interest until 2027. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
l | These Notes bear a fixed rate of interest until 2009. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on European interbank rates. |
m | These Loans bear a fixed rate of interest until 2028 based on a US Dollar principal amount, but the interest payments have been swapped, resulting in a Yen interest rate payable, which is fixed periodically in advance based on London interbank rates. After that date, in the event that the Loans are not redeemed, the Loans will bear Yen interest rates fixed periodically in advance, based on London interbank rates. |
n | These RCIs bear a fixed rate of interest until 2019. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
o | These RCIs bear a fixed rate of interest until 2017. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
p | These Notes bear a fixed rate of interest until 2018. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance, based on London interbank rates. |
The Bank is not obliged to make a payment of interest on its Undated Notes and Loans excluding the 9.25% Perpetual Subordinated Bonds, 7.7% Undated Subordinated Notes and 8.25% Undated Subordinated Notes if, in the preceding six months, a dividend has not been declared or paid on any class of shares of Barclays PLC or, in certain cases, any class of preference shares of the Bank. The Bank is not obliged to make a payment of interest on its 9.25% Perpetual Subordinated Bonds if, in the immediately preceding 12 months interest period, a dividend has not been paid on any class of its share capital. Interest not so paid becomes payable in each case if such a dividend is subsequently paid or in certain other circumstances. During the year, the Bank declared and paid dividends on its ordinary shares and on all classes of preference shares.
No payment of principal or any interest may be made unless the Bank satisfies a specified solvency test.
The Bank may elect to defer any payment of interest on the 7.7% Undated Subordinated Notes and 8.25% Undated Subordinated Notes. Until such time as any deferred interest has been paid in full, neither the Bank nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares, preference shares, or other share capital or satisfy any payments of interest or coupons on certain other junior obligations.
The Bank may elect to defer any payment of interest on the RCIs (b, c, e, n and o above). Any such deferred payment of interest must be paid on the earlier of (i) the date of redemption of the RCIs, (ii) the coupon payment date falling on or nearest to the tenth anniversary of the date of deferral of such payment, and (iii) in respect of e above only, substitution. Whilst such deferral is continuing, neither the Bank nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares or preference shares.
The Bank may elect to defer any payment of interest on the TONs if it determines that it is, or such payment would result in it being, in non-compliance with capital adequacy requirements and policies of the FSA. Any such deferred payment of interest will only be payable on a redemption of the TONs. Until such time as the Bank next makes a payment of interest on the TONs, neither the Bank nor Barclays PLC may (i) declare or pay a dividend, subject to certain exceptions, on any of their respective ordinary shares or Preference Shares, or make payments of interest in respect of the Banks Reserve Capital Instruments and (ii) certain restrictions on the redemption, purchase or reduction of their respective share capital and certain other securities also apply.
Repayment
Notes
q | These TONs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after June 2032. |
r | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2036. |
s | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2016. |
t | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after June 2019. |
u | These Notes are repayable, at the option of the Bank, in whole or in part on any interest payment date. |
v | These Notes are repayable, at the option of the Bank, in whole on any interest payment date. |
w | These Bonds are repayable, at the option of the Bank, in whole in 2021, or on any fifth anniversary thereafter. |
x | These Bonds are repayable, at the option of the Bank, in whole at any time. |
y | These Notes are repayable, at the option of the Bank, in whole in 2020, or on any fifth anniversary thereafter. |
z | These Notes are repayable, at the option of the Bank, in whole in 2015, or on any fifth anniversary thereafter. |
aa | These Notes are repayable, at the option of the Bank, in whole in 2017, or on any fifth anniversary thereafter. |
ab | These Notes are repayable, at the option of the Bank, in whole in 2027, or on any fifth anniversary thereafter. |
ac | These Notes are repayable, at the option of the Bank, in whole in 2009, or on any fifth anniversary thereafter. |
ad | These Loans are repayable, at the option of the Bank, in whole in 2028, or on any fifth anniversary thereafter. |
ae | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2019. |
af | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2017. |
ag | These Notes are repayable, at the option of the Bank, in whole on any interest payment date falling in or after December 2018. |
ah | These Notes are repayable, at the option of the Bank, in whole on any interest payment date falling in or after April 2018. |
In addition, each issue of undated loan capital is repayable, at the option of the Bank, in whole for certain tax reasons, either at any time, or on an interest payment date. There are no events of default except non-payment of principal or mandatory interest.
Any repayments require the prior notification to the FSA.
All issues of undated loan capital have been made in the eurocurrency market and/or under Rule 144A, and no issues have been registered under the US Securities Act of 1933.
Barclays Annual Report 2008 |
215 |
Notes to the accounts
For the year ended 31st December 2008
27 Subordinated liabilities (continued)
(b) Dated loan capital
Dated loan capital, issued by the Bank for the development and expansion of the Groups business and to strengthen its capital base, by Barclays Bank Spain SA (Barclays Spain), Barclays Bank of Botswana Ltd (BBB), Barclays Bank Zambia PLC (Barclays Zambia) and Barclays Bank of Kenya (Barclays Kenya) to enhance their respective capital bases and by Absa and Barclays Bank of Ghana Ltd (BBG) for general corporate purposes, comprise:
Notes | 2008 £m |
2007 £m | ||||
Non-convertible |
||||||
The Bank |
||||||
7.4% Subordinated Notes 2009 (US$400m) |
a | 275 | 200 | |||
Subordinated Fixed to CMS-Linked Notes 2009 (31m) |
b | 31 | 23 | |||
12% Unsecured Capital Loan Stock 2010 |
a | 27 | 27 | |||
5.75% Subordinated Notes 2011 (1,000m) |
a | 943 | 724 | |||
5.25% Subordinated Notes 2011 (250m) (ex-Woolwich plc) |
a | 260 | 200 | |||
Floating Rate Subordinated Notes 2013 (US$1,000m) |
| 501 | ||||
5.015% Subordinated Notes 2013 (US$150m) |
a | 112 | 77 | |||
4.875% Subordinated Notes 2013 (750m) |
a | 750 | 583 | |||
5.5% Subordinated Notes 2013 (DM 500m) |
| 196 | ||||
Floating Rate Subordinated Step-up Callable Notes 2013 (Yen 5,500m) |
| 25 | ||||
Floating Rate Subordinated Notes 2013 (AU$150m) |
| 67 | ||||
5.93% Subordinated Notes 2013 (AU$100m) |
| 44 | ||||
Callable Floating Rate Subordinated Notes 2015 (US$1,500m) |
b,k | 1,031 | 753 | |||
4.38% Fixed Rate Subordinated Notes 2015 (US$75m) |
a | 88 | 30 | |||
4.75% Fixed Rate Subordinated Notes 2015 (US$150m) |
a | 81 | 85 | |||
Floating Rate Subordinated Step-up Callable Notes 2016 (US$750m) |
b,k | 514 | 375 | |||
Callable Floating Rate Subordinated Notes 2016 (1,250m) |
b,k | 1,211 | 927 | |||
Callable Floating Rate Subordinated Notes 2017 (US$500m) |
b,k | 343 | 250 | |||
10.125% Subordinated Notes 2017 (ex-Woolwich plc) |
h,k | 109 | 111 | |||
Floating Rate Subordinated Step-up Callable Notes 2017 (US$1,500m) |
b,k | 1,029 | 749 | |||
Floating Rate Subordinated Step-up Callable Notes 2017 (1,500m) |
b,k | 1,444 | 1,106 | |||
6.05% Fixed Rate Subordinated Notes 2017 (US$2,250m) |
a | 1,856 | 1,125 | |||
Floating Rate Subordinated Notes 2018 (40m) |
b | 38 | 29 | |||
6% Fixed Rate Subordinated Notes due 2018 (1,750m) |
a | 1,767 | | |||
CMS-Linked Subordinated Notes due 2018 (100m) |
b | 100 | | |||
CMS-Linked Subordinated Notes due 2018 (135m) |
b | 135 | | |||
Floating Rate Subordinated Notes 2019 (50m) |
b | 47 | 36 | |||
Callable Fixed/Floating Rate Subordinated Notes 2019 (1,000m) |
i | 984 | 761 | |||
9.5% Subordinated Bonds 2021 (ex-Woolwich plc) |
a | 298 | 282 | |||
Subordinated Floating Rate Notes 2021 (100m) |
b | 94 | 72 | |||
Subordinated Floating Rate Notes 2022 (50m) |
b | 49 | 37 | |||
Subordinated Floating Rate Notes 2023 (50m) |
b | 48 | 37 | |||
Fixed/Floating Rate Subordinated Callable Notes 2023 |
o,k | 571 | 505 | |||
5.75% Fixed Rate Subordinated Notes 2026 |
a | 690 | 600 | |||
5.4% Reverse Dual Currency Subordinated Loan 2027 (Yen 15,000m) |
j | 128 | 71 | |||
6.33% Subordinated Notes 2032 |
a | 53 | 49 | |||
Subordinated Floating Rate Notes 2040 (100m) |
b | 96 | 73 | |||
Barclays Bank SA, Spain (Barclays Spain) |
||||||
Subordinated Floating Rate Capital Notes 2011 (11m) |
b | 11 | 10 | |||
Absa |
||||||
14.25% Subordinated Callable Notes 2014 (ZAR 3,100m) |
c,k | 240 | 253 | |||
10.75% Subordinated Callable Notes 2015 (ZAR 1,100m) |
d,k | 85 | 87 | |||
Subordinated Callable Notes 2015 (ZAR 400m) |
e,k | 30 | 29 | |||
8.75% Subordinated Callable Notes 2017 (ZAR 1,500m) |
f,k | 115 | 111 | |||
Subordinated Callable Notes 2018 (ZAR 3,700m) |
e,k | 144 | | |||
8.8% Subordinated Fixed Rate Callable Notes 2019 (ZAR 1,725m) |
p,k | 146 | 123 | |||
8.1% Subordinated Callable Notes 2020 (ZAR 2,000m) |
g,k | 130 | 138 | |||
Barclays Bank of Ghana Ltd (BBG) |
||||||
14% Fixed Rate BBG Subordinated Callable Notes 2016 (GHC 100,000m) |
a,k | 5 | 5 | |||
Barclays Bank of Kenya (Barclays Kenya) |
||||||
Floating Rate Subordinated Notes 2014 (KES 2,965m) |
q | 26 | 8 | |||
Dated loan capital non-convertible |
16,134 | 11,494 |
216 | Barclays Annual Report 2008 |
27 Subordinated liabilities (continued)
Notes | 2008 £m |
2007 £m | ||||
Convertible |
||||||
Barclays Bank of Botswana (BBB) |
||||||
Subordinated Unsecured Floating Rate Capital Notes 2014 (BWP 190m) |
k,l | 17 | 8 | |||
Barclays Bank Zambia PLC (Barclays Zambia) |
||||||
Subordinated Unsecured Floating Rate Capital Notes 2015 (ZMK 49,086m) |
k,m | 7 | 6 | |||
Absa |
||||||
Redeemable cumulative option-holding preference shares (ZAR 147m) |
n | 11 | 11 | |||
Total convertible |
35 | 25 |
None of the Groups dated loan capital is secured. The debt obligations of the Bank, Barclays Spain, BBG, BBB, Barclays Zambia, Barclays Kenya and Absa rank ahead of the interests of holders of their equity. Dated loan capital of the Bank, Barclays Spain, BBG, BBB, Barclays Zambia, Barclays Kenya and Absa has been issued on the basis that the claims there under are subordinated to the respective claims of their depositors and other unsecured unsubordinated creditors.
Interest
Notes
a | The interest rates on these Notes are fixed for the life of those issues. |
b | These Notes bear interest at rates fixed periodically in advance based on London or European interbank rates. |
c | These Notes bear a fixed rate of interest until 2009. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference rate for a further period of five years. |
d | These Notes bear a fixed rate of interest until 2010. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
e | These Notes bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
f | These Notes bear a fixed rate of interest until 2012. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
g | These Notes bear a fixed rate of interest until 2015. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
h | These Notes bear a fixed rate of interest until 2012. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
i | These Notes bear a fixed rate of interest until 2014. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on European interbank rates. |
j | This Loan bears a fixed rate of interest based on a US Dollar principal amount, but the interest payments have been swapped, resulting in a Yen interest rate payable which is fixed periodically in advance based on London interbank rates. |
k | Repayable at the option of the issuer, prior to maturity, on conditions governing the respective debt obligations, some in whole or in part, and some only in whole. |
l | These Notes bear interest at rates fixed periodically in advance based on the Bank of Botswana Certificate Rate. All of these Notes will be compulsorily converted to Preference Shares of BBB, having a total par value equal in sum to the principal amount of Notes outstanding at the time of conversion, should BBB experience pre-tax losses in excess of its retained earnings and other capital surplus accounts. |
m | These Notes bear interest at rates fixed periodically in advance based on the Bank of Zambia Treasury Bill rate. All of these Notes will be compulsorily converted to Preference Shares of Barclays Zambia, having a total par value equal in sum to the principal amount of Notes outstanding at the time of conversion, should Barclays Zambia experience pre-tax losses in excess of its retained earnings and other capital surplus accounts. |
n | The dividends are compounded and payable semi-annually in arrears on 30th September and 31st March of each year. The shares were issued by Absa Group Limited on 1st July 2004 and the redemption dates commence on the first business day after the third anniversary of the date of issue of the redeemable preference shares and ending on the fifth anniversary of the date of issue. Such exercise and notice will be deemed to be effective only on the option exercise dates, being 1st March, 1st June, 1st September or 1st December of each year. The shares are convertible into ordinary shares at the option of the preference shareholders on the redemption dates in lots of 100. |
o | These Notes bear a fixed rate of interest until 2018. After that date in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on London interbank rates. |
p | These Notes bear a fixed rate of interest until 2014. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
q | These Notes bear interest at rates fixed periodically in advance based on the Central Bank of Kenya Treasury Bill rates. |
Barclays Annual Report 2008 |
217 |
Notes to the accounts
For the year ended 31st December 2008
27 Subordinated liabilities (continued)
The 7.4% Subordinated Notes 2009 (the 7.4% Notes) issued by the Bank have been registered under the US Securities Act of 1933. All other issues of dated loan capital by the Bank, Barclays Spain, BBG, BBB, Barclays Zambia, Barclays Kenya and Absa, which were made in non-US markets, have not been so registered. With respect to the 7.4% Notes, the Bank is not obliged to make (i) a payment of interest on any interest payment date unless a dividend is paid on any class of share capital and (ii) a payment of principal until six months after the respective maturity date with respect to such Notes.
Repayment terms
Unless otherwise indicated, the Groups dated loan capital outstanding at 31st December 2008 is redeemable only on maturity, subject in particular cases, to provisions allowing an early redemption in the event of certain changes in tax law or, in the case of BBB and Barclays Zambia to certain changes in legislation or regulations.
Any repayments prior to maturity require in the case of the Bank, the prior notification to the FSA, in the case of BBB, the prior approval of the Bank of Botswana, in the case of Barclays Zambia, the prior approval of the Bank of Zambia, and in the case of Absa, the prior approval of the South African Registrar of Banks.
There are no committed facilities in existence at the balance sheet date which permit the refinancing of debt beyond the date of maturity.
28 Provisions
Onerous contracts £m |
Redundancy restructuring |
Undrawn £m |
Sundry provisions £m |
Total £m |
|||||||||||
At 1st January 2008 |
64 | 82 | 475 | 209 | 830 | ||||||||||
Acquisitions and disposals of subsidiaries |
9 | (9 | ) | | (1 | ) | (1 | ) | |||||||
Exchange |
2 | | 63 | 15 | 80 | ||||||||||
Additions |
12 | 269 | 461 | 102 | 844 | ||||||||||
Amounts used |
(41 | ) | (213 | ) | (794 | ) | (42 | ) | (1,090 | ) | |||||
Unused amounts reversed |
| (11 | ) | (96 | ) | (25 | ) | (132 | ) | ||||||
Amortisation of discount |
4 | | | | 4 | ||||||||||
At 31st December 2008 |
50 | 118 | 109 | 258 | 535 | ||||||||||
At 1st January 2007 |
71 | 102 | 46 | 243 | 462 | ||||||||||
Acquisitions and disposals of subsidiaries |
1 | (2 | ) | | 74 | 73 | |||||||||
Exchange |
| | 8 | 5 | 13 | ||||||||||
Additions |
18 | 117 | 560 | 121 | 816 | ||||||||||
Amounts used |
(25 | ) | (117 | ) | (113 | ) | (60 | ) | (315 | ) | |||||
Unused amounts reversed |
(5 | ) | (18 | ) | (26 | ) | (174 | ) | (223 | ) | |||||
Amortisation of discount |
4 | | | | 4 | ||||||||||
At 31st December 2007 |
64 | 82 | 475 | 209 | 830 |
Provisions expected to be recovered or settled within no more than 12 months after 31st December 2008 were £333m (2007:£645m).
Sundry provisions are made with respect to commission clawbacks, warranties and litigation claims.
There were no undrawn contractually committed facilities and guarantees provided against undrawn facilities on ABS CDO Super Senior positions (2007: £360m).
218 | Barclays Annual Report 2008 |
29 Securitisations
The Group was party to securitisation transactions involving Barclays residential mortgage loans, business loans and credit card balances. In addition, the Group acts as a conduit for commercial paper, whereby it acquires static pools of residential mortgage loans from other lending institutions for securitisation transactions.
In these transactions, the assets, or interests in the assets, or beneficial interests in the cash flows arising from the assets, are transferred to a special purpose entity, or to a trust which then transfers its beneficial interests to a special purpose entity, which then issues floating rate debt securities to third-party investors.
Securitisations may, depending on the individual arrangement result in continued recognition of the securitised assets and the recognition of the debt securities issued in the transaction; lead to partial continued recognition of the assets to the extent of the Groups continuing involvement in those assets or to derecognition of the assets and the separate recognition, as assets or liabilities, of any rights and obligations created or retained in the transfer. Full derecognition only occurs when the Group transfers both its contractual right to receive cash flows from the financial assets, or retains the contractual rights to receive the cash flows, but assumes a contractual obligation to pay the cash flows to another party without material delay or reinvestment, and also transfers substantially all the risks and rewards of ownership, including credit risk, prepayment risk and interest rate risk.
The following table shows the carrying amount of securitised assets, stated at the amount of the Groups continuing involvement where appropriate, together with the associated liabilities, for each category of asset in the balance sheet:
2008 | 2007 | |||||||||
Carrying £m |
Associated liabilities £m |
Carrying amount of assets £m |
Associated liabilities £m |
|||||||
Loans and advances to customers |
||||||||||
Residential mortgage loans |
12,754 | (13,172 | ) | 16,000 | (16,786 | ) | ||||
Credit card receivables |
1,888 | (2,109 | ) | 4,217 | (3,895 | ) | ||||
Other personal lending |
212 | (256 | ) | 422 | (485 | ) | ||||
Wholesale and corporate loans and advances |
7,702 | (8,937 | ) | 8,493 | (8,070 | ) | ||||
Total |
22,556 | (24,474 | ) | 29,132 | (29,236 | ) | ||||
Assets designated at fair value through profit or loss |
||||||||||
Retained interest in residential mortgage loans |
316 | | 895 | |
Retained interests in residential mortgage loans are securities which represent a continuing exposure to the prepayment and credit risk in the underlying securitised assets. The total amount of the loans was £31,734m (2007:£23,097m). The retained interest is initially recorded as an allocation of the original carrying amount based on the relative fair values of the portion derecognised and the portion retained.
Barclays Annual Report 2008 |
219 |
Notes to the accounts
For the year ended 31st December 2008
30 Retirement benefit obligations
Pension schemes
The UK Retirement Fund (UKRF), which is the main scheme of the Group, amounting to 91% of all the Groups schemes in terms of benefit obligations, comprises ten sections.
The 1964 Pension Scheme
Most employees recruited before July 1997 are members of this non-contributory defined benefit scheme. Pensions are calculated by reference to service and pensionable salary and are normally subject to a deduction from State pension age.
The Retirement Investment Scheme (RIS)
A defined contribution plan for most joiners between July 1997 and 1st October 2003. This was closed to new entrants on 1st October 2003 and the large majority of existing members of the RIS transferred to afterwork in respect of future benefit accrual with effect from 1st January 2004. There are now no longer any active members of the RIS.
The Pension Investment Plan (PIP)
A defined contribution plan created from 1st July 2001 to provide benefits for certain employees of Barclays Capital.
afterwork
Combines a contributory cash balance element with a voluntary defined contribution element. New employees since 1st October 2003 are eligible to join afterwork. In addition, the large majority of active members of the RIS (now closed) were transferred to afterwork in respect of future benefit accrual after 1st January 2004.
Career Average Section
The Career Average Section was established in the UKRF with effect from 1st May 2004 following the transfer of members from the Woolwich Pension Fund. The Career Average Section is a non-contributory career average scheme and was closed to new entrants on 1st December 2006.
1951 Fund Section, AP89 Section, BCPS Section, CCS Section and Mercantile Section
Five new sections were established in the UKRF with effect from 31st March 2007 following the merger of the UKRF with five smaller schemes sponsored from within the Group. All five sections are closed to new members.
The 1951 Fund Section, AP89 Section and Mercantile Section provide final salary benefits calculated by reference to service and pensionable salary.
The BCPS and CCS Sections provide defined contribution benefits. The benefits built up in these sections in relation to service before 6th April 1997 are subject to a defined benefit minimum.
In addition, the costs of ill-health retirements and death in service benefits are generally borne by the UKRF for each of the ten sections. From November 2008, members were given the option to pay member contributions by way of salary sacrifice.
Governance
The assets of the UKRF are held separately from the assets of the Group and are administered by trustees.
Barclays Pension Fund Trustees Ltd (BPFTL) acts as corporate trustee for the UKRF. BPFTL is a private limited company, incorporated on 20th December 1990, and is a subsidiary of Barclays Bank PLC.
As the corporate trustee for the UKRF, BPFTL is the legal owner of the assets of the UKRF and BPFTL holds these assets in trust for the beneficiaries of the scheme.
BPFTL comprises nine Directors, of which six are Employer Directors selected by the Bank and three are Employee Directors nominated by the Pension Fund Advisory Committee (PFAC). Employee Directors are selected from those eligible active employees and pensioner members who apply to be considered for the role.
Employee Director vacancies are advertised to all eligible active and pensioner members. This enables any eligible member with an interest in becoming an Employee Director to express that interest and be considered for the role. The PFAC provides the mechanism through which Employee Directors are selected. The PFAC will accept nominations from eligible members and select from amongst all properly nominated candidates.
There are also three Alternate Employer Directors and three Alternate Employee Directors. The selection process for these appointments are as detailed above. The role of alternate directors is to provide cover for individual directors, should they not be available for meetings.
Under the Pensions Act 2004 the Bank and the Trustee must agree on the funding rate (including a recovery plan to fund any deficit against the scheme specific statutory funding objective). The first ongoing funding valuation to be completed under this legislation had an effective date of 30th September 2007.
In addition to the UKRF, there are other defined benefit and defined contribution schemes in the UK and overseas. The same approach to pensions governance applies to the other schemes in the UK but different legislation covers schemes outside of the UK where in most cases the Bank has the power to determine the funding rate.
220 | Barclays Annual Report 2008 |
30 Retirement benefit obligations (continued)
The following tables present an analysis of defined benefit obligation and fair value of plan assets for all the Groups pension schemes and post-retirement benefits (the latter are unfunded) and present the amounts recognised in the income statement including those related to post-retirement health care.
Income statement charge
2008 | 2007 | 2006 | |||||||||||||||||||||||
Pensions £m |
Other post- retirement benefits £m |
Total £m |
Pensions £m |
Other post- retirement benefits £m |
Total £m |
Pensions £m |
Other post- retirement |
Total £m |
|||||||||||||||||
Staff cost charge |
|||||||||||||||||||||||||
Current service cost |
299 | 2 | 301 | 332 | 2 | 334 | 378 | 21 | 399 | ||||||||||||||||
Interest cost |
991 | 8 | 999 | 905 | 8 | 913 | 900 | 8 | 908 | ||||||||||||||||
Expected return on scheme assets |
(1,175 | ) | | (1,175 | ) | (1,074 | ) | | (1,074 | ) | (999 | ) | | (999 | ) | ||||||||||
Recognised actuarial (gain)/loss |
(23 | ) | (1 | ) | (24 | ) | (1 | ) | | (1 | ) | 3 | 1 | 4 | |||||||||||
Past service cost |
2 | (8 | ) | (6 | ) | 20 | | 20 | 29 | | 29 | ||||||||||||||
Curtailment or settlements |
(5 | ) | | (5 | ) | (32 | ) | | (32 | ) | (29 | ) | | (29 | ) | ||||||||||
Total included in staff costs |
89 | 1 | 90 | 150 | 10 | 160 | 282 | 30 | 312 |
Staff costs are included in other operating expenses.
Change in benefit obligation
2008 | 2007 | |||||||||||||||||||||||||||||
Pensions | Post-retirement benefits |
Total | Pensions | Post-retirement benefits |
Total | |||||||||||||||||||||||||
UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | |||||||||||||||||||||
Benefit obligation at beginning of the year |
(16,563 | ) | (913 | ) | (60 | ) | (98 | ) | (17,634 | ) | (17,256 | ) | (894 | ) | (97 | ) | (76 | ) | (18,323 | ) | ||||||||||
Current service cost |
(276 | ) | (23 | ) | | (2 | ) | (301 | ) | (317 | ) | (15 | ) | (1 | ) | (1 | ) | (334 | ) | |||||||||||
Interest cost |
(946 | ) | (45 | ) | (3 | ) | (5 | ) | (999 | ) | (869 | ) | (36 | ) | (4 | ) | (4 | ) | (913 | ) | ||||||||||
Past service cost |
(2 | ) | (11 | ) | 7 | | (6 | ) | (20 | ) | | | | (20 | ) | |||||||||||||||
Curtailments or settlements |
7 | 2 | | | 9 | 35 | 1 | | | 36 | ||||||||||||||||||||
Actuarial gain/(loss) |
2,807 | | 11 | (5 | ) | 2,813 | 1,292 | 25 | 19 | 1 | 1,337 | |||||||||||||||||||
Contributions by plan participants |
(20 | ) | (3 | ) | | | (23 | ) | (19 | ) | (2 | ) | | | (21 | ) | ||||||||||||||
Benefits paid |
598 | 42 | 2 | 9 | 651 | 589 | 31 | 2 | 15 | 637 | ||||||||||||||||||||
Business combinations |
| | | | | | | | | | ||||||||||||||||||||
Exchange and other adjustments |
| (269 | ) | | (24 | ) | (293 | ) | 2 | (23 | ) | 21 | (33 | ) | (33 | ) | ||||||||||||||
Benefit obligation at end of the year |
(14,395 | ) | (1,220 | ) | (43 | ) | (125 | ) | (15,783 | ) | (16,563 | ) | (913 | ) | (60 | ) | (98 | ) | (17,634 | ) |
The benefit obligation arises from plans that are wholly unfunded and wholly or partly funded as follows:
2008 £m |
2007 £m |
|||||
Unfunded obligations |
(297 | ) | (248 | ) | ||
Wholly or partly funded obligations |
(15,486 | ) | (17,386 | ) | ||
Total |
(15,783 | ) | (17,634 | ) |
Barclays Annual Report 2008 |
221 |
Notes to the accounts
For the year ended 31st December 2008
30 Retirement benefit obligations (continued)
Change in plan assets
2008 | 2007 | |||||||||||||||||||||||||||||
Pensions | Post-retirement benefits |
Total | Pensions | Post-retirement benefits |
Total | |||||||||||||||||||||||||
UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | |||||||||||||||||||||
Fair value of plan assets at beginning of the year |
17,231 | 796 | | | 18,027 | 16,761 | 745 | | | 17,506 | ||||||||||||||||||||
Expected return on plan assets |
1,134 | 41 | | | 1,175 | 1,041 | 33 | | | 1,074 | ||||||||||||||||||||
Employer contribution |
336 | 71 | 2 | 9 | 418 | 355 | 34 | 2 | 15 | 406 | ||||||||||||||||||||
Settlements |
| (2 | ) | | | (2 | ) | | (1 | ) | | | (1 | ) | ||||||||||||||||
Contributions by plan participants |
20 | 3 | | | 23 | 19 | 2 | | | 21 | ||||||||||||||||||||
Actuarial loss |
(4,534 | ) | (121 | ) | | | (4,655 | ) | (332 | ) | (11 | ) | | | (343 | ) | ||||||||||||||
Benefits paid |
(598 | ) | (42 | ) | (2 | ) | (9 | ) | (651 | ) | (589 | ) | (31 | ) | (2 | ) | (15 | ) | (637 | ) | ||||||||||
Business combinations |
| | | | | | | | | | ||||||||||||||||||||
Exchange and other adjustments |
(52 | ) | 213 | | | 161 | (24 | ) | 25 | | | 1 | ||||||||||||||||||
Fair value of plan assets at the end of the year |
13,537 | 959 | | | 14,496 | 17,231 | 796 | | | 18,027 |
Amounts recognised on balance sheet
The pension and post-retirement benefit assets and liabilities recognised on the balance sheet are as follows:
2008 | 2007 | |||||||||||||||||||||||||||||
Pensions | Post-retirement benefits |
Total | Pensions | Post-retirement benefits |
Total | |||||||||||||||||||||||||
UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | |||||||||||||||||||||
Benefit obligation at end of period |
(14,395 | ) | (1,220 | ) | (43 | ) | (125 | ) | (15,783 | ) | (16,563 | ) | (913 | ) | (60 | ) | (98 | ) | (17,634 | ) | ||||||||||
Fair value of plan assets at end of period |
13,537 | 959 | | | 14,496 | 17,231 | 796 | | | 18,027 | ||||||||||||||||||||
Net (deficit)/asset |
(858 | ) | (261 | ) | (43 | ) | (125 | ) | (1,287 | ) | 668 | (117 | ) | (60 | ) | (98 | ) | 393 | ||||||||||||
Unrecognised actuarial (gains)/losses |
(167 | ) | 150 | (11 | ) | 23 | (5 | ) | (1,912 | ) | 7 | (3 | ) | 14 | (1,894 | ) | ||||||||||||||
Net recognised liability |
(1,025 | ) | (111 | ) | (54 | ) | (102 | ) | (1,292 | ) | (1,244 | ) | (110 | ) | (63 | ) | (84 | ) | (1,501 | ) | ||||||||||
Recognised assets |
| 65 | | | 65 | | 36 | | | 36 | ||||||||||||||||||||
Recognised liability |
(1,025 | ) | (176 | ) | (54 | ) | (102 | ) | (1,357 | ) | (1,244 | ) | (146 | ) | (63 | ) | (84 | ) | (1,537 | ) | ||||||||||
Net recognised liability |
(1,025 | ) | (111 | ) | (54 | ) | (102 | ) | (1,292 | ) | (1,244 | ) | (110 | ) | (63 | ) | (84 | ) | (1,501 | ) |
The UKRF funded status, as measured using the IAS 19 assumptions, has decreased from a £0.7bn surplus at 31st December 2007 to a deficit of £0.9bn at 31st December 2008.
The assumptions used for the current year and prior year are detailed below. Among the reasons for this change were the large loss on the assets over the year and, to a lesser extent, a strengthening of the allowance made for future improvements in mortality. Offsetting these were the increase in AA long-term corporate bond yields which resulted in a higher discount rate of 6.75% (31st December 2007: 5.82%), a decrease in the inflation assumption to 3.16% (31st December 2007: 3.45%) and contributions paid.
Assumptions
Obligations arising under defined benefit schemes are actuarially valued using the projected unit credit method. Under this method, where a defined benefit scheme is closed to new members, such as in the case of the 1964 Pension Scheme, the current service cost expressed as a percentage of salary is expected to increase in the future, although this higher rate will be applied to a decreasing payroll. The latest actuarial IAS valuations were carried out as at 31st December using the following assumptions:
UK schemes | Overseas schemes | |||||||
2008 % p.a. |
2007 % p.a. |
2008 % p.a. |
2007 % p.a. | |||||
Discount rate |
6.75 | 5.82 | 7.09 | 7.51 | ||||
Rate of increase in salaries |
3.66 | 3.95 | 5.93 | 5.60 | ||||
Inflation rate |
3.16 | 3.45 | 3.98 | 4.13 | ||||
Rate of increase for pensions in payment |
3.06 | 3.45 | 3.17 | 3.55 | ||||
Rate of increase for pensions in deferment |
3.16 | 3.30 | 4.37 | 2.50 | ||||
Initial health care inflation |
8.00 | 8.00 | 9.00 | 10.00 | ||||
Long-term health care inflation |
5.00 | 5.00 | 5.01 | 5.01 | ||||
Expected return on plan assets |
6.80 | 6.70 | 7.95 | 7.84 |
222 | Barclays Annual Report 2008 |
30 Retirement benefit obligations (continued)
Assumptions (continued)
The expected return on plan assets assumption is weighted on the basis of the fair value of these assets. Health care inflation assumptions are weighted on the basis of the health care cost for the period. All other assumptions are weighted on the basis of the defined benefit obligation at the end of the period.
The UK Schemes discount rate assumption is based on a liability-weighted rate derived from a AA corporate bond yield curve.
The overseas health care inflation assumptions relate to the US and Mauritius.
Mortality assumptions
The post-retirement mortality assumptions used in valuing the liabilities of the UKRF were based on the standard 2000 series tables as published by the Institute and Faculty of Actuaries. These tables are considered to be most relevant to the population of the UKRF based on their mortality history. These were then adjusted in line with the actual experience of the UKRFs own pensioners relative to the standard table. An allowance has been made for future mortality improvements based on the medium cohort projections published by the CMIB subject to a floor of 1% pa on future improvements. On this basis the post-retirement mortality assumptions for the UKRF includes:
2008 | 2007 | 2006 | 2005 | 2004 | ||||||
Longevity at 60 for current pensioners (years) |
||||||||||
Males |
27.4 | 26.7 | 25.8 | 25.8 | 25.7 | |||||
Females |
28.5 | 27.9 | 29.5 | 29.5 | 29.4 | |||||
Longevity at 60 for future pensioners currently aged 40 (years) |
||||||||||
Males |
29.5 | 28.0 | 27.1 | 27.1 | 27.0 | |||||
Females |
30.5 | 29.1 | 30.7 | 30.6 | 30.6 |
Sensitivity analysis
Sensitivity analysis for each of the principal assumptions used to measure the benefit obligation of the UKRF are as follows:
Impact on UKRF benefit obligation | ||||||
(Decrease)/ % |
(Decrease)/ £bn |
|||||
0.5% increase to: |
||||||
Discount rate |
(8.5 | ) | (1.2 | ) | ||
Rate of inflation |
8.8 | 1.3 | ||||
Rate of salary growth |
1.0 | 0.2 | ||||
1 year increase to longevity at 60 |
2.5 | 0.4 |
Post-retirement health care
A one percentage point change in assumed health care trend rates, assuming all other assumptions remain constant would have the following effects for 2008:
1% increase £m |
1% decrease £m |
||||
Effect on total of service and interest cost components |
1 | (1 | ) | ||
Effect on post-retirement benefit obligation |
17 | (14 | ) |
Assets
A long-term strategy has been set for the asset allocation of the UKRF which comprises a mixture of equities, bonds, property and other appropriate assets. This recognises that different asset classes are likely to produce different long-term returns and some asset classes may be more volatile than others.
The long-term strategy ensures that investments are adequately diversified. Asset managers are permitted some flexibility to vary the asset allocation from the long-term strategy within control ranges agreed with the trustee from time to time.
The UKRF also employs derivative instruments, where appropriate, to achieve a desired exposure or return, or to match assets more closely to liabilities. The value of assets shown below reflects the actual physical assets held by the scheme, with any derivative holdings reflected on a mark to market basis. The expected return on asset assumptions, both for individual asset classes and overall, have been based on the portfolio of assets created after allowing for the net impact of the derivatives on the risk and return profile of the holdings.
Barclays Annual Report 2008 |
223 |
Notes to the accounts
For the year ended 31st December 2008
30 Retirement benefit obligations (continued)
Assets (continued)
The value of the assets of the schemes, their percentage in relation to total scheme assets, and their expected rate of return at 31st December 2008 and 31st December 2007 were as follows:
2008 | |||||||||||||||||||||||
UK schemes | Overseas schemes | Total | |||||||||||||||||||||
Value £m |
% of total fair value of scheme assets |
Expected of return % |
Value £m |
% of total fair value of scheme assets |
Expected of return % |
Value £m |
% of total fair value of scheme assets |
Expected of return % | |||||||||||||||
Equities |
5,813 | 43 | 8.5 | 217 | 23 | 9.3 | 6,030 | 42 | 8.5 | ||||||||||||||
Bonds |
6,360 | 47 | 5.3 | 166 | 17 | 6.2 | 6,526 | 45 | 5.3 | ||||||||||||||
Property |
1,214 | 9 | 7.2 | 16 | 2 | 13.4 | 1,230 | 8 | 7.3 | ||||||||||||||
Derivatives |
(420 | ) | (3 | ) | | | | | (420 | ) | (3 | ) | | ||||||||||
Cash |
(131 | ) | (1 | ) | 2.0 | 415 | 43 | 7.6 | 284 | 2 | 3.9 | ||||||||||||
Other |
701 | 5 | 7.4 | 145 | 15 | 6.4 | 846 | 6 | 7.2 | ||||||||||||||
Fair value of plan assetsa |
13,537 | 100 | 6.8 | 959 | 100 | 8.0 | 14,496 | 100 | 6.9 | ||||||||||||||
2007 | |||||||||||||||||||||||
UK schemes | Overseas schemes | Total | |||||||||||||||||||||
Value £m |
% of total fair value of scheme assets |
Expected of return % |
Value £m |
% of total fair value of scheme assets |
Expected of return % |
Value £m |
% of total fair value of scheme assets |
Expected of return % | |||||||||||||||
Equities |
7,467 | 43 | 8.3 | 441 | 55 | 8.4 | 7,908 | 44 | 8.3 | ||||||||||||||
Bonds |
7,445 | 43 | 5.1 | 300 | 38 | 7.6 | 7,745 | 43 | 5.2 | ||||||||||||||
Property |
1,712 | 10 | 7.0 | 16 | 2 | 11.5 | 1,728 | 10 | 7.0 | ||||||||||||||
Derivatives |
(12 | ) | | | | | | (12 | ) | | | ||||||||||||
Cash |
284 | 2 | 5.1 | 42 | 5 | 5.6 | 326 | 1 | 5.2 | ||||||||||||||
Other |
335 | 2 | 5.3 | (3 | ) | | | 332 | 2 | 5.4 | |||||||||||||
Fair value of plan assetsa |
17,231 | 100 | 6.7 | 796 | 100 | 7.8 | 18,027 | 100 | 6.8 |
The UKRF plan assets include £27m relating to UK private equity investments (2007: £39m) and £735m relating to overseas private equity investments (2007: £664m). These are disclosed within Equities.
Amounts included in the fair value of plan assets include £5m (2007: £6m) relating to shares in Barclays Group, £11m (2007: £6m) relating to bonds issued by the Barclays Group, £nil (2007: £nil) relating to other investments in the Barclays Group, and £17m (2007: £10m) relating to property occupied by Group companies.
The expected return on assets is determined by calculating a total return estimate based on weighted average estimated returns for each asset class. Asset class returns are estimated using current and projected economic and market factors such as inflation, credit spreads and equity risk premiums.
The Group actual return on plan assets was a decrease of £3,480m (2007: £731m increase.)
Note
a | Excludes £675m (2007: £782m) representing the money purchase assets of the UKRF. |
224 | Barclays Annual Report 2008 |
30 Retirement benefit obligations (continued)
Actuarial gains and losses
The actuarial gains and losses arising on plan liabilities and plan assets are as follows:
UK schemes | |||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004 £m |
|||||||||||
Present value of obligations |
(14,438 | ) | (16,623 | ) | (17,353 | ) | (18,252 | ) | (15,574 | ) | |||||
Fair value of plan assets |
13,537 | 17,231 | 16,761 | 15,571 | 13,261 | ||||||||||
Net (deficit)/surplus in the plans |
(901 | ) | 608 | (592 | ) | (2,681 | ) | (2,313 | ) | ||||||
Experience gains and (losses) on plan liabilities |
|||||||||||||||
amount |
(81 | ) | (297 | ) | 48 | (2 | ) | 16 | |||||||
as percentage of plan liabilities |
(1% | ) | (2% | ) | | | | ||||||||
Difference between actual and expected return on plan assets |
|||||||||||||||
amount |
(4,534 | ) | (332 | ) | 423 | 1,599 | 570 | ||||||||
as percentage of plan assets |
(33% | ) | (2% | ) | 3% | 10% | 4% | ||||||||
Overseas schemes | |||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004 £m |
|||||||||||
Present value of obligations |
(1,345 | ) | (1,011 | ) | (970 | ) | (1,017 | ) | (587 | ) | |||||
Fair value of plan assets |
959 | 796 | 745 | 819 | 436 | ||||||||||
Net (deficit)/surplus in the plans |
(386 | ) | (215 | ) | (225 | ) | (198 | ) | (151 | ) | |||||
Experience losses on plan liabilities |
|||||||||||||||
amount |
(96) | (79 | ) | (54 | ) | (2 | ) | (31 | ) | ||||||
as percentage of plan liabilities |
(7% | ) | (8% | ) | (6% | ) | | (5% | ) | ||||||
Difference between actual and expected return on plan assets |
|||||||||||||||
amount |
(121 | ) | (11 | ) | 25 | 2 | 9 | ||||||||
as percentage of plan assets |
(13% | ) | | 3% | | 2% | |||||||||
Total UK and Overseas schemes | |||||||||||||||
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2004 £m |
|||||||||||
Present value of obligations |
(15,783 | ) | (17,634 | ) | (18,323 | ) | (19,269 | ) | (16,161 | ) | |||||
Fair value of plan assets |
14,496 | 18,027 | 17,506 | 16,390 | 13,697 | ||||||||||
Net (deficit)/surplus in the plans |
(1,287 | ) | 393 | (817 | ) | (2,879 | ) | (2,464 | ) | ||||||
Experience losses on plan liabilities |
|||||||||||||||
amount |
(177 | ) | (376 | ) | (6 | ) | (4 | ) | (15 | ) | |||||
as percentage of plan liabilities |
(1% | ) | (2% | ) | | | | ||||||||
Difference between actual and expected return on plan assets |
|||||||||||||||
amount |
(4,655 | ) | (343 | ) | 448 | 1,601 | 579 | ||||||||
as percentage of plan assets |
(32% | ) | (2% | ) | 3% | 10% | 4% |
Barclays Annual Report 2008 |
225 |
Notes to the accounts
For the year ended 31st December 2008
30 Retirement benefit obligations (continued)
Funding
The most recent triennial funding valuation of the UK Retirement Fund was performed with an effective date of 30th September 2007. In compliance with the Pensions Act 2004, the Group and Trustee have agreed a scheme specific funding target, statement of funding principles, and a schedule of contributions. This agreement forms the basis of the Groups commitment that the fund has sufficient assets to make payments to members in respect of their accrued benefits as and when they fall due. This funding valuation uses a discount rate that reflects a prudent expectation of long-term future investment returns from the current and assumed future investment strategy, and takes into account projected future salary increases when assessing liabilities arising from accrued service.
As at 30th September 2007 the funding valuation showed a surplus of £0.2bn. The Scheme Actuary prepares an annual update of the funding position as at 30th September. The first annual update was carried out as at 30th September 2008 and showed a deficit of £2.2bn.
The Group has agreed funding contributions which, in aggregate, are no less than those which are sufficient to meet the Groups share of the cost of benefits accruing over each year. The Group has, in the recent past, chosen to make funding contributions in excess of this, more consistent with the IAS service cost.
Defined benefit contributions paid with respect to the UKRF were as follows:
£m | ||
Contributions paid |
||
2008 |
336 | |
2007 |
355 | |
2006 |
351 |
Excluding the UKRF, the Group is expected to pay contributions of approximately £2m to UK schemes and £53m to overseas schemes in 2009.
The total contribution to be paid in 2009 to the UKRF is not expected to be significantly different than in previous years.
31 Ordinary shares, share premium, and other equity
Ordinary shares and share premium
Number of m |
Ordinary shares £m |
Share premium £m |
Total £m |
|||||||||
At 1st January 2008 |
6,601 | 1,651 | 56 | 1,707 | ||||||||
Issued to staff under the Sharesave Share Option Scheme |
3 | 1 | 13 | 14 | ||||||||
Issued under the Incentive Share Option Plana |
1 | | 3 | 3 | ||||||||
Issued to staff under the Share Incentive Plana |
1 | | 2 | 2 | ||||||||
Issue of new ordinary shares |
1,803 | 451 | 3,971 | 4,422 | ||||||||
Repurchase of shares |
(37 | ) | (10 | ) | | (10 | ) | |||||
At 31st December 2008 |
8,372 | 2,093 | 4,045 | 6,138 | ||||||||
At 1st January 2007 |
6,535 | 1,634 | 5,818 | 7,452 | ||||||||
Issued to staff under the Sharesave Share Option Scheme |
19 | 6 | 62 | 68 | ||||||||
Issued under the Incentive Share Option Plan |
10 | 2 | 40 | 42 | ||||||||
Issued under the Executive Share Option Schemeb |
| | 1 | 1 | ||||||||
Issued under the Woolwich Executive Share Option Planb |
| | 1 | 1 | ||||||||
Transfer to retained earnings |
| | (7,223 | ) | (7,223 | ) | ||||||
Issue of new ordinary shares |
337 | 84 | 1,357 | 1,441 | ||||||||
Repurchase of shares |
(300 | ) | (75 | ) | | (75 | ) | |||||
At 31st December 2007 |
6,601 | 1,651 | 56 | 1,707 |
Note
a | The nominal value for share options issued during 2008 for the Incentive Share Option Plan and Share Incentive Plan was less than £500,000 in each case. |
b | The nominal value for share options issued during 2007 for the Executive Share Option Scheme and Woolwich Executive Share Option Plan was less than £500,000 in each case. |
226 | Barclays Annual Report 2008 |
31 Ordinary shares, share premium, and other equity (continued)
The authorised share capital of Barclays PLC is £3,540m, $77.5m, 40m and ¥4,000m. (31st December 2007: £2,500m) comprising 13,996 million (31st December 2007: 9,996 million) ordinary shares of 25p each, 0.4 million Sterling preference shares of £100 each, 0.4 million US Dollar preference shares of $100 each, 150 million US Dollar preference shares of $0.25 each, 0.4 million Euro preference shares of 100 each, 0.4 million Yen preference shares of ¥10,000 each and 1 million (31st December 2007: 1 million) staff shares of £1 each.
Called up share capital, allotted and fully paid | 2008 £m |
2007 £m |
||||
Ordinary shares: |
||||||
At beginning of year |
1,650 | 1,633 | ||||
Issued to staff under the Sharesave Share Option Scheme |
1 | 6 | ||||
Issued under the Incentive Share Option Plan |
| 2 | ||||
Issue of new ordinary shares |
451 | 84 | ||||
Repurchase of shares |
(9 | ) | (75 | ) | ||
At end of year |
2,093 | 1,650 | ||||
Staff shares: |
||||||
At beginning of year |
1 | 1 | ||||
Repurchase of shares |
(1 | ) | | |||
At end of year |
| 1 | ||||
Total |
2,093 | 1,651 |
Issue of new ordinary shares
During the year, the following share issues took place:
On 4th July 2008, Barclays PLC raised approximately £500m (before issue costs) through the issue of 168.9 million new ordinary shares at £2.96 per share in a firm placing to Sumitomo Mitsui Banking Corporation.
On 22nd July 2008, Barclays PLC raised approximately £3,969m (before issue costs) through the issue of 1,407.4 million new ordinary shares at £2.82 per share in a placing to Qatar Investment Authority, Challenger Universal Limited (a company representing the beneficial interests of His Excellency Sheikh Hamad Bin Jassim Bin Jabr Al-Thani, the Chairman of Qatar Holding LLC, and his family), China Development Bank, Temasek Holdings (Private) Limited and certain leading institutional shareholders and other investors, which shares were available for clawback in full by means of an open offer to existing shareholders. Valid applications under the open offer were received from qualifying shareholders in respect of approximately 267 million new ordinary shares in aggregate, representing 19.0 per cent. of the shares offered pursuant to the open offer. Accordingly, the remaining 1,140.3 million shares were allocated to the various investors with whom they had been conditionally placed.
On 18th September 2008, Barclays PLC raised approximately £701m (before issue costs) through the issue of 226 million new ordinary shares at £3.10 per share to certain institutional investors. The proceeds of the issuance, in excess of the nominal value and issue costs, of £634m were credited to retained earnings. This resulted from the operation of section 131 of the Companies Act 1985 with regard to the issue of shares by Barclays PLC in exchange for shares in Long Island Investments Jersey No. 1 Limited and the subsequent redemption of redeemable preference shares of that company for cash.
During the period from 27th November 2008 to 31st December 2008, 33,000 ordinary shares have been issued following conversion of Mandatorily Convertible Notes (see below) at the option of their holders.
Share repurchase
During the year Barclays PLC purchased in the market 36 million of its own ordinary shares of 25p each at a total cost of £173m. These transactions represent less than 0.5% of the issued share capital at 31st December 2008. These shares purchased during the period were open market transactions.
Barclays PLC purchased all of its staff shares in issue, following approval for such purchase being given at the 2008 Annual General Meeting, at a total cost of £1m.
At the 2008 AGM on 24th April, Barclays PLC was authorised to repurchase 984,960,000 of its ordinary shares of 25p. The authorisation is effective until the AGM in 2009.
Cancellation of share premium account
On 11th October 2007, the order of the High Court confirming the cancellation of £7,223m of the share premium account was registered with the Registrar of Companies. This created £7,223m of additional distributable reserves in Barclays PLC. The purpose of the cancellation of the share premium account was to create distributable profits in order to allow the payment of dividends following the completion of the share buy-back programme, the redemption of the preference shares which were to have been issued in connection with the proposed merger with ABN AMRO, and to provide maximum flexibility to manage the Groups capital resources.
Warrants
On 31st October 2008 Barclays PLC issued, in conjunction with a simultaneous issue of Reserve Capital Instruments, warrants to subscribe for up to 1516.9 million new ordinary shares at a price of £1.97775 to Qatar Holding and HH Sheikh Mansour Bin Zayed Al Nahyan. A fair value of £800m before transaction costs of £24m was attributed to the warrants, which may be exercised at any time up to close of business 31st October 2013.
The fair value (net of transaction costs) of the warrants have been included in retained earnings (see Note 32).
Shares under option
The Group has four schemes that give employees rights to subscribe for new shares in Barclays PLC. A summary of the key terms of each scheme are included in Note 45.
At 31st December 2008, 94.1 million (2007: 74.0 million) options were outstanding under the terms of the Sharesave Share Option Scheme (Sharesave), 0.5 million (2007: 1.4 million) options were outstanding under the terms of the Executive Share Option Scheme (ESOS), 0.4 million (2007: 0.5 million) options were outstanding under the terms of the Woolwich Executive Share Option Plan (Woolwich ESOP) and 20.5 million (2007: 20.5 million) options were outstanding under the terms of the Incentive Share Option Plan (ISOP), enabling certain Directors and members of staff to subscribe for ordinary shares between 2008 and 2016 at prices ranging from 144p to 551p.
Barclays Annual Report 2008 |
227 |
Notes to the accounts
For the year ended 31st December 2008
31 Ordinary shares, share premium, and other equity (continued)
In addition to the above, the independent trustee of the Barclays Group (ESAS) Employees Benefit Trust (ESAS Trust), established by Barclays Bank PLC in 1996, operates the Executive Share Award Scheme (ESAS). ESAS is a deferred share bonus plan for employees of the Group. The key terms of the ESAS are described in Note 45. The independent trustees of the ESAS Trust make awards of Barclays shares and grant options over Barclays shares to beneficiaries of the ESAS Trust. Beneficiaries of the ESAS Trust include employees and former employees of the Barclays Group.
The independent trustee of the Barclays Group (PSP and ESOS) Employees Benefit Trust (PSP Trust), established by Barclays Bank PLC in 1996, operates the Performance Share Plan (PSP) and may satisfy awards under the ESOS. No awards have been made under this trust since 1999. All awards are in the form of options over Barclays shares.
The Sharepurchase scheme which was established in 2002 is open to all eligible UK employees, including executive Directors. The key terms of the Sharepurchase scheme are described in Note 45.
Other equity Mandatorily Convertible Notes
On 27th November 2008, Barclays Bank PLC issued £4,050m of 9.75% Mandatorily Convertible Notes (MCNs) maturing on 30th September 2009 to Qatar Holding LLC, Challenger Universal Limited and entities representing the beneficial interests of HH Sheikh Mansour Bin Zayed Al Nahyan, a member of the Royal Family of Abu Dhabi and existing institutional shareholders and other institutional investors. If not converted at the holders option beforehand, these instruments mandatorily convert to ordinary shares of Barclays PLC on 30th June 2009. The conversion price is £1.53276, and, after taking into account MCNs that were converted on or before 31st December 2008, will result in the issue of 2,642 million new ordinary shares. Following conversion the relevant amounts will be credited to share capital and share premium.
Of the proceeds of the MCNs, £233m has been included in the Groups liabilities, being the fair value of the coupon before issue costs at the date of issue. The remaining proceeds are included in other equity and will be transferred to share capital and share premium on conversion in both the Barclays PLC Group and Company.
32 Reserves
Other reserves Barclays PLC Group
Capital £m |
Other capital reserve £m |
Available for sale reserve £m |
Cash flow hedging reserve £m |
Currency translation reserve £m |
Total £m |
|||||||||||
At 1st January 2008 |
384 | 617 | 154 | 26 | (307 | ) | 874 | |||||||||
Net (losses)/gains from changes in fair value |
| | (1,736 | ) | 252 | | (1,484 | ) | ||||||||
Net (gains)/losses transferred to net profit |
| | (212 | ) | 19 | | (193 | ) | ||||||||
Currency translation differences |
| | | | 2,307 | 2,307 | ||||||||||
Losses transferred to net profit due to impairment |
| | 382 | | | 382 | ||||||||||
Changes in insurance liabilities |
| | 17 | | | 17 | ||||||||||
Net gains transferred to net profit due to fair value hedging |
| | (2 | ) | | | (2 | ) | ||||||||
Tax |
| | 207 | (165 | ) | 840 | 882 | |||||||||
Repurchase of shares |
10 | | | | | 10 | ||||||||||
At 31st December 2008 |
394 | 617 | (1,190 | ) | 132 | 2,840 | 2,793 |
Capital £m |
Other capital reserve £m |
Available for sale reserve £m |
Cash flow hedging reserve £m |
Currency translation reserve £m |
Total £m |
|||||||||||
At 1st January 2007 |
309 | 617 | 132 | (230 | ) | (438 | ) | 390 | ||||||||
Net gains from changes in fair value |
| | 480 | 182 | | 662 | ||||||||||
Net (gains)/losses transferred to net profit |
| | (560 | ) | 198 | | (362 | ) | ||||||||
Currency translation differences |
| | | | 29 | 29 | ||||||||||
Losses transferred to net profit due to impairment |
| | 13 | | | 13 | ||||||||||
Changes in insurance liabilities |
| | 22 | | | 22 | ||||||||||
Net losses transferred to net profit due to fair value hedging |
| | 68 | | | 68 | ||||||||||
Tax |
| | (1 | ) | (124 | ) | 102 | (23 | ) | |||||||
Repurchase of shares |
75 | | | | | 75 | ||||||||||
At 31st December 2007 |
384 | 617 | 154 | 26 | (307 | ) | 874 |
The capital redemption reserve and other capital reserve represent transfers from retained earnings in accordance with relevant legislation. These reserves are not distributable.
The available for sale reserve represents the unrealised change in the fair value of available for sale investments since initial recognition.
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Groups net investment in foreign operations, net of the effects of hedging.
Transfers from cash flow hedging reserve
Gains and losses transferred from the cash flow hedging reserve were to: interest income: £4m loss (2007: £93m), interest expense: £74m loss (2007: £11m gain), net trading income: £119m gain (2007: £100m loss), and administration and general expenses: £60m loss (2007: £16m loss).
228 | Barclays Annual Report 2008 |
32 Reserves (continued)
Retained earnings and treasury shares Barclays PLC Group
Retained earnings £m |
Treasury shares £m |
Total £m |
|||||||
At 1st January 2008 |
20,970 | (260 | ) | 20,710 | |||||
Profit attributable to equity holders of the parent |
4,382 | | 4,382 | ||||||
Equity-settled share schemes |
463 | | 463 | ||||||
Tax on equity-settled share schemes |
(4 | ) | | (4 | ) | ||||
Other taxes |
(52 | ) | | (52 | ) | ||||
Net purchases of treasury shares |
| (350 | ) | (350 | ) | ||||
Transfer |
(437 | ) | 437 | | |||||
Dividends paid |
(2,344 | ) | | (2,344 | ) | ||||
Repurchase of shares |
(173 | ) | | (173 | ) | ||||
Arising on share issue |
634 | | 634 | ||||||
Issue of warrants |
776 | | 776 | ||||||
Other |
(7 | ) | | (7 | ) | ||||
At 31st December 2008 |
24,208 | (173 | ) | 24,035 | |||||
At 1st January 2007 |
12,169 | (212 | ) | 11,957 | |||||
Profit attributable to equity holders of the parent |
4,417 | | 4,417 | ||||||
Equity-settled share schemes |
567 | | 567 | ||||||
Tax on equity-settled share schemes |
28 | | 28 | ||||||
Net purchases of treasury shares |
| (572 | ) | (572 | ) | ||||
Transfer |
(524 | ) | 524 | | |||||
Dividends paid |
(2,079 | ) | | (2,079 | ) | ||||
Repurchase of shares |
(1,802 | ) | | (1,802 | ) | ||||
Transfer from share premium account |
7,223 | | 7,223 | ||||||
Arising on share issue |
941 | | 941 | ||||||
Other |
30 | | 30 | ||||||
At 31st December 2007 |
20,970 | (260 | ) | 20,710 |
The Treasury shares primarily relate to Barclays PLC shares held by employee benefit trusts in relation to the Executive Share Award Scheme, Performance Share Plan and Sharepurchase Scheme, to the extent that such shares have not been allocated to employees. These schemes are described in Note 45.
The total number of Barclays shares held in Group employee benefit trusts at 31st December 2008 was 217.9 million (2007: 211.4 million). Dividend rights have been waived on nil (2007: nil) of these shares. The total market value of the shares held in trust based on the year-end share price of £1.53 (2007: £5.04) was £333m (2007: £1,065m). As at 31st December 2008, options over 19.1 million (2007: 16.6 million) of the total shares held in the trusts were exercisable.
The Group operates in a number of countries subject to regulations under which a local subsidiary has to maintain a minimum level of capital. The current policy of the Group is that local capital requirements are met, as far as possible, by the retention of profit. Certain countries operate exchange control regulations which limit the amount of dividends that can be remitted to non-resident shareholders. It is not possible to determine the amount of profit retained and other reserves that are restricted by these regulations, but the net profit retained of overseas subsidiaries, associates and joint ventures at 31st December 2008 totalled £4,581m (2007: £7,311m). If such overseas reserves were to be remitted, other tax liabilities, which have not been provided for in the accounts, might arise.
Retained earnings Barclays PLC (Parent company)
Retained earnings £m |
Capital £m |
Total £m |
||||||
At 1st January 2008 |
8,990 | 384 | 9,374 | |||||
Profit after tax |
1,193 | | 1,193 | |||||
Dividends paid |
(2,414 | ) | | (2,414 | ) | |||
Arising on share issue |
634 | | 634 | |||||
Repurchase of shares |
(173 | ) | 10 | (163 | ) | |||
Issue of warrants |
776 | | 776 | |||||
At 31st December 2008 |
9,006 | 394 | 9,400 | |||||
At 1st January 2007 |
1,468 | 309 | 1,777 | |||||
Profit after tax |
3,289 | | 3,289 | |||||
Dividends paid |
(2,129 | ) | | (2,129 | ) | |||
Transfer from share premium account |
7,223 | | 7,223 | |||||
Arising on share issue |
941 | | 941 | |||||
Repurchase of shares |
(1,802 | ) | 75 | (1,727 | ) | |||
At 31st December 2007 |
8,990 | 384 | 9,374 |
Details of principal subsidiaries held through Barclays Bank PLC are shown in Note 41.
Barclays Annual Report 2008 |
229 |
Notes to the accounts
For the year ended 31st December 2008
33 Minority interests
2008 £m |
2007 £m |
|||||
At beginning of year |
9,185 | 7,591 | ||||
Share of profit after tax |
905 | 678 | ||||
Dividend and other payments |
(703 | ) | (480 | ) | ||
Equity issued by subsidiaries |
1,349 | 1,381 | ||||
Available for sale reserve: net (loss)/gain from changes in fair value |
(1 | ) | 1 | |||
Cash flow hedges: net gain/(loss) from changes in fair value |
76 | (16 | ) | |||
Currency translation differences |
100 | 25 | ||||
Additions |
| 27 | ||||
Disposals |
(11 | ) | (111 | ) | ||
Other |
(107 | ) | 89 | |||
At end of year |
10,793 | 9,185 |
During the year, Barclays Bank PLC issued the following Preference Shares:
106 million Preference Shares of nominal US$0.25 each (Principal amount: US$2,650m; £1,345m) with a 8.125% dividend issued on 11th April 2008 and 25th April 2008.
34 Contingent liabilities and commitments
Contingent liabilities and commitments
The following table summarises the nominal principal amount of contingent liabilities and commitments with off-balance sheet risk:
2008 £m |
2007 £m | |||
Acceptances and endorsements |
585 | 365 | ||
Guarantees and letters of credit pledged as collateral security |
15,652 | 12,973 | ||
Securities lending arrangements |
38,290 | 22,719 | ||
Other contingent liabilities |
11,783 | 9,717 | ||
Contingent liabilities |
66,310 | 45,774 | ||
Documentary credits and other short-term trade related transactions |
859 | 522 | ||
Undrawn note issuance and revolving underwriting facilities: |
||||
Forward asset purchases and forward deposits placed |
291 | 283 | ||
Standby facilities, credit lines and other |
259,666 | 191,834 | ||
Commitments |
260,816 | 192,639 |
Nature of instruments
In common with other banks, the Group conducts business involving acceptances, performance bonds and indemnities. The majority of these facilities are offset by corresponding obligations of third parties.
An acceptance is an undertaking by a bank to pay a bill of exchange drawn on a customer. The Group expects most acceptances to be presented, but reimbursement by the customer is normally immediate. Endorsements are residual liabilities of the Group in respect of bills of exchange, which have been paid and subsequently rediscounted.
Guarantees and letters of credit are given as security to support the performance of a customer to third parties. As the Group will only be required to meet these obligations in the event of the customers default, the cash requirements of these instruments are expected to be considerably below their nominal amounts.
The Group facilitates securities lending arrangements for its investment management clients whereby securities held by funds are lent to third parties. The borrowers provide the funds with collateral in the form of cash or other assets equal to at least 100% of the securities lent plus a margin of at least 2% up to 8%. Over the period of the loan, the funds may make margin calls to the extent that the collateral is less than the market value of the securities lent. Amounts disclosed above represent the total market value of the lent securities at 31st December 2008. The market value of collateral held by the funds was £39,690m (2007: £23,559m).
230 | Barclays Annual Report 2008 |
34 Contingent liabilities and commitments (continued)
Other contingent liabilities include transaction related customs and performance bonds and are, generally, short-term commitments to third parties which are not directly dependent on the customers creditworthiness.
Commitments to lend are agreements to lend to a customer in the future, subject to certain conditions. Such commitments are either made for a fixed period, or have no specific maturity but are cancellable by the lender subject to notice requirements.
Documentary credits commit the Group to make payments to third parties, on production of documents, which are usually reimbursed immediately by customers.
Capital commitments
At 31st December 2008 the commitments for capital expenditure under contract amounted to £48m (2007: £6m).
Assets pledged
Assets are pledged as collateral to secure liabilities under repurchase agreements, securitisations and stock lending agreements or as security deposits relating to derivatives. The disclosure includes any asset transfers associated with liabilities under repurchase agreements and securities lending transactions.
The following table summarises the nature and carrying amount of the assets pledged as security against these liabilities:
2008 £m |
2007 £m | |||
Trading portfolio assets |
81,186 | 76,226 | ||
Loans and advances |
28,789 | 32,846 | ||
Available for sale investments |
32,321 | 16,378 | ||
Other |
3,812 | 580 | ||
Assets pledged |
146,108 | 126,030 |
Collateral held as security for assets
Under certain transactions, including reverse repurchase agreements and stock borrowing transactions, the Group is allowed to resell or repledge the collateral held. The fair value at the balance sheet date of collateral accepted and repledged to others was as follows:
2008 £m |
2007 £m | |||
Fair value of securities accepted as collateral |
424,819 | 343,986 | ||
Of which fair value of securities repledged / transferred to others |
374,222 | 269,157 |
35 Legal proceedings
Barclays has for some time been party to proceedings, including a class action, in the United States against a number of defendants following the collapse of Enron; the class action claim is commonly known as the Newby litigation. On 20th July 2006 Barclays received an Order from the United States District Court for the Southern District of Texas Houston Division which dismissed the claims against Barclays PLC, Barclays Bank PLC and Barclays Capital Inc. in the Newby litigation. On 4th December 2006 the Court stayed Barclays dismissal from the proceedings and allowed the plaintiffs to file a supplemental complaint. On 19th March 2007 the United States Court of Appeals for the Fifth Circuit issued its decision on an appeal by Barclays and two other financial institutions contesting a ruling by the District Court allowing the Newby litigation to proceed as a class action. The Court of Appeals held that because no proper claim against Barclays and the other financial institutions had been alleged by the plaintiffs, the case could not proceed against them. The plaintiffs applied to the United States Supreme Court for a review of this decision. On 22nd January 2008, the United States Supreme Court denied the plaintiffs request for review. Following the Supreme Courts decision, the District Court ordered a further briefing concerning the status of the plaintiffs claims. Barclays is seeking the dismissal of the plaintiffs claims. Barclays considers that the Enron related claims against it are without merit and is defending them vigorously. It is not possible to estimate Barclays possible loss in relation to these matters, nor the effect that they might have upon operating results in any particular financial period.
Like other UK financial services institutions, the Group faces numerous County Court claims and complaints by customers who allege that its unauthorised overdraft charges either contravene the Unfair Terms in Consumer Contracts Regulations 1999 (UTCCR) or are unenforceable penalties or both. In July 2007, by agreement with all parties, the OFT commenced proceedings against seven banks and one building society, including Barclays, to resolve the matter by way of a test case process. Preliminary issues hearings took place in January, July and December 2008 with judgments handed down in April and October 2008 and January 2009 (a further judgment not concerning Barclays terms). As to current terms, in April 2008 the Court held in favour of the banks on the issue of the penalty doctrine. The OFT did not appeal that decision. In the same judgment the Court held in favour of the OFT on the issue of the applicability of the UTCCR. The banks appealed that decision. As to past terms, in a judgment on 8th October 2008, the Court held that Barclays historic terms, including those of Woolwich, were not capable of being penalties. The OFT indicated at the January 2009 hearing that it was not seeking permission to appeal the Courts findings in relation to the applicability of the penalty doctrine to historic terms. Accordingly, it is now clear that no declarations have or will be made against Barclays that any of its unauthorised overdraft terms assessed in the test case constitute unenforceable penalties and that the OFT will not pursue this aspect of the test case further. The proceedings will now concentrate exclusively on UTCCR issues. The banks appeal against the decision in relation to the applicability of the UTCCR (to current and historic terms) took place at a hearing in late October 2008. On 26th February 2009 the Court of Appeal dismissed the banks appeal, holding, in a judgment of broad application, that the relevant charges were not exempt from the UTCCR. The banks will petition the House of Lords for leave to appeal the decision. It is likely that the proceedings will still take a significant period of time to conclude. Pending resolution of the test case process, existing and new claims in the County Courts remain stayed, and there is an FSA waiver of the complaints handling process (which is reviewable in July 2009) and a standstill of Financial Ombudsman Service decisions. The Group is defending the test case vigorously. It is not practicable to estimate the Groups possible loss in relation to these matters, nor the effect that they may have upon operating results in any particular financial period.
Barclays Annual Report 2008 |
231 |
Notes to the accounts
For the year ended 31st December 2008
35 Legal proceedings (continued)
Barclays is engaged in various other litigation proceedings both in the United Kingdom and a number of overseas jurisdictions, including the United States, involving claims by and against it which arise in the ordinary course of business. Barclays does not expect the ultimate resolution of any of the proceedings to which Barclays is party to have a significant adverse effect on the financial position of the Group and Barclays has not disclosed the contingent liabilities associated with these claims either because they cannot reasonably be estimated or because such disclosure could be prejudicial to the conduct of the claims.
36 Competition and regulatory matters
The scale of regulatory change remains challenging, arising in part from the implementation of some key European Union (EU) directives. Many changes to financial services legislation and regulation have come into force in recent years and further changes will take place in the near future. Concurrently, there is continuing political and regulatory scrutiny of the operation of the retail banking and consumer credit industries in the UK and elsewhere. The nature and impact of future changes in policies and regulatory action are not predictable and beyond the Groups control but could have an impact on the Groups businesses and earnings.
In September 2005, the Office of Fair Trading (OFT) received a super-complaint from the Citizens Advice Bureau relating to payment protection insurance (PPI). As a result, the OFT commenced a market study on PPI in April 2006. In October 2006 the OFT announced the outcome of the market study and the OFT referred the PPI market to the UK Competition Commission (CC) for an in-depth inquiry in February 2007. In June 2008, the CC published its provisional findings. The CC published its final report into the PPI market on 29th January 2009. The CCs conclusion is that the businesses which offer PPI alongside credit face little or no competition when selling PPI to their credit customers. The CC has set out a package of measures which it considers will introduce competition into the market (the Remedies). The Remedies, which are expected to be implemented (following consultation) in 2010, are: a ban on sale of PPI at the point of sale; a prohibition on the sale of single premium PPI; mandatory personal PPI quotes to customers; annual statements for all regular premium policies, including the back book (for example credit card and mortgage protection policies); measures to ensure that improved information is available to customers; obliging providers to give information to the OFT to monitor the Remedies and to provide claims ratios to any person on request. Barclays is reviewing the report and considering the next steps, including how this might affect the Groups different products.
In October 2006, the FSA published the outcome of its broad industry thematic review of PPI sales practices in which it concluded that some firms fail to treat customers fairly and that the FSA would strengthen its actions against such firms. Tackling poor PPI sales practices remains a priority for the FSA, with their most recent update on their thematic work published in September 2008. Barclays voluntarily complied with the FSAs request to cease selling single premium PPI by the end of January 2009. There has been no enforcement action against Barclays in respect of its PPI products. The Group has cooperated fully with these investigations into PPI and will continue to do so.
The OFT has carried out investigations into Visa and MasterCard credit card interchange rates. The decision by the OFT in the MasterCard interchange case was set aside by the Competition Appeals Tribunal in June 2006. The OFT is progressing its investigations in the Visa interchange case and a second MasterCard interchange case in parallel and both are ongoing. The outcome is not known but these investigations may have an impact on the consumer credit industry in general and therefore on the Groups business in this sector. In February 2007 the OFT announced that it was expanding its investigation into interchange rates to include debit cards.
In September 2006, the OFT announced that it had decided to undertake a fact find on the application of its statement on credit card fees to current account unauthorised overdraft fees. The fact find was completed in March 2007. On 29th March 2007, the OFT announced its decision to conduct a formal investigation into the fairness of bank current account charges. The OFT initiated a market study into personal current accounts (PCAs) in the UK on 26th April 2007. The studys focus was PCAs but it also included an examination of other retail banking products, in particular savings accounts, credit cards, personal loans and mortgages in order to take into account the competitive dynamics of UK retail banking. On 16th July 2008, the OFT published its market study report, in which it concluded that certain features of the UK PCA market were not working well for consumers. The OFT reached the provisional view that some form of regulatory intervention is necessary in the UK PCA market. On 16th July 2008, the OFT also announced a consultation to seek views on the findings and possible measures to address the issues raised in its report. The consultation period closed on 31st October 2008. The Group has participated fully in the market study process and will continue to do so.
US laws and regulations require compliance with US economic sanctions, administered by the Office of Foreign Assets Control, against designated foreign countries, nationals and others. HM Treasury regulations similarly require compliance with sanctions adopted by the UK government. The Group has been conducting an internal review of its conduct with respect to US Dollar payments involving countries, persons and entities subject to these sanctions and has been reporting to governmental authorities about the results of that review. The Group received inquiries relating to these sanctions and certain US Dollar payments processed by its New York branch from the New York County District Attorneys Office and the US Department of Justice, which along with other authorities, has been reported to be conducting investigations of sanctions compliance by non-US financial institutions. The Group has responded to those inquiries and is cooperating with the regulators, the Department of Justice and the District Attorneys Office in connection with their investigations of Barclays conduct with respect to sanctions compliance. Barclays has also received a formal notice of investigation from the FSA, and has been keeping the FSA informed of the progress of the US investigations and Barclays internal review. Barclays review is ongoing. It is currently not possible to predict the ultimate resolution of the issues covered by Barclays review and the investigations, including the timing and potential financial impact of any resolution, which could be substantial.
The Financial Services Compensation Scheme provides compensation to customers of financial institutions in the event that an institution is unable, or is likely to be unable, to pay claims against it. During the year, a number of institutions, including Bradford & Bingley plc, Heritable Bank plc, Kaupthing Singer & Friedlander Limited, Landsbanki Icesave, and London Scottish Bank plc, were declared in default by the FSA. In order to meet its obligations to the depositors of these institutions, the FSCS has borrowed £19.7 billion from HM Treasury, which is on an interest only basis until September 2011. These borrowings are anticipated to be repaid wholly or substantially from the realisation of the assets of the above named institutions. The FSCS raises annual levies from the banking industry to meet its management expenses and compensation costs. Individual institutions make payments based on their level of market participation (in the case of deposits, the proportion that their protected deposits represent of total market protected deposits) at 31st December each year. If an institution is a market participant on this date it is obligated to pay a levy. Barclays Bank PLC was a market participant at 31st December 2007 and 2008. The Group has accrued £101m for its share of levies that will be raised by the FSCS including the interest on the loan from HM Treasury in respect of the levy years to 31st March 2010. The accrual includes estimates for the interest FSCS will pay on the loan and estimates of Barclays market participation in the relevant periods. Interest will continue to accrue on the HM Treasury loan to the FSCS until September 2011 and will form part of future FSCS management expenses levies. If the assets of the defaulting institutions are insufficient to repay the HM Treasury loan in 2011, the FSCS will agree a schedule of repayments with HM Treasury, which will be recouped from the industry in the form of additional levies. At the date of these financial statements, it is not possible to estimate whether there will ultimately be additional levies on the industry, the level of Barclays market participation or other factors that may affect the amounts or timing of amounts that may ultimately become payable, nor the effect that such levies may have upon operating results in any particular financial period.
232 | Barclays Annual Report 2008 |
37 Leasing
The Group is both lessor and lessee under finance and operating leases, providing asset financing for its customers and leasing assets for its own use. In addition, assets leased by the Group may be sublet to other parties. An analysis of the impact of these transactions on the Group balance sheet and income statement is as follows:
(a) As Lessor
Finance lease receivables
The Group specialises in asset-based lending and works with a broad range of international technology, industrial equipment and commercial companies to provide customised finance programmes to assist manufacturers, dealers and distributors of assets.
Finance lease receivables are included within loans and advances to customers.
The Groups net investment in finance lease receivables was as follows:
2008 | 2007 | |||||||||||||||||
Gross investment in finance lease receivables £m |
Future finance income £m |
Present value of £m |
Unguaranteed £m |
Gross investment in finance lease receivables £m |
Future finance income £m |
Present value of £m |
Unguaranteed £m | |||||||||||
Not more than one year | 3,929 | (689 | ) | 3,240 | 149 | 3,657 | (780 | ) | 2,877 | 213 | ||||||||
Over one year but not more than five years | 8,668 | (1,673 | ) | 6,995 | 355 | 7,385 | (1,613 | ) | 5,772 | 374 | ||||||||
Over five years |
3,419 | (768 | ) | 2,651 | 25 | 3,476 | (935 | ) | 2,541 | 14 | ||||||||
Total |
16,016 | (3,130 | ) | 12,886 | 529 | 14,518 | (3,328 | ) | 11,190 | 601 |
The allowance for uncollectable finance lease receivables included in the allowance for impairment amounted to £189m at 31st December 2008 (2007: £113m).
Operating lease receivables
The Group acts as lessor, whereby items of plant and equipment are purchased and then leased to third parties under arrangements qualifying as operating leases. The items purchased to satisfy these leases are treated as plant and equipment in the Groups financial statements and are generally disposed of at the end of the lease term (see Note 23).
The future minimum lease payments expected to be received under non-cancellable operating leases at 31st December 2008 were as follows:
2008 Plant and |
2007 Plant and equipment £m | |||
Not more than one year |
80 | 29 | ||
Over one year but not more than two years |
42 | 24 | ||
Over two years but not more than three years |
36 | 22 | ||
Over three years but not more than four years |
24 | 20 | ||
Over four years but not more than five years |
13 | 11 | ||
Over five years |
39 | 10 | ||
Total |
234 | 116 |
(b) As Lessee
Finance lease commitments
The Group leases items of property, plant and equipment on terms that meet the definition of finance leases. Finance lease commitments are included within other liabilities (see Note 25).
Obligations under finance leases were as follows:
2008 Total future minimum payments £m |
2007 Total future minimum payments £m | |||
Not more than one year |
35 | 12 | ||
Over one year but not more than two years |
13 | 14 | ||
Over two years but not more than three years |
14 | 13 | ||
Over three years but not more than four years |
17 | 12 | ||
Over four years but not more than five years |
14 | 15 | ||
Over five years |
3 | 17 | ||
Net obligations under finance leases |
96 | 83 |
Barclays Annual Report 2008 |
233 |
Notes to the accounts
For the year ended 31st December 2008
37 Leasing (continued)
The carrying amount of assets held under finance leases at the balance sheet date was:
2008 £m |
2007 £m |
|||||
Cost |
87 | 94 | ||||
Accumulated depreciation |
(67 | ) | (24 | ) | ||
Net book value |
20 | 70 |
Operating lease commitments
The Group leases various offices, branches and other premises under non-cancellable operating lease arrangements. The leases have various terms, escalation and renewal rights. There are no contingent rents payable. The Group also leases equipment under non-cancellable lease arrangements.
Where the Group is the lessee the future minimum lease payment under non-cancellable operating leases are as follows:
2008 | 2007 | |||||||
Property £m |
Equipment £m |
Property £m |
Equipment £m | |||||
Not more than one year |
275 | 5 | 191 | 6 | ||||
Over one year but not more than two years |
354 | 1 | 396 | 1 | ||||
Over two years but not more than three years |
334 | 1 | 357 | 1 | ||||
Over three years but not more than four years |
315 | | 323 | | ||||
Over four years but not more than five years |
465 | 5 | 287 | | ||||
Over five years |
2,744 | 1 | 2,225 | | ||||
Total |
4,487 | 13 | 3,779 | 8 |
The total of future minimum sublease payments to be received under non-cancellable subleases at the balance sheet date is £158m (2007: £167m).
38 Disposals
The Group made the following material disposals in 2008:
% Disposal | Date | |||
Barclays Life Assurance Limited |
100 | 31/10/08 |
2008 £m |
|||
Total disposal consideration |
762 | ||
Costs associated with disposal |
(33 | ) | |
Net assets disposed |
(403 | ) | |
Profit on disposal of subsidiaries |
326 | ||
Total disposal consideration |
762 | ||
Costs associated with disposal |
(7 | ) | |
Repayment of loan on disposal |
(386 | ) | |
Cash and cash equivalents disposed of |
(131 | ) | |
Disposal of subsidiaries, net of cash disposed |
238 | ||
Cash received in respect of disposal of ownership in BGI UK Holdings Limited through the exercise of options under the BGI EOP scheme |
19 | ||
Decrease in investment in subsidiaries |
19 |
234 | Barclays Annual Report 2008 |
39 Acquisitions
The Group made the following material acquisitions in 2008:
Acquisition date |
Gains on acquisitions £m |
Goodwill £m | ||||||
Lehman Brothers North American businesses |
(a) | 22nd September 2008 | 2,262 | | ||||
Macquarie Bank Limited residential mortgage businesses |
(b) | 6th November 2008 | 52 | | ||||
Goldfish credit card UK businesses |
(b) | 31st March 2008 | 92 | | ||||
Expobank (100% of ordinary shares) |
(c) | 1st July 2008 | | 243 | ||||
Gains on acquisitions |
2,406 |
(a) Lehman Brothers North American businesses
On 22nd September 2008, the Group completed the acquisition of Lehman Brothers North American businesses.
The assets and liabilities of Lehman Brothers North American businesses after the acquisition, details of the purchase price and the gain on acquisition arising were as follows:
Fair values £m |
|||
Assets |
|||
Cash and balances at central banks |
861 | ||
Trading portfolio assets |
23,837 | ||
Loans and advances to customers |
3,642 | ||
Available-for-sale financial investments |
1,948 | ||
Other assets |
41 | ||
Intangible assets a |
888 | ||
Property, plant and equipment |
886 | ||
Deferred tax asset |
229 | ||
Total assets |
32,332 | ||
Liabilities |
|||
Customer accounts |
2,459 | ||
Derivative financial instruments |
599 | ||
Repurchase agreements and cash collateral on securities lent |
24,409 | ||
Other liabilities |
1,049 | ||
Deferred tax liabilities |
517 | ||
Total liabilities |
29,033 | ||
Net assets acquired (excludes Obligation to be settled in shares) |
3,299 | ||
Obligation to be settled in shares b |
(163 | ) | |
Acquisition cost |
|||
Cash paid |
834 | ||
Attributable costs |
40 | ||
Total consideration |
874 | ||
Gain on acquisition |
2,262 |
The acquired assets and liabilities summarised in the table above do not represent the entire balance sheet of Lehman Brothers North American businesses, or of discrete business lines within those operations. For this reason it is not practical to reliably determine the carrying amount of the assets and liabilities in the pre-acquisition books and records of Lehman Brothers.
Notes
a | Intangible assets included an amount of £636m relating to customer lists. |
b | Under the terms of the acquisition, the Group assumed an obligation to make payments to employees of the acquired business in respect of their pre-acquisition service provided to Lehman Brothers. This amount represents the equity-settled portion of that obligation and is recognised as a component of shareholders equity. |
Barclays Annual Report 2008 |
235 |
Notes to the accounts
For the year ended 31st December 2008
39 Acquisitions (continued)
Certain assets were received subsequent to the acquisition date, since it was first necessary to agree their status as assets of the Group with the relevant regulators, custodians, trustees, exchanges and bankruptcy courts. Such assets were initially classified within loans and advances. Once they were received, the related receivable was derecognised and the resulting asset recognised within the appropriate balance sheet category. In the table such assets are classified accordingly.
The initial accounting for the acquisition has been determined only provisionally. Any revisions to fair values that result from the conclusion of the acquisition process with respect to assets not yet received by the Group will be recognised as an adjustment to the initial accounting. Any such revisions must be effected within 12 months of the acquisition date and would result in a restatement of the 2008 income statement and balance sheet.
The excess of the fair value of net assets acquired over consideration paid resulted in £2,262m of gain on acquisition.
It is impracticable to disclose the profit or loss of the acquired Lehman Brothers North American businesses since the acquisition date. The acquired business has been integrated into the corresponding existing business lines and there is no reliable basis for allocating post-acquisition results between the acquirer and the acquiree. Similarly, it is impracticable to disclose the revenue and profit or loss of the combined entity as though the acquisition date had been 1st January 2008. Only parts of Lehman Brothers US and Canadian businesses, and specified assets and liabilities, were acquired. There is no reliable basis for identifying the proportion of the pre-acquisition results of Lehman Brothers that relates to the business acquired by the Group.
(b) Macquarie Bank Limited Italian residential mortgage businesses and Goldfish credit card UK businesses
On 6th November 2008, the Group purchased the Italian residential mortgage businesses of Macquarie Bank Limited.
On 31st March 2008, the Group completed the acquisition of Discovers UK credit card businesses, Goldfish.
The assets and liabilities of Macquarie Bank Limited Italian residential mortgage businesses and Goldfish credit card UK businesses before and after the acquisition, details of the purchase price and gains on acquisitions arising were as follows:
Macquarie Bank businesses | Goldfish credit card UK businesses | |||||||||||||
Carrying value pre-acquisition £m |
Fair value adjustments £m |
Fair values £m |
Carrying value pre-acquisition £m |
Fair value adjustments £m |
Fair values £m | |||||||||
Assets |
||||||||||||||
Cash and balances at central banks |
3 | | 3 | 172 | | 172 | ||||||||
Loans and advances to banks |
| | | 8 | | 8 | ||||||||
Loans and advances to customers |
833 | (20 | ) | 813 | 1,900 | (34 | ) | 1,866 | ||||||
Other assets |
| | | 39 | (1 | ) | 38 | |||||||
Intangible assets |
| | | | 32 | 32 | ||||||||
Property, plant and equipment |
1 | | 1 | 39 | 1 | 40 | ||||||||
Deferred tax asset |
| | | | 12 | 12 | ||||||||
Total assets |
837 | (20) | 817 | 2,158 | 10 | 2,168 | ||||||||
Liabilities |
||||||||||||||
Long- and short-term borrowings |
| | | 1,974 | | 1,974 | ||||||||
Other liabilities |
| | | 55 | | 55 | ||||||||
Deferred tax liabilities |
| | | | 9 | 9 | ||||||||
Total liabilities |
| | | 2,029 | 9 | 2,038 | ||||||||
Net assets acquired |
837 | (20) | 817 | 129 | 1 | 130 | ||||||||
Acquisition cost |
||||||||||||||
Cash paid |
765 | 35 | ||||||||||||
Attributable costs |
| 3 | ||||||||||||
Total consideration |
765 | 38 | ||||||||||||
Gains on acquisitions |
52 | 92 |
The contribution to the consolidated profit before tax of the acquired businesses in the table above for the period from the acquisition date to 31st December 2008 is £1m loss for Macquarie Bank Limited businesses and £40m profit for the Goldfish credit card UK businesses.
The excess remaining after the reassessment of the acquirees identifiable assets, liabilities and contingent liabilities which has been recognised within the consolidated income statement as a gain on acquisition is £52m for Macquarie Bank Limited businesses and £92m for Goldfish credit card UK businesses.
236 | Barclays Annual Report 2008 |
39 Acquisitions (continued)
(c) Expobank
On 1st July 2008, the Group acquired 100% of the ordinary shares of Expobank, a Russian bank.
The assets and liabilities of the Russian bank, Expobank before and after the acquisition, details of the purchase price and the goodwill arising were as follows:
Carrying value pre-acquisition |
Fair value adjustments £m |
Fair values £m | ||||
Assets |
||||||
Cash and balances at central banks |
73 | | 73 | |||
Trading portfolio assets |
52 | | 52 | |||
Loans and advances to customers |
446 | 5 | 451 | |||
Other assets |
9 | | 9 | |||
Intangible assets |
| 45 | 45 | |||
Property, plant and equipment |
28 | | 28 | |||
Total assets |
608 | 50 | 658 | |||
Liabilities |
||||||
Deposits from banks |
71 | | 71 | |||
Customer accounts |
318 | | 318 | |||
Debt securities in issue |
103 | | 103 | |||
Other liabilities |
16 | | 16 | |||
Total liabilities |
508 | | 508 | |||
Net assets acquired |
100 | 50 | 150 | |||
Goodwill |
243 | |||||
Total |
393 | |||||
Acquisition cost |
||||||
Cash paid |
386 | |||||
Attributable costs |
7 | |||||
Total consideration |
393 |
The excess of proceeds over the net assets acquired has generated goodwill of £243m and is attributable to the operational synergies and earnings potential expected to be realised over the longer term.
The results of the businesss operations have been included from 1st July 2008 and contributed £13m loss to the consolidated profit before tax.
Cash outflows in respect of acquisitions
The aggregate net outflow of cash from the acquisition of the above Group businesses and entities was as follows:
2008 £m |
|||
Cash consideration on acquisitions |
2,070 | ||
Cash and cash equivalents acquired |
(1,109 | ) | |
Cash outflow on acquisition |
961 | ||
Cash paid in respect of acquisition of shares in Barclays Global Investors UK Holdings Limited |
157 | ||
Increase in investment in subsidiaries |
157 |
Barclays Annual Report 2008 |
237 |
Notes to the accounts
For the year ended 31st December 2008
40 Investment in subsidiaries
The investment in Barclays Bank PLC is stated in the balance sheet of Barclays PLC at a cost of £15,340m (2007: £10,186m). The increase of £5,154m (2007: £1,545m) during the year represents the cost of additional shares of £16m (2007: £111m), capital contributions of £4,362m (2007: £1,434m), and a non-cash capital contribution of £776m.
The investment in Barclays Investments (Netherlands) N.V. was liquidated in September 2008. The investment was stated in the balance sheet of Barclays PLC at a cost of £205m in 2007.
The investment in Odysseus Jersey (No. 1) Limited was liquidated in September 2008. The investment was stated in the balance sheet of Barclays PLC at a cost of £0.1m in 2007.
41 Principal subsidiaries
Country of registration or incorporation |
Company name | Nature of business | Percentage of equity capital held % |
||||
Botswana |
Barclays Bank of Botswana Limited |
Banking |
74.9 | ||||
Egypt |
Barclays Bank Egypt SAE |
Banking |
100 | ||||
England |
Barclays Bank PLC |
Banking, holding company |
100 | * | |||
England |
Barclays Mercantile Business Finance Limited |
Loans and advances including leases to customers |
100 | * | |||
England |
Barclays Global Investors UK Holdings Limited |
Holding company |
95.5 | ||||
England |
Barclays Global Investors Limited |
Investment management |
95.5 | * | |||
England |
Barclays Bank Trust Company Limited |
Banking, securities industries and trust services |
100 | * | |||
England |
Barclays Stockbrokers Limited |
Stockbroking |
100 | * | |||
England |
Barclays Capital Securities Limited |
Securities dealing |
100 | * | |||
England |
Barclays Global Investors Pensions Management Limited |
Investment management |
95.5 | * | |||
England |
FIRSTPLUS Financial Group PLC |
Secured loan provider |
100 | ||||
England |
Gerrard Investment Management Limited |
Investment management |
100 | * | |||
Ghana |
Barclays Bank of Ghana Limited |
Banking |
100 | ||||
Ireland |
Barclays Insurance (Dublin) Limited |
Insurance provider |
100 | * | |||
Ireland |
Barclays Assurance (Dublin) Limited |
Insurance provider |
100 | * | |||
Isle of Man |
Barclays Private Clients International Limited a |
Banking |
100 | * | |||
Japan |
Barclays Capital Japan Limited |
Securities dealing |
100 | * | |||
Jersey |
Barclays Private Bank & Trust Limited |
Banking, trust company |
100 | * | |||
Kenya |
Barclays Bank of Kenya Limited |
Banking |
68.5 | ||||
Russia |
Barclays Bank LLC |
Banking |
100 | * | |||
South Africa |
Absa Group Limited |
Banking |
58.6 | ||||
Spain |
Barclays Bank SA |
Banking |
99.7 | ||||
Switzerland |
Barclays Bank (Suisse) S.A. |
Banking and trust services |
100 | ||||
USA |
Barclays Capital Inc. |
Securities dealing |
100 | * | |||
USA |
Barclays Financial Corporation |
Holding company for US credit card issuer |
100 | * | |||
USA |
Barclays Global Investors, National Association |
Investment management and securities industry |
95.5 | * | |||
USA |
Barclays Group USA Inc. |
Holding company |
100 | ||||
Zimbabwe |
Barclays Bank of Zimbabwe Limited |
Banking |
67.8 | * |
In accordance with Section 231(5) of the Companies Act 1985, the above information is provided solely in relation to principal subsidiaries.
The country of registration or incorporation is also the principal area of operation of each of the above subsidiaries. Investments in these subsidiaries are held directly by Barclays Bank PLC except where marked *.
Full information of all subsidiaries will be included in the Annual Return to be filed at Companies House.
Note
a | BBPLC is the beneficial owner of 38.1% of shares and Barclays Holdings (Isle of Man) Limited is the beneficial owner of 61.9% of shares. |
238 | Barclays Annual Report 2008 |
42 Other entities
There are a number of entities that do not qualify as subsidiaries under UK Law but which are consolidated when the substance of the relationship between the Group and the entity (usually a Special Purpose Entity (SPE)) indicates that the entity is controlled by the Group. Such entities are deemed to be controlled by the Group when relationships with such entities gives rise to benefits that are in substance no different from those that would arise were the entity a subsidiary.
The consolidation of such entities may be appropriate in a number of situations, but primarily when:
| the operating and financial policies of the entity are closely defined from the outset (i.e. it operates on an autopilot basis) with such policies being largely determined by the Group; |
| the Group has rights to obtain the majority of the benefits of the entity and/or retains the majority of the residual or ownership risks related to the entity; or |
| the activities of the entity are being conducted largely on behalf of the Group according to its specific business objectives. |
Such entities are created for a variety of purposes including securitisation, structuring, asset realisation, intermediation and management.
Entities may have a different reporting date from that of the parent of 31st December. Dates may differ for a variety of reasons including local reporting regulations or tax laws. In accordance with our accounting policies, for the purpose of inclusion in the consolidated financial statements of Barclays PLC, entities with different reporting dates are made up until 31st December.
Entities may have restrictions placed on their ability to transfer funds, including payment of dividends and repayment of loans, to their parent entity. Reasons for the restrictions include:
| Central bank restrictions relating to local exchange control laws. |
| Central bank capital adequacy requirements. |
| Company law restrictions relating to treatment of the entities as going concerns. |
Although the Groups interest in the equity voting rights in certain entities exceeds 50%, or it may have the power to appoint a majority of their Boards of Directors, they are excluded from consolidation because the Group either does not direct the financial and operating policies of these entities, or on the grounds that another entity has a superior economic interest in them. Consequently, these entities are not deemed to be controlled by Barclays.
The table below includes information in relation to such entities as required by the Companies Act 1985, Section 231(5).
Country of registration or incorporation |
Name | Percentage of % |
Equity share- holders funds £m |
Retained loss for the year £m |
||||||
UK |
Oak Dedicated Limited |
100 | (4 | ) | (1 | ) | ||||
UK |
Oak Dedicated Two Limited |
100 | (4 | ) | | |||||
UK |
Oak Dedicated Three Limited |
100 | 1 | | ||||||
UK |
Fitzroy Finance Limited |
100 | | | ||||||
Cayman Islands |
St James Fleet Investments Two Limited |
100 | 2 | | ||||||
Cayman Islands |
BNY BT NewCo Limited |
| | |
Barclays Annual Report 2008 |
239 |
Notes to the accounts
For the year ended 31st December 2008
43 Related party transactions and Directors remuneration
(a) Related party transactions
Parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operation decisions, or one other party controls both. The definition includes subsidiaries, associates, joint ventures and the Groups pension schemes, as well as other persons.
Subsidiaries
Transactions between Barclays PLC and subsidiaries also meet the definition of related party transactions. Where these are eliminated on consolidation, they are not disclosed in the Group financial statements. Transactions between Barclays PLC and its subsidiary, Barclays Bank PLC are fully disclosed directly in its balance sheet and income statement. A list of the Groups principal subsidiaries is shown in Note 41.
Associates, joint ventures and other entities
The Group provides banking services to its associates, joint ventures, the Group pension funds (principally the UK Retirement Fund) and to entities under common directorships, providing loans, overdrafts, interest and non-interest bearing deposits and current accounts to these entities as well as other services. Group companies, principally within Barclays Global Investors, also provide investment management and custodian services to the Group pension schemes. The Group also provides banking services for unit trusts and investment funds managed by Group companies and are not individually material. All of these transactions are conducted on the same terms as third-party transactions.
Amounts included in the accounts, in aggregate, by category of related party entity are as follows:
For the year ended and as at 31st December 2008 | ||||||||||||||
Associates £m |
Joint ventures £m |
Entities under common directorships £m |
Pension £m |
Total £m |
||||||||||
Income statement: |
||||||||||||||
Interest received |
| 105 | 3 | | 108 | |||||||||
Interest paid |
| (73 | ) | | | (73 | ) | |||||||
Fees received for services rendered (including investment management and custody and commissions) | | 15 | | 5 | 20 | |||||||||
Fees paid for services provided |
(44 | ) | (146 | ) | | | (190 | ) | ||||||
Principal transactions |
8 | 59 | 60 | (25 | ) | 102 | ||||||||
Assets: |
||||||||||||||
Loans and advances to banks and customers |
110 | 954 | 34 | | 1,098 | |||||||||
Derivative transactions |
| 9 | 311 | 15 | 335 | |||||||||
Other assets |
67 | 276 | | 3 | 346 | |||||||||
Liabilities: |
||||||||||||||
Deposits from banks |
| 592 | | | 592 | |||||||||
Customer accounts |
| 167 | 74 | 10 | 251 | |||||||||
Derivative transactions |
| | 111 | 41 | 152 | |||||||||
Other liabilities |
3 | 18 | | 28 | 49 |
240 | Barclays Annual Report 2008 |
43 Related party transactions and Directors remuneration (continued)
For the year ended and as at 31st December 2007a | ||||||||||||||
Associates £m |
Joint ventures £m |
Entities £m |
Pension £m |
Total £m |
||||||||||
Income statement: |
||||||||||||||
Interest received |
5 | 88 | 1 | | 94 | |||||||||
Interest paid |
(1 | ) | (58 | ) | (1 | ) | | (60 | ) | |||||
Fees received for services rendered (including investment management and custody and commissions) | 1 | 34 | | 26 | 61 | |||||||||
Fees paid for services provided |
(52 | ) | (78 | ) | | | (130 | ) | ||||||
Principal transactions |
(27 | ) | 45 | (16 | ) | | 2 | |||||||
Assets: |
||||||||||||||
Loans and advances to banks and customers |
142 | 1,285 | 40 | | 1,467 | |||||||||
Derivative transactions |
| 4 | 36 | | 40 | |||||||||
Other assets |
213 | 106 | | 14 | 333 | |||||||||
Liabilities: |
||||||||||||||
Deposits from banks |
11 | | | | 11 | |||||||||
Customer accounts |
| 61 | 33 | 12 | 106 | |||||||||
Derivative transactions |
| 10 | 50 | | 60 | |||||||||
Other liabilities |
4 | 125 | | | 129 |
For the year ended and as at 31st December 2006a | |||||||||||||||
Associates £m |
Joint ventures £m |
Entities under common directorships £m |
Pension £m |
Total £m |
|||||||||||
Income statement: |
|||||||||||||||
Interest received |
45 | 38 | | 2 | 85 | ||||||||||
Interest paid |
(31 | ) | (57 | ) | | | (88 | ) | |||||||
Fees received for services rendered (including investment management and custody and commissions) | 14 | 7 | | 28 | 49 | ||||||||||
Fees paid for services provided |
(115 | ) | (51 | ) | | (1 | ) | (167 | ) | ||||||
Principal transactions |
3 | | (2 | ) | | 1 | |||||||||
Assets: |
|||||||||||||||
Loans and advances to banks and customers |
784 | 146 | 65 | | 995 | ||||||||||
Derivative transactions |
| | | | | ||||||||||
Other assets |
19 | 3 | | 17 | 39 | ||||||||||
Liabilities: |
|||||||||||||||
Deposits from banks |
9 | | | 3 | 12 | ||||||||||
Customer accounts |
19 | 18 | 5 | 34 | 76 | ||||||||||
Derivative transactions |
| | 2 | | 2 | ||||||||||
Other liabilities |
13 | 8 | | | 21 |
No guarantees, pledges or commitments have been given or received in respect of these transactions in 2008, 2007 or 2006.
Derivatives transacted on behalf of the Pensions Funds Unit Trusts and Investment Funds amounted to £318m (2007: £22m, 2006: £1,209m).
In 2008 Barclays paid £12m (2007: £18m) of its charitable donations through the Charities Aid Foundation, a registered charitable organisation, in which a Director of the Company is a Trustee.
Note
a | The amounts reported in prior periods have been restated to reflect new related parties. |
Barclays Annual Report 2008 |
241 |
Notes to the accounts
For the year ended 31st December 2008
43 Related party transactions and Directors remuneration (continued)
Key Management Personnel
The Groups Key Management Personnel, and persons connected with them, are also considered to be related parties for disclosure purposes. Key Management Personnel are defined as those persons having authority and responsibility for planning, directing and controlling the activities of Barclays PLC (directly or indirectly) and comprise the Directors of Barclays PLC and the Officers of the Group, certain direct reports of the Group Chief Executive and the heads of major business units.
In the ordinary course of business, the Bank makes loans to companies where a Director or other member of Key Management Personnel (or any connected person) is also a Director or other member of Key Management Personnel (or any connected person) of Barclays.
There were no material related party transactions with companies where a Director or other member of Key Management Personnel (or any connected person) is also a Director or other member of Key Management Personnel (or any connected person) of Barclays.
The Group provides banking services to Directors and other Key Management Personnel and persons connected to them. Transactions during the year and the balances outstanding at 31st December 2008 were as follows:
Directors, other Key Management Personnel and connected persons |
|||||||||
2008 £m |
|
2007 £m |
|
2006 £m |
| ||||
Loans outstanding at 1st January |
7.4 | 7.8 | 7.4 | ||||||
Loans issued during the year |
6.9 | 2.7 | 2.7 | ||||||
Loan repayments during the year |
(5.5 | ) | (3.2 | ) | (2.3 | ) | |||
Loans outstanding at 31st December |
8.8 | 7.3 | 7.8 | ||||||
Interest income earned |
0.4 | 0.4 | 0.3 | ||||||
No allowances for impairment were recognised in respect of loans to Directors or other members of Key Management Personnel (or any connected person) in 2008, 2007 or 2006.
|
| ||||||||
2008 £m |
2007 £m |
2006 £m |
|||||||
Deposits outstanding at 1st January |
8.9 | 15.0 | 4.7 | ||||||
Deposits received during the year |
235.7 | 114.4 | 105.2 | ||||||
Deposits repaid during the year |
(221.9 | ) | (115.0 | ) | (94.8 | ) | |||
Deposits outstanding at 31st December |
22.7 | 14.4 | 15.1 | ||||||
Interest expense on deposits |
0.5 | 0.6 | 0.2 |
Of the loans outstanding above, £1.6m (2007: £nil, 2006: £nil) relates to Directors and other Key Management Personnel (and persons connected to them) that left the Group during the year. Of the deposits outstanding above, £6.1m (2007: £2.8m, 2006: £0.1m) related to Directors and other Key Management Personnel (and persons connected to them) that left the Group during the year.
All loans are provided on normal commercial terms to Directors and other Key Management Personnel (and persons connected to them), with the exception of £692 of loans which are provided on an interest free basis.
The loans of £692 provided on an interest free basis relate to the granting of loans to one non-Director member of Barclays key management to purchase commuter rail tickets. The commuter rail ticket loans are still provided to all Barclays staff members upon request on the same terms.
All loans to Directors and other key management personnel (a) were made in the ordinary course of business, (b) were made on substantially the same terms, including interest rates and collateral, as those prevailing at the same time for comparable transactions with other persons and (c) did not involve more than a normal risk of collectability or present other unfavourable features.
242 | Barclays Annual Report 2008 |
43 Related party transactions and Directors remuneration (continued)
Remuneration of Directors and other Key Management Personnel
Directors, other Key Management | ||||||
2008 £m |
2007 £m |
2006 £m | ||||
Salaries and other short-term benefits |
10.7 | 23.7 | 34.2 | |||
Pension costs |
0.9 | 1.1 | 0.8 | |||
Other long-term benefits |
1.6 | 9.2 | 9.3 | |||
Termination benefits |
| | 1.4 | |||
Share-based payments |
11.8 | 31.7 | 27.2 | |||
Employer social security charges on emoluments |
2.7 | 7.8 | 10.0 | |||
27.7 |
73.5 | 82.9 |
(b) Disclosure required by the Companies Act 1985
The following information is presented in accordance with the Companies Act 1985:
Directors remuneration
2008 |
2007 £m | |||
Aggregate emoluments |
6.0 | 29.2 | ||
Gains made on the exercise of share options |
| 0.3 | ||
Amounts paid under long-term incentive schemes |
7.4 | | ||
Actual pension contributions to money purchase scheme (2008: one Director, £11,745 and 2007: one Director, £10,233) |
| | ||
Notional pension contributions to money purchase scheme (2008: no Directors and 2007: no Directors) |
| | ||
13.4 |
29.5 |
As at 31st December 2008, two Directors were accruing retirement benefits under a defined benefit scheme (2007: three Directors).
One Director (Frits Seegers) agreed to waive his fees as non-executive Director of Absa Group Limited and Absa Bank Limited. The fees for 2008 were ZAR 0.4m (£0.03m). The fees for 2007 were ZAR 0.5m (£0.03m). In both 2007 and 2008 the fees were paid to Barclays.
Directors and Officers shareholdings and options
The beneficial ownership of the ordinary share capital of Barclays PLC by all Directors and Officers of Barclays PLC (involving 20 persons) and Barclays Bank PLC (involving 21 persons) at 31st December 2008 amounted to 8,036,962 ordinary shares of 25p each (0.10% of the ordinary share capital outstanding) and 8,037,498 ordinary shares of 25p each (0.10% of the ordinary share capital outstanding), respectively.
Executive Directors and Officers of Barclays PLC as a group (involving 8 persons) held, at 31st December 2008, options to purchase 2,185,380 Barclays PLC ordinary shares of 25p each at prices ranging from 255p to 510p under Sharesave and at 397p under the Executive Share Option Scheme and ranging from 317p to 534p under the Incentive Share Option Plan, respectively.
Contracts with Directors (and their connected persons) and Managers
The aggregate amounts outstanding at 31st December 2008 under transactions, arrangements and agreements made by banking companies within the Group for persons who are, or were during the year, Directors of Barclays PLC and persons connected with them, as defined in the Companies Act 2006, and for Managers, within the meaning of the Financial Services and Markets Act 2000, of Barclays Bank PLC were:
Number of |
Number of connected persons |
Amount £m | ||||
Directors |
||||||
Loans |
1 | 1 | 6.1 | |||
Quasi-loans and credit card accounts |
8 | 1 | | |||
Managers | ||||||
Loans |
3 | n/a | 14.0 | |||
Quasi-loans and credit card accounts |
7 | n/a | |
(c) US disclosures
For US disclosure purposes, the aggregate emoluments of all Directors and Officers of Barclays PLC who held office during the year (2008: 24 persons, 2007: 22 persons, 2006: 24 persons) for the year ended 31st December 2008 amounted to £26.8m (2007: £64.6m, 2006: £72.1m). In addition, the aggregate amount set aside for the year ended 31st December 2008, to provide pension benefits for the Directors and Officers amounted to £0.9m (2007: £1.1m, 2006: £0.8m). The aggregate emoluments of all Directors and Officers of Barclays Bank PLC who held office during the year (2008: 25 persons, 2007: 23 persons, 2006: 25 persons) for the year ended 31st December 2008 amounted to £26.9m, (2007: £64.9m and 2006: £72.2m). In addition, the aggregate amount set aside by the Bank and its subsidiaries for the year ended 31st December 2008, to provide pension benefits for the Directors and Officers amounted to £0.9m (2007: £1.1m, 2006: £0.8m).
Barclays Annual Report 2008 |
243 |
Notes to the accounts
For the year ended 31st December 2008
44 Events after the balance sheet date
On 2nd February 2009, Barclays completed the acquisition of PT Bank Akita, which was announced initially on 17th September 2008, following the approval of the Central Bank of Indonesia.
On 17th February 2009, Barclays announced that Barclays Capital will discontinue operations at its Equifirst subsidiary due to the market environment and strategic direction of the Group.
45 Share-based payments
The Group operates share schemes for employees throughout the world. The main current schemes are:
Sharesave
Eligible employees in the UK, Spain and Ireland may participate in the Barclays Sharesave scheme. Under this scheme, employees may enter into contracts to save up to £250 per month (Ireland: 500, Spain: 135) and, at the expiry of a fixed term of three, five or seven years (Spain: three years), have the option to use these savings to acquire shares in the Company at a discount, calculated in accordance with the rules of the scheme. The discount is currently 20% of the market price at the date the options are granted. Participants in the scheme have six months from the date of vest in which the option can be exercised.
Sharepurchase
Sharepurchase was introduced in January 2002. It is an HM Revenue & Customs approved all-employee share plan. The plan is open to all eligible UK employees, including executive Directors. Under the plan, participants are able to purchase up to £1,500 worth of Barclays PLC ordinary shares per tax year, which, if kept in trust for five years, can be withdrawn from the plan tax-free. Matching shares were introduced to the scheme during 2005 where the purchase of Barclays shares by the participant are matched equally by the Company up to a value of £600 per tax year. Any shares in the plan will earn dividends in the form of additional shares, which must normally be held by the trustee for three years before being eligible for release.
Executive Share Award Scheme (ESAS)
For certain employees of the Group an element of their annual bonus is in the form of a deferred award of a provisional allocation of Barclays PLC shares under ESAS. The total value of the bonus made to the employee of which ESAS is an element is dependent upon the business unit, Group and individual employee performance. The ESAS element of the annual bonus must normally be held for at least three years. Additional bonus shares are subsequently awarded to recipients of the provisional allocation and vest upon achieving continued service for three and five years from the date of award. ESAS awards are also made to eligible employees for recruitment purposes. All awards are subject to potential forfeit if the individual resigns and commences work with a competitor business.
Performance Share Plan (PSP)
The Performance Share Plan (PSP) was approved by shareholders at the 2005 AGM to replace the ISOP scheme. Performance shares are free Barclays shares for which no exercise price is payable and which qualify for dividends. Performance share awards are communicated to participants as an initial allocation. Barclays performance over a three-year period determines the final number of shares that may be released to participants.
Incentive Share Plan (Incentive Shares)
The Incentive Share Plan (Incentive Shares) was introduced in March 2008. Incentive Shares are granted to participants in the form of a provisional allocation of Barclays shares which vest upon achieving continued service after three years. Participants do not pay to receive an award or to receive a release of shares. Incentive Shares qualify for dividends.
Options granted under the following schemes are over subsidiaries of Barclays PLC:
Absa Group Broad-based Black Economic Empowerment Transaction (BEE)
On 25th June 2004, Absa shareholders approved the allocation of 73,152,300, redeemable cumulative option-holding Absa preference shares to Batho Bonke Capital Limited. Each redeemable preference share carries the option to acquire one Absa ordinary share. The shares carry the same rights as ordinary shares including voting rights, and receive dividends which are payable semi-annually. Options vested immediately on date of issue and lapse after five years from the date of issue. Exercise may occur in lots of 100 only and within a price range varying from R48 to R69 (£3.16£4.55) dependent on the 30-day volume weighted trading price on the JSE Limited. Options are redeemed by Absa on the final exercise date.
244 | Barclays Annual Report 2008 |
45 Share-based payments (continued)
Absa Group Limited Share Incentive Trust (AGLSIT)
In terms of the rules of Absa Group Limited Share Incentive Trust, the maximum number of shares which may be issued or transferred and/or in respect of which options may be granted to the participants shall be limited to shares representing 10% of the total number of issued shares from time to time. This is an equity-settled share-based payment arrangement and options are allocated to Absa employees according to the normal human resources talent management processes. The options issued up to August 2005 had no performance criteria linked to them and vested in equal tranches after three, four and five years respectively. No dividends accrue to the option holder over the vesting period. The options expire after a period of ten years from the issuing date. Options issued since August 2005 have performance criteria associated with them, which require headline earnings per share to exceed an agreed benchmark over a three-year period from the grant date for the options to vest. Participants need to be in the employ of Absa at the vesting date in order to be entitled to the options.
Absa Group Limited Share Ownership Administrative Trust (AGLSOT)
AGLSOT enabled all Absa employees to participate in a one-off offer to purchase 200 redeemable cumulative option-holding preference shares. Each redeemable preference share carries the option to acquire one Absa ordinary share. Options vest after three years and lapse after five years from the date of issue. Exercise may occur in lots of 100 only and within a price range varying from R48 to R69 (£3.16£4.55) dependent on the 30-day volume weighted trading price on the JSE Limited. Options are redeemed by Absa on the final exercise date.
Absa Group Limited Executive Share Award Scheme (AGLESAS)
The ESAS is an equity-settled share-based payment arrangement, where the participants notional bonus comprises a number of restricted nil-cost options, based on the allocation price of ordinary shares. Such an initial allocation is held in trust or in the name of the participant. If the participant is in the employ of the Group after the three-year vesting period, the participant will receive 20% matched shares. If the bonus award remains in the ESAS for another two years, the participant receives another 10% matched shares. Dividend shares are paid to participants on the ordinary shares as if the shares were held from inception. The number of dividend shares awarded is therefore calculated on the initial allocation and on the 20% and/or 10% matched shares, over the three- or five-year period. Employees that receive a performance bonus in excess of a predetermined amount were compelled to place a set percentage of their bonus award into the ESAS. Employees also had the option of utilising more of their bonus award for voluntary ESAS options.
In addition, options remain outstanding under the following closed schemes:
Barclays Global Investors Equity Ownership Plan (BGI EOP)
The Equity Ownership Plan was extended to key employees of BGI. The exercise price of the options was determined by the Remuneration Committee of Barclays PLC based on the fair value of BGI as determined by an independent appraiser. The options were granted over shares in Barclays Global Investors UK Holdings Limited, a subsidiary of Barclays Bank PLC.
Options are not exercisable until vesting, with a third of the options held generally becoming exercisable at each anniversary of grant. The shareholder has the right to offer to sell the shares to Barclays Bank PLC 355 days following the exercise of the option. Barclays Bank PLC may accept the offer and purchase the shares at the most recently agreed valuation but is under no obligation to do so. Options lapse ten years after grant. The most recently agreed valuation was £87.22, at 31st March 2008. No awards were made under the BGI EOP in 2008.
Incentive Share Option Plan (ISOP)
The ISOP was open by invitation to the employees and Directors of Barclays PLC. Options were granted at the market price at the date of grant calculated in accordance with the rules of the plan, and are normally exercisable between three and ten years from that date. The final number of shares over which the option may be exercised is determined by reference to set performance criteria. The number of shares under option represents the maximum possible number that may be exercised. No awards were made under ISOP during 2008.
Executive Share Option Scheme (ESOS)
The ESOS is a long-term incentive scheme and was available by invitation to certain senior executives of the Group with grants usually made annually. Options were issued with an exercise price equivalent to the market price at the date of the grant without any discount, calculated in accordance with the rules of the scheme, and are normally exercisable between three and ten years from that date. No further awards are made under ESOS.
Woolwich Executive Share Option Plan (Woolwich ESOP)
Options originally granted over Woolwich PLC shares at market value were exercised in 2001 or exchanged, in accordance with the proposals made under the offer to acquire the Woolwich, for options over Barclays PLC shares. Under the rules of ESOP, the performance conditions attached to the exercise of options were disapplied on acquisition of Woolwich PLC by Barclays. Options lapse ten years after grant.
At the balance sheet date the following cash-settled schemes operated within the Group:
Absa Group Limited Phantom Performance Share Plan (Phantom PSP)
The Phantom PSP is a cash-settled plan and payments made to participants in respect of their awards are in the form of cash. The Phantom PSP shares (and any associated notional dividend shares) are awarded at no cost to the participants. The amount that is ultimately paid to the participants is equal to the market value of a number of ordinary shares as determined after a three-year vesting period. The vesting of the Phantom PSP awards will be subject to two non-market performance conditions which will be measured over a three-year period, starting on the first day of the financial year in which the award is made. The award will vest after three years to the extent that the performance conditions are satisfied. These awards are forfeited in total if Absa performance fails to meet the minimum criteria
Absa Group Limited Phantom Executive Share Award Scheme (Phantom ESAS)
The Phantom ESAS is a cash-settled share-based payment arrangement, where the participants notional bonus comprises a number of restricted nil-cost options, based on the allocation price of ordinary shares. If the participant is in the employ of the Group after the three-year vesting period, the participant will receive 20% bonus phantom shares. If the bonus award remains in the Phantom ESAS for another two years, the participant receives an additional 10% bonus phantom shares. Dividend phantom shares are paid to participants on the ordinary phantom shares as if the shares were held from inception. The number of dividend phantom shares awarded is therefore calculated on the initial allocation and on the 20% and 10% bonus phantom shares, over the five-year period. Employees that receive performance bonuses in excess of a predetermined amount are compelled to place a set percentage of the bonus award in the Phantom ESAS. Employees also have the option of utilising more of their bonus award for voluntary ESAS phantom shares.
Barclays Annual Report 2008 |
245 |
Notes to the accounts
For the year ended 31st December 2008
45 Share-based payments (continued)
The weighted average fair value per option granted during the year is as follows:
2008 £ |
2007 £ | |||
Sharesave |
0.92 | 1.25 | ||
Sharepurchase |
3.38 | 6.84 | ||
ISP |
4.22 | n/a | ||
ESAS |
4.09 | 6.96 | ||
PSP |
4.89 | 8.03 | ||
BGI EOP |
n/a | 22.18 | ||
AGLSIT |
n/a | 3.18 | ||
AGLESAS |
7.17 | n/a |
Fair values for Sharesave, PSP, BGI EOP and AGLSIT are calculated at the date of grant using either a Black-Scholes model or Monte Carlo simulation. No further grants have been made under the BGI EOP since 2008. Sharepurchase, ESAS, and AGLESAS are nil cost awards on which the performance conditions are substantially completed at the date of grant. Consequently the fair value of these awards is based on the market value at that date.
As described above, the terms of the ESAS scheme require shares to be held for a set number of years from the date of vest. The calculation of the vest date fair value of such awards includes a reduction for this post-vesting restriction. This discount is determined by calculating how much a willing market participant would rationally pay to remove the restriction using a Black-Scholes option pricing model. The total discount required in 2008 is £10m (2007: £66m, 2006: £62m).
The significant weighted average assumptions used to estimate the fair value of the options granted in 2008 are as follows:
2008 | ||||||
Sharesave | PSP | AGLESAS | ||||
Weighted average share price |
3.11 | 5.45 | 7.17 | |||
Weighted average exercise price |
2.51 | 2.07 | | |||
Expected volatility |
37% | 37% | 0% | |||
Expected option life |
4 years | 3 years | 5 years |
The significant weighted average assumptions used to estimate the fair value of the options granted in 2007 are as follows:
2007 | ||||||||
Sharesave | PSP | BGI EOP | AGLSIT | |||||
Weighted average share price |
5.82 | 7.07 | 95.33 | 9.18 | ||||
Weighted average exercise price |
4.81 | | 95.33 | 7.62 | ||||
Expected volatility |
25% | 25% | 20% | 30% | ||||
Expected option life |
4 years | 3 years | 4 years | 5 years |
The significant weighted average assumptions used to estimate the fair value of the options granted in 2006 are as follows:
2006 | ||||||||
Sharesave | PSP | BGI EOP | AGLSIT | |||||
Weighted average share price |
6.20 | 6.74 | 81.12 | 8.92 | ||||
Weighted average exercise price |
5.11 | | 81.12 | 6.57 | ||||
Expected volatility |
25% | 25% | 24% | 29% | ||||
Expected option life |
4 years | 3 years | 4 years | 5 years |
Expected volatility and dividend yield on the date of grant have been used as inputs into the respective valuation models for Sharesave and PSP. Expected volatility has been determined using historical volatility of its peers over the expected life of the options for BGI EOP and AGLSIT applies a five-year rolling period.
The yield on UK government bonds with a commensurate life has been used to determine the risk-free discount rate of 4% for all schemes other than AGLSIT. Option life is estimated based upon historical data for the holding period of options between grant and exercise dates. The risk-free rate on the AGLSIT scheme represents the yield, recorded on date of option grant, on South African government zero coupon bond of a term commensurate to the expected life of the option.
246 | Barclays Annual Report 2008 |
45 Share-based payments (continued)
For the purposes of determining the expected life and number of options to vest, historical exercise patterns have been used, together with an assumption that a certain percentage of options will lapse due to leavers.
The assumed dividend yield for Barclays PLC is the average annual dividend yield on the date of grant of 5%. Dividend yield for AGLSIT of 3.5% was based on the average 12-month trailing yield over the year to grant date.
Analysis of the movement in the number and weighted average exercise price of options is set out below:
Sharesave a | Sharepurchase a, c | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2008 | 2007 | 2008 | 2007 | 2008 | 2007 | 2008 | 2007 | |||||||||||||
Outstanding at beginning of year |
74,027 | 78,929 | 4.48 | 4.22 | 3,824 | 2,472 | | | ||||||||||||
Granted in the year |
56,024 | 18,748 | 2.51 | 4.81 | 3,834 | 1,852 | | | ||||||||||||
Adjustment in grants for open offer |
1,354 | | 4.33 | | | | | | ||||||||||||
Exercised/released in the year |
(3,357 | ) | (18,018 | ) | 3.71 | 3.70 | (64 | ) | (256 | ) | | | ||||||||
Less: forfeited in the year |
(33,917 | ) | (5,632 | ) | 4.35 | 4.53 | (633 | ) | (244 | ) | | | ||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
94,131 | 74,027 | 1.83 | 4.48 | 6,961 | 3,824 | | | ||||||||||||
Of which exercisable: |
4,025 | 2,324 | 3.71 | 3.69 | 737 | | | | ||||||||||||
ESAS a, c | PSP a, c | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2008 | 2007 | 2008 | 2007 | 2008 | 2007 | 2008 | 2007 | |||||||||||||
Outstanding at beginning of year |
182,200 | 142,359 | | | 63,163 | 42,832 | | | ||||||||||||
Granted in the year |
141,269 | 76,064 | | | 8,528 | 20,331 | | | ||||||||||||
Adjustment in grants for open offer |
6,884 | | | | 1,370 | | | | ||||||||||||
Exercised/released in the year |
(56,231 | ) | (31,036 | ) | | | (1,467 | ) | | | | |||||||||
Less: forfeited in the year |
(6,185 | ) | (5,187 | ) | | | (20,865 | ) | | | | |||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
267,937 | 182,200 | | | 50,729 | 63,163 | | | ||||||||||||
Of which exercisable: |
15,131 | 16,587 | | | | | | | ||||||||||||
ISP a ,c | Absa BEE b | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2008 | 2007 | 2008 | 2007 | 2008 | 2007 | 2008 | 2007 | |||||||||||||
Outstanding at beginning of year/acquisition date |
| | | | 73,152 | 73,152 | 3.40-3.89 | 3.50-5.03 | ||||||||||||
Granted in the year |
6,923 | | | | | | | | ||||||||||||
Adjustment in grants for open offer |
177 | | | | | | | | ||||||||||||
Exercised/released in the year |
| | | | | | | | ||||||||||||
Less: forfeited in the year |
| | | | | | | | ||||||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
7,100 | | | | 73,152 | 73,152 | 3.16-4.55 | 3.40-3.89 | ||||||||||||
Of which exercisable: |
| | | | 73,152 | 73,152 | 3.16-4.55 | 3.40-3.89 | ||||||||||||
AGLSIT b | AGLSOT b | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2008 | 2007 | 2008 | 2007 | 2008 | 2007 | 2008 | 2007 | |||||||||||||
Outstanding at beginning of year/acquisition date |
13,618 | 18,778 | 4.81 | 3.87 | 946 | 4,847 | 3.40-3.89 | 3.50-5.03 | ||||||||||||
Granted in the year |
| 260 | | 7.62 | | | | | ||||||||||||
Exercised/released in the year |
(3,252 | ) | (4,668 | ) | 3.37 | 3.60 | (368 | ) | (3,592 | ) | | | ||||||||
Less: forfeited in the year |
(399 | ) | (752 | ) | 4.96 | 5.22 | (19 | ) | (309 | ) | 3.16-4.55 | 3.40-3.89 | ||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
9,967 | 13,618 | 4.91 | 4.81 | 559 | 946 | 3.16-4.55 | 3.40-3.89 | ||||||||||||
Of which exercisable: |
5,944 | 5,603 | 3.86 | 3.25 | 559 | 946 | 3.16-4.55 | 3.40-3.89 |
Notes
a | Options/award granted over Barclays PLC shares. |
b | Options/award granted over Absa Group Limited shares. |
c | Nil cost award. |
Barclays Annual Report 2008 |
247 |
Notes to the accounts
For the year ended 31st December 2008
45 Share-based payments (continued)
AGLESAS c, d | BGI EOP b | ||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | ||||||||||||||||
2008 | 2007 | 2008 | 2007 | 2008 | 2007 | 2008 | 2007 | ||||||||||||
Outstanding at beginning of year/acquisition date | 37 | 37 | | | 7,502 | 6,929 | 75.66 | 57.79 | |||||||||||
Granted in the year |
1,019 | | | | | 2,599 | | 95.33 | |||||||||||
Exercised/released in the year |
| | | | (550 | ) | (1,632 | ) | 34.35 | 34.99 | |||||||||
Less: forfeited in the year |
(41 | ) | | | | (368 | ) | (394 | ) | 86.57 | 59.63 | ||||||||
Less: expired in the year |
| | | | | | | | |||||||||||
Outstanding at end of year |
1,015 | 37 | | | 6,584 | 7,502 | 78.50 | 75.66 | |||||||||||
Of which exercisable: |
| | | | 3,631 | 1,556 | 69.29 | 47.00 |
ISOP a | ESOS a | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2008 | 2007 | 2008 | 2007 | 2008 | 2007 | 2008 | 2007 | |||||||||||||
Outstanding at beginning of year |
20,549 | 77,507 | 4.56 | 4.59 | 1,423 | 1,748 | 4.13 | 4.14 | ||||||||||||
Granted in the year |
| | | | | | | | ||||||||||||
Adjustment in grants for open offer |
537 | | 4.44 | | 12 | | 4.33 | | ||||||||||||
Exercised/released in the year |
(539 | ) | (9,718 | ) | 4.06 | 4.35 | (70 | ) | (325 | ) | 3.97 | 4.20 | ||||||||
Less: forfeited in the year |
| (47,240 | ) | | 4.66 | (892 | ) | | 3.97 | | ||||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
20,547 | 20,549 | 4.44 | 4.56 | 473 | 1,423 | 4.33 | 4.13 | ||||||||||||
Of which exercisable: |
20,547 | 20,238 | 4.44 | 4.54 | 473 | 1,423 | 4.33 | 4.13 |
Woolwich ESOP a | ||||||||||
Number (000s) |
Weighted average ex. price (£) | |||||||||
2008 | 2007 | 2008 | 2007 | |||||||
Outstanding at beginning of year |
540 | 700 | 3.81 | 3.81 | ||||||
Granted in the year |
| | | | ||||||
Adjustment in grants for open offer |
12 | | 3.70 | | ||||||
Exercised/released in the year |
(104 | ) | (160 | ) | 3.10 | 3.84 | ||||
Less: forfeited in the year |
(6 | ) | | 3.65 | | |||||
Less: expired in the year |
| | | | ||||||
Outstanding at end of year |
442 | 540 | 3.70 | 3.81 | ||||||
Of which exercisable: |
442 | 540 | 3.70 | 3.81 |
The table below shows the weighted average share price at the date of exercise/release of shares:
2008 £ |
2007 £ | |||
Sharesave a |
4.70 | 5.72 | ||
Sharepurchase a, d |
1.59 | 6.74 | ||
ESAS a, d |
4.07 | 6.71 | ||
PSP |
2.07 | n/a | ||
BGI EOP b |
87.22 | 97.06 | ||
AGLSIT c |
6.78 | 9.52 | ||
AGLSOT c |
6.79 | n/a | ||
ISOP a |
4.59 | 7.31 | ||
ESOS a |
4.74 | 7.26 | ||
Woolwich ESOP a |
4.72 | 7.24 |
Notes
a | Options/award granted over Barclays PLC shares. |
b | Options/award granted over Barclays Global Investors UK Holdings Limited shares. |
c | Options/award granted over Absa Group Limited shares. |
d | Nil cost award. |
248 | Barclays Annual Report 2008 |
45 Share-based payments (continued)
The exercise price range, the weighted average contractual remaining life and number of options outstanding (including those exercisable) at the balance sheet date are as follows:
2008 | 2007 | |||||||
Exercise Price Range | Weighted average remaining contractual life in years |
Number of options outstanding |
Weighted average remaining contractual life in years |
Number of options outstanding | ||||
Sharesave a |
||||||||
£1.44-£2.49 |
3 | 2,121,926 | | | ||||
£2.50-£3.49 |
4 | 54,437,940 | | 328,822 | ||||
£3.50-£4.49 |
1 | 19,986,642 | 2 | 40,371,606 | ||||
£4.50-£5.49 |
3 | 17,584,689 | 4 | 33,327,119 | ||||
Sharepurchase a, d |
2 | 6,960,593 | 2 | 3,824,021 | ||||
ESAS a, d |
3 | 267,936,513 | 3 | 182,200,170 | ||||
ISP a, d |
2 | 7,099,655 | | | ||||
PSP a, d |
1 | 50,729,245 | 1 | 63,162,894 | ||||
BGI EOP b |
||||||||
£6.11-£13.99 |
4 | 101,000 | 4 | 239,717 | ||||
£14.00-£20.11 |
5 | 236,503 | 6 | 285,671 | ||||
£20.12-£56.94 |
6 | 759,213 | 7 | 1,059,430 | ||||
£56.95-£95.33 |
8 | 5,487,520 | 9 | 5,916,863 | ||||
Absa BEE c |
||||||||
£3.16-£4.55 |
1 | 73,152,300 | 2 | 73,152,300 | ||||
AGLSIT c |
||||||||
£1.66-£7.50 |
6 | 9,967,000 | 7 | 13,618,000 | ||||
AGLSOT c |
||||||||
£3.16-£4.55 |
1 | 559,000 | 2 | 946,000 | ||||
AGLESAS c, d |
3 | 1,015,000 | 3 | 37,059 | ||||
ISOP a |
||||||||
£2.50-£3.49 |
4 | 3,862,322 | 5 | 3,965,300 | ||||
£3.50-£4.49 |
2 | 1,558,449 | 3 | 1,409,828 | ||||
£4.50-£5.49 |
4 | 14,899,933 | 5 | 14,896,227 | ||||
£5.50-£6.49 |
7 | 225,894 | 7 | 277,096 | ||||
ESOS a |
||||||||
£2.50-£3.49 |
| | | 4,000 | ||||
£3.50-£4.49 |
1 | 472,561 | 1 | 1,418,818 | ||||
Woolwich ESOP a |
||||||||
£2.50-£3.49 |
1 | 89,644 | 2 | 110,616 | ||||
£3.50-£4.49
|
1
|
352,961
|
2
|
429,584
|
There were no modifications to the share-based payment arrangements in the years 2008, 2007 and 2006. As at 31st December 2008, the total liability arising from cash-settled share-based payment transactions was £23m (2007: £16m).
At 31st December 2008, 6.6 million (2007: 7.5 million) options were outstanding under the terms of the BGI EOP (which would represent a 7.3% interest if exercised). Employees in BGI own 4.5% of the shares in Barclays Global Investors UK Holdings Limited (2007: 5.9%). If all the current options were exercised, £516.9m (2007: £567.6m) would be subscribed. Since the scheme was introduced, options over 21.5 million (2007: 20.9 million) shares have been exercised, of which 3.8 million are still held by employees and represent a minority interest in the Group.
At 31st December 2008, there were 73.2 million, 10 million and 0.6 million options granted over Absa Group Limited shares under the Absa Group Limited Black Economic Empowerment Transaction, Absa Group Limited Share Incentive Trust and Absa Group Limited Share Ownership Administrative Trust respectively. In aggregate, these options would represent a 11.0% interest in Absa Group Limited if exercised.
Impact of capital raising
During 2008, the number of shares in each award or option has been increased by 2.68% and any corresponding option exercise price has been decreased by 2.68% to reflect the impact of the capital raising in July. No adjustments were made for any other capital raising during 2008.
Notes
a | Options /award granted over Barclays PLC shares. |
b | Options /award granted over Barclays Global Investors UK Holdings Limited shares. |
c | Options /award granted over Absa Group Limited shares. |
d | Nil cost award. |
Barclays Annual Report 2008 |
249 |
Notes to the accounts
For the year ended 31st December 2008
46 Financial risks
Financial risk management
Barclays PLC is a major global financial services provider engaged in retail and commercial banking, credit cards, investment banking, wealth management and investment management services. Financial instruments are fundamental to the Groups business and managing financial risks, especially credit risk, is a fundamental part of its business activity.
Barclays risk management policies and processes are designed to identify and analyse risk, to set appropriate risk appetite, limits, and controls, and to monitor the risks and adherence to limits by means of reliable and up-to-date data. Risk management policies, models and systems are regularly reviewed to reflect changes to markets, products and best market practice.
Risk responsibilities
The Board approves risk appetite and the Board Risk Committee monitors the Groups risk profile against this appetite:
| The Group Risk Director, under delegated authority from the Group Chief Executive and Group Finance Director, has responsibility for ensuring effective risk management and control; |
| Business Heads are responsible for the identification and management of risk in their businesses; |
| Business risk teams, each under the management of a Business Risk Director, are responsible for assisting Business Heads in the identification and management of their business risk profiles for implementing appropriate controls. These risk management teams also assist Group Risk in the formulation of Group Risk policy and the implementation of it across the businesses; |
| Within Group Risk, Risk-Type Heads and their teams are responsible for establishing a risk control framework and risk oversight; and |
| Internal Audit is responsible for the independent review of risk management and the control environment. |
Oversight of risk management is exercised by the Risk Oversight Committee which is chaired by the Group Risk Director under authority delegated by the Group Finance Director. The Risk Oversight Committee oversees management of the Groups risk profile, exercised through the setting, review and challenge of the size and constitution of the profile when viewed against the Group risk appetite.
The Executive Committee monitors and manages risk-adjusted performance of businesses and receives a regular update on forward risk trends and the Group Risk Profile Report.
The Board Risk Committee (BRC) reviews the Group risk profile, approves the Group Control Framework and approves minimum control requirements for principal risks.
The Board Audit Committee (BAC) considers the adequacy and effectiveness of the Group Control Framework and receives quarterly reports on control issues of significance and half-yearly reports on impairment allowances and regulatory reports.
Both BRC and BAC also receive reports dealing in more depth with specific issues relevant at the time. The proceedings of both Committees are reported to the full Board. The Board approves the overall Group risk appetite.
The Risk Oversight Committee is chaired by the Group Risk Director and oversees the management of the Groups risk profile and all of its significant risks. Oversight is exercised through the setting, review and challenge of the size and constitution of the profile when viewed against the Groups risk appetite. It has delegated and apportioned responsibility for credit risk management to the Retail and Wholesale Credit Risk Management Committees.
The main financial risks affecting the Group are discussed in Notes 47 to 49.
47 Credit risk
Credit risk is the risk of suffering financial loss, should any of the Groups customers, clients or market counterparties fail to fulfil their contractual obligations to the Group. Credit risk arises mainly from commercial and consumer loans and advances, credit cards, and loan commitments arising from such lending activities, but can also arise from credit enhancement provided, such as financial guarantees, letters of credit, endorsements and acceptances.
Barclays is also exposed to other credit risks arising from investments in debt securities and other exposures arising from its trading activities (trading exposures) including, non-equity trading portfolio assets, derivatives as well as settlement balances with market counterparties and reverse repurchase loans.
Losses arising from exposures held for trading (derivatives, debt securities) are accounted for as trading losses, rather than impairment charges, even though the fall in value causing the loss may be attributable to credit deterioration.
Maximum exposure to credit risk before collateral held or other credit enhancements
The following table presents the maximum exposure at 31st December 2008 and 2007 to credit risk of balance sheet and off balance sheet financial instruments, before taking account of any collateral held or other credit enhancements and after allowance for impairment and netting where appropriate.
For financial assets recognised on the balance sheet, the exposure to credit risk equals their carrying amount. For financial guarantees granted, the maximum exposure to credit risk is the maximum amount that Barclays would have to pay if the guarantees were to be called upon. For loan commitments and other credit related commitments that are irrevocable over the life of the respective facilities, the maximum exposure to credit risk is the full amount of the committed facilities.
This analysis and all subsequent analyses of credit risk include only financial assets subject to credit risk. They exclude other financial assets, mainly equity securities held in trading portfolio or available for sale as well as non-financial assets. The nominal value of off-balance sheet credit related instruments are also shown, where appropriate.
Financial assets designated at fair value held in respect of linked liabilities to customers under investment contracts have not been included as the Group is not exposed to credit risk on these assets. Credit losses in these portfolios, if any, would lead to a reduction in the linked liabilities and result in no direct loss to the Group.
250 | Barclays Annual Report 2008 |
47 Credit risk (continued)
Whilst the Groups maximum exposure to credit risk is the carrying value of the assets or, in the case of off-balance sheet items, the amount guaranteed, committed, accepted or endorsed, in most cases the likely exposure is far less due to collateral, credit enhancements and other actions taken to mitigate the Groups exposure.
A description of the credit risk management and measurement methodologies, the credit quality of the assets and the collateral and other credit enhancements held against them is included in the relevant sections within this Note, for each of the categories in the following table:
As at 31st December 2008
Loans and advances £m |
Debt securities £m |
Derivatives £m |
Reverse repurchase agreements £m |
Others £m |
Total £m |
Credit market exposure £m | ||||||||
On-balance sheet: |
||||||||||||||
Cash and balances at central banks |
30,019 | 30,019 | ||||||||||||
Items in course of collection from other banks |
1,695 | 1,695 | ||||||||||||
Trading portfolio: |
||||||||||||||
Treasury and other eligible bills |
4,544 | 4,544 | ||||||||||||
Debt securities |
148,686 | 148,686 | 4,745 | |||||||||||
Traded loans |
1,070 | 1,070 | ||||||||||||
Total trading portfolio |
1,070 | 153,230 | 154,300 | |||||||||||
Financial assets designated at fair value held on own account: | ||||||||||||||
Loans and advances |
30,057 | 130 | 30,187 | 14,429 | ||||||||||
Debt securities |
8,628 | 8,628 | ||||||||||||
Other financial assets |
1,469 | 7,283 | 479 | 9,231 | ||||||||||
Total financial assets designated at fair value held on own account | 31,526 | 8,628 | 7,283 | 609 | 48,046 | |||||||||
Derivative financial instruments |
984,802 | 984,802 | 9,234 | |||||||||||
Loans and advances to banks |
47,707 | 47,707 | ||||||||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
135,077 | 135,077 | ||||||||||||
Credit card receivables |
22,304 | 22,304 | ||||||||||||
Other personal lending |
32,038 | 32,038 | ||||||||||||
Wholesale and corporate loans and advances |
259,699 | 259,699 | ||||||||||||
Finance lease receivables |
12,697 | 12,697 | ||||||||||||
Total loans and advances to customers |
461,815 | 461,815 | 12,808 | |||||||||||
Available for sale financial investments: |
||||||||||||||
Treasury and other eligible bills |
4,003 | 4,003 | ||||||||||||
Debt securities |
58,831 | 58,831 | 727 | |||||||||||
Total available for sale financial investments |
62,834 | 62,834 | ||||||||||||
Reverse repurchase agreements |
130,354 | 130,354 | ||||||||||||
Other assets |
3,096 | 3,096 | 109 | |||||||||||
Total on-balance sheet |
542,118 | 224,692 | 984,802 | 137,637 | 35,419 | 1,924,668 | ||||||||
Off-balance sheet: |
||||||||||||||
Acceptances and endorsements |
585 | |||||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 53,942 | |||||||||||||
Commitments |
260,816 | 1,030 | ||||||||||||
Total off-balance sheet |
315,343 | |||||||||||||
Total maximum exposure at 31st December |
2,240,011 |
Barclays Annual Report 2008 |
251 |
Notes to the accounts
For the year ended 31st December 2008
47 Credit risk (continued)
At 31st December 2007
Loans and advances £m |
Debt securities £m |
Derivatives £m |
Reverse repurchase agreements £m |
Others £m |
Total £m |
Credit market exposure £m | ||||||||
On-balance sheet: |
||||||||||||||
Cash and balances at central banks |
5,801 | 5,801 | ||||||||||||
Items in course of collection from other banks |
1,836 | 1,836 | ||||||||||||
Trading portfolio: |
||||||||||||||
Treasury and other eligible bills |
2,094 | 2,094 | ||||||||||||
Debt securities |
152,778 | 152,778 | 6,239 | |||||||||||
Traded loans |
1,780 | 1,780 | ||||||||||||
Total trading portfolio |
1,780 | 154,872 | 156,652 | |||||||||||
Financial assets designated at fair value held on own account: | ||||||||||||||
Loans and advances |
23,334 | 157 | 23,491 | 15,218 | ||||||||||
Debt securities |
24,217 | 24,217 | ||||||||||||
Other financial assets |
98 | 3,056 | 391 | 3,545 | ||||||||||
Total financial assets designated at fair value held on own account | 23,432 | 24,217 | 3,056 | 548 | 51,253 | |||||||||
Derivative financial instruments |
248,088 | 248,088 | 445 | |||||||||||
Loans and advances to banks |
40,120 | 40,120 | ||||||||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
106,619 | 106,619 | ||||||||||||
Credit card receivables |
14,289 | 14,289 | ||||||||||||
Other personal lending |
29,857 | 29,857 | ||||||||||||
Wholesale and corporate loans and advances |
183,556 | 183,556 | 11,535 | |||||||||||
Finance lease receivables |
11,077 | 11,077 | ||||||||||||
Total loans and advances to customers |
345,398 | 345,398 | ||||||||||||
Available for sale financial investments: |
||||||||||||||
Treasury and other eligible bills |
2,723 | 2,723 | ||||||||||||
Debt securities |
38,673 | 38,673 | 1,244 | |||||||||||
Total available for sale financial in vestments |
41,396 | 41,396 | ||||||||||||
Reverse repurchase agreements |
183,075 | 183,075 | 225 | |||||||||||
Other assets |
3,966 | 3,966 | 57 | |||||||||||
Total on-balance sheet |
410,730 | 220,485 | 248,088 | 186,131 | 12,151 | 1,077,585 | ||||||||
Off-balance sheet: |
||||||||||||||
Acceptances and endorsements |
365 | |||||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 35,692 | |||||||||||||
Commitments |
192,639 | 3,225 | ||||||||||||
Total off-balance sheet |
228,696 | |||||||||||||
Total maximum exposure at 31st December |
1,306,281 |
252 | Barclays Annual Report 2008 |
47 Credit risk (continued)
Credit risk concentrations
A concentration of credit risk exists when a number of counterparties are engaged in similar activities and have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions.
The analyses of credit risk concentrations presented below are based on the location of the counterparty or customer or the industry in which they are engaged.
Credit risk concentrations by geographical sector
2008 | ||||||||||||
United Kingdom £m |
Other £m |
United States £m |
Africa £m |
Rest of the World £m |
Total £m | |||||||
On-balance sheet: |
||||||||||||
Cash and balances at central banks |
8,406 | 11,039 | 8,381 | 1,712 | 481 | 30,019 | ||||||
Items in the course of collection from other banks |
1,447 | 59 | | 169 | 20 | 1,695 | ||||||
Trading portfolio |
23,865 | 35,396 | 66,084 | 2,770 | 26,185 | 154,300 | ||||||
Financial assets designated at fair value held on own account |
14,158 | 7,388 | 19,738 | 2,904 | 3,858 | 48,046 | ||||||
Derivative financial instruments |
317,621 | 215,054 | 366,161 | 4,403 | 81,563 | 984,802 | ||||||
Loans and advances to banks |
7,524 | 12,591 | 13,616 | 2,189 | 11,787 | 47,707 | ||||||
Loans and advances to customers |
213,079 | 91,109 | 75,826 | 44,373 | 37,428 | 461,815 | ||||||
Available for sale financial investments |
15,423 | 18,928 | 16,583 | 3,351 | 8,549 | 62,834 | ||||||
Reverse repurchase agreements |
22,659 | 41,724 | 47,034 | 848 | 18,089 | 130,354 | ||||||
Other assets |
1,198 | 548 | 550 | 520 | 280 | 3,096 | ||||||
Total on-balance sheet |
625,380 | 433,836 | 613,973 | 63,239 | 188,240 | 1,924,668 | ||||||
Off-balance sheet: |
||||||||||||
Acceptances and endorsements |
274 | | 6 | 41 | 264 | 585 | ||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements |
4,433 | 3,742 | 42,227 | 1,738 | 1,802 | 53,942 | ||||||
Commitments |
103,548 | 32,445 | 90,298 | 23,210 | 11,315 | 260,816 | ||||||
Total off-balance sheet |
108,255 | 36,187 | 132,531 | 24,989 | 13,381 | 315,343 | ||||||
Total |
733,635 | 470,023 | 746,504 | 88,228 | 201,621 | 2,240,011 |
Credit risk concentrations by geographical sector
2007 | ||||||||||||
United Kingdom £m |
Other £m |
United States £m |
Africa £m |
Rest of the World £m |
Total £m | |||||||
On-balance sheet: |
||||||||||||
Cash and balances at central banks |
1,458 | 2,170 | 206 | 1,406 | 561 | 5,801 | ||||||
Items in the course of collection from other banks |
1,638 | 75 | | 110 | 13 | 1,836 | ||||||
Trading portfolio |
28,959 | 41,675 | 53,208 | 877 | 31,933 | 156,652 | ||||||
Financial assets designated at fair value held on own account |
15,713 | 5,907 | 20,396 | 958 | 8,279 | 51,253 | ||||||
Derivative financial instruments |
60,534 | 75,017 | 82,975 | 2,229 | 27,333 | 248,088 | ||||||
Loans and advances to banks |
5,515 | 11,102 | 13,443 | 2,581 | 7,479 | 40,120 | ||||||
Loans and advances to customers |
187,824 | 56,189 | 39,944 | 38,653 | 22,788 | 345,398 | ||||||
Available for sale financial investments |
5,934 | 18,354 | 7,818 | 2,944 | 6,346 | 41,396 | ||||||
Reverse repurchase agreements |
42,160 | 51,734 | 67,018 | 2,156 | 20,007 | 183,075 | ||||||
Other assets |
1,813 | 617 | 424 | 698 | 414 | 3,966 | ||||||
Total on-balance sheet |
351,548 | 262,840 | 285,432 | 52,612 | 125,153 | 1,077,585 | ||||||
Off-balance sheet: |
||||||||||||
Acceptances and endorsements |
227 | 5 | 5 | 34 | 94 | 365 | ||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements |
7,377 | 1,468 | 23,696 | 1,286 | 1,865 | 35,692 | ||||||
Commitments |
90,964 | 23,946 | 48,657 | 20,471 | 8,601 | 192,639 | ||||||
Total off-balance sheet |
98,568 | 25,419 | 72,358 | 21,791 | 10,560 | 228,696 | ||||||
Total |
450,116 | 288,259 | 357,790 | 74,403 | 135,713 | 1,306,281 |
Barclays Annual Report 2008 |
253 |
Notes to the accounts
For the year ended 31st December 2008
47 Credit risk (continued)
Credit risk concentrations by industrial sector | ||||||||||||||||||||
2008 | ||||||||||||||||||||
Government £m |
Financial Services £m |
Transport, and other £m |
Agriculture, £m |
Construction Property £m |
Energy and water £m |
Residential £m |
Other personal lending £m |
Finance lease receivables £m |
Total £m | |||||||||||
On-balance sheet: |
||||||||||||||||||||
Cash and balances at central banks | 30,019 | | | | | | | | | 30,019 | ||||||||||
Items in the course of collection from other banks | 10 | 1,685 | | | | | | | | 1,695 | ||||||||||
Trading portfolio | 68,962 | 73,729 | 3,320 | 2,590 | 1,404 | 4,272 | | 4 | 19 | 154,300 | ||||||||||
Financial assets designated at fair value held on own account | 5,871 | 21,860 | 1,080 | 1,286 | 17,415 | 271 | | 263 | | 48,046 | ||||||||||
Derivative financial instruments | 10,370 | 928,793 | 9,265 | 14,420 | 3,779 | 18,054 | | 121 | | 984,802 | ||||||||||
Loans and advances to banks | 2,794 | 44,913 | | | | | | | | 47,707 | ||||||||||
Loans and advances to customers | 5,296 | 112,506 | 52,243 | 49,068 | 29,988 | 14,078 | 135,077 | 50,862 | 12,697 | 461,815 | ||||||||||
Available for sale financial investments | 14,891 | 44,865 | 1,288 | 436 | 333 | 354 | 569 | 98 | | 62,834 | ||||||||||
Reverse repurchase agreements | 17,939 | 110,645 | 536 | 428 | 806 | | | | | 130,354 | ||||||||||
Other assets
|
103 | 1,397 | 602 | 260 | 8 | 12 | 155 | 554 | 5 | 3,096 | ||||||||||
Total on-balance sheet
|
156,255
|
1,340,393
|
68,334
|
68,488
|
53,733
|
37,041
|
135,801
|
51,902
|
12,721
|
1,924,668
| ||||||||||
Off-balance sheet: |
||||||||||||||||||||
Acceptances and endorsements | | 151 | 180 | 231 | 14 | 3 | | 6 | | 585 | ||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | | 44,858 | 4,161 | 2,275 | 778 | 1,604 | | 266 | | 53,942 | ||||||||||
Commitments
|
5,096 | 33,746 | 32,769 | 36,815 | 11,405 | 16,279 | 12,196 | 112,510 | | 260,816 | ||||||||||
Total off-balance sheet
|
5,096
|
78,755
|
37,110
|
39,321
|
12,197
|
17,886
|
12,196
|
112,782
|
|
315,343
| ||||||||||
Total
|
161,351
|
1,419,148
|
105,444
|
107,809
|
65,930
|
54,927
|
147,997
|
164,684
|
12,721
|
2,240,011
|
254 | Barclays Annual Report 2008 |
47 Credit risk (continued)
Credit risk concentrations by industrial sector | ||||||||||||||||||||
2007 | ||||||||||||||||||||
Government £m |
Financial Services £m |
Transport, and other £m |
Agriculture, £m |
Construction £m |
Energy and |
Residential £m |
Other personal lending £m |
Finance lease receivables £m |
Total £m | |||||||||||
On-balance sheet: |
||||||||||||||||||||
Cash and balances at central banks | 5,801 | | | | | | | | | 5,801 | ||||||||||
Items in the course of collection from other banks | 8 | 1,828 | | | | | | | | 1,836 | ||||||||||
Trading portfolio | 58,608 | 83,790 | 4,434 | 3,928 | 924 | 4,072 | 895 | 1 | | 156,652 | ||||||||||
Financial assets designated at fair value held on own account | 10,914 | 23,742 | 570 | 699 | 11,325 | 396 | 3,509 | 98 | | 51,253 | ||||||||||
Derivative financial instruments | 2,886 | 227,609 | 2,771 | 5,567 | 1,106 | 8,031 | 87 | 31 | | 248,088 | ||||||||||
Loans and advances to banks | 7,881 | 32,239 | | | | | | | | 40,120 | ||||||||||
Loans and advances to customers | 2,036 | 70,699 | 41,678 | 38,170 | 22,288 | 8,623 | 106,619 | 44,208 | 11,077 | 345,398 | ||||||||||
Available for sale financial investments | 8,880 | 29,693 | 2,142 | 249 | 167 | 246 | | 19 | | 41,396 | ||||||||||
Reverse repurchase agreements | 1,713 | 179,459 | 416 | 735 | 752 | | | | | 183,075 | ||||||||||
Other assets
|
270 | 1,506 | 542 | 307 | 168 | 5 | 112 | 1,056 | | 3,966 | ||||||||||
Total on-balance sheet
|
98,997
|
650,565
|
52,553
|
49,655
|
36,730
|
21,373
|
111,222
|
45,413
|
11,077
|
1,077,585
| ||||||||||
Off-balance sheet: |
||||||||||||||||||||
Acceptances and endorsements | | 125 | 111 | 91 | 21 | 4 | | 13 | | 365 | ||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 51 | 17,021 | 12,847 | 1,867 | 538 | 2,687 | 1 | 680 | | 35,692 | ||||||||||
Commitments | 4,511
|
30,492
|
26,370
|
32,388
|
11,282
|
9,961
|
10,969
|
66,666
|
|
192,639
| ||||||||||
Total off-balance sheet
|
4,562
|
47,638
|
39,328
|
34,346
|
11,841
|
12,652
|
10,970
|
67,359
|
|
228,696
| ||||||||||
Total
|
103,559
|
698,203
|
91,881
|
84,001
|
48,571
|
34,025
|
122,192
|
112,772
|
11,077
|
1,306,281
|
Loans and advances to customers in the above table has been reanalysed between Agriculture, Manufacturing and Wholesale and retail trade, Residential mortgage loans and Other personal to reflect changes in classification of assets.
Barclays Annual Report 2008 |
255 |
Notes to the accounts
For the year ended 31st December 2008
47 Credit risk (continued)
Loans and advances
Credit risk management
Governance and responsibilities
The credit risk management teams in each business are accountable to the Business Risk Directors in those businesses who, in turn, report to the heads of their businesses and also to the Group Risk Director.
The credit risk function provides Group-wide direction of credit risk-taking. The teams within this function manage the resolution of all significant credit policy issues and run the Credit Committee, which approves major credit decisions. Each business segment has an embedded credit risk management team. These teams assist Group Risk in the formulation of Group Risk policy and its implementation across the businesses.
The principal committees that review credit risk management, formulate overall Group credit policy and resolve all significant credit policy issues are the Wholesale Credit Risk Management Committee, the Retail Credit Risk Management Committee, the Risk Oversight Committee and the Board Risk Committee.
The Retail Credit Risk Management Committee (RCRMC) oversees exposures, which comprise unsecured personal lending (including small businesses), mortgages and credit cards. The RCRMC monitors the risk profile and performance of the retail portfolios by receipt of key risk measures and indicators at an individual portfolio level, ensuring mitigating actions taken to address performance are appropriate and timely. Metrics reviewed will consider portfolio composition and both an overall stock and new flow level.
The Wholesale Credit Risk Management Committee (WCRMC) oversees wholesale exposures, comprising lending to businesses, banks and other financial institutions. The WCRMC monitors exposure by country, industry sector, individual large exposures and exposures to sub-investment grade countries.
The monthly Wholesale and Retail Credit Risk Management Committees exercise oversight through review and challenge of the size and constitution of the portfolios when viewed against Group risk appetite for wholesale and retail credit risks. They are chaired by the Group Wholesale and Retail Credit Risk Directors.
Credit monitoring
Wholesale and corporate loans which are deemed to contain heightened levels of risk are recorded on early-warning or watch lists. These lists are graded in line with the perceived severity of the risk attached to the lending and its probability of default. The lists are updated on a monthly basis and are closely monitored.
Regardless of whether they are recorded on early-warning or watch lists, all wholesale and corporate loans are subject to a full review of all facilities on, at least, an annual basis. More frequent interim reviews may be undertaken should circumstances dictate.
Retail loans (which tend to comprise homogeneous assets) are monitored on a portfolio basis.
Credit risk measurement
Barclays uses statistical modelling techniques throughout its business in its credit rating systems. They enable a coherent approach to risk measurement across all credit exposures, retail and wholesale. The key building blocks in the measurement system are the probability of customer default (PD), exposure in the event of default (EAD), and severity of loss-given-default (LGD). The models are reviewed regularly to monitor their robustness relative to actual performance and amended as necessary to optimise their effectiveness.
For wholesale and corporate lending, Barclays assesses the credit quality of borrowers and other counterparties and assigns them an internal risk rating. Barclays credit rating contains 21 grades, representing the Groups best estimate of credit risk for a counterparty based on current economic conditions. Retail customers are not all assigned internal risk ratings in this way for account management purposes, therefore their probability of default is considered.
The Group considers Credit Risk Loans (defined as all customers overdue by 90 days or more, and/or individually impaired or restructured) and loan loss rates when assessing the credit performance of its loan portfolios, other than those held at fair value. For the purposes of historical and business unit comparison, loan loss rates are defined as total credit impairment charge (excluding available for sale assets and reverse repurchase agreements) divided by gross loans and advances to customers and banks (at amortised cost).
Credit risk mitigation
Where appropriate, the Group takes action to mitigate credit risk such as reducing amounts outstanding (in discussion with the customers, clients or counterparties if appropriate), using credit derivatives, securitising assets; and selling them.
Diversification to avoid unwanted credit risk concentrations is achieved through setting maximum exposure guidelines to individual counterparties. Excesses are reported to the Risk Oversight Committee and the Board Risk Committee. Mandate and scale limits are used to limit the stock of current exposures in a loan portfolio and the flow of new exposures into a loan portfolio. Limits are typically based on the tenor and nature of the lending.
Collateral and security
The Group routinely obtains collateral and security to mitigate credit risk.
The Group ensures that any collateral held is sufficiently liquid, legally effective, enforceable and regularly reassessed. Before attaching value to collateral, businesses holding specific, agreed classes of collateral must ensure that they are holding a correctly perfected charge.
Before reliance is placed on third party protection in the form of bank, government or corporate guarantees or credit derivative protection from financial intermediary counterparties, a credit assessment is undertaken.
Security structures and legal covenants are subject to regular review, at least annually, to ensure that they remain fit for purpose and remain consistent with accepted local market practice.
256 | Barclays Annual Report 2008 |
47 Credit risk (continued)
All loans and advances are categorised as either:
neither past due nor individually impaired;
past due but not individually impaired; or
individually impaired.
The impairment allowance includes allowances against financial assets that have been individually impaired and those subject to collective impairment.
Credit risk loans comprise loans and advances to banks and customers 90 days overdue or more and those subject to individual impairment. The coverage ratio is calculated by reference to the total impairment allowance and the carrying value (before impairment) of credit risk loans.
As at 31st December 2008 | |||||||||||||||||
Neither past £m |
Past due £m |
Individually £m |
Total £m |
Impairment £m |
Total £m |
Credit Risk £m |
Coverage % | ||||||||||
Trading portfolio: |
|||||||||||||||||
Traded loans |
1,070 | | | 1,070 | | 1,070 | | | |||||||||
Financial assets designated at fair value held on own account: | |||||||||||||||||
Loans and advances |
29,182 | 875 | | 30,057 | | 30,057 | | | |||||||||
Other financial assets |
1,469 | | | 1,469 | | 1,469 | | | |||||||||
Loans and advances to banks |
46,665 | 1,045 | 48 | 47,758 | (51 | ) | 47,707 | 48 | 100.0 | ||||||||
Loans and advances to customers: |
|||||||||||||||||
Residential mortgage loans |
126,363 | 7,413 | 1,608 | 135,384 | (307 | ) | 135,077 | 2,403 | 12.8 | ||||||||
Credit card receivables |
21,092 | 1,426 | 1,231 | 23,749 | (1,445 | ) | 22,304 | 1,990 | 72.6 | ||||||||
Other personal lending |
30,539 | 1,342 | 2,040 | 33,921 | (1,883 | ) | 32,038 | 2,685 | 70.1 | ||||||||
Wholesale and corporate loans and advances | 246,505 | 8,307 | 7,586 | 262,398 | (2,699 | ) | 259,699 | 8,277 | 32.6 | ||||||||
Finance lease receivables
|
12,367 | 285 | 234 | 12,886 | (189 | ) | 12,697 | 297 | 63.6 | ||||||||
Total
|
515,252
|
20,693
|
12,747
|
548,692
|
(6,574
|
)
|
542,118
|
15,700
|
41.9
| ||||||||
As at 31st December 2007 | |||||||||||||||||
Neither past due nor individually impaired a £m |
Past due but not individually impaired b £m |
Individually impaired £m |
Total £m |
Impairment allowance £m |
Total £m |
Credit Risk £m |
Coverage % | ||||||||||
Trading portfolio: |
|||||||||||||||||
Traded loans |
1,780 | | | 1,780 | | 1,780 | | | |||||||||
Financial assets designated at fair value held on own account: | |||||||||||||||||
Loans and advances |
22,977 | 357 | | 23,334 | | 23,334 | | | |||||||||
Other financial assets |
98 | | | 98 | | 98 | | | |||||||||
Loans and advances to banks |
37,601 | 2,522 | | 40,123 | (3 | ) | 40,120 | | | ||||||||
Loans and advances to customers: | |||||||||||||||||
Residential mortgage loans |
100,323 | 5,813 | 615 | 106,751 | (132 | ) | 106,619 | 1,014 | 13.0 | ||||||||
Credit card receivables |
12,587 | 1,026 | 1,517 | 15,130 | (841 | ) | 14,289 | 1,568 | 53.6 | ||||||||
Other personal lending |
28,569 | 1,020 | 1,641 | 31,230 | (1,373 | ) | 29,857 | 1,822 | 75.4 | ||||||||
Wholesale and corporate loans and advances | 171,949 | 7,987 | 4,930 | 184,866 | (1,310 | ) | 183,556 | 5,058 | 25.9 | ||||||||
Finance lease receivables
|
10,890 | 159 | 141 | 11,190 | (113 | ) | 11,077 | 179 | 63.1 | ||||||||
Total
|
386,774
|
18,884
|
8,844
|
414,502
|
(3,772
|
)
|
410,730
|
9,641
|
39.1
|
Notes
a | Financial assets subject to collective impairment allowance are included in this column if they are not past due. |
b | Financial assets subject to collective impairment allowance are included in this column if they are past due. |
Barclays Annual Report 2008 |
257 |
Notes to the accounts
For the year ended 31st December 2008
47 Credit risk (continued)
Credit quality of loans and advances neither past due nor individually impaired
2008 | 2007 | |||||||||||||||
Strong £m |
Satisfactory £m |
Higher risk £m |
Total £m |
Strong £m |
Satisfactory £m |
Higher risk £m |
Total £m | |||||||||
Trading portfolio: |
||||||||||||||||
Traded loans |
759 | 220 | 91 | 1,070 | 223 | 1,228 | 329 | 1,780 | ||||||||
Financial assets designated at fair value held on own account: | ||||||||||||||||
Loans and advances |
25,665 | 2,792 | 725 | 29,182 | 13,687 | 6,186 | 3,104 | 22,977 | ||||||||
Other financial assets |
| 1,469 | | 1,469 | 98 | | | 98 | ||||||||
Loans and advances to banks |
40,181 | 6,384 | 100 | 46,665 | 35,635 | 1,955 | 11 | 37,601 | ||||||||
Loans and advances to customers: |
||||||||||||||||
Residential mortgage loans |
82,363 | 42,770 | 1,230 | 126,363 | 60,563 | 38,000 | 1,760 | 100,323 | ||||||||
Credit card receivables |
| 20,426 | 666 | 21,092 | | 12,582 | 5 | 12,587 | ||||||||
Other personal lending |
7,549 | 21,750 | 1,240 | 30,539 | 5,061 | 22,619 | 889 | 28,569 | ||||||||
Wholesale and corporate loans and advances |
141,868 | 94,453 | 10,184 | 246,505 | 114,693 | 54,828 | 2,428 | 171,949 | ||||||||
Finance lease receivables
|
4,214 | 7,504 | 649 | 12,367 | 4,586 | 6,036 | 268 | 10,890 | ||||||||
Total loans and advances
|
302,599 |
197,768 |
14,885 |
515,252 |
234,546 |
143,434 |
8,794 |
386,774 |
For the purposes of the analysis of credit quality, the following internal measures of credit quality have been used:
Retail lending | Wholesale lending | |||||
Financial statements description
|
Probability of default
|
Probability of default
|
Default grade
| |||
Strong |
0.0-0.60% |
0.0-0.05%
|
1-3
| |||
Satisfactory |
0.60-10.00% |
0.60-2.15%
|
11-14
| |||
Higher risk
|
10.00% +
|
11.35% +
|
20-21
|
Financial statement descriptions can be summarised as follows:
Strong there is a very high likelihood of the asset being recovered in full.
Satisfactory whilst there is a high likelihood that the asset will be recovered and therefore, of no cause for concern to the Group, the asset may not be collateralised, or may relate to retail facilities, such as credit card balances and unsecured loans, which have been classified as satisfactory, regardless of the fact that the output of internal grading models may have indicated a higher classification. At the lower end of this grade there are customers that are being more carefully monitored, for example, corporate customers which are indicating some evidence of some deterioration, mortgages with a high loan to value ratio, and unsecured retail loans operating outside normal product guidelines.
Higher risk there is concern over the obligors ability to make payments when due. However, these have not yet converted to actual delinquency. There may also be doubts over value of collateral or security provided. However, the borrower or counterparty is continuing to make payments when due and is expected to settle all outstanding amounts of principal and interest.
258 | Barclays Annual Report 2008 |
47 Credit risk (continued)
Loans and advances that are past due but not individually impaired
An age analysis of loans and advances that are past due but not individually impaired is set out below.
For the purposes of this analysis an asset is considered past due and included below when any payment due under strict contractual terms is received late or missed. The amount included is the entire financial asset, not just the payment, of principal or interest or both, overdue.
The table below provides a breakdown of total financial assets past due but not individually impaired. In general, retail and wholesale loans fall into this category for two separate reasons. Retail loans and advances to customers may come under this category because the impairment allowance on such loans is calculated on a collective not individual basis. This reflects the homogenous nature of the assets, which allows statistical techniques to be used, rather than individual assessment.
In contrast, some loans to wholesale and corporate customers and banks may come under this category because of instances where a payment on a loan is past due without requiring an individual impairment allowance. For example, an individual impairment allowance will not be required when a loss is not expected due to a corporate loan being fully secured or collateralised. As a result, it is past due but not individually impaired.
2008 | ||||||||||||||
Past due £m |
Past due 1-2 months £m |
Past due 2-3 months £m |
Past due 3-6 months £m |
Past due 6 months and over £m |
Total £m |
Of which Credit Risk Loans £m | ||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||
Loans and advances
|
315 | 147 | 81 | 82 | 250 | 875 | | |||||||
Loans and advances to banks
|
1,044 |
1 |
|
|
|
1,045 |
| |||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
4,420 | 1,568 | 630 | 713 | 82 | 7,413 | 795 | |||||||
Credit card receivables |
293 | 224 | 150 | 291 | 468 | 1,426 | 759 | |||||||
Other personal lending |
220 | 204 | 273 | 338 | 307 | 1,342 | 645 | |||||||
Wholesale and corporate loans and advances |
6,229 | 540 | 847 | 477 | 214 | 8,307 | 691 | |||||||
Finance lease receivables
|
130 | 53 | 39 | 63 | | 285 | 63 | |||||||
Total loans and advances to customers
|
11,292 |
2,589 |
1,939 |
1,882 |
1,071 |
18,773 |
2,953 | |||||||
Total financial assets past due but not individually impaired
|
12,651 |
2,737 |
2,020 |
1,964 |
1,321 |
20,693 |
2,953 | |||||||
2007 | ||||||||||||||
Past due up to 1 month £m |
Past due 1-2 months £m |
Past due months |
Past due 3-6 months £m |
Past due 6 months and over £m |
Total £m |
Of which Risk Loans | ||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||
Loans and advances
|
261 | 4 | 1 | 24 | 67 | 357 | | |||||||
Loans and advances to banks
|
2,031 |
305 |
186 |
|
|
2,522 |
| |||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
3,609 | 1,349 | 456 | 215 | 184 | 5,813 | 399 | |||||||
Credit card receivables |
558 | 155 | 107 | 205 | 1 | 1,026 | 51 | |||||||
Other personal lending |
271 | 199 | 193 | 152 | 205 | 1,020 | 181 | |||||||
Wholesale and corporate loans and advances |
6,970 | 622 | 267 | 62 | 66 | 7,987 | 128 | |||||||
Finance lease receivables
|
75 | 28 | 18 | 38 | | 159 | 38 | |||||||
Total loans and advances to customers
|
11,483
|
2,353
|
1,041
|
672
|
456
|
16,005
|
797
| |||||||
Total financial assets past due but not individually impaired
|
13,775
|
2,662
|
1,228
|
696
|
523
|
18,884
|
797
|
Loans and advances individually assessed as impaired
An analysis of financial assets individually assessed as impaired is as follows:
2008 | 2007 | |||||||||||||
Original £m |
Impairment allowance £m |
Revised carrying amount £m |
Original carrying amount £m |
Impairment allowance £m |
Revised carrying amount £m | |||||||||
Loans and advances to banks individually impaired
|
48
|
(44
|
)
|
4
|
|
|
|
| ||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
1,608 | (227 | ) | 1,381 | 615 | (88 | ) | 527 | ||||||
Credit card receivables |
1,231 | (727 | ) | 504 | 1,517 | (725 | ) | 792 | ||||||
Other personal lending |
2,040 | (1,250 | ) | 790 | 1,641 | (1,030 | ) | 611 | ||||||
Wholesale and corporate loans and advances |
7,586 | (2,310 | ) | 5,276 | 4,930 | (944 | ) | 3,986 | ||||||
Finance lease receivables
|
234 | (140 | ) | 94 | 141 | (102 | ) | 39 | ||||||
Total loans and advances individually impaired
|
12,747
|
(4,698
|
)
|
8,049
|
8,844
|
(2,889
|
)
|
5,955
| ||||||
Collective impairment allowance
|
(1,876
|
)
|
(883
|
)
|
||||||||||
Total impairment allowance
|
(6,574
|
)
|
(3,772
|
)
|
Barclays Annual Report 2008 |
259 |
Notes to the accounts
For the year ended 31st December 2008
47 Credit risk (continued)
The movements on the impairment allowance during the year were as follows:
2008 | |||||||||||||||||||
At beginning of year £m |
Acquisitions and disposals £m |
Unwind discount |
Exchange and other adjustments £m |
Amounts £m |
Recoveries £m |
Amounts charged to income statement £m |
Balance at 31st December | ||||||||||||
Loans and advances to banks
|
3 |
|
|
|
|
1 |
|
|
7 |
40 |
51 | ||||||||
Loans and advances to customers: |
|||||||||||||||||||
Residential mortgage loans |
132 | | (35 | ) | 19 | (44 | ) | 3 | 232 | 307 | |||||||||
Credit card receivables |
841 | 306 | (68 | ) | 94 | (845 | ) | 69 | 1,048 | 1,445 | |||||||||
Other personal lending |
1,373 | 1 | (32 | ) | 134 | (525 | ) | 42 | 890 | 1,883 | |||||||||
Wholesale and corporate loans and advances | 1,310 | | | 506 | (1,428 | ) | 41 | 2,270 | 2,699 | ||||||||||
Finance lease receivables
|
113 | | | 37 | (77) | 12 | 104 | 189 | |||||||||||
Total loans and advances to customers
|
3,769 |
307 |
|
(135) |
|
790 |
(2,919) |
|
167 |
4,544 |
6,523 | ||||||||
Total impairment allowance
|
3,772 |
307 |
|
(135) |
|
791 |
(2,919) |
|
174 |
4,584 |
6,574 | ||||||||
2007 | |||||||||||||||||||
At £m |
Acquisitions £m |
Unwind of discount |
Exchange £m |
Amounts £m |
Recoveries £m |
Amounts charged to income statement £m |
Balance at 31st | ||||||||||||
Loans and advances to banks
|
4 | | | | (1) | 13 | (13) | 3 | |||||||||||
Loans and advances to customers: |
|||||||||||||||||||
Residential mortgage loans |
124 | | | 2 | (5 | ) | 5 | 6 | 132 | ||||||||||
Credit card receivables |
1,030 | (75 | ) | (60 | ) | 4 | (819 | ) | 103 | 658 | 841 | ||||||||
Other personal lending |
1,139 | | (53 | ) | 10 | (668 | ) | 54 | 891 | 1,373 | |||||||||
Wholesale and corporate loans and advances | 939 | 1 | | 37 | (440 | ) | 46 | 727 | 1,310 | ||||||||||
Finance lease receivables
|
99 | 1 | | | (30 | ) | 6 | 37 | 113 | ||||||||||
Total loans and advances to customers
|
3,331 |
(73) |
|
(113) |
|
53 |
(1,962) |
|
214 |
2,319 |
3,769 | ||||||||
Total impairment allowance
|
3,335 |
(73) |
|
(113) |
|
53 |
(1,963) |
|
227 |
2,306 |
3,772 |
Loan Loss Rates |
|||||||||||
Gross loans and |
Impairment allowance £m |
Loans and advances net of impairment £m |
Impairment £m |
Loan Loss Rate | |||||||
As at 31st December 2008 |
516,096 | (6,574 | ) | 509,522 | 4,913 | 95 | |||||
As at 31st December 2007 |
389,290 | (3,772 | ) | 385,518 | 2,782 | 71 |
260 | Barclays Annual Report 2008 |
47 Credit risk (continued)
Renegotiated loans and advances
Loans and advances are generally renegotiated either as part of an ongoing customer relationship or in response to an adverse change in the circumstances of the borrower. In the latter case renegotiation can result in an extension of the due date of payment or repayment plans under which the Group offers a concessionary rate of interest to genuinely distressed borrowers. This will result in the asset continuing to be overdue and will be individually impaired where the renegotiated payments of interest and principal will not recover the original carrying amount of the asset. In other cases, renegotiation will lead to a new agreement, which is treated as a new loan.
Collateral and other credit enhancements held
Financial assets that are past due or individually assessed as impaired may be partially or fully collateralised or subject to other forms of credit enhancement.
Assets in these categories subject to collateralisation are mainly corporate loans, residential mortgage loans and finance lease receivables. Credit card receivables and other personal lending are generally unsecured (although in some instances a charge over the borrowers property of other assets may be sought).
Corporate loans
Security is usually taken in the form of a fixed charge over the borrowers property or a floating charge over the assets of the borrower. Loan covenants may be put in place to safeguard the Groups financial position. If the exposure is sufficiently large, either individually or at the portfolio level, credit protection in the form of guarantees, credit derivatives or insurance may be taken out.
For these and other reasons collateral given is only accurately valued on origination of the loan or in the course of enforcement actions and as a result it is not practicable to estimate the fair value of the collateral held.
Residential mortgage loans
These are secured by a fixed charge over the property.
A description and the estimated fair value of collateral held in respect of residential mortgage loans that are past due or individually assessed as impaired is as follows:
Nature of assets |
||||
2008 Fair value £m |
2007 Fair value £m | |||
Residential property
|
7,264 |
6,488 |
Collateral included in the above table reflects the Groups interest in the property in the event of default. That held in the form of charges against residential property in the UK is restricted to the outstanding loan balance. In other territories, where the Group is not obliged to return any sale proceeds to the mortgagee, the full estimated fair value has been included.
Finance lease receivables
The net investment in the lease is secured through retention of legal title to the leased assets.
Collateral and other credit enhancements obtained
The carrying value of assets held by the Group as at 31st December 2008 as a result of the enforcement of collateral was as follows:
Nature of assets |
||||
2008 Carrying amount £m |
2007 Carrying amount £m | |||
Residential property |
171 | 34 | ||
Commercial and industrial property |
2 | 1 | ||
Other credit enhancements
|
61 | | ||
Total
|
234 |
35 |
Any properties repossessed are made available for sale in an orderly and timely fashion, with any proceeds realised being used to reduce or repay the outstanding loan. For business customers, in some circumstances, where excess funds are available after repayment in full of the outstanding loan, they are offered to any other, lower ranked, secured lenders. Any additional funds are returned to the customer. Barclays does not, as a rule, occupy repossessed properties for its business use.
The Group does not use assets obtained in its operations. Assets obtained are normally sold, generally at auction, or realised in an orderly manner for the maximum benefit of the Group, the borrower and the borrowers other creditors in accordance with the relevant insolvency regulations.
Barclays Annual Report 2008 |
261 |
Notes to the accounts
For the year ended 31st December 2008
47 Credit risk (continued)
Debt securities
Trading portfolio assets, financial assets designated at fair value and available for sale assets are measured on a fair value basis. The fair value will reflect, among other things, the credit risk of the issuer.
Most listed and some unlisted securities are rated by external rating agencies. The Group mainly uses external credit ratings provided by Standard & Poors or Moodys. Where such ratings are not available or are not current, the Group will use its own internal ratings for the securities.
An analysis of the credit quality of the Groups debt securities is set out below:
2008 | 2007 | |||||||||||||||
AAA to BBB- £m |
BB+ to B £m |
B- and below £m |
Total £m |
AAA to BBB- £m |
BB+ to B £m |
B- and below £m |
Total £m | |||||||||
Trading portfolio: |
||||||||||||||||
Treasury and other eligible bills |
4,491 | 53 | | 4,544 | 1,984 | 110 | | 2,094 | ||||||||
Debt securities
|
141,454 | 5,556 | 1,676 | 148,686 | 143,161 | 8,958 | 659 | 152,778 | ||||||||
Total trading portfolio
|
145,945 |
5,609 |
1,676 |
153,230 |
145,145 |
9,068 |
659 |
154,872 | ||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||||
Debt securities
|
1,222 | 7,406 | | 8,628 | 10,010 | 14,207 | | 24,217 | ||||||||
Available for sale financial investments: |
||||||||||||||||
Treasury and other eligible bills |
2,823 | 1,180 | | 4,003 | 2,130 | 593 | | 2,723 | ||||||||
Debt securities
|
55,817 | 2,347 | 667 | 58,831 | 36,623 | 1,528 | 522 | 38,673 | ||||||||
Total available for sale financial investments
|
58,640 |
3,527 |
667 |
62,834 |
38,753 |
2,121 |
522 |
41,396 | ||||||||
Total debt securities
|
205,807 |
16,542 |
2,343 |
224,692 |
193,908 |
25,396 |
1,181 |
220,485 | ||||||||
%
|
91.6 |
7.4 |
1.0 |
100.0 |
88.0 |
11.5 |
0.5 |
100 |
In addition to the above, there are impaired available for sale debt securities with a carrying value at 31st December 2008 of £329m (2007: £432m), after a write-down of £363m (2007: £13m).
Collateral is not generally obtained directly from the issuers of debt securities. Certain debt securities may be collateralised by specifically identified assets that would be obtained in the event of default.
Derivatives
Derivatives are measured on a fair value basis.
The credit quality of the Groups derivative assets according to the credit quality of the counterparty at 31st December 2008 and 2007 was as follows:
2008 | 2007 | |||||||||||||||
AAA to BBB- £m |
BB+ to B £m |
B and below £m |
Total £m |
AAABBB- £m |
BB+ to B £m |
B and below £m |
Total £m | |||||||||
Derivatives
|
939,071 |
42,266 |
3,465 |
984,802 |
243,491 |
3,630 |
967 |
248,088 | ||||||||
%
|
95.3 |
4.3 |
0.4 |
100.0 |
98.1 |
1.5 |
0.4 |
100.0 |
Credit risk from derivatives is mitigated where possible through netting agreements whereby derivative assets and liabilities with the same counterparty can be offset. Group policy requires all netting arrangements to be legally documented. The ISDA Master Agreement is the Groups preferred agreement for documenting OTC derivatives. It provides the contractual framework within which dealing activities across a full range of OTC products are conducted and contractually binds both parties to apply close-out netting across all outstanding transactions covered by an agreement if either party defaults or other pre-determined events occur.
Collateral is obtained against derivative assets, depending on the creditworthiness of the counterparty and/or nature of the transaction. Any collateral taken in respect of OTC trading exposures will be subject to a haircut which is negotiated at the time of signing the collateral agreement. A haircut is the valuation percentage applicable to each type of collateral and will be largely based on liquidity and price volatility of the underlying security. The collateral obtained for derivatives is either cash, direct debt obligation government (G14+) bonds denominated in the domestic currency of the issuing country, debt issued by supranationals or letters of credit issued by an institution with a long-term unsecured debt rating of A+/A3 or better. Where the Group has ISDA master agreements, the collateral document will be the ISDA Credit Support Annex (CSA). The collateral document must give Barclays the power to realise any collateral placed with it in the event of the failure of the counterparty, and to place further collateral when requested or in the event of insolvency, administration or similar processes, as well as in the case of early termination.
Derivative assets and liabilities would be £917,074m (2007: £215,585m) lower than reported if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral.
262 | Barclays Annual Report 2008 |
47 Credit risk (continued)
Reverse repurchase agreements
Reverse repurchase agreements and securities borrowing arrangements are collateralised loans typically of short maturities.
The loans are fully collateralised with highly liquid securities legally transferred to the Group. The level of collateral is monitored daily and further collateral called when required.
2008 | 2007 | |||||||||||||||
AAA to BBB £m |
BB+ to B £m |
B and below £m |
Total £m |
AAA to BBB £m |
BB+ to B £m |
B and below £m |
Total £m | |||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||||
Other financial assets |
3,882 | 3,401 | | 7,283 | 3,056 | | | 3,056 | ||||||||
Reverse repurchase agreements
|
122,188 | 6,101 | 2,065 | 130,354 | 180,637 | 2,391 | 47 | 183,075 | ||||||||
Total Reverse repurchase agreements
|
126,070 |
9,502 |
2,065 |
137,637 |
183,693 |
2,391 |
47 |
186,131 | ||||||||
%
|
91.6 |
6.9 |
1.5 |
100.0 |
98.7 |
1.3 |
|
100.0 |
No reverse repurchase agreements held by the Group at 31st December 2008 or 2007 were individually impaired, however during the year, the Group wrote off £124m of reverse repurchase agreements (2007: £nil).
Other credit risk assets
The Groups other assets that are subject to credit risk are cash with central banks of £30,019m (2007: £5,801m), items in course of collection from other Banks £1,695m (2007: £1,836m), other financial assets £3,096m (2007: £3,966m).
Cash and balances at central banks
Substantially all balances are held with central banks. There is limited credit risk in relation to balances at central banks.
Items in the course of collection from other banks
There is limited credit risk in relation to items in the course of collection through the clearing system from other banks.
Other financial assets
Other financial assets comprise £3,096m (2007: £3,966m) of other assets and £609m (2007: £548m) of assets held at fair value.
Off-balance sheet
The Group applies fundamentally the same risk management policies for off-balance sheet risks as it does for its on-balance sheet risks. In the case of committments to lend, customers and counterparties will be subject to the same credit management policies as for loans and advances. Collateral may be sought depending on the strength of the counterparty and the nature of the transaction.
Credit market exposures
Barclays Capitals credit market exposures primarily relate to US residential mortgages, commercial mortgages and leveraged finance businesses that have been significantly impacted by the continued deterioration in the global credit markets. The exposures include both significant positions subject to fair value movements in the profit and loss account and positions that are classified as loans and advances and available for sale. None of the exposure disclosed below has been reclassified to loans and advances under the amendments to IAS 39.
The exposures are set out by asset class below:
US Residential Mortgages | As at 31.12.08 £m |
As at 31.12.07 £m | ||
ABS CDO Super Senior
|
3,104 |
4,671 | ||
Other US sub- prime
|
3,441 |
5,037 | ||
Alt-A
|
4,288 |
4,916 | ||
US RMBS exposure wrapped by monoline insurers
|
1,639 |
730 | ||
Commercial mortgages
|
||||
Commercial real estate |
11,578 | 11,103 | ||
Commercial mortgage-backed securities |
735 | 1,296 | ||
CMBS exposure wrapped by monoline insurers
|
1,854 | 197 | ||
Other Credit Market Exposures
|
||||
Leveraged finance
|
10,391 |
9,027 | ||
SIVs and SIV-Lites
|
963 |
784 | ||
CDPCs
|
150 |
19 | ||
CLO and other exposure wrapped by monoline insurers
|
4,939 |
408 |
Barclays Annual Report 2008 |
263 |
Notes to the accounts
For the year ended 31st December 2008
48 Market risk
Market risk management
Market risk is the risk that Barclays earnings or capital, or its ability to meet business objectives, will be adversely affected by changes in the level or volatility of market rates or prices such as interest rates, credit spreads, commodity prices, equity prices and foreign exchange rates. Market risk mainly arises from trading activities. Barclays is also exposed to market risk through interest rate risk on its non-trading activities and through the pension fund.
Organisation and structure
The Board approves market risk appetite for trading and non-trading activities. The Market Risk Director is responsible for the Market Risk Control Framework and, under delegated authority from the Group Risk Director, sets a limit framework within the context of the approved market risk appetite. A daily market risk report summarises Barclays market risk exposures against agreed limits. This daily report is sent to the Group Risk Director, the Market Risk Director, the Group Finance Director and the appropriate Business Risk Directors.
The head of each business, assisted by the business risk management team, is accountable for all market risks associated with its activities. Each business is responsible for the identification, measurement, management, control and reporting of market risk as outlined in Barclays Market Risk Control Framework. Oversight and support is provided to the business by the Market Risk Director, assisted by the central market risk team. The Market Risk Committee reviews, approves, and makes recommendations concerning the market risk profile across Barclays including risk appetite, limits and utilisation. The Committee meets monthly and is chaired by the Market Risk Director. Attendees include the Risk Director, respective business risk managers and senior managers from the central market risk team.
Traded market risk
Barclays policy is to concentrate trading activities in Barclays Capital. This includes transactions where Barclays Capital acts as principal with clients or with the market. For maximum efficiency, client and market activities are managed together.
Risk measurement and control
The measurement techniques used to measure and control traded market risk include Daily Value at Risk (DVaR), Expected Shortfall (ES), stress testing and scenario testing.
DVaR is an estimate of the potential loss arising from unfavourable market movements, if the current positions were to be held unchanged for one business day. Barclays Capital uses the historical simulation method with a two year unweighted historical period.
In 2008, the confidence level was changed to 95% from 98% as an increasing incidence of significant market movements made the existing measure more volatile and less effective for risk management purposes. Switching to 95% made DVaR more stable and consequently improved management, transparency and control of the market risk profile.
The historical simulation calculation can be split into three parts:
Calculate hypothetical daily profit or loss for each position over the most recent two years, using observed daily market moves.
Sum hypothetical profit or losses, for day 1 giving one total profit or loss. This is repeated for all other days in the two year history.
DVaR is the 95th percentile selected from the two years of daily hypothetical total profit or loss.
The DVaR model has been approved by the FSA to calculate regulatory capital for the trading book. The approval covers general market risk in interest rate, foreign exchange, commodities and equity products, and issuer specific risk for the majority of single name and portfolio traded credit products.
DVaR is an important market risk measurement and control tool and consequently the model is regularly assessed. The main approach employed is the technique known as back-testing which counts the number of days when a loss (as defined by the FSA in BIPRU 7.10), exceeds the corresponding DVaR estimate, measured at the 99% confidence level.
The FSA categorises a DVaR model as green (being best), amber or red. A green model is consistent with a good working DVaR model and is achieved for models that have four or less back-testing exceptions in a 12-month period. For Barclays Capitals trading book, green model status was maintained for 2008 and 2007.
264 | Barclays Annual Report 2008 |
48 Market risk (continued)
To further improve the control framework, formal daily monitoring of ES was started. This metric is the average of all the hypothetical losses beyond DVaR. Other controls, includes stress testing and scenario testing.
Stress testing provides an indication of the potential size of losses that could arise in extreme conditions. It helps to identify risk concentrations across business lines and assist senior management in capital planning decisions. A variety of different types of stress tests are performed in order to fulfil the objectives of stress testing. The global asset class stress tests have been designed to cover major asset classes including interest rate, credit spread, commodity, equity, foreign exchange rates and emerging markets.
Stress results are produced at least fortnightly. If a potential stress loss exceeds the corresponding trigger limit, the positions captured by the stress test are reviewed and discussed by Barclays Capital market risk management and the respective Barclays Capital business heads. The minutes of the discussion, including the merits of the position and the appropriate course of action, are then sent to the Market Risk Director for review.
Scenario tests are hypothetical events which could lead to extreme yet plausible stress type moves under which profitability is seriously challenged. The scenarios are devised by senior risk managers and economists and are reviewed quarterly. Examples include Global pandemic, Problems with GBP sovereign issuances and Liquidity crisis. The scenarios are calculated at least fortnightly and the results are included in the Traded Positions Risk Review meeting information pack.
Analysis of traded market risk exposures
Barclays Capital market risk exposure, as measured by average total DVaR (95%), increased by 64% to £53.4m in 2008. This was mainly due to higher market volatility within the credit spread and interest rate DVaRs.
Total DVaR increased significantly in the fourth quarter, mainly due to extreme market volatility following the failure of several financial intuitions and a material deterioration in the global economic outlook. Total DVaR (95%) at 31st December 2008 was £86.6m (31st December 2007: £39.6m), which was within limit.
On a 98% basis, average total DVaR increased 82% to £76.5m.
The daily average, maximum and minimum values of DVaR, 95% and 98%, were calculated as below.
DVaR (95%) | ||||||||||||||
12 months to 31st December 2008 |
12 months to 31st December 2007 | |||||||||||||
Average |
High £m |
Low £m |
Average £m |
High £m |
Low £m | |||||||||
Interest rate risk |
28.9 | 47.8 | 15.1 | 15.3 | 26.5 | 10.0 | ||||||||
Credit spread risk |
31.1 | 71.7 | 15.4 | 17.3 | 28.0 | 10.8 | ||||||||
Commodity risk |
18.1 | 25.4 | 12.5 | 15.3 | 19.0 | 10.7 | ||||||||
Equity risk |
9.1 | 21.0 | 4.8 | 8.0 | 12.1 | 4.5 | ||||||||
Foreign exchange risk |
5.9 | 13.0 | 2.1 | 3.8 | 7.2 | 2.1 | ||||||||
Diversification effect a
|
(39.7 | ) | n/a | n/a | (27.2 | ) | n/a | n/a | ||||||
Total DVaR
|
53.4
|
|
95.2
|
35.5
|
32.5
|
|
40.9
|
25.2
|
DVaR (98%) | ||||||||||||||
12 months to 31st December 2008 |
12 months to 31st December 2007 | |||||||||||||
Average |
High £m |
Low £m |
Average £m |
High £m |
Low £m | |||||||||
Interest rate risk |
45.0 | 80.9 | 21.0 | 20.0 | 33.3 | 12.6 | ||||||||
Credit spread risk |
54.0 | 143.4 | 30.1 | 24.9 | 43.3 | 14.6 | ||||||||
Commodity risk |
23.9 | 39.6 | 16.5 | 20.2 | 27.2 | 14.8 | ||||||||
Equity risk |
12.8 | 28.9 | 6.7 | 11.2 | 17.6 | 7.3 | ||||||||
Foreign exchange risk |
8.1 | 21.0 | 2.9 | 4.9 | 9.6 | 2.9 | ||||||||
Diversification effect a
|
(67.3 | ) | n/a | n/a | (39.2 | ) | n/a | n/a | ||||||
Total DVaR
|
76.5
|
|
158.8
|
47.5
|
42.0
|
|
59.3
|
33.1
|
The average ES in 2008 was £70.0m, a rise of £34.7m compared with 2007.
Note
a | The high (and low) DVaR figures reported for each category did not necessarily occur on the same day as the high (and low) DVaR reported as a whole. Consequently a diversification effect number for the high (and low) DVaR figures would not be meaningful and it is therefore omitted from the above table. |
Barclays Annual Report 2008 |
265 |
Notes to the accounts
For the year ended 31st December 2008
48 Market risk (continued)
Non-trading interest rate risk
Non-traded interest rate risk arises from the provision of retail and wholesale (non-traded) banking products and services.
Barclays objective is to minimise non-traded risk. This is achieved by transferring risk from the business to a local treasury or Group Treasury, who in turn hedge the net exposure with the external market. Limits exist to ensure no material risk is retained within any business or product area. The majority of exposures are within Global Retail and Commercial Banking .
Risk measurement and control
The techniques used to measure and control non-traded interest rate risk include Annual Earnings at Risk, DVaR and Stress Testing. Book limits such as foreign exchange and interest position limits are also in place.
Annual Earnings at Risk (AEaR) measures the sensitivity of net interest income (NII) over the next 12 months. It is calculated as the difference between the estimated income using the current yield curve and the lowest estimated income following a 100 basis points increase or decrease in interest rates.
DVaR is also used as a complementary tool to AEaR.
Stress testing is also carried out by the business centres and is reviewed by senior management and business-level asset and liability committees. The stress testing is tailored to the business and typically incorporates scenario analysis and historical stress movements applied to respective portfolios.
Analysis of Net Interest Income sensitivity
The tables below show the pre-tax net interest income sensitivity for the non-trading financial assets and financial liabilities held at 31st December 2008. The sensitivity has been measured using AEaR methodology as described above. The benchmark interest rate for each currency is set as at 31st December 2008. The figures include the effect of hedging instruments but exclude exposures held or issued by Barclays Capital as these are measured and managed using DVaR.
Net interest in come sensitivity(AEaR) by currency |
| |||||||||||
+100 basis points 2008 £m |
100 basis points 2008 £m |
+100 basis points 2007 £m |
100 basis points 2007 £m |
|||||||||
GBP |
3 | (273 | ) | 36 | (37 | ) | ||||||
USD |
(25 | ) | 7 | (3 | ) | 1 | ||||||
EUR |
(34 | ) | 30 | (23 | ) | 23 | ||||||
ZAR |
13 | (13 | ) | 19 | (19 | ) | ||||||
Others
|
| (8 | ) | 4 | (5 | ) | ||||||
Total
|
(43 | ) | (257 | ) | 33 | (37 | ) | |||||
As percentage of net interest in come
|
(0.37% | ) | (2.24% | ) | 0.34% | (0.39% | ) |
Non-traded interest rate risk, as measured by AEaR, was £257m in 2008, an increase of £220m compared to 2007. This estimate takes into account the rates in place as at 31st December 2008. The increase mainly reflects the reduced spread generated on retail and commercial banking liabilities in the lower interest rate environment. If the interest rate hedges had not been in place then the AEaR risk for 2008 would have been £670m.
DVaR is also used to control market risk in GRCB Western Europe, and Group Treasury. The indicative average DVaRs for 2008, using a simplified DVaR approach, were £1.3m and £0.6m respectively.
Analysis of Equity sensitivity
+100 basis points 2008 £m |
100 basis points 2008 £m |
+100 basis points 2007 £m |
100 basis points 2007 £m |
|||||||||
Net interest income |
(43 | ) | (257 | ) | 33 | (37 | ) | |||||
Taxation effects on the above
|
6 | 33 | (9 | ) | 10 | |||||||
Effect on profit for the year
|
(37 | ) | (224 | ) | 24 | (27 | ) | |||||
As percentage of net profit after tax
|
(0.70% | ) | (4.24% | ) | 0.47% | (0.53% | ) | |||||
Effect on profit for the year (per above) |
(37 | ) | (224 | ) | 24 | (27 | ) | |||||
Available for sale reserve |
(806 | ) | 806 | (390 | ) | 390 | ||||||
Cash flow hedging reserve |
(473 | ) | 474 | (476 | ) | 476 | ||||||
Taxation effects on the above
|
166 | (166 | ) | 242 | (242 | ) | ||||||
Effect on equity
|
(1,150 | ) | 890 | (600 | ) | 597 | ||||||
As a percentage of equity
|
(2.43% | ) | 1.88% | (1.85% | ) | 1.84% |
266 | Barclays Annual Report 2008 |
48 Market risk (continued)
Foreign exchange risk
The Group is exposed to two sources of foreign exchange risk.
(a) Transactional foreign currency exposure
Transactional foreign exchange exposures represent exposure on banking assets and liabilities, denominated in currencies other than the functional currency of the transacting entity.
The Groups risk management policies prevent the holding of significant open positions in foreign currencies outside the trading portfolio managed by Barclays Capital which is monitored through DVaR.
There were no material net transactional foreign currency exposures outside the trading portfolio at either 31st December 2008 or 2007. Due to the low level of non-trading exposures no reasonably possible change in foreign exchange rates would have a material effect on either the Groups profit or movements in equity for the year ended 31st December 2008 or 2007.
(b) Translational foreign exchange exposure
The Groups translational foreign currency exposure arises from both its capital resources (including investments in subsidiaries and branches, intangible assets, minority interests and debt capital) and risk weighted assets denominated in non-Sterling currencies. Changes in foreign exchange rates result in changes in the Sterling equivalent value of non-Sterling denominated capital resources and risk weighted assets. As a result, the Groups regulatory capital ratios are sensitive to foreign exchange rate movements.
The Groups hedge strategy is to minimise the volatility of all capital ratios whilst taking into account the impact on hedging of non-Sterling net investments, the cost of hedging, the availability of a suitable foreign exchange market and prevailing foreign exchange rates.
To minimise volatility in the equity ratio, the Group aims over time to maintain the ratio of foreign currency equity capital resources to RWAs the same as the Groups equity ratio. To create equity capital resources denominated in non-Sterling currencies, the Group leaves some investments in core non-Sterling subsidiaries and branches un-hedged. The resultant change in the Sterling value of the investments is captured in the currency translation reserve, resulting in an equity capital movement.
Depending on the value of non-Sterling net investments, it may not always be possible to maintain the ratio, leaving some capital ratio sensitivity to foreign exchange movements.
The proceeds from equity accounted foreign currency preference shares are also used in the equity ratio hedge. If a preference share is redeemed, the cumulative movement in the currency translation reserve will be offset by an equal and opposite movement in other reserves reflecting the revaluation of the preference shares to prevailing foreign exchange rates.
The exposure of Tier 1 and Total capital ratios is managed by issuing, where possible, debt capital in non-Sterling currencies such that the ratio of Tier 1 and total capital resources to risk weighted assets is the same as the Groups Tier 1 and Total capital ratios. This is primarily achieved by the issuance of debt capital from Barclays Bank PLC in major currencies, but can also be achieved by subsidiaries issuing capital in local currencies.
The carrying value of the Groups foreign currency net investments in subsidiaries and branches and the foreign currency borrowings and derivatives used to hedge them as at 31st December 2008 were as follows:
At 31st December 2008 Functional currency of the operation involved
|
Foreign currency net investments £m |
Borrowings which hedge the net investments £m |
Derivatives which hedge the net investments £m |
Structural £m |
Economic hedges £m |
Remaining structural currency exposures £m |
||||||||
United States Dollar |
14,577 | 6,019 | | 8,558 | 6,720 | 1,838 | ||||||||
Euro |
6,336 | 2,922 | | 3,414 | 3,125 | 289 | ||||||||
Rand |
3,725 | | 1,306 | 2,419 | 164 | 2,255 | ||||||||
Japanese Yen |
5,009 | 801 | 4,212 | (4 | ) | | (4 | ) | ||||||
Swiss Franc |
3,042 | 2,936 | 101 | 5 | | 5 | ||||||||
Other
|
2,940 | | 880 | 2,060 | | 2,060 | ||||||||
Total
|
35,629 | 12,678 | 6,499 | 16,452 | 10,009 | 6,443 |
At 31st December 2007 Functional currency of the operation involved
|
Foreign currency net investments £m |
Borrowings which hedge the net investments £m |
Derivatives which hedge the net investments £m |
Structural £m |
Economic hedges £m |
Remaining structural currency exposures £m |
|||||||
United States Dollar |
3,273 | 1,000 | | 2,273 | 3,575 | (1,302 | ) | ||||||
Euro |
3,690 | 1,506 | | 2,184 | 2,387 | (203 | ) | ||||||
Rand |
3,205 | | 2,599 | 606 | 165 | 441 | |||||||
Japanese Yen |
2,986 | 180 | 2,773 | 33 | | 33 | |||||||
Swiss Franc |
2,140 | | 2,131 | 9 | | 9 | |||||||
Other
|
1,847 | 53 | 465 | 1,329 | | 1,329 | |||||||
Total
|
17,141 | 2,739 | 7,968 | 6,434 | 6,127 | 307 |
Barclays Annual Report 2008 |
267 |
Notes to the accounts
For the year ended 31st December 2008
48 Market risk (continued)
The economic hedges represent the US Dollar and Euro Preference Shares and Reserve Capital Instruments in issue that are treated as equity under IFRS, and do not qualify as hedges for accounting purposes.
The impact of a change in the exchange rate between Sterling and any of the major currencies would be:
A higher or lower Sterling equivalent value of non-Sterling denominated capital resources and risk weighted assets. This includes a higher or lower currency translation reserve within equity, representing the retranslation of non-Sterling subsidiaries, branches and associated undertakings net of the impact of foreign exchange rate changes on derivatives and borrowings designated as hedges of net investments.
A higher or lower profit after tax, arising from changes in the exchange rates used to translate items in the consolidated income statement.
A higher or lower value of available for sale investments denominated in foreign currencies, impacting the available for sale reserve.
49 Liquidity risk
Liquidity risk is the risk that the Group is unable to meet its obligations when they fall due as a result of customer deposits being withdrawn, cash requirements from contractual commitments, or other cash outflows, such as debt maturities. Such outflows would deplete available cash resources for client lending, trading activities and investments. In extreme circumstances lack of liquidity could result in reductions in balance sheet and sales of assets, or potentially an inability to fulfil lending commitments. The risk that it will be unable to do so is inherent in all banking operations and can be affected by a range of institution-specific and market-wide events including, but not limited to, credit events, merger and acquisition activity, systemic shocks and natural disasters.
Liquidity risk management and measurement
Liquidity management within the Group has several components.
Intraday liquidity
The need to monitor, manage and control intraday liquidity in real time is recognised by the Group as a critical process: any failure to meet specific intraday commitments would have significant consequences, such as visible market disruption.
The Group policy is that each operation must ensure that it has access to sufficient intraday liquidity to meet any obligations it may have to clearing and settlement systems. Major currency payment flows and payment system collateral are monitored and managed in real time to ensure that at all times there is sufficient collateral to make payments. The Group actively engages in payment system development to help ensure that new payment systems are robust.
Day to day funding
Day to day funding is managed through limits on wholesale borrowings, secured borrowings and funding mismatches. These ensure that on any day and over any period there is a limited amount of refinancing required. These requirements include replacement of funds as liabilities mature or are borrowed by customers. The Retail and Commercial Bank together with Wealth maintain no reliance on wholesale funding. The Group maintains an active presence in global money markets through Barclays Capital, and monitors and manages the wholesale money market capacity for the Groups name to enable that to happen.
In addition to cash flow management, Treasury also monitors term mismatches between assets and liabilities, as well as the level and type of undrawn lending commitments, the usage of overdraft facilities and the impact of contingent liabilities such as standby letters of credit and guarantees.
Liquid assets
The Group maintains a portfolio of highly marketable assets including UK, US and Euro-area government bonds that can be sold or funded on a secured basis as protection against any unforeseen interruption to cash flow. The Group accesses secured funding markets in these assets on a regular basis. The Group does not rely on committed funding lines for protection against unforeseen interruptions to cash flow.
Diversification of liquidity sources
Sources of liquidity are regularly reviewed to maintain a wide diversification by currency, geography, provider, product and term. In addition, to avoid reliance on a particular group of customers or market sectors, the distribution of sources and the maturity profile of deposits are also carefully managed. Important factors in assuring liquidity are strength of relationships and the maintenance of depositors confidence. Such confidence is based on a number of factors including the Groups reputation and relationship with those clients, the strength of earnings and the Groups financial position.
Structural liquidity
An important source of structural liquidity is provided by our core retail deposits in the UK, Europe and Africa, mainly current accounts and savings accounts. Although current accounts are repayable on demand and savings accounts at short notice, the Groups broad base of customers numerically and by depositor type helps to protect against unexpected fluctuations. Such accounts form a stable funding base for the Groups operations and liquidity needs.
The Group policy is to fund the balance sheet assets of the Retail and Commercial Bank together with Wealth and Head office functions on a global basis with customer deposits and capital without recourse to the wholesale markets. This provides protection from the liquidity risk of wholesale market funding. The exception to this policy is Absa, which has a large portion of wholesale funding due to the structural nature of the South African financial sector.
Scenario analysis and stress testing
Stress testing is undertaken to assess and plan for the impact of various scenarios which may put the Groups liquidity at risk.
Treasury develops and monitors a range of stress tests on the Groups projected cash flows. These stress scenarios include Barclays-specific scenarios such an unexpected rating downgrade and operational problems, and external scenarios such as Emerging Market crises, payment system disruption and macro-economic shocks. The output informs both the liquidity mismatch limits and the Groups contingency funding plan. This is maintained by Treasury and is aligned with the Group and country business resumption plans to encompass decision-making authorities, internal and external communication and, in the event of a systems failure, the restoration of liquidity management and payment systems.
The ability to raise funds is in part dependent on maintaining the Banks credit rating. The funding impact of a credit downgrade is closely tracked. Whilst the impact of a single downgrade may affect the price at which funding is available, the effect on liquidity is not considered material in Group terms.
268 | Barclays Annual Report 2008 |
49 Liquidity risk (continued)
Year-end assessment of liquidity
Barclays maintained a strong liquidity profile in 2008, sufficient to absorb the impact of a stressed funding environment. The Group has access to a substantial pool of liquidity both in secured markets and from unsecured depositors including numerous foreign governments and central banks. In addition, our limited reliance on securitisations as a source of funding has meant that the uncertainty in securitisation markets has not impacted our liquidity risk profile.
Whilst funding markets were extremely difficult in the latter half of 2008, and particularly since September 2008, Barclays was able to increase available liquidity, extend the term of unsecured liabilities, and reduce reliance on unsecured funding. Barclays has participated in various government and central bank liquidity facilities, both to aid central banks implementation of monetary policy and support central bank initiatives, where participation has enabled the lengthening of the term of our refinancing. These facilities have improved access to term funding, and helped moderate money market rates.
Global Retail and Commercial Banking
The sum of liabilities in Global Retail and Commercial Banking, Barclays Wealth and Head office functions exceeds assets in those businesses. As a result they have no reliance on wholesale funding. The balance sheet is modelled to reflect behavioural experience in both assets and liabilities, and is managed to maintain a positive cash profile.
Throughout 2008 Global Retail and Commercial Banking continued to grow the amount of customer deposits despite competitive pressures.
Barclays Capital
Barclays Capital manages liquidity to be self-funding through wholesale sources, managing access to liquidity to ensure that potential cash outflows in a stressed environment are covered.
Funding reliability is maintained by accessing a wide variety of investors and geographies and by building and maintaining strong relationships with these providers of liquidity. The depositors include asset managers, money market funds, corporates, government bodies, central banks and other financial institutions. Deposits are predominantly sourced from Western Europe and North America.
Unsecured Funding
Additionally, unsecured funding is managed within specific term limits. The term of unsecured liabilities has been extended, with average life increasing year over year.
Our capital markets debt issuance includes issues of senior and subordinated debt in US registered offerings and medium-term note programmes and European medium-term note programs. Substantially all of our unsecured senior issuance is without covenants that trigger increased cost or accelerate maturity.
Secured Funding
Barclays funds securities based on liquidity characteristics. Limits are in place for each security asset class reflecting liquidity in the cash and financing markets for these assets. The vast majority of assets funded in repurchase and stock loan transactions are fundable within central bank facilities (excluding Bank of England Emergency facilities and the Federal Reserve Primary Dealer Credit Facility). These are largely composed of G7 government securities, US mortgage agency debentures and mortgage backed securities, investment grade corporate securities and listed equities.
Liquidity risk to secured funding is also mitigated by:
| selecting reliable counterparties |
| maintaining term financing and by limiting the amount of overnight funding |
| limiting overall secured funding usage |
Readily available liquidity
Substantial resources are maintained to offset maturing deposits and debt. These readily available assets are sufficient to absorb stress level losses of liquidity from unsecured as well as contingent cash outflows, such as collateral requirements on ratings downgrades. The sources of liquidity and contingent liquidity are from a wide variety of sources, including deposits held with central banks and unencumbered securities.
Barclays Annual Report 2008 |
269 |
Notes to the accounts
For the year ended 31st December 2008
49 Liquidity risk (continued)
Contractual maturity of financial assets and liabilities
Details of contractual maturities for assets and liabilities form an important source of information for the management of liquidity risk. In order to more accurately reflect the expected behaviour of the Groups assets and liabilities measurement and modelling of each is constructed. This forms the foundation of the liquidity controls.
The table below provides detail on the contractual maturity of all financial instruments and other assets and liabilities. Derivatives (other than those designated in a hedging relationship) and trading portfolio assets and liabilities which are included in the on demand column at their fair value. Liquidity risk on these items is not managed on the basis of contractual maturity since they are not held for settlement according to such maturity and will frequently be settled before contractual maturity at fair value. Derivatives designated in a hedging relationship are included according to their contractual maturity.
Financial assets designated at fair value in respect of linked liabilities to customers under investment contracts have been included in Other assets and Other liabilities as the Group is not exposed to liquidity risk arising from them; any request for funds from creditors would be met by simultaneously liquidating or transferring the related investment
At 31st December 2008
On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six months but not more than one year £m |
Over one year but not more than three years £m |
Over three years but not more than five years £m |
Over five years but not more than ten years £m |
Over ten years £m |
Total £m | ||||||||||||||||
Assets |
||||||||||||||||||||||||
Cash and balances at central banks | 29,774 | 245 | | | | | | | 30,019 | |||||||||||||||
Items in the course of collection from other banks | 1,619 | 76 | | | | | | | 1,695 | |||||||||||||||
Trading portfolio assets | 185,637 | | | | | | | | 185,637 | |||||||||||||||
Financial assets designated at fair value: | ||||||||||||||||||||||||
held on own account |
661 | 13,861 | 1,648 | 5,861 | 5,420 | 6,738 | 4,159 | 16,194 | 54,542 | |||||||||||||||
Derivative financial instruments: | ||||||||||||||||||||||||
held for trading |
981,996 | | | | | | | | 981,996 | |||||||||||||||
designated for risk management | | 381 | 91 | 542 | 505 | 336 | 419 | 532 | 2,806 | |||||||||||||||
Loans and advances to banks | 4,882 | 35,690 | 505 | 1,892 | 1,887 | 1,854 | 52 | 945 | 47,707 | |||||||||||||||
Loans and advances to customers | 51,155 | 87,624 | 12,447 | 21,976 | 60,927 | 44,982 | 57,409 | 125,295 | 461,815 | |||||||||||||||
Available for sale financial investments | 132 | 11,539 | 5,129 | 13,461 | 10,266 | 6,660 | 9,779 | 8,010 | 64,976 | |||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed
|
29
|
107,415
|
|
8,947
|
|
2,582
|
|
10,124
|
|
1,019
|
|
238
|
|
|
130,354
| |||||||||
Total financial assets
|
1,255,885 | 256,831 | 28,767 | 46,314 | 89,129 | 61,589 | 72,056 | 150,976 | 1,961,547 | |||||||||||||||
Other assets
|
| | | | | | | 91,433 | 91,433 | |||||||||||||||
Total assets
|
1,255,885 | 256,831 | 28,767 | 46,314 | 89,129 | 61,589 | 72,056 | 242,409 | 2,052,980 | |||||||||||||||
Liabilities |
||||||||||||||||||||||||
Deposits from other banks | 10,850 | 94,083 | 6,040 | 1,273 | 1,585 | 461 | 433 | 185 | 114,910 | |||||||||||||||
Items in the course of collection due to other banks | 1,633 | 2 | | | | | | | 1,635 | |||||||||||||||
Customer accounts | 195,728 | 112,582 | 9,389 | 10,099 | 2,451 | 1,555 | 1,395 | 2,306 | 335,505 | |||||||||||||||
Trading portfolio liabilities | 59,474 | | | | | | | | 59,474 | |||||||||||||||
Financial liabilities designated at fair value: | ||||||||||||||||||||||||
held on own account |
1,043 | 16,573 | 10,630 | 5,115 | 12,229 | 12,041 | 11,825 | 7,436 | 76,892 | |||||||||||||||
Derivative financial instruments: | ||||||||||||||||||||||||
held for trading |
964,071 | | | | | | | | 964,071 | |||||||||||||||
designated for risk management | | 222 | 141 | 1,345 | 1,197 | 108 | 781 | 207 | 4,001 | |||||||||||||||
Debt securities in issue | 2,567 | 79,600 | 10,049 | 17,197 | 23,355 | 9,856 | 2,528 | 4,415 | 149,567 | |||||||||||||||
Repurchase agreements and cash collateral on securities lent | 69 | 176,169 | 3,409 | 2,067 | 245 | 267 | 59 | | 182,285 | |||||||||||||||
Subordinated liabilities
|
| 260 | 49 | 281 | 1,345 | 999 | 10,176 | 16,732 | 29,842 | |||||||||||||||
Total financial liabilities
|
1,235,435 | 479,491 | 39,707 | 37,377 | 42,407 | 25,287 | 27,197 | 31,281 | 1,918,182 | |||||||||||||||
Other liabilities
|
| | | | | | | 87,387 | 87,387 | |||||||||||||||
Total liabilities
|
1,235,435 | 479,491 | 39,707 | 37,377 | 42,407 | 25,287 | 27,197 | 118,668 | 2,005,569 | |||||||||||||||
Cumulative liquidity gap
|
20,450 | (202,210 | ) | (213,150 | ) | (204,213 | ) | (157,491 | ) | (121,189 | ) | (76,330 | ) | 47,411 | 47,411 |
270 | Barclays Annual Report 2008 |
49 Liquidity risk (continued)
At 31st December 2007
On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six months but not more than one year £m |
Over one year but not more than three years £m |
Over three years but not more than five years £m |
Over five years but not more than ten years £m |
Over ten years £m |
Total £m | |||||||||||||||||
Assets |
|||||||||||||||||||||||||
Cash and balances at central banks | 4,785 | 1,016 | | | | | | | 5,801 | ||||||||||||||||
Items in course of collection from other banks | 1,651 | 185 | | | | | | | 1,836 | ||||||||||||||||
Trading portfolio assets | 193,691 | | | | | | | | 193,691 | ||||||||||||||||
Financial assets designated at fair value: | |||||||||||||||||||||||||
held on own account |
1,901 | 3,202 | 657 | 3,029 | 13,882 | 7,022 | 10,637 | 16,299 | 56,629 | ||||||||||||||||
Derivative financial instruments: | |||||||||||||||||||||||||
held for trading |
246,950 | | | | | | | | 246,950 | ||||||||||||||||
designated for risk management |
| 76 | 92 | 39 | 260 | 105 | 317 | 249 | 1,138 | ||||||||||||||||
Loans and advances to banks | 5,882 | 22,143 | 446 | 3,189 | 1,259 | 1,035 | 5,680 | 486 | 40,120 | ||||||||||||||||
Loans and advances to customers | 43,469 | 62,294 | 12,793 | 19,307 | 35,195 | 30,926 | 47,297 | 94,117 | 345,398 | ||||||||||||||||
Available for sale financial investments | 994 | 9,009 | 4,544 | 2,377 | 10,831 | 6,466 | 5,268 | 3,583 | 43,072 | ||||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed
|
|
|
158,475
|
|
7,369
|
|
7,835
|
|
4,921
|
|
4,348
|
|
127
|
|
|
183,075
| |||||||||
Total financial assets
|
499,323 | 256,400 | 25,901 | 35,776 | 66,348 | 49,902 | 69,326 | 114,734 | 1,117,710 | ||||||||||||||||
Other assets
|
| | | | | | | 109,651 | 109,651 | ||||||||||||||||
Total assets
|
499,323 | 256,400 | 25,901 | 35,776 | 66,348 | 49,902 | 69,326 | 224,385 | 1,227,361 | ||||||||||||||||
Liabilities |
|||||||||||||||||||||||||
Deposits from other banks | 16,288 | 69,049 | 1,977 | 991 | 651 | 1,171 | 231 | 188 | 90,546 | ||||||||||||||||
Items in the course of collection due to other banks | 1,781 | 11 | | | | | | | 1,792 | ||||||||||||||||
Customer accounts | 174,269 | 101,667 | 5,692 | 4,097 | 1,656 | 1,240 | 993 | 5,373 | 294,987 | ||||||||||||||||
Trading portfolio liabilities | 65,402 | | | | | | | | 65,402 | ||||||||||||||||
Financial liabilities designated at fair value: | |||||||||||||||||||||||||
held on own account |
655 | 18,022 | 8,331 | 6,933 | 10,830 | 11,601 | 12,625 | 5,492 | 74,489 | ||||||||||||||||
Derivative financial instruments: | |||||||||||||||||||||||||
held for trading |
247,378 | | | | | | | | 247,378 | ||||||||||||||||
designated for risk management |
| 51 | 43 | 82 | 310 | 150 | 215 | 59 | 910 | ||||||||||||||||
Debt securities in issue | 698 | 70,760 | 11,798 | 6,945 | 13,308 | 7,696 | 3,123 | 5,900 | 120,228 | ||||||||||||||||
Repurchase agreements and cash collateral on securities lent | | 160,822 | 2,906 | 5,547 | 40 | 92 | 22 | | 169,429 | ||||||||||||||||
Subordinated liabilities
|
| | | | 250 | 934 | 7,511 | 9,455 | 18,150 | ||||||||||||||||
Total financial liabilities
|
506,471 | 420,382 | 30,747 | 24,595 | 27,045 | 22,884 | 24,720 | 26,467 | 1,083,311 | ||||||||||||||||
Other liabilities
|
| | | | | | | 111,574 | 111,574 | ||||||||||||||||
Total liabilities
|
506,471 | 420,382 | 30,747 | 24,595 | 27,045 | 22,884 | 24,720 | 138,041 | 1,194,885 | ||||||||||||||||
Cumulative liquidity gap
|
(7,148 | ) | (171,130 | ) | (175,976 | ) | (164,795 | ) | (125,492 | ) | (98,474 | ) | (53,868 | ) | 32,476 | 32,476 |
Barclays Annual Report 2008 |
271 |
Notes to the accounts
For the year ended 31st December 2008
49 Liquidity risk (continued)
Contractual maturity of financial liabilities on an undiscounted basis
The table below presents the cash flows payable by the Group under financial liabilities by remaining contractual maturities at the balance sheet date. The amounts disclosed in the table are the contractual undiscounted cash flows of all financial liabilities (i.e nominal values), whereas the Group manages the inherent liquidity risk based on discounted expected cash inflows. Derivative financial instruments held for trading and trading portfolio liabilities are included in the on demand column at their fair value.
At 31st December 2008
On demand £m |
Within one year £m |
Over one year but less than five years £m |
Over five years £m |
Total £m | ||||||
Deposits from other banks |
10,850 | 101,537 | 2,224 | 671 | 115,282 | |||||
Items in the course of collection due to other banks |
1,633 | 2 | | | 1,635 | |||||
Customer accounts |
195,728 | 132,927 | 5,249 | 5,807 | 339,711 | |||||
Trading portfolio liabilities |
59,474 | | | | 59,474 | |||||
Financial liabilities designated at fair value: |
||||||||||
held on own account |
1,043 | 33,860 | 28,300 | 30,427 | 93,630 | |||||
Derivative financial instruments: |
||||||||||
held for trading |
964,071 | | | | 964,071 | |||||
designated for risk management |
| 1,809 | 1,671 | 1,206 | 4,686 | |||||
Debt securities in issue |
2,567 | 108,955 | 34,510 | 11,853 | 157,885 | |||||
Repurchase agreements and cash collateral on securities lent |
69 | 181,895 | 547 | 24 | 182,535 | |||||
Subordinated liabilities |
| 1,273 | 10,166 | 22,593 | 34,032 | |||||
Other financial liabilities
|
| 4,573 | 1,572 | | 6,145 | |||||
Total financial liabilities
|
1,235,435 | 566,831 | 84,239 | 72,581 | 1,959,086 | |||||
Off balance sheet items |
||||||||||
Loan commitments |
222,801 | 30,502 | 5,799 | 917 | 260,019 | |||||
Other commitments
|
493 | 318 | 340 | | 1,151 | |||||
Total off balance sheet items
|
223,294 | 30,820 | 6,139 | 917 | 261,170 | |||||
Total financial liabilities and off balance sheet items
|
1,458,729 | 597,651 | 90,378 | 73,498 | 2,220,256 | |||||
At 31st December 2007 | ||||||||||
On demand £m |
Within one year £m |
Over one year but not more than five years £m |
Over five years £m |
Total £m | ||||||
Deposits from other banks |
16,288 | 72,533 | 2,099 | 275 | 91,195 | |||||
Items in the course of collection due to other banks |
1,781 | 11 | | | 1,792 | |||||
Customer accounts |
174,269 | 112,875 | 3,739 | 10,280 | 301,163 | |||||
Trading portfolio liabilities |
65,402 | | | | 65,402 | |||||
Financial liabilities designated at fair value: |
||||||||||
held on own account |
655 | 34,008 | 25,870 | 31,868 | 92,401 | |||||
Derivative financial instruments: |
||||||||||
held for trading |
247,378 | | | | 247,378 | |||||
designated for risk management |
| 226 | 479 | 186 | 891 | |||||
Debt securities in issue |
698 | 91,201 | 22,926 | 15,020 | 129,845 | |||||
Repurchase agreements and cash collateral on securities lent |
| 169,725 | 146 | 23 | 169,894 | |||||
Subordinated liabilities |
| 463 | 4,964 | 17,875 | 23,302 | |||||
Other financial liabilities
|
| 2,968 | 1,456 | | 4,424 | |||||
Total financial liabilities
|
506,471 | 484,010 | 61,679 | 75,527 | 1,127,687 | |||||
Off balance sheet items |
||||||||||
Loan commitments |
183,784 | 3,111 | 4,513 | 963 | 192,371 | |||||
Other commitments
|
453 | 200 | 145 | 12 | 810 | |||||
Total off balance sheet items
|
184,237 | 3,311 | 4,658 | 975 | 193,181 | |||||
Total financial liabilities and off balance sheet items
|
690,708 | 487,321 | 66,337 | 76,502 | 1,320,868 |
Financial liabilities designated at fair value in respect of linked liabilities under investment contracts have been excluded from this analysis as the Group is not exposed to liquidity risk arising from them. Any request for funds from investors would be met simultaneously from the linked assets.
The balances in the above table will not agree directly to the balances in the consolidated balance sheet as the table incorporates all cash flows, on an undiscounted basis, related to both principal as well as those associated with all future coupon payments.
The principal due under perpetual subordinated liability instruments has been included in the over five years category. Further interest payments have not been included on this amount, which according to their strict contractual terms, could carry on indefinitely.
272 | Barclays Annual Report 2008 |
50 Fair value of financial instruments
The fair value of a financial instrument is the amount for which an asset could be exchanged, or a liability settled, in an arms length transaction between knowledgeable willing parties.
Comparison of carrying amounts and fair values
The following table summarises the carrying amounts of financial assets and liabilities presented on the Groups balance sheet, and their fair values differentiating between financial assets and liabilities subsequently measured at fair value and those subsequently measured at amortised cost:
2008 | 2007 | |||||||||
Notes | Carrying amount £m |
Fair value £m |
Carrying amount £m |
Fair value £m | ||||||
Financial assets: |
||||||||||
Cash and balances at central banks |
a | 30,019 | 30,019 | 5,801 | 5,801 | |||||
Items in the course of collection from other banks |
a | 1,695 | 1,695 | 1,836 | 1,836 | |||||
Trading portfolio assets |
||||||||||
Treasury and other eligible bills |
b | 4,544 | 4,544 | 2,094 | 2,094 | |||||
Debt securities |
b | 148,686 | 148,686 | 152,778 | 152,778 | |||||
Equity securities |
b | 30,535 | 30,535 | 36,307 | 36,307 | |||||
Traded Loans |
b | 1,070 | 1,070 | 1,780 | 1,780 | |||||
Commodities |
b | 802 | 802 | 732 | 732 | |||||
Financial assets designated at fair value: |
||||||||||
held in respect of linked liabilities under investment contracts |
b | 66,657 | 66,657 | 90,851 | 90,851 | |||||
held under own account: |
||||||||||
Equity securities |
b | 6,496 | 6,496 | 5,376 | 5,376 | |||||
Loans and advances |
b | 30,187 | 30,187 | 23,491 | 23,491 | |||||
Debt securities |
b | 8,628 | 8,628 | 24,217 | 24,217 | |||||
Other financial assets designated at fair value |
b | 9,231 | 9,231 | 3,545 | 3,545 | |||||
Derivative financial instruments |
b | 984,802 | 984,802 | 248,088 | 248,088 | |||||
Loans and advances to banks |
c | 47,707 | 47,594 | 40,120 | 40,106 | |||||
Loans and advances to customers |
||||||||||
Residential mortgage loans |
c | 135,077 | 133,605 | 106,619 | 106,615 | |||||
Credit card receivables |
c | 22,304 | 22,312 | 14,289 | 14,289 | |||||
Other personal lending |
c | 32,038 | 31,264 | 29,857 | 29,857 | |||||
Wholesale and corporate loans and advances |
c | 259,699 | 247,798 | 183,556 | 182,036 | |||||
Finance lease receivables |
c | 12,697 | 12,697 | 11,077 | 11,066 | |||||
Available for sale financial instruments |
||||||||||
Treasury and other eligible bills |
b | 4,003 | 4,003 | 2,723 | 2,723 | |||||
Debt securities |
b | 58,831 | 58,831 | 38,673 | 38,673 | |||||
Equity securities |
b | 2,142 | 2,142 | 1,676 | 1,676 | |||||
Reverse repurchase agreements and cash collateral on securities borrowed |
c | 130,354 | 129,296 | 183,075 | 183,075 | |||||
Financial liabilities: |
||||||||||
Deposits from banks |
d | 114,910 | 114,912 | 90,546 | 90,508 | |||||
Items in the course of collection due to other banks |
a | 1,635 | 1,635 | 1,792 | 1,792 | |||||
Customer accounts: |
||||||||||
Current and demand accounts |
d | 82,515 | 82,515 | 80,006 | 80,006 | |||||
Savings accounts |
d | 76,008 | 76,008 | 74,599 | 74,599 | |||||
Other time deposits |
d | 176,982 | 176,966 | 140,382 | 141,917 | |||||
Trading portfolio liabilities: |
||||||||||
Treasury and other eligible bills |
b | 79 | 79 | 486 | 486 | |||||
Debt securities |
b | 44,309 | 44,309 | 50,506 | 50,506 | |||||
Equity securities |
b | 14,919 | 14,919 | 13,702 | 13,702 | |||||
Commodities |
b | 167 | 167 | 708 | 708 | |||||
Financial liabilities designated at fair value: |
||||||||||
Held on own account |
b | 76,892 | 76,892 | 74,489 | 74,489 | |||||
Liabilities to customers under investment contracts |
b | 69,183 | 69,183 | 92,639 | 92,639 | |||||
Derivative financial instruments |
b | 968,072 | 968,072 | 248,288 | 248,288 | |||||
Debt securities in issue |
d | 149,567 | 148,736 | 120,228 | 120,176 | |||||
Repurchase agreements and cash collateral on securities lent |
d | 182,285 | 182,285 | 169,429 | 169,429 | |||||
Subordinated liabilities |
d | 29,842 | 22,944 | 18,150 | 17,410 |
Barclays Annual Report 2008 |
273 |
Notes to the accounts
For the year ended 31st December 2008
50 Fair value of financial instruments (continued)
Notes
a | Fair value approximates carrying value due to the short-term nature of these financial assets and liabilities. |
b | The carrying value of financial instruments subsequently measured at fair value (including those held for trading, designated at fair value, derivatives and available for sale) is determined in accordance with accounting policy 7 on page 180 and further description and analysis of these fair values are set out below. |
c | The carrying value of financial assets subsequently measured at amortised cost (including loans and advances, and other lending such as reverse repurchase agreements and cash collateral on securities borrowed) is determined in accordance with the accounting policy 7 on page 180. In many cases the fair value disclosed approximates the carrying value because the instruments are short term in nature or have interest rates that reprice frequently. In other cases, fair value is determined using discounted cash flows, applying either market derived interest rates or, where the counterparty is a bank, rates currently offered by other financial institutions for placings with similar characteristics. Additionally, fair value can be determined by applying an average of available regional and industry segmental credit spreads to the loan portfolio, taking the contractual maturity of the loan facilities into consideration. |
d | The carrying value of financial liabilities subsequently measured at amortised cost (including customer accounts and other deposits such as repurchase agreements and cash collateral on securities lent, debt securities in issue, subordinated liabilities) is determined in accordance with the accounting policy 7 on page 180. In many cases, the fair value disclosed approximates the carrying value because the instruments are short term in nature or have interest rates that reprice frequently such as customer accounts and other deposits and short term debt securities. Fair values of other debt securities in issue are based on quoted prices where available, or where these are unavailable, are estimated using a valuation model. Fair values for dated and undated convertible and non-convertible loan capital are based on quoted market rates for the issue concerned or similar issues with similar terms and conditions. |
Valuation methodology
The table below shows the Groups financial assets and liabilities that are recognised and measured at fair value analysed by valuation technique. A description of the nature of the techniques used to calculate valuations based on observable inputs and valuations based on unobservable inputs is set out on the next page.
At 31st December 2008 | |||||||||||||||
Valuations | Valuations based on unobservable inputs | ||||||||||||||
based on £m |
Vanilla £m |
Exotic products £m |
Total £m |
Total £m |
|||||||||||
Trading portfolio assets |
174,168 | 11,469 | | 11,469 | 185,637 | ||||||||||
Financial assets designated at fair value: |
|||||||||||||||
held on own account |
37,618 | 16,559 | 365 | 16,924 | 54,542 | ||||||||||
held in respect of linked liabilities to customers under investment contracts | 66,657 | | | | 66,657 | ||||||||||
Derivative financial assets |
970,028 | 12,436 | 2,338 | 14,774 | 984,802 | ||||||||||
Available for sale assets |
63,149 | 1,827 | | 1,827 | 64,976 | ||||||||||
Total assets |
1,311,620 | 42,291 | 2,703 | 44,994 | 1,356,614 | ||||||||||
Trading portfolio liabilities |
(59,436 | ) | (38 | ) | | (38 | ) | (59,474 | ) | ||||||
Financial liabilities designated at fair value |
(71,044 | ) | (290 | ) | (5,558 | ) | (5,848 | ) | (76,892 | ) | |||||
Liabilities to customers under investment contracts |
(69,183 | ) | | | | (69,183 | ) | ||||||||
Derivative financial liabilities |
(959,518 | ) | (6,151 | ) | (2,403 | ) | (8,554 | ) | (968,072 | ) | |||||
Total liabilities |
(1,159,181 | ) | (6,479 | ) | (7,961 | ) | (14,440 | ) | (1,173,621 | ) | |||||
At 31st December 2007 | |||||||||||||||
Valuations | Valuations based on unobservable inputs | ||||||||||||||
based on £m |
Vanilla products £m |
Exotic products £m |
Total £m |
Total £m |
|||||||||||
Trading portfolio assets |
189,234 | 4,457 | | 4,457 | 193,691 | ||||||||||
Financial assets designated at fair value: |
|||||||||||||||
held on own account |
39,810 | 16,819 | | 16,819 | 56,629 | ||||||||||
held in respect of linked liabilities to customers under investment contracts | 90,851 | | | | 90,851 | ||||||||||
Derivative financial assets |
245,381 | 1,118 | 1,589 | 2,707 | 248,088 | ||||||||||
Available for sale assets |
42,262 | 810 | | 810 | 43,072 | ||||||||||
Total assets |
607,538 | 23,204 | 1,589 | 24,793 | 632,331 | ||||||||||
Trading portfolio liabilities |
(65,360 | ) | (42 | ) | | (42 | ) | (65,402 | ) | ||||||
Financial liabilities designated at fair value |
(68,317 | ) | (951 | ) | (5,221 | ) | (6,172 | ) | (74,489 | ) | |||||
Liabilities to customers under investment contracts |
(92,639 | ) | | | | (92,639 | ) | ||||||||
Derivative financial liabilities |
(243,906 | ) | (1,178 | ) | (3,204 | ) | (4,382 | ) | (248,288 | ) | |||||
Total liabilities |
(470,222 | ) | (2,171 | ) | (8,425 | ) | (10,596 | ) | (480,818 | ) |
Of the total Group assets of £1,356,614m measured at fair value, £44,994m (2007: £24,793m) were valued using models with unobservable inputs. While the derivative assets associated with our Monoline exposure accounted for a significant portion of the increase in assets valued using unobservable inputs, further increases arose due to weakness in Sterling, as well as increased illiquidity in the market.
274 | Barclays Annual Report 2008 |
50 Fair value of financial instruments (continued)
The nature of the valuation techniques set out in the table above are summarised as follows:
Valuations based on observable inputs
Valuations based on observable inputs include
| Financial instruments for which their valuations are determined by reference to unadjusted quoted prices in active markets where the quoted price is readily available and the price represents actual and regularly occurring market transactions on an arms length basis; |
| Financial instruments valued using recent arms length market transactions or with reference to the current fair value of similar instruments; |
| Linear financial instruments such as swaps and forwards which are valued using market standard pricing techniques; |
| Options that are commonly traded in markets whereby all the inputs to the market-standard pricing models are deemed observable. |
Valuations based on unobservable inputs
Valuations based on unobservable inputs include:
(a) Vanilla products
Products valued using simple models, such as discounted cash flow or Black Scholes models, where some of the inputs are not observable. This would include, for example, commercial loans, commercial mortgage backed securities, selected mortgage products, Alt As and subprime loans, as well as long-dated vanilla options with tenors different to those commonly traded in the markets and hence unobservable volatilities.
(b) Exotic products
Exotic products are over-the-counter products that are relatively bespoke, not commonly traded in the markets, and are valued using sophisticated mathematical models where some of the inputs are not observable.
In determining the value of vanilla and exotic products the following are the principal inputs that can require judgement:
(i) Volatility
Volatility is a critical input to all option pricing models, across all asset classes. In most cases volatility is observable from the vanilla options that are traded across the various asset classes but, on occasion, volatility is unobservable, for example, for long maturity option.
(ii) Correlation
Across asset classes, correlation is another important input to some pricing models, for example for products whose value depends on two equity indices. In some developed markets there are products traded from which correlation can be implied, for example spread products in commodities.
(iii) Model input parameters
Some exotic models have input parameters that define the models, for example interest rate models tend to have parameters that are needed to capture the rich dynamics of the yield curve. These model parameters are typically not directly observable but may be inferred from observable inputs.
(iv) Spreads to discount rates
For certain product types, particularly credit related such as asset backed financial instruments, the discount rate is set at a spread to the standard discount (LIBOR) rates. In these cases, in addition to standard discount rates, the spread is a significant input to the valuation. For some assets this spread data can be unobservable.
(v) Default rates and recovery rates
In certain credit products valued using pricing models, default rates and recovery rates may be necessary inputs. Some default rates and recovery rates are deemed observable but for others which are less frequently traded in the markets they may not be.
(vi) Prepayment rates
For products in the securitisation businesses, for example mortgage backed securities, prepayment rates are key inputs. Some of the drivers of prepayment are understood (such as the nature of assets/loans, e.g. quality of mortgage pool and macroeconomic factors) however, future prepayment rates are considered unobservable.
The following summary sets out the principal instruments whose valuation may involve judgmental inputs.
Corporate bonds
Corporate bonds are generally valued using observable quoted prices or recently executed transactions. Where observable price quotations are not available, the fair value is determined based on cash flow models where significant inputs may include yield curves, bond or single name credit default swap spreads.
Mortgage whole loans
Wherever possible, the fair value of mortgage whole loans is determined using observable quoted prices or recently executed transactions for comparable assets. Where observable price quotations or benchmark proxies are not available, fair value is determined using cash flow models where significant inputs include yield curves, collateral specific loss assumptions, asset specific prepayment assumptions, yield spreads and expected default rates.
Commercial mortgage backed securities and asset backed securities
Commercial mortgage backed securities and asset backed securities (ABS) (residential mortgages, credit cards, auto loans, student loans and leases) are valued using observable information to the greatest extent possible. Wherever possible, the fair value is determined using quoted prices or recently executed transactions. Where observable price quotations are not available, fair value is determined based on cash flow models where the significant inputs may include yield curves, credit spreads and prepayment rates. Securities that are backed by the residual cash flows of an asset portfolio are generally valued using similar cash flow models. The fair value of home equity loan bonds are determined using models which use scenario analysis with significant inputs including age, rating, internal grade, and index prices.
Barclays Annual Report 2008 |
275 |
Notes to the accounts
For the year ended 31st December 2008
50 Fair value of financial instruments (continued)
Collateralised debt obligations
The valuation of collateralised debt obligations (CDOs) notes is first based on an assessment of the probability of an event of default occurring due to a credit deterioration. This is determined by reference to the probability of event of default occurring and the probability of exercise of contractual rights related to event of default. The notes are then valued by determining appropriate valuation multiples to be applied to the contractual cash flows. These are based on inputs including the prospective cash flow performance of the underlying securities, the structural features of the transaction and the net asset value of the underlying portfolio.
Private equity
The fair value of private equity is determined using appropriate valuation methodologies which, dependent on the nature of the investment, may include discounted cash flow analysis, enterprise value comparisons with similar companies, price:earnings comparisons and turnover multiples. For each investment the relevant methodology is applied consistently over time.
OTC Derivatives
Derivative contracts can be exchange traded or over the counter (OTC). OTC derivative contracts include forward, swap and option contracts related to interest rates, bonds, foreign currencies, credit standing of reference entities, equity prices, fund levels, commodity prices or indices on these assets.
The fair value of OTC derivative contracts are modelled using a series of techniques, including closed form analytical formulae (such as the Black-Scholes option pricing model) and simulation based models. The choice of model is dependant on factors such as; the complexity of the product, inherent risks and hedging strategy: statistical behaviour of the underlying, and ability of the model to price consistently with observed market transactions. For many pricing models there is no material subjectivity because the methodologies employed do not necessitate significant judgement and the pricing inputs are observed from actively quoted markets, as is the case for generic interest rate swaps and option markets. In the case of more established derivative products, the pricing models used are widely accepted and used by the other market participants. Significant inputs used in these models may include yield curves, credit spreads, default rates, recovery rates, dividend rates, volatility of underlying interest rates, equity prices or foreign exchange rates and, in some cases, correlation between these inputs. These inputs are determined with reference to quoted prices, recently executed trades, independent market quotes and consensus data.
New, long dated or complex derivative products may require a greater degree of judgement in the implementation of appropriate valuation techniques, due to the complexity of the valuation assumptions and the reduced observability of inputs. The valuation of more complex products may use more generic derivatives as a component to calculating the overall value.
Derivatives where valuation involves a significant degree of judgement include:
Fund derivatives
Fund derivatives are derivatives whose underlyings include mutual funds, hedge funds, indices and multi-asset portfolios. They are valued using underlying fund prices, yield curves and available market information on the level of the hedging risk. Some fund derivatives are valued using unobservable information, generally where the level of the hedging risk is not observable in the market. These are valued taking account of risk of the underlying fund or collection of funds, diversification of the fund by asset, concentration by geographic sector, strategy of the fund, size of the transaction and concentration of specific fund managers.
Commodity derivatives
Commodity derivatives are valued using models where the significant inputs may include interest rate yield curves, commodity price curves, volatility of the underlying commodities and, in some cases, correlation between these inputs, which are generally observable. This approach is applied to base metal, precious metal, energy, power, gas, emissions, soft commodities and freight positions. Due to the significant time span in the various market closes, curves are constructed using differentials to a benchmark curve to ensure that all curves are valued using the dominant market base price.
Structured credit derivatives
Collateralised synthetic obligations (CSOs) are structured credit derivatives which reference the loss profile of a portfolio of loans, debts or synthetic underlyings. The reference asset can be a corporate credit or an asset backed credit. For CSOs that reference corporate credits an analytical model is used. For CSOs on asset backed underlyings, due to the path dependent nature of a CSO on an amortising portfolio a Monte Carlo simulation is used rather than analytic approximation. The expected loss probability for each reference credit in the portfolio is derived from the single name credit default swap spread curve and in addition, for ABS references, a prepayment rate assumption. A simulation is then used to compute survival time which allows us to calculate the marginal loss over each payment period by reference to estimated recovery rates. Significant inputs include prepayment rates, cumulative default rates, and recovery rates.
Sensitivity analysis of valuations using unobservable inputs
As part of our risk management processes, stress tests are applied on the significant unobservable parameters to generate a range of potentially possible alternative valuations. The financial instruments that most impact this sensitivity analysis are those with the more illiquid and/or structured portfolios. The stresses are applied independently and do not take account of any cross correlation between separate asset classes that would reduce the overall effect on the valuations.
At 31st December 2008 |
Significant unobservable parameters a |
Potential effect recorded in profit or loss Favourable (Unfavourable) |
Potential effect recorded in equity Favourable (Unfavourable) |
|||||||||
£m | £m | £m | £m | |||||||||
Asset backed securities and loans and derivatives with asset backed underlyings | iii, iv, v, vi | 1,470 | (1,896 | ) | 46 | (54 | ) | |||||
Private equity b |
iii, iv | 209 | (208 | ) | 64 | (142 | ) | |||||
Derivative assets and liabilities and financial liabilities designated at fair value: | ||||||||||||
Derivative exposure to Monoline insurers |
iii, iv, v, vi | 21 | (329 | ) | | | ||||||
Funds derivatives and structured notes |
iii | 226 | (123 | ) | | | ||||||
Other structured derivatives and notes |
i, ii, iii | 304 | (196 | ) | | | ||||||
Other |
i, ii, iii, iv, v, vi | 55 | (43 | ) | | | ||||||
Total |
2,285 | (2,795 | ) | 110 | (196 | ) |
Notes
a | (i )-(vi) refer to valuation inputs listed on page 275. |
b | Available for sale assets (Private Equity) and assets designated at fair value (Principal Investments). |
276 | Barclays Annual Report 2008 |
50 Fair value of financial instruments (continued)
At 31st December 2007 | Significant unobservable parameters a |
Potential effect recorded in profit or loss Favourable (Unfavourable) |
Potential effect recorded in equity Favourable (Unfavourable) |
|||||||||
£m | £m | £m | £m | |||||||||
Asset backed securities and loans and derivatives with asset backed underlyings | iii, iv, v, vi | 868 | (868 | ) | 5 | (5 | ) | |||||
Private equity |
iii, iv | 75 | (75 | ) | 36 | (36 | ) | |||||
Derivative assets and liabilities and financial liabilities designated at fair value: | ||||||||||||
Fund derivatives and structured notes |
iii | 441 | (147 | ) | | | ||||||
Other structured derivatives and notes |
i, ii, iii | 57 | (56 | ) | | | ||||||
Other |
i, ii, iii, iv, v, vi | 3 | (1 | ) | | | ||||||
Total |
1,444 | (1,147 | ) | 41 | (41 | ) |
The effect of stressing the significant unobservable assumptions to a range of reasonably possible alternatives would be to increase the fair values by up to £2.4bn (2007: £1.5bn) or to decrease the fair values by up to £3.0bn (2007: £1.2bn) with substantially all the potential effect being recorded in profit or loss rather than equity.
Asset backed securities and loans, and derivatives with asset backed underlyings
Asset backed securities, loans and related derivatives contribute most to the sensitivity analysis as at 31st December 2008. The stress effect increased in this area in 2008 due to continued market dislocation and increased levels of unobservability. The stresses having the most significant impact on the analysis are: for commercial mortgage backed securities and loans, changing the spreads to discount rates to close to originated levels (favourable stress) and increasing spreads to between 2 and 6% (unfavourable stress); for residential mortgage backed securities and loans, changing the spreads to discount rates by +/-10%; and for collateralised debt obligations that reference asset backed securities and loans, primarily by changing the spreads to discount rates by +/-20%.
Private equity
The sensitivity amounts are calculated by stressing the key valuation inputs to each individual valuation generally either price:earnings ratios or EBITDA analysis. The stresses are then determined by comparing these metrics with a range of similar companies.
Derivative exposure to Monoline insurers
The favourable stress is calculated by reference to counterparty quotes for second loss protection on the appropriate reference obligations. The unfavourable stress is calculated by applying a default scenario to the monolines that are rated BBB or below.
Fund derivatives and structured notes
The valuation of these transactions takes into account the risk that the underlying fund-linked asset value will decrease too quickly to be able to re-hedge with risk-free instruments (gap risk). The sensitivity amounts are determined by applying stresses to market quotes for hedging the relevant gap risk. The unfavourable stress is based on a shift in the gap risk price of 34bp, the favourable stress applies to a pricing level that assumes no gap event will occur.
Other structured derivatives and notes
The sensitivity amounts are calculated principally by adjusting the relevant correlation sensitivity used in the valuation model by a range based on structured derivative data available in consensuses pricing services. The range applied to correlation sensitivity is an adverse or beneficial move of 15bp applied to the correlation sensitivity.
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, was as follows:
At 31st December | 2008 £m |
2007 £m |
||||
At 1st January |
154 | 534 | ||||
New transactions |
77 | 134 | ||||
Amounts recognised in profit or loss during the year |
(103 | ) | (514 | ) | ||
At 31st December |
128 | 154 |
The net asset fair value position of the related financial instruments increased by £16,357m for the year ended 31st December 2008 (31st December 2007: £2,842m). In many cases these changes in fair values were offset by changes in fair values of other financial instruments, which were priced in active markets or valued by using a valuation technique which is supported by observable market prices or rates, or by transactions which have been realised.
Notes
a | (i )-(vi) refer to valuation inputs listed on page 289. |
Barclays Annual Report 2008 |
277 |
Notes to the accounts
For the year ended 31st December 2008
51 Reclassification of financial assets held for trading
On 16th December the Group reclassified certain financial assets originally classified as held for trading that were no longer held for the purpose of selling or repurchasing in the near term out of fair value through profit or loss to loans and receivables. In making this reclassification, the Group identified those trading assets, comprising portfolios of bank-issued fixed rate notes and mortgage and other asset backed securities, for which it had a clear change of intent to hold for the foreseeable future or until maturity rather than to trade in the short term. At the time of the transfer, the Group identified rare circumstances permitting such reclassification, being severe illiquidity in the relevant market.
The following table shows carrying values and fair values of the assets reclassified at 16th December 2008.
16th December 2008 | 31st December 2008 | |||||
Carrying value £m |
Carrying £m |
Fair value £m | ||||
Trading assets reclassified to loans and receivables |
4,046 | 3,986 | 3,984 | |||
Total financial assets reclassified to loans and receivables |
4,046 | 3,986 | 3,984 |
As at the date of reclassification, the effective interest rates on reclassified trading assets ranged from 0.18% to 9.29% with expected recoverable cash flows of £7.4bn.
If the reclassifications had not been made, the Groups income statement for 2008 would have included unrealised fair value losses on the reclassified trading assets of £1.5m.
After reclassification, the reclassified financial assets contributed the following amounts to the 2008 income before income taxes.
2008 £m | ||
Net interest income |
4 | |
Provision for credit losses |
| |
Income before income taxes on reclassified trading assets |
4 |
Prior to reclassification in 2008, £144m of unrealised fair value losses on the reclassified trading assets was recognised in the consolidated income statement for 2008 (2007: £218m loss).
52 Capital Management
Barclays operates a centralised capital management model, considering both regulatory and economic capital. The capital management strategy is to continue to maximise shareholder value through optimising both the level and mix of capital resources. Decisions on the allocation of capital resources are conducted as part of the strategic planning review.
The Groups capital management objectives are to:
| Maintain sufficient capital resources to meet the minimum regulatory capital requirements set by the FSA and the US Federal Reserve Banks requirements that a financial holding company be well capitalised. |
| Maintain sufficient capital resources to support the Groups risk appetite and economic capital requirements. |
| Support the Groups credit rating. |
| Ensure locally regulated subsidiaries can meet their minimum capital requirements. |
| Allocate capital to businesses to support the Groups strategic objectives, including optimising returns on economic and regulatory capital. |
External Regulatory Capital Requirements
The Group is subject to minimum capital requirements imposed by the Financial Services Authority (FSA), following guidelines developed by the Basel Committee on Banking Supervision (the Basel Committee) and implemented in the UK via European Union Directives.
Under Basel II, effective from 1st January 2008, the Group has approval by the FSA to use the advanced approaches to credit and operational risk management. Pillar 1 capital requirements are generated using the Groups risk models.
Under Pillar 2 of Basel II, the Group is subject to an overall regulatory capital requirement based on individual capital guidance (ICG) received from the FSA. The ICG imposes additional capital requirements in excess of Pillar 1 minimum capital requirements.
Outside the UK, the Group has operations (and main regulators) located in continental Europe, in particular France, Germany, Spain, Portugal and Italy (local central banks and other regulatory authorities); Asia Pacific (various regulatory authorities including the Hong Kong Monetary Authority, the Japanese FSA and the Monetary Authority of Singapore); Africa, where the Groups operations are headquartered in Johannesburg, South Africa (The South African Reserve Bank and the Financial Services Board (FSB)) and the United States of America (the Board of Governors of the Federal Reserve System (FRB) and the Securities and Exchange Commission).
The Group manages its capital resources to ensure that those Group entities that are subject to local capital adequacy regulation in individual countries meet their minimum capital requirements. Local management manages compliance with subsidiary entity minimum regulatory capital requirements with reporting to local Asset and Liability Committees and to Treasury Committee, as required.
278 | Barclays Annual Report 2008 |
52 Capital Management (continued)
Regulatory Capital
The table below provides details of the regulatory capital resources managed by the Group.
Basel ll 2008 £m |
Basel I 2007 £m |
|||||
Total qualifying Tier 1 capital |
37,250 | 27,408 | ||||
Total qualifying Tier 2 capital |
22,333 | 17,123 | ||||
Total deductions |
(856 | ) | (1,889 | ) | ||
Total net capital resources |
58,727 | 42,642 |
Insurance businesses
Insurance businesses are subject to separate regulation regarding Capital management and have constraints on the transfer of capital. Capital resource requirements are assessed at company level in accordance with local laws and regulations. However, the requirement is that each life fund should be able to meet its own liabilities. In the event that this should not be the case, shareholders equity would be required to meet its liabilities to the extent that they could not otherwise be met.
The capital resource requirement of the insurance businesses at 31st December 2008 was £192m (31st December 2007: £216m).
53 Segmental reporting
The following section analyses the Groups performance by business. For management and reporting purposes, Barclays is organised into the following business groupings:
Global Retail and Commercial Banking
| UK Retail Banking |
| Barclays Commercial Bank |
| Barclaycard |
| GRCB Western Europe |
| GRCB Emerging Markets |
| GRCB Absa |
Investment Banking and Investment Management
| Barclays Capital |
| Barclays Global Investors |
| Barclays Wealth |
Head Office Functions and Other Operations
UK Retail Banking
UK Retail Banking comprises Personal Customers, Home Finance, Local Business, Consumer Lending and Barclays Financial Planning. This cluster of businesses aims to build broader and deeper relationships with its Personal and Local Business customers through providing a wide range of products and financial services. Personal Customers and Home Finance provide access to current account and savings products, Woolwich branded mortgages and general insurance. Consumer Lending provides unsecured loan and protection products and Barclays Financial Planning provides investment advice and products. Local Business provides banking services, including money transmission, to small businesses.
Barclays Commercial Bank
Barclays Commercial Bank provides banking services to organisations with an annual turnover of more than £1m. Customers are served via a network of relationship and industry sector specialists, which provides solutions constructed from a comprehensive suite of banking products, support, expertise and services, including specialist asset financing and leasing facilities. Customers are also offered access to the products and expertise of other businesses in the Group, particularly Barclays Capital, Barclaycard and Barclays Wealth.
Barclaycard
Barclaycard is a multi-brand credit card and consumer lending business which also processes card payments for retailers and merchants and issues credit and charge cards to corporate customers and the UK Government. It is one of Europes leading credit card businesses and has an increasing presence in the United States and South Africa.
In the UK, Barclaycard comprises Barclaycard UK Cards, Barclaycard Partnerships, Barclays Partner Finance and FirstPlus.
Outside the UK, Barclaycard provides credit cards in the United States, Germany, South Africa (through management of the Absa credit card portfolio) and in the Scandinavian region, where Barclaycard operates through Entercard, a joint venture with Swedbank.
Barclaycard works closely with other parts of the Group, including UK Retail Banking, Barclays Commercial Bank and GRCB Western Europe and GRCB Emerging Markets, to leverage their distribution capabilities.
Global Retail and Commercial Banking Western Europe
GRCB Western Europe encompasses Barclays Global Retail and Commercial Banking as well as Barclaycard operations in Spain, Italy, Portugal and France. GRCB Western Europe serves customers through a variety of distribution channels. GRCB Western Europe provides a variety of products including retail mortgages, current and deposit accounts, commercial lending, unsecured lending, credit cards, investments, and insurance serving the needs of Barclays retail, mass affluent, and corporate customers.
Barclays Annual Report 2008 |
279 |
Notes to the accounts
For the year ended 31st December 2008
53 Segmental reporting (continued)
Global Retail and Commercial Banking Emerging Markets
GRCB Emerging Markets encompasses Barclays Global Retail and Commercial Banking, as well as Barclaycard operations, in 14 countries organised in six geographic areas: India and Indian Ocean (India, Mauritius and Seychelles); Middle East and North Africa (UAE and Egypt); East and West Africa (Ghana, Tanzania, Uganda and Kenya); Southern Africa (Botswana, Zambia and Zimbabwe); Russia; and Pakistan (from 23rd July 2008). GRCB Emerging Markets serves its customers through a variety of distribution channels. GRCB Emerging Markets provides a variety of traditional retail and commercial products including retail mortgages, current and deposit accounts, commercial lending, unsecured lending, credit cards, treasury and investments. In addition to this, it provides specialist services such as Sharia compliant products and mobile banking.
Global Retail and Commercial Banking Absa
GRCB Absa represents Barclays consolidation of Absa, excluding Absa Capital and Absa Card which is included as part of Barclays Capital and Barclaycard respectively. Absa Group Limited is a South African financial services organisation serving personal, commercial and corporate customers predominantly in South Africa. GRCB Absa serves retail customers through a variety of distribution channels and offers a full range of banking services, including current and deposit accounts, mortgages, instalment finance, credit cards, bancassurance products and wealth management services. It also offers customised business solutions for commercial and large corporate customers.
Barclays Capital
Barclays Capital is the investment banking division of Barclays that provides large corporate, institutional and government clients with solutions to their financing and risk management needs.
Barclays Capital services a wide variety of client needs, covering strategic advisory and M&A; equity and fixed income capital raising and corporate lending; and risk management across foreign exchange, interest rates, equities and commodities.
Activities are organised into three principal areas: Global Markets, which includes commodities, credit products, equities, foreign exchange, interest rate products; Investment Banking, which includes corporate advisory, Mergers and Acquisitions, equity and fixed-income capital raising and corporate lending; and Private Equity and Principal Investments. Barclays Capital includes Absa Capital, the investment banking business of Absa. Barclays Capital works closely with all other parts of the Group to leverage synergies from client relationships and product capabilities.
Barclays Global Investors
BGI is an asset manager and a provider of investment management products and services.
BGI offers structured investment strategies such as indexing, global asset allocation and risk controlled active products including hedge funds and provides related investment services such as securities lending, cash management and portfolio transition services. BGI collaborates with the other Barclays businesses, particularly Barclays Capital and Barclays Wealth, to develop and market products and leverage capabilities to better serve the client base.
Barclays Wealth
Barclays Wealth serves high net worth, affluent and intermediary clients worldwide, providing private banking, asset management, stockbroking, offshore banking, wealth structuring and financial planning services and managed the closed life assurance activities of Barclays and Woolwich in the UK.
Barclays Wealth works closely with all other parts of the Group to leverage synergies from client relationships and product capabilities.
Head Office Functions and Other Operations
Head Office Functions and Other Operations comprises head office and central support functions, businesses in transition and inter-segment adjustments.
Head office and central support functions comprises the following areas: Executive Management, Finance, Treasury, Corporate Affairs, Human Resources, Strategy and Planning, Internal Audit, Legal, Corporate Secretariat, Property, Tax, Compliance and Risk. Costs incurred wholly on behalf of the businesses are recharged to them.
Businesses in transition principally relate to certain lending portfolios that are centrally managed with the objective of maximising recovery from the assets.
280 | Barclays Annual Report 2008 |
53 Segmental reporting (continued)
As at 31st December 2008 |
UK Retail Banking £m |
|
Barclays Commercial Bank £m |
|
Barclaycard £m |
|
GRCB Western Europe £m |
|
GRCB Emerging Markets £m |
|
GRCB Absa £m |
|
Barclays Capital £m |
|
Barclays Global Investors £m |
|
Barclays Wealth £m |
|
Head office functions and other operations £m |
|
Total £m |
| |||||||||||
Interest income from external customers | 2,816 | 1,589 | 1,677 | 808 | 644 | 1,223 | 2,026 | (52 | ) | 496 | 242 | 11,469 | |||||||||||||||||||||
Other income from external customers | 1,702 | 1,068 | 1,492 | 625 | 375 | 946 | 2,989 | 1,890 | 914 | (355 | ) | 11,646 | |||||||||||||||||||||
Income from external customers, net of insurance claims | 4,518 | 2,657 | 3,169 | 1,433 | 1,019 | 2,169 | 5,015 | 1,838 | 1,410 | (113 | ) | 23,115 | |||||||||||||||||||||
Inter-segment income |
(36 | ) | 88 | 50 | (3 | ) | | 29 | 216 | 6 | (86 | ) | (264 | ) | | ||||||||||||||||||
Total income net of insurance claims | 4,482 | 2,745 | 3,219 | 1,430 | 1,019 | 2,198 | 5,231 | 1,844 | 1,324 | (377 | ) | 23,115 | |||||||||||||||||||||
Impairment charges and other credit provisions | (602 | ) | (414 | ) | (1,097 | ) | (296 | ) | (166 | ) | (347 | ) | (2,423 | ) | | (44 | ) | (30 | ) | (5,419 | ) | ||||||||||||
Segment expenses external | (2,138 | ) | (934 | ) | (1,405 | ) | (1,108 | ) | (856 | ) | (1,576 | ) | (3,789 | ) | (1,231 | ) | (809 | ) | (520 | ) | (14,366 | ) | |||||||||||
Inter-segment expenses |
(381 | ) | (129 | ) | (17 | ) | 179 | 137 | 271 | 15 | (18 | ) | (126 | ) | 69 | | |||||||||||||||||
Total expenses |
(2,519 | ) | (1,063 | ) | (1,422 | ) | (929 | ) | (719 | ) | (1,305 | ) | (3,774 | ) | (1,249 | ) | (935 | ) | (451 | ) | (14,366 | ) | |||||||||||
Share of post-tax results of associates and joint ventures | 8 | (2 | ) | (3 | ) | | | 5 | 6 | | | | 14 | ||||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures | | | | | | 1 | | | 326 | | 327 | ||||||||||||||||||||||
Gains on acquisitions |
| | 92 | 52 | | | 2,262 | | | | 2,406 | ||||||||||||||||||||||
Business segment profit before tax | 1,369 | 1,266 | 789 | 257 | 134 | 552 | 1,302 | 595 | 671 | (858 | ) | 6,077 | |||||||||||||||||||||
Additional information |
|||||||||||||||||||||||||||||||||
Depreciation and amortisation | 111 | 69 | 114 | 69 | 58 | 117 | 272 | 40 | 40 | 31 | 921 | ||||||||||||||||||||||
Impairment loss intangible assets | | | | | | | | | (3 | ) | | (3 | ) | ||||||||||||||||||||
Impairment of goodwill |
| | 37 | | | | 74 | | | | 111 | ||||||||||||||||||||||
Investments in associates and joint ventures | 1 | (3 | ) | (13 | ) | | | 84 | 150 | | | 122 | 341 | ||||||||||||||||||||
Total assets |
101,384 | 84,029 | 30,925 | 64,732 | 14,653 | 40,391 | 1,629,117 | 71,340 | 13,263 | 3,146 | 2,052,980 | ||||||||||||||||||||||
Total liabilities |
104,640 | 64,997 | 3,004 | 37,250 | 10,517 | 20,720 | 1,603,093 | 68,372 | 45,846 | 47,130 | 2,005,569 |
Barclays Annual Report 2008 |
281 |
Notes to the accounts
For the year ended 31st December 2008
53 Segmental reporting (continued)
As at 31st December 2007 |
UK Retail Banking |
|
Barclays Commercial Bank £m |
|
Barclaycard £m |
|
GRCB Western Europe £m |
|
GRCB Emerging Markets |
|
GRCB Absa |
|
Barclays Capital £m |
|
Barclays Global Investors |
|
Barclays Wealth £m |
|
Head office functions and other operations £m |
|
Total £m |
| |||||||||||
Net interest income from external customers | 2,725 | 1,624 | 1,303 | 472 | 344 | 1,140 | 1,536 | (2 | ) | 453 | 15 | 9,610 | |||||||||||||||||||||
Other income from external customers | 1,652 | 922 | 1,086 | 474 | 189 | 832 | 5,398 | 1,917 | 890 | 30 | 13,390 | ||||||||||||||||||||||
Income from external customers, net of insurance claims | 4,377 | 2,546 | 2,389 | 946 | 533 | 1,972 | 6,934 | 1,915 | 1,343 | 45 | 23,000 | ||||||||||||||||||||||
Inter-segment income | (80 | ) | 18 | 141 | (9 | ) | | 27 | 185 | 11 | (56 | ) | (237 | ) | | ||||||||||||||||||
Total income net of insurance claims | 4,297 | 2,564 | 2,530 | 937 | 533 | 1,999 | 7,119 | 1,926 | 1,287 | (192 | ) | 23,000 | |||||||||||||||||||||
Impairment charges and other credit provisions | (559 | ) | (292 | ) | (827 | ) | (76 | ) | (39 | ) | (146 | ) | (846 | ) | | (7 | ) | (3 | ) | (2,795 | ) | ||||||||||||
Segment expenses external |
(2 ,154 | ) | (785 | ) | (1,079 | ) | (859 | ) | (553 | ) | (1,518 | ) | (3,989 | ) | (1,180 | ) | (829 | ) | (253 | ) | (13,199 | ) | |||||||||||
Inter-segment expenses |
(316 | ) | (144 | ) | (14 | ) | 186 | 158 | 251 | 16 | (12 | ) | (144 | ) | 19 | | |||||||||||||||||
Total expenses |
(2 ,470 | ) | (929 | ) | (1,093 | ) | (673 | ) | (395 | ) | (1,267 | ) | (3,973 | ) | (1,192 | ) | (973 | ) | (234 | ) | (13,199 | ) | |||||||||||
Share of post-tax results of associates and joint ventures | 7 | | (7 | ) | | 1 | 6 | 35 | | | | 42 | |||||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures | | 14 | | 8 | | 5 | | | | 1 | 28 | ||||||||||||||||||||||
Business segment profit before tax | 1,275 | 1,357 | 603 | 196 | 100 | 597 | 2,335 | 734 | 307 | (428 | ) | 7,076 | |||||||||||||||||||||
Additional information |
|||||||||||||||||||||||||||||||||
Depreciation and amortisation |
101 | 33 | 79 | 42 | 30 | 121 | 181 | 22 | 18 | 26 | 653 | ||||||||||||||||||||||
Impairment loss intangible assets | | 13 | | | | 1 | | | | | 14 | ||||||||||||||||||||||
Investments in associates and joint ventures | (7 | ) | 1 | (8 | ) | | | 108 | 171 | | | 112 | 377 | ||||||||||||||||||||
Total assets |
88,477 | 74,566 | 22,121 | 43,702 | 9,188 | 36,368 | 839,850 | 89,218 | 18,188 | 5,683 | 1,227,361 | ||||||||||||||||||||||
Total liabilities |
101,516 | 66,251 | 1,952 | 24,004 | 7,507 | 17,176 | 811,704 | 87,096 | 44,152 | 33,527 | 1,194,885 |
As at 31st December 2006 |
UK Retail Banking |
|
Barclays Commercial Bank £m |
|
Barclaycard £m |
|
GRCB Western Europe £m |
|
GRCB Emerging Markets |
|
GRCB Absa |
|
Barclays Capital £m |
|
Barclays Global Investors |
|
Barclays Wealth £m |
|
Head office functions and other operations £m |
|
Total £m |
| |||||||||||
Net interest income from external customers | 2,649 | 1,618 | 1,294 | 389 | 274 | 1,030 | 1,460 | 17 | 404 | 8 | 9,143 | ||||||||||||||||||||||
Other income from external customers | 1,673 | 771 | 1,226 | 364 | 122 | 967 | 4,746 | 1,653 | 795 | 135 | 12,452 | ||||||||||||||||||||||
Income from external customers, net of insurance claims | 4,322 | 2,389 | 2,520 | 753 | 396 | 1,997 | 6,206 | 1,670 | 1,199 | 143 | 21,595 | ||||||||||||||||||||||
Inter-segment income |
24 | 15 | 56 | (2 | ) | | 34 | 61 | (5 | ) | (39 | ) | (144 | ) | | ||||||||||||||||||
Total income net of insurance claims | 4,346 | 2,404 | 2,576 | 751 | 396 | 2,031 | 6,267 | 1,665 | 1,160 | (1 | ) | 21,595 | |||||||||||||||||||||
Impairment charges and other credit provisions | (635 | ) | (253 | ) | (1,053 | ) | (38 | ) | (30 | ) | (112 | ) | (42 | ) | | (2 | ) | 11 | (2,154 | ) | |||||||||||||
Segment expenses external |
(2 ,263 | ) | (696 | ) | (861 | ) | (693 | ) | (461 | ) | (1,529 | ) | (3,988 | ) | (940 | ) | (772 | ) | (471 | ) | (12,674 | ) | |||||||||||
Inter-segment expenses |
(269 | ) | (172 | ) | (132 | ) | 143 | 191 | 210 | (21 | ) | (11 | ) | (141 | ) | 202 | | ||||||||||||||||
Total expenses |
(2 ,532 | ) | (868 | ) | (993 | ) | (550 | ) | (270 | ) | (1,319 | ) | (4,009 | ) | (951 | ) | (913 | ) | (269 | ) | (12,674 | ) | |||||||||||
Share of post-tax results of associates and joint ventures | 2 | 3 | (8 | ) | (1 | ) | 41 | 9 | | | | | 46 | ||||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures | | 76 | | | 247 | | | | | | 323 | ||||||||||||||||||||||
Business segment profit before tax | 1,181 | 1,362 | 522 | 162 | 384 | 609 | 2,216 | 714 | 245 | (259 | ) | 7,136 | |||||||||||||||||||||
Additional information |
|||||||||||||||||||||||||||||||||
Depreciation and amortisation |
100 | 23 | 69 | 44 | 28 | 141 | 132 | 13 | 10 | 31 | 591 | ||||||||||||||||||||||
Impairment loss intangible assets | | | | 1 | 1 | 5 | | | | | 7 | ||||||||||||||||||||||
Investments in associates and joint ventures | (6 | ) | 9 | 7 | (1 | ) | | 51 | 71 | | | 97 | 228 | ||||||||||||||||||||
Total assets |
81,693 | 66,224 | 20,033 | 33,487 | 5,219 | 29,575 | 657,922 | 80,515 | 15,023 | 7,096 | 996,787 | ||||||||||||||||||||||
Total liabilities |
94,694 | 62,335 | 2,062 | 17,545 | 5,207 | 13,974 | 632,208 | 79,366 | 37,652 | 24,354 | 969,397 |
282 | Barclays Annual Report 2008 |
53 Segmental reporting (continued)
Revenue by products and services
An analysis of revenue from external customers by product or service is presented below:
As at 31st December |
2008 £m |
|
2007 £m |
|
2006 £m |
| |||
Net interest income |
|||||||||
Cash and balances with central banks |
174 | 145 | 91 | ||||||
Available for sale investments |
2,355 | 2,580 | 2,811 | ||||||
Loans and advances to banks |
1,267 | 1,416 | 903 | ||||||
Loans and advances to customers |
23,754 | 19,559 | 16,290 | ||||||
Other |
460 | 1,608 | 1,710 | ||||||
Interest income |
28,010 | 25,308 | 21,805 | ||||||
Deposits from banks |
(2,189 | ) | (2,720 | ) | (2,819 | ) | |||
Customer accounts |
(6,697 | ) | (4,110 | ) | (3,076 | ) | |||
Debt securities in issue |
(5,910 | ) | (6,651 | ) | (5,282 | ) | |||
Subordinated liabilities |
(1,349 | ) | (878 | ) | (777 | ) | |||
Other |
(396 | ) | (1,339 | ) | (708 | ) | |||
Interest expense |
(16,541 | ) | (15,698 | ) | (12,662 | ) | |||
Net interest income |
11,469 | 9,610 | 9,143 | ||||||
Net fee and commission income |
|||||||||
Brokerage fees |
87 | 109 | 70 | ||||||
Investment management fees |
1,616 | 1,787 | 1,535 | ||||||
Securities lending |
389 | 241 | 185 | ||||||
Banking and credit related fees and commissions |
7,208 | 6,363 | 6,031 | ||||||
Foreign exchange commissions |
189 | 178 | 184 | ||||||
Fee and commission income |
9,489 | 8,678 | 8,005 | ||||||
Fee and commission expense |
(1,082 | ) | (970 | ) | (828 | ) | |||
Net fee and commission income |
8,407 | 7,708 | 7,177 | ||||||
Principal transactions |
|||||||||
Rates related business |
4,751 | 4,162 | 2,848 | ||||||
Credit related business |
(3,422 | ) | (403 | ) | 766 | ||||
Net investment income |
680 | 1,216 | 962 | ||||||
Principal transactions |
2,009 | 4,975 | 4,576 | ||||||
Net premiums from insurances contracts |
1,090 | 1,011 | 1,060 | ||||||
Net claims and benefits incurred on insurance contracts |
(237 | ) | (492 | ) | (575 | ) | |||
Other income |
377 | 188 | 214 | ||||||
Total income net of insurance claims |
23,115 | 23,000 | 21,595 |
Interest income
Cash and balances with central banks interest income consists of interest income from cash on deposit with central banks. Available for sale investments interest income consists of the interest yield on debt securities, treasury bills and other eligible bills. Loans and advances to banks interest income consists of interest income from loans and advances to other banks. Loans and advances to customers interest income consists of interest income from loans, mortgages, advances and credit cards to customers. Other interest income principally consists of interest income relating to reverse repurchase agreements.
Interest expense
Deposits from banks interest expense consists of interest expense paid to other banks on their deposits with Barclays. Customer accounts interest expense consists of interest expense paid to customers on their current and savings account with Barclays. Debt securities in issue interest expense consists of interest expense paid to customers who hold Barclays debt securities in issue. Subordinated liabilities interest expense consists of interest expense paid to customers who hold Barclays subordinated liabilities. Other interest expense principally consists of interest expense relating to repurchase agreements and hedging activity.
Fee and commission income
Brokerage fees income consists of fees charged to facilitate transactions between buyers and sellers. The brokerage fee is charged for services such as negotiations, sales, purchases, delivery or advice on the transaction. Investment management fees are levied on assets under management. Securities lending fees are charged when stock is lent to third parties. Banking and credit related fees and commissions consist of fees and commissions charged on banking and credit card transactions. Foreign exchange commissions are earned on foreign exchange transactions with customers.
Fee and commission expense
Fee and commission expense consists of fees paid to third parties to facilitate transactions between buyers and sellers. The fee is charged for services such as negotiations, sales, purchases, delivery or advice on the transaction.
Barclays Annual Report 2008 |
283 |
Notes to the accounts
For the year ended 31st December 2008
53 Segmental reporting (continued)
Principal transactions
Rates and Credit related business consists of profits and losses arising both on the purchase and sale of trading instruments and from the revaluation to market value together with the interest income and expense from these instruments and the related funding costs. Net investment income consists of the net gain from disposal of available for sale assets, dividend income, net gain from financial instruments designated at fair value and other investment income.
Total income net of insurance claims
Net premiums from insurance contracts consists of gross premiums from insurance contracts and premiums ceded to reinsurers. Net claims and benefits incurred on insurance contracts consists of gross claims and benefits incurred on insurance contracts and reinsurers share of claims incurred. Other income consists of increase in fair value of assets held under linked liabilities to customers under investment contracts, increase in liabilities to customers under investment contracts, property rentals and other income.
Geographical information
(i) A geographical analysis of revenues from external customers is presented below:
2008 £m |
2007 £m |
2006 £m | ||||
Attributed to the UK |
12,277 | 13,127 | 12,154 | |||
Attributed to other regions |
||||||
Other European Union |
3,633 | 3,374 | 2,882 | |||
United States |
710 | 2,209 | 2,840 | |||
Africa |
3,633 | 3,188 | 2,791 | |||
Rest of the World |
2,862 | 1,102 | 928 | |||
Total |
23,115 | 23,000 | 21,595 | |||
Individual countries included in Other European Union, Africa and Rest of the World contributing to more than 5% of income from external customers are as follows:
| ||||||
South Africa |
2,618 |
2,374 |
2,359 |
284 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
285 |
Consolidated income statement
For the year ended 31st December
Notes | 2008 £m |
2007 £m |
2006 £m |
||||||||
Continuing operations |
|||||||||||
Interest income |
a | 28,010 | 25,308 | 21,805 | |||||||
Interest expense
|
a | (16,595 | ) | (15,707 | ) | (12,662 | ) | ||||
Net interest income
|
11,415 | 9,601 | 9,143 | ||||||||
Fee and commission income |
b | 9,489 | 8,682 | 8,005 | |||||||
Fee and commission expense
|
b | (1,082 | ) | (970 | ) | (828 | ) | ||||
Net fee and commission income
|
8,407 | 7,712 | 7,177 | ||||||||
Net trading income |
c | 1,260 | 3,759 | 3,632 | |||||||
Net investment income
|
c | 680 | 1,216 | 962 | |||||||
Principal transactions
|
1,940 | 4,975 | 4,594 | ||||||||
Net premiums from insurance contracts |
5 | 1,090 | 1,011 | 1,060 | |||||||
Other income
|
f | 454 | 224 | 257 | |||||||
Total income |
23,306 | 23,523 | 22,231 | ||||||||
Net claims and benefits incurred on insurance contracts
|
5 | (237 | ) | (492 | ) | (575 | ) | ||||
Total income net of insurance claims |
23,069 | 23,031 | 21,656 | ||||||||
Impairment charges
|
7 | (5,419 | ) | (2,795 | ) | (2,154 | ) | ||||
Net income
|
17,650 | 20,236 | 19,502 | ||||||||
Staff costs |
8 | (7,779 | ) | (8,405 | ) | (8,169 | ) | ||||
Administration and general expenses |
d | (5,662 | ) | (4,141 | ) | (3,914 | ) | ||||
Depreciation of property, plant and equipment |
23 | (630 | ) | (467 | ) | (455 | ) | ||||
Amortisation of intangible assets
|
22 | (291 | ) | (186 | ) | (136 | ) | ||||
Operating expenses
|
(14,362 | ) | (13,199 | ) | (12,674 | ) | |||||
Share of post-tax results of associates and joint ventures |
20 | 14 | 42 | 46 | |||||||
Profit on disposal of subsidiaries, associates and joint ventures |
327 | 28 | 323 | ||||||||
Gains on acquisitions
|
39 | 2,406 | | | |||||||
Profit before tax |
6,035 | 7,107 | 7,197 | ||||||||
Tax
|
e | (786 | ) | (1,981 | ) | (1,941 | ) | ||||
Profit after tax
|
5,249 | 5,126 | 5,256 | ||||||||
Profit attributable to minority interests |
403 | 377 | 342 | ||||||||
Profit attributable to equity holders
|
4,846 | 4,749 | 4,914 | ||||||||
5,249
|
|
5,126
|
|
5,256
|
|
The note numbers refer to the notes on pages 196 to 289, whereas the note letters refer to those on pages 290 to 298.
286 | Barclays Annual Report 2008 |
Consolidated balance sheet
As at 31st December
Notes | 2008 £m |
2007 £m |
|||||
Assets |
|||||||
Cash and balances at central banks |
30,019 | 5,801 | |||||
Items in the course of collection from other banks |
1,695 | 1,836 | |||||
Trading portfolio assets |
g | 185,646 | 193,726 | ||||
Financial assets designated at fair value: |
|||||||
held on own account |
13 | 54,542 | 56,629 | ||||
held in respect of linked liabilities to customers under investment contracts |
13 | 66,657 | 90,851 | ||||
Derivative financial instruments |
14 | 984,802 | 248,088 | ||||
Loans and advances to banks |
15 | 47,707 | 40,120 | ||||
Loans and advances to customers |
15 | 461,815 | 345,398 | ||||
Available for sale financial investments |
h | 65,016 | 43,256 | ||||
Reverse repurchase agreements and cash collateral on securities borrowed |
17 | 130,354 | 183,075 | ||||
Other assets |
i | 6,302 | 5,153 | ||||
Current tax assets |
389 | 518 | |||||
Investments in associates and joint ventures |
20 | 341 | 377 | ||||
Goodwill |
21 | 7,625 | 7,014 | ||||
Intangible assets |
22 | 2,777 | 1,282 | ||||
Property, plant and equipment |
23 | 4,674 | 2,996 | ||||
Deferred tax assets
|
19 | 2,668 | 1,463 | ||||
Total assets
|
2,053,029 | 1,227,583 | |||||
Liabilities |
|||||||
Deposits from banks |
114,910 | 90,546 | |||||
Items in the course of collection due to other banks |
1,635 | 1,792 | |||||
Customer accounts |
335,533 | 295,849 | |||||
Trading portfolio liabilities |
12 | 59,474 | 65,402 | ||||
Financial liabilities designated at fair value |
24 | 76,892 | 74,489 | ||||
Liabilities to customers under investment contracts |
13 | 69,183 | 92,639 | ||||
Derivative financial instruments |
14 | 968,072 | 248,288 | ||||
Debt securities in issue |
153,426 | 120,228 | |||||
Repurchase agreements and cash collateral on securities lent |
17 | 182,285 | 169,429 | ||||
Other liabilities |
j | 12,640 | 10,514 | ||||
Current tax liabilities |
1,215 | 1,311 | |||||
Insurance contract liabilities, including unit-linked liabilities |
26 | 2,152 | 3,903 | ||||
Subordinated liabilities |
27 | 29,842 | 18,150 | ||||
Deferred tax liabilities |
19 | 304 | 855 | ||||
Provisions |
28 | 535 | 830 | ||||
Retirement benefit liabilities
|
30 | 1,357 | 1,537 | ||||
Total liabilities
|
2,009,455 | 1,195,762 | |||||
Shareholders equity |
|||||||
Called up share capital |
k | 2,398 | 2,382 | ||||
Share premium account |
k | 12,060 | 10,751 | ||||
Other reserves |
l | 1,723 | (170 | ) | |||
Other shareholders equity |
m | 2,564 | 2,687 | ||||
Retained earnings |
l | 22,457 | 14,222 | ||||
Shareholders equity excluding minority interests |
41,202 | 29,872 | |||||
Minority interests
|
n | 2,372 | 1,949 | ||||
Total shareholders equity
|
43,574 | 31,821 | |||||
Total liabilities and shareholders equity
|
2,053,029 | 1,227,583 |
The note numbers refer to the notes on pages 196 to 284, whereas the note letters refer to those on pages 290 to 298.
These financial statements have been approved for issue by the Board of Directors on 5th March 2009.
Barclays Annual Report 2008 |
287 |
Consolidated statement of recognised income and expense
For the year ended 31st December
2008 £m |
2007 £m |
2006 £m |
|||||||
Available for sale reserve: |
|||||||||
Net (losses)/gains from changes in fair value |
(1,757 | ) | 389 | 107 | |||||
Losses transferred to net profit due to impairment |
382 | 13 | 86 | ||||||
Net gains transferred to net profit on disposal |
(209 | ) | (563 | ) | (327 | ) | |||
Net (gains)/losses transferred to net profit due to fair value hedging |
(2 | ) | 68 | 14 | |||||
Cash flow hedging reserve: |
|||||||||
Net gains/(losses) from changes in fair value |
305 | 106 | (437 | ) | |||||
Net losses/(gains) transferred to net profit |
71 | 253 | (50 | ) | |||||
Currency translation differences |
2,407 | 54 | (781 | ) | |||||
Tax |
841 | 54 | 253 | ||||||
Other
|
(56 | ) | 22 | 25 | |||||
Amounts included directly in equity |
1,982 | 396 | (1,110 | ) | |||||
Profit after tax
|
5,249 | 5,126 | 5,256 | ||||||
Total recognised income and expense for the year
|
7,231 | 5,522 | 4,146 | ||||||
Attributable to: |
|||||||||
Equity holders |
6,654 | 5,135 | 4,132 | ||||||
Minority interests
|
577 | 387 | 14 | ||||||
7,231
|
|
5,522
|
|
4,146
|
|
288 | Barclays Annual Report 2008 |
Consolidated cash flow statement
For the year ended 31st December
2008 £m |
2007 £m |
2006 £m |
|||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: |
|||||||||||||
Profit before tax |
6,035 | 7,107 | 7,197 | ||||||||||
Adjustment for non-cash items: |
|||||||||||||
Allowance for impairment |
5,419 | 2,795 | 2,154 | ||||||||||
Depreciation and amortisation and impairment of property, plant, equipment and intangibles |
951 | 669 | 612 | ||||||||||
Other provisions, including pensions |
804 | 753 | 558 | ||||||||||
Net profit from associates and joint ventures |
(14 | ) | (42 | ) | (46 | ) | |||||||
Net profit on disposal of investments and property, plant and equipment |
(371 | ) | (862 | ) | (778 | ) | |||||||
Net profit from disposal of associates and joint ventures |
| (26 | ) | (263 | ) | ||||||||
Net profit from disposal of subsidiaries |
(327 | ) | (2 | ) | (60 | ) | |||||||
Net gains on acquisitions |
(2,406 | ) | | | |||||||||
Other non-cash movements |
830 | (1,471 | ) | 1,661 | |||||||||
Changes in operating assets and liabilities: |
|||||||||||||
Net increase in loans and advances to banks and customers |
(58,432 | ) | (77,987 | ) | (27,385 | ) | |||||||
Net increase in deposits and debt securities in issue |
76,886 | 91,451 | 46,944 | ||||||||||
Net (increase)/decrease in derivative financial instruments |
(17,529 | ) | (2,144 | ) | 1,196 | ||||||||
Net decrease/(increase) in trading portfolio assets |
26,945 | (18,245 | ) | (18,333 | ) | ||||||||
Net (decrease)/increase in trading liabilities |
(5,928 | ) | (6,472 | ) | 310 | ||||||||
Net decrease/(increase) in financial investments |
5,229 | (4,379 | ) | 1,538 | |||||||||
Net (increase)/decrease in other assets |
(3,005 | ) | 1,296 | (1,527 | ) | ||||||||
Net decrease in other liabilities |
(492 | ) | (1,056 | ) | (1,580 | ) | |||||||
Tax paid
|
(1,725 | ) | (1,583 | ) | (2,141 | ) | |||||||
Net cash from operating activities
|
32,870 | (10,198 | ) | 10,057 | |||||||||
Purchase of available for sale financial investments |
(57,756 | ) | (26,947 | ) | (47,109 | ) | |||||||
Proceeds from sale or redemption of available for sale financial investments |
51,429 | 38,423 | 46,069 | ||||||||||
Purchase of intangible assets |
(687 | ) | (263 | ) | (212 | ) | |||||||
Purchase of property, plant and equipment |
(1,720 | ) | (1,241 | ) | (654 | ) | |||||||
Proceeds from sale of property, plant and equipment |
799 | 617 | 786 | ||||||||||
Acquisition of subsidiaries, net of cash acquired |
(961 | ) | (270 | ) | (248 | ) | |||||||
Disposal of subsidiaries, net of cash disposed |
238 | 383 | (15 | ) | |||||||||
Increase in investment in subsidiaries |
(157 | ) | (668 | ) | (432 | ) | |||||||
Decrease in investment in subsidiaries |
19 | 57 | 44 | ||||||||||
Acquisition of associates and joint ventures |
(96 | ) | (220 | ) | (162 | ) | |||||||
Disposal of associates and joint ventures |
137 | 145 | 739 | ||||||||||
Other cash flows associated with investing activities
|
| | 17 | ||||||||||
Net cash from investing activities
|
(8,755 | ) | 10,016 | (1,177 | ) | ||||||||
Dividends paid |
(1,796 | ) | (3,418 | ) | (2,373 | ) | |||||||
Proceeds from borrowings and issuance of debt securities |
9,645 | 4,625 | 2,493 | ||||||||||
Repayments of borrowings and redemption of debt securities |
(1,207 | ) | (683 | ) | (366 | ) | |||||||
Net issue of shares and other equity instruments |
1,327 | 1,355 | 585 | ||||||||||
Capital injection from Barclays PLC |
5,137 | 1,434 | | ||||||||||
Net issues of shares to minority interests
|
11 | 199 | 226 | ||||||||||
Net cash from financing activities
|
13,117 | 3,512 | 565 | ||||||||||
Effect of exchange rates on cash and cash equivalents
|
(5,801 | ) | (654 | ) | 552 | ||||||||
Net increase in cash and cash equivalents
|
31,431 | 2,676 | 9,997 | ||||||||||
Cash and cash equivalents at beginning of year
|
33,078 | 30,402 | 20,405 | ||||||||||
Cash and cash equivalents at end of year
|
64,509 | 33,078 | 30,402 | ||||||||||
Cash and cash equivalents comprise: |
|||||||||||||
Cash and balances at central banks |
30,019 | 5,801 | 6,795 | ||||||||||
Loans and advances to banks |
47,707 | 40,120 | 30,926 | ||||||||||
Less: non-cash amounts and amounts with original maturity greater than three months |
(15,428 | ) | (19,376 | ) | (15,892 | ) | |||||||
32,279 | 20,744 | 15,034 | |||||||||||
Available for sale treasury and other eligible bills |
65,016 | 43,256 | 51,952 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(62,916 | ) | (41,872 | ) | (50,933 | ) | |||||||
2,100 | 1,384 | 1,019 | |||||||||||
Trading portfolio assets |
185,646 | 193,726 | 177,884 | ||||||||||
Less: non-cash and amounts with maturity greater than three months |
(185,535 | ) | (188,591 | ) | (170,346 | ) | |||||||
111 | 5,135 | 7,538 | |||||||||||
Other |
| 14 | 16 | ||||||||||
64,509
|
|
33,078
|
|
30,402
|
|
Barclays Annual Report 2008 |
289 |
Notes to the accounts
a Net interest income
2008 £m |
2007 £m |
2006 £m |
|||||||
Cash and balances with central banks |
174 | 145 | 91 | ||||||
Available for sale investments |
2,355 | 2,580 | 2,811 | ||||||
Loans and advances to banks |
1,267 | 1,416 | 903 | ||||||
Loans and advances to customers |
23,754 | 19,559 | 16,290 | ||||||
Other |
460 | 1,608 | 1,710 | ||||||
Interest income |
28,010 | 25,308 | 21,805 | ||||||
Deposits from banks |
(2,189 | ) | (2,720 | ) | (2,819 | ) | |||
Customer accounts |
(6,714 | ) | (4,110 | ) | (3,076 | ) | |||
Debt securities in issue |
(5,947 | ) | (6,651 | ) | (5,282 | ) | |||
Subordinated liabilities |
(1,349 | ) | (878 | ) | (777 | ) | |||
Other |
(396 | ) | (1,348 | ) | (708 | ) | |||
Interest expense |
(16,595 | ) | (15,707 | ) | (12,662 | ) | |||
Net interest income |
11,415 | 9,601 | 9,143 |
Interest income includes £135m (2007: £113m, 2006: £98m) accrued on impaired loans.
Other interest income principally includes interest income relating to reverse repurchase agreements. Similarly, other interest expense principally includes interest expense relating to repurchase agreements and hedging activity.
Included in net interest income is hedge ineffectiveness as detailed in Note 14.
b Net fee and commission income
2008 £m |
2007 £m |
2006 £m |
|||||||
Fee and commission income |
|||||||||
Brokerage fees |
87 | 109 | 70 | ||||||
Investment management fees |
1,616 | 1,787 | 1,535 | ||||||
Securities lending |
389 | 241 | 185 | ||||||
Banking and credit related fees and commissions |
7,208 | 6,367 | 6,031 | ||||||
Foreign exchange commissions |
189 | 178 | 184 | ||||||
Fee and commission income |
9,489 | 8,682 | 8,005 | ||||||
Fee and commission expense |
(1,082 | ) | (970 | ) | (828 | ) | |||
Net fee and commission in come |
8,407 | 7,712 | 7,177 |
c Principal transactions
2008 £m |
2007 £m |
2006 £m | ||||||
Rates related business |
4,682 | 4,162 | 2,866 | |||||
Credit related business |
(3,422 | ) | (403 | ) | 766 | |||
Net trading in come |
1,260 | 3,759 | 3,632 | |||||
Net gain from disposal of available for sale assets |
212 | 560 | 307 | |||||
Dividend income |
196 | 26 | 15 | |||||
Net gain from financial instruments designated at fair value |
33 | 293 | 447 | |||||
Other investment income |
239 | 337 | 193 | |||||
Net investment in come |
680 | 1,216 | 962 | |||||
Principal transactions |
1,940 | 4,975 | 4,594 |
Net trading income includes the profits and losses arising both on the purchase and sale of trading instruments and from the revaluation to fair value, together with the interest income earned from these instruments and the related funding cost.
Of the total net trading income, a £2,096m net loss (2007: £116m loss, 2006: £1,427m gain) was made on the purchase and sale of securities and the revaluation of both securities and derivatives. This included a £1,272m gain (2007: £640m gain, 2006: £480m gain) that was earned in foreign exchange dealings.
The net loss on financial assets designated at fair value included within principal transactions was £6,602m (2007: £78m gain, 2006: £489m gain) of which losses of £6,635m (2007: £215m loss, 2006: £42m gain) were included in net trading income and gains of £33m (2007: £293m, 2006: £447m) were included in net investment income.
290 | Barclays Annual Report 2008 |
c Principal transactions (continued)
The net gain on financial liabilities designated at fair value included within principal transactions was £3,328m (2007: £231m loss, 2006: £920m loss), all of which was included within net trading income.
Net trading income includes the net gain from widening of credit spreads relating to Barclays Capital issued notes held at fair value was £1,663m (2007: £658m, 2006: £nil).
d Administration and general expenses
2008 £m |
2007 £m |
2006 £m |
|||||||
Administrative expenses |
5,149 | 3,978 | 3,980 | ||||||
Impairment charges/(releases): |
|||||||||
property and equipment (Note 23) |
33 | 2 | 14 | ||||||
intangible assets (Note 22) |
(3 | ) | 14 | 7 | |||||
goodwill (Note 21) |
111 | | | ||||||
Operating lease rentals |
520 | 414 | 345 | ||||||
Gain on property disposals |
(148 | ) | (267 | ) | (432 | ) | |||
Administration and general expenses |
5,662 | 4,141 | 3,914 |
Auditors remuneration
2008 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
12 | | | | 12 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Banks associates pursuant to legislation |
20 | | | | 20 | |||||
Other services supplied pursuant to such legislation |
| 2 | | | 2 | |||||
Other services relating to taxation |
| | 10 | | 10 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Bank or any of its associates |
| | | 3 | 3 | |||||
Other |
| 4 | | 1 | 5 | |||||
Total auditors remuneration |
32 | 6 | 10 | 4 | 52 | |||||
2007 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
7 | | | | 7 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Banks associates pursuant to legislation |
12 | | | | 12 | |||||
Other services supplied pursuant to such legislation |
6 | 2 | | | 8 | |||||
Other services relating to taxation |
| | 8 | | 8 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Bank or any of its associates |
| | | 5 | 5 | |||||
Other |
| 2 | | 2 | 4 | |||||
Total auditors remuneration |
25 | 4 | 8 | 7 | 44 | |||||
2006 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
7 | | | | 7 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Banks associates pursuant to legislation |
11 | | | | 11 | |||||
Other services supplied pursuant to such legislation |
10 | 1 | | | 11 | |||||
Other services relating to taxation |
| | 6 | | 6 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Bank or any of its associates |
| | | 4 | 4 | |||||
Other |
| 4 | | 1 | 5 | |||||
Total auditors remuneration |
28 | 5 | 6 | 5 | 44 |
The figures shown in the above table relate to fees paid to PricewaterhouseCoopers LLP and its associates. Fees paid to other auditors not associated with PricewaterhouseCoopers LLP in respect of the audit of the Banks subsidiaries were £3m (2007: £2m, 2006: £2m).
Barclays Annual Report 2008 |
291 |
Barclays Bank PLC data
Notes to the accounts
d Administration and general expenses (continued)
Fees payable for the audit of the Banks associates pursuant to legislation comprise the fees for the statutory audit of the subsidiaries and associated pension schemes both inside and outside Great Britain and fees for the work performed by the associates of PricewaterhouseCoopers LLP in respect of the consolidated financial statements of the Bank. The fees relating to the audit of the associated pension schemes were £0.2m (2007: £0.3m, 2006: £0.3m).
Other services supplied pursuant to such legislation comprise services in relation to statutory and regulatory filings. These includes audit services for the review of the interim financial information under the Listing Rules of the UK listing authority and fees paid for reporting under Section 404 of the US Sarbanes-Oxley Act (Section 404). In 2008 fees paid for reporting under Section 404 are not separately identifiable from the fees of the audit of the Banks annual accounts and the Banks associates. Fees for the audit of Barclays Bank PLC Group accounts are not separately identifiable from Barclays PLC, therefore there is no difference in the amounts reported in both Annual Reports. In addition, other services include Section 404 advisory, reporting accountant work for capital raising, securitisations and services relating to acquisition activities.
Taxation services include compliance services such as tax return preparation and advisory services such as consultation on tax matters, tax advice relating to transactions and other tax planning and advice.
Services relating to corporate finance transactions comprise due diligence related to transactions and other work in connection with such transactions.
e Tax
The charge for tax is based upon the UK corporation tax rate of 28.5% (2007: 30%, 2006: 30%) and comprises:
2008 £m |
2007 £m |
2006 £m |
|||||||
Current tax charge/(credit) |
|||||||||
Current year |
1,559 | 2,385 | 1,929 | ||||||
Adjustment for prior years |
97 | (11 | ) | 8 | |||||
1,656 | 2,374 | 1,937 | |||||||
Deferred tax (credit)/charge |
|||||||||
Current year |
(597 | ) | (367 | ) | (16 | ) | |||
Adjustment for prior years |
(273 | ) | (26 | ) | 20 | ||||
(870 | ) | (393 | ) | 4 | |||||
Total charge |
786 | 1,981 | 1,941 | ||||||
The effective tax rate for the years 2008, 2007 and 2006 is lower than the standard rate of corporation tax in the UK of 28.5% (2007: 30%, 2006: 30%). The differences are set out below:
|
| ||||||||
2008 £m |
2007 £m |
2006 £m |
|||||||
Profit before tax |
6,035 | 7,107 | 7,197 | ||||||
Tax charge at standard UK corporation tax rate of 28.5% (2007: 30%, 2006: 30%) |
1,720 | 2,132 | 2,159 | ||||||
Adjustment for prior years |
(176 | ) | (37 | ) | 24 | ||||
Differing overseas tax rates |
215 | (77 | ) | (17 | ) | ||||
Non-taxable gains and income (including amounts offset by unrecognised tax losses) |
(833 | ) | (136 | ) | (393 | ) | |||
Share-based payments |
229 | 72 | 27 | ||||||
Deferred tax assets not previously recognised |
(514 | ) | (158 | ) | (4 | ) | |||
Change in tax rates |
(1 | ) | 24 | 4 | |||||
Other non-allowable expenses |
146 | 161 | 141 | ||||||
Overall tax charge |
786 | 1,981 | 1,941 | ||||||
Effective tax rate |
13 | % | 28 | % | 27 | % |
The effective rate of tax for 2008, based on profit before tax, was 13% (2007: 28%). The effective tax rate differs from the 2007 effective rate and the UK corporation tax rate of 28.5% principally due to the Lehman Brothers North American businesses acquisition. Under IFRS the gain on acquisition of £2,262m is calculated net of deferred tax liabilities included in the acquisition balance sheet and is thus not subject to further tax in calculating the tax charge for the year. Furthermore, Barclays has tax losses previously unrecognised as a deferred tax asset but capable of sheltering part of this deferred tax liability. This gives rise to a tax benefit of £492m which, in accordance with IAS 12, is included as a credit within the tax charge for the year. The effective rate has been adversely impacted by the effect of the fall in the Barclays share price on the deferred tax asset recognised on share awards. In common with prior years there have been offsetting adjustments relating to different overseas tax rates, disallowable expenditure and non taxable gains and income.
292 | Barclays Annual Report 2008 |
f Other income
2008 £m |
2007 £m |
2006 £m |
|||||||
(Decrease)/increase in fair value of assets held in respect of linked liabilities to customers under investment contracts |
(10,422 | ) | 5,592 | 7,417 | |||||
Decrease/(increase) in liabilities to customers under investment contracts |
10,422 | (5,592 | ) | (7,417 | ) | ||||
Property rentals |
73 | 53 | 55 | ||||||
Other income |
381 | 171 | 202 | ||||||
Other income |
454 | 224 | 257 |
Included in other income are sub-lease rentals of £18m (2007: £18m, 2006: £18m), and in 2008 only is a £47m gain from the Visa IPO.
g Trading portfolio assets
2008 £m |
2007 £m |
|||||
Trading portfolio assets |
||||||
Treasury and other eligible bills |
4,544 | 2,094 | ||||
Debt securities |
148,686 | 152,778 | ||||
Equity securities |
30,544 | 36,342 | ||||
Traded loans |
1,070 | 1,780 | ||||
Commodities |
802 | 732 | ||||
Trading portfolio assets |
185,646 | 193,726 | ||||
h Available for sale financial investments
|
||||||
2008 £m |
2007 £m |
|||||
Debt securities |
58,831 | 38,673 | ||||
Treasury bills and other eligible bills |
4,003 | 2,723 | ||||
Equity securities |
2,182 | 1,860 | ||||
Available for sale financial investments |
65,016 | 43,256 | ||||
Movement in available for sale financial investments |
||||||
2008 £m |
2007 £m |
|||||
At beginning of year |
43,256 | 51,952 | ||||
Exchange and other adjustments |
14,275 | 1,499 | ||||
Acquisitions and transfers |
59,703 | 26,950 | ||||
Disposals (through sale and redemption) |
(50,629 | ) | (37,498 | ) | ||
(Losses)/gains from changes in fair value recognised in equity |
(1,190 | ) | 391 | |||
Impairment |
(382 | ) | (13 | ) | ||
Amortisation of discounts/premium |
(17 | ) | (25 | ) | ||
At end of year |
65,016 | 43,256 | ||||
i Other assets
|
||||||
2008 £m |
2007 £m |
|||||
Sundry debtors |
4,814 | 4,045 | ||||
Prepayments |
882 | 551 | ||||
Accrued income |
483 | 400 | ||||
Reinsurance assets |
123 | 157 | ||||
Other assets |
6,302 | 5,153 |
Included in the above Group balances are £4,704m (2007: £4,541m) expected to be recovered within no more than 12 months after the balance sheet date; and balances of £1,598m (2007: £612m) expected to be recovered more than 12 months after the balance sheet date.
Other assets include £3,096m (2007: £3,966m) of receivables which meet the definition of financial assets.
Barclays Annual Report 2008 |
293 |
Barclays Bank PLC data
Notes to the accounts
j Other liabilities
2008 £m |
2007 £m | |||
Accruals and deferred income |
6,495 | 6,075 | ||
Sundry creditors |
6,049 | 4,356 | ||
Obligations under finance leases |
96 | 83 | ||
Other liabilities |
12,640 | 10,514 |
Included in the above are balances of £11,068m (2007: £9,058m) expected to be settled within no more than 12 months after the balance sheet date; and balances of £1,572m (2007: £1,456m) expected to be settled more than 12 months after the balance sheet date.
Accruals and deferred income included £nil (2007: £102m) in relation to deferred income from investment contracts and £nil (2007: £677m) in relation to deferred income from insurance contracts for the Group.
k Called up share capital
Ordinary Shares
The authorised ordinary share capital of the Bank, as at 31st December 2008, was 3,000 million (2007: 3,000 million) ordinary shares of £1 each.
During the year, the Bank issued 1 million ordinary shares, for cash consideration of £17m.
Preference Shares
The authorised preference share capital of Barclays Bank PLC, as at 31st December 2008, was 1,000 Preference Shares (2007: 1,000) of £1; 400,000 Preference Shares of 100 each (2007: 400,000); 400,000 Preference Shares of £100 each (2007: 400,000); 400,000 Preference Shares of US$100 each (2007: 400,000); 300 million Preference Shares of US$0.25 each (2007: 150 million).
The issued preference share capital of Barclays Bank PLC, as at 31st December 2008, comprised 1,000 (2007: 1,000) Sterling Preference Shares of £1 each; 240,000 (2007: 240,000) Euro Preference Shares of 100 each; 75,000 (2007: 75,000) Sterling Preference Shares of £100 each; 100,000 (2007: 100,000) US Dollar Preference Shares of US$100 each; 237 million (2007: 131 million) US Dollar Preference Shares of US$0.25 each.
2008 £m |
2007 £m | |||
Called up share capital, allotted and fully paid |
||||
At beginning of year |
2,336 | 2,329 | ||
Issued for cash |
2 | 7 | ||
At end of year |
2,338 | 2,336 | ||
Called up preference share capital, allotted and fully paid |
||||
At beginning of year |
46 | 34 | ||
Issued for cash |
14 | 12 | ||
At end of year |
60 | 46 | ||
Called up share capital |
2,398 | 2,382 | ||
Share premium |
||||
2008 £m |
2007 £m | |||
At beginning of year |
10,751 | 9,452 | ||
Ordinary shares issued for cash |
15 | 104 | ||
Preference shares issued for cash |
1,294 | 1,195 | ||
At end of year |
12,060 | 10,751 |
294 | Barclays Annual Report 2008 |
k Called up share capital (continued)
Sterling £1 Preference Shares
1,000 Sterling cumulative callable preference shares of £1 each (the £1 Preference Shares) were issued on 31st December 2004 at nil premium.
The £1 Preference Shares entitle the holders thereof to receive Sterling cumulative cash dividends out of distributable profits of Barclays Bank PLC, semi-annually at a rate reset semi-annually equal to the Sterling interbank offered rate for six-month sterling deposits.
Barclays Bank PLC shall be obliged to pay such dividends if: (1) it has profits available for the purpose of distribution under the Companies Act 1985 as at each dividend payment date; and (2) it is solvent on the relevant dividend payment date, provided that a capital regulations condition is satisfied on such dividend payment date. The dividends shall not be due and payable on the relevant dividend payment date except to the extent that Barclays Bank PLC could make such payment and still be solvent immediately thereafter. Barclays Bank PLC shall be considered solvent on any date if: (1) it is able to pay its debts to senior creditors as they fall due; and (2) its auditors have reported within the previous six months that its assets exceed its liabilities. If Barclays Bank PLC shall not pay, or shall pay only in part, a dividend for a period of seven days or more after the due date for payment, the holders of the £1 Preference Shares may institute proceedings for the winding-up of Barclays Bank PLC. No remedy against Barclays Bank PLC shall be available to the holder of any £1 Preference Shares for the recovery of amounts owing in respect of £1 Preference Shares other than the institution of proceedings for the winding-up of Barclays Bank PLC and/or proving in such winding-up. On a winding-up or other return of capital (other than a redemption or purchase by Barclays Bank PLC of any of its issued shares, or a reduction of share capital, permitted by the Articles of Barclays Bank PLC and under applicable law), the assets of Barclays Bank PLC available to shareholders shall be applied in priority to any payment to the holders of ordinary shares and any other class of shares in the capital of Barclays Bank PLC then in issue ranking junior to the £1 Preference Shares on such a return of capital and pari passu on such a return of capital with the holders of any other class of shares in the capital of Barclays Bank PLC then in issue (other than any class of shares in the capital of Barclays Bank PLC then in issue ranking in priority to the £1 Preference Shares on a winding-up or other such return of capital), in payment to the holders of the £1 Preference Shares of a sum equal to the aggregate of: (1) an amount equal to the dividends accrued thereon for the then current dividend period (and any accumulated arrears thereof) to the date of the commencement of the winding-up or other such return of capital; and (2) an amount equal to £1 per £1 Preference Share. After payment of the full amount of the liquidating distributions to which they are entitled, the holders of the £1 Preference Shares will have no right or claim to any of the remaining assets of Barclays Bank PLC and will not be entitled to any further participation in such return of capital. The £1 Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, subject to the Companies Act 1985 and its Articles. Holders of the £1 Preference Shares are not entitled to receive notice of, or to attend, or vote at, any general meeting of Barclays Bank PLC.
Euro Preference Shares
100,000 Euro 4.875% non-cumulative callable preference shares of 100 each (the 4.875% Preference Shares) were issued on 8th December 2004 for a consideration of 993.6m (£688.4m), of which the nominal value was 10m and the balance was share premium. The 4.875% Preference Shares entitle the holders thereof to receive Euro non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, annually at a fixed rate of 4.875% per annum on the amount of 10,000 per preference share until 15th December 2014, and thereafter quarterly at a rate reset quarterly equal to 1.05% per annum above the Euro interbank offered rate for three-month Euro deposits.
The 4.875% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th December 2014, and on each dividend payment date thereafter at 10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
140,000 Euro 4.75% non-cumulative callable preference shares of 100 each (the 4.75% Preference Shares) were issued on 15th March 2005 for a consideration of 1,383.3m (£966.7m), of which the nominal value was 14m and the balance was share premium. The 4.75% Preference Shares entitle the holders thereof to receive Euro non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, annually at a fixed rate of 4.75% per annum on the amount of 10,000 per preference share until 15th March 2020, and thereafter quarterly at a rate reset quarterly equal to 0.71% per annum above the Euro interbank offered rate for three-month Euro deposits.
The 4.75% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th March 2020, and on each dividend payment date thereafter at 10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
Sterling Preference Shares
75,000 Sterling 6.0% non-cumulative callable preference shares of £100 each (the 6.0% Preference Shares) were issued on 22nd June 2005 for a consideration of £732.6m, of which the nominal value was £7.5m and the balance was share premium. The 6.0% Preference Shares entitle the holders thereof to receive Sterling non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, annually at a fixed rate of 6.0% per annum on the amount of £10,000 per preference share until 15th December 2017, and thereafter quarterly at a rate reset quarterly equal to 1.42% per annum above the London interbank offered rate for three-month Sterling deposits.
The 6.0% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th December 2017, and on each dividend payment date thereafter at £10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
US Dollar Preference Shares
100,000 US Dollar 6.278% non-cumulative callable preference shares of US$100 each (the 6.278% Preference Shares), represented by 100,000 American Depositary Shares, Series 1, were issued on 8th June 2005 for a consideration of US$995.4m (£548.1m), of which the nominal value was US$10m and the balance was share premium. The 6.278% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, semi-annually at a fixed rate of 6.278% per annum on the amount of US$10,000 per preference share until 15th December 2034, and thereafter quarterly at a rate reset quarterly equal to 1.55% per annum above the London interbank offered rate for three-month US Dollar deposits.
The 6.278% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th December 2034, and on each dividend payment date thereafter at US$10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
30 million US Dollar 6.625% non-cumulative callable preference shares of US$0.25 each (the 6.625% Preference Shares), represented by 30 million American Depositary Shares, Series 2, were issued on 25th and 28th April 2006 for a consideration of US$727m (£406m), of which the nominal value was US$7.5m and the balance was share premium. The 6.625% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 6.625% per annum on the amount of US$25 per preference share.
Barclays Annual Report 2008 |
295 |
Barclays Bank PLC data
Notes to the accounts
k Called up share capital (continued)
The 6.625% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th September 2011, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
55 million US Dollar 7.1% non-cumulative callable preference shares of US$0.25 each (the 7.1% Preference Shares), represented by 55 million American Depositary Shares, Series 3, were issued on 13th September 2007 for a consideration of US$1,335m (£657m), of which the nominal value was US$13.75m and the balance was share premium. The 7.1% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 7.1% per annum on the amount of US$25 per preference share.
The 7.1% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole or in part, on 15th December 2012, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
46 million US Dollar 7.75% non-cumulative callable preference shares of US$0.25 each (the 7.75% Preference Shares), represented by 46 million American Depositary Shares, Series 4, were issued on 7th December 2007 for a consideration of US$1,116m (£550m), of which the nominal value was US$11.5m and the balance was share premium. The 7.75% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 7.75% per annum on the amount of US$25 per preference share.
The 7.75% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole or in part, on 15th December 2013, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
106 million US Dollar 8.125% non-cumulative callable preference shares of US$0.25 each (the 8.125% Preference Shares), represented by 106 million American Depositary Shares, Series 5, were issued on 11th April 2008 and 25th April 2008 for a total consideration of US$2,650m (£1,345m), of which the nominal value was US$26.5m and the balance was share premium. The 8.125% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 8.125% per annum on the amount of US$25 per preference share.
The 8.125% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole or in part, on 15th June 2013, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
No redemption or purchase of any 4.875% Preference Shares, the 4.75% Preference Shares, the 6.0% Preference Shares, the 6.278% Preference Shares, the 6.625% Preference Shares, the 7.1% Preference Shares, the 7.75% Preference Shares and the 8.125% Preference Shares (together, the Preference Shares) may be made by Barclays Bank PLC without the prior notification to the UK FSA and any such redemption will be subject to the Companies Act 1985 and the Articles of Barclays Bank PLC.
On a winding-up of Barclays Bank PLC or other return of capital (other than a redemption or purchase of shares of Barclays Bank PLC, or a reduction of share capital), a holder of Preference Shares will rank in the application of assets of Barclays Bank PLC available to shareholders: (1) junior to the holder of any shares of Barclays Bank PLC in issue ranking in priority to the Preference Shares; (2) equally in all respects with holders of other preference shares and any other shares of Barclays Bank PLC in issue ranking pari passu with the Preference Shares; and (3) in priority to the holders of ordinary shares and any other shares of Barclays Bank PLC in issue ranking junior to the Preference Shares.
The holders of the £400m 6% Callable Perpetual Core Tier One Notes and the US$1,000m 6.86% Callable Perpetual Core Tier One Notes of Barclays Bank PLC (together, the TONs) and the holders of the US$1,250m 8.55% Step-up Callable Perpetual Reserve Capital Instruments, the US$750m 7.375% Step-up Callable Perpetual Reserve Capital Instruments, the 850m 7.50% Step-up Callable Perpetual Reserve Capital Instruments, the £500m 5.3304% Step-up Callable Perpetual Reserve Capital Instruments, the US$1,350m 5.926% Step-up Callable Perpetual Reserve Capital Instruments, the £500m 6.3688% Step-up Callable Perpetual Reserve Capital Instruments, the US$1,250m 7.434% Step-up Callable Perpetual Reserve Capital Instruments and the £3,000m 14% Step-up Callable Perpetual Reserve Capital Instruments of Barclays Bank PLC (together, the RCIs) would, for the purposes only of calculating the amounts payable in respect of such securities on a winding-up of Barclays Bank PLC, subject to limited exceptions and to the extent that the TONs and the RCIs are then in issue, rank pari passu with the holders of the most senior class or classes of preference shares then in issue in the capital of Barclays Bank PLC. Accordingly, the holders of the preference shares would rank equally with the holders of such TONs and RCIs on such a winding-up of Barclays Bank PLC (unless one or more classes of shares of Barclays Bank PLC ranking in priority to the preference shares are in issue at the time of such winding-up, in which event the holders of such TONs and RCIs would rank equally with the holders of such shares and in priority to the holders of the preference shares).
Subject to such ranking, in such event, holders of the preference shares will be entitled to receive out of assets of Barclays Bank PLC available for distributions to shareholders, liquidating distributions in the amount of 10,000 per 4.875% Preference Share, 10,000 per 4.75% Preference Share, £10,000 per 6.0% Preference Share, US$10,000 per 6.278% Preference Share, US$25 per 6.625% Preference Share, US$25 per 7.1% Preference Share, US$25 per 7.75% Preference Share and US$0.25 per 8.125% Preference Share, plus, in each case, an amount equal to the accrued dividend for the then current dividend period to the date of the commencement of the winding-up or other such return of capital. If a dividend is not paid in full on any preference shares on any dividend payment date, then a dividend restriction shall apply.
This dividend restriction will mean that neither Barclays Bank PLC nor Barclays PLC may (a) declare or pay a dividend (other than payment by Barclays PLC of a final dividend declared by its shareholders prior to the relevant dividend payment date, or a dividend paid by Barclays Bank PLC to Barclays PLC or to a wholly owned subsidiary) on any of their respective ordinary shares, other preference shares or other share capital or (b) redeem, purchase, reduce or otherwise acquire any of their respective share capital, other than shares of Barclays Bank PLC held by Barclays PLC or a wholly owned subsidiary, until the earlier of: (1) the date on which Barclays Bank PLC next declares and pays in full a preference dividend; and (2) the date on or by which all the preference shares are redeemed in full or purchased by Barclays Bank PLC.
Holders of the preference shares are not entitled to receive notice of, or to attend, or vote at, any general meeting of Barclays Bank PLC. Barclays Bank PLC is not permitted to create a class of shares ranking as regards participation in the profits or assets of Barclays Bank PLC in priority to the preference shares, save with the sanction of a special resolution of a separate general meeting of the holders of the preference shares (requiring a majority of not less than three-fourths of the holders of the preference shares voting at the separate general meeting) or with the consent in writing of the holders of three-fourths of the preference shares.
Except as described above, the holders of the preference shares have no right to participate in the surplus assets of Barclays Bank PLC.
296 | Barclays Annual Report 2008 |
l Reserves
Other reserves |
|||||||||||
Available for sale reserve £m |
Cash flow hedging reserve £m |
Translation £m |
Total £m |
||||||||
At 1st January 2008 |
111 | 26 | (307 | ) | (170 | ) | |||||
Net (losses)/gains from changes in fair value |
(1,752 | ) | 252 | | (1,500 | ) | |||||
Net (gains)/losses transferred to net profit |
(212 | ) | 19 | | (193 | ) | |||||
Currency translation differences |
| | 2,307 | 2,307 | |||||||
Losses transferred to net profit due to impairment |
382 | | | 382 | |||||||
Changes in insurance liabilities |
17 | | | 17 | |||||||
Net gains transferred to net profit due to fair value hedging |
(2 | ) | | | (2 | ) | |||||
Tax |
207 | (165) | 840 | 882 | |||||||
At 31st December 2008 |
(1,249) | 132 | 2,840 | 1,723 |
Retained earnings |
|||
Retained earnings £m |
|||
At 1st January 2008 |
14,222 | ||
Profit attributable to equity holders |
4,846 | ||
Equity-settled share schemes |
463 | ||
Tax on equity-settled shares schemes |
(4 | ) | |
Other taxes |
(52 | ) | |
Vesting of Barclays PLC shares under share-based payment schemes |
(437 | ) | |
Dividends paid |
(1,160 | ) | |
Dividends on preference shares and other shareholders equity |
(502 | ) | |
Capital injection from Barclays PLC |
5,137 | ||
Other movements |
(56) | ||
At 31st December 2008 |
22,457 | ||
At 1st January 2007 |
11,556 | ||
Profit attributable to equity holders |
4,749 | ||
Equity-settled share schemes |
567 | ||
Tax on equity-settled shares schemes |
28 | ||
Vesting of Barclays PLC shares under share-based payment schemes |
(524 | ) | |
Dividends paid |
(3,287 | ) | |
Dividends on preference shares and other shareholders equity |
(345 | ) | |
Capital injection from Barclays PLC |
1,434 | ||
Other movements |
44 | ||
At 31st December 2007 |
14,222 |
Transfers from the cash flow hedging reserve to the income statement were: interest income £4m loss (2007: £93m loss), interest expense £74m loss (2007: £11m gain), net trading income £119m gain (2007: £100m loss) and administration and general expenses of £60m loss (2007: £16m loss).
m Other shareholders equity
2008 £m |
2007 £m | |||
At 1st January |
2,687 | 2,534 | ||
Appropriations |
23 | 8 | ||
Other movements |
(146) | 145 | ||
At 31st December |
2,564 | 2,687 |
Included in other shareholders equity are:
Issuances of reserve capital instruments which bear a fixed rate of interest ranging between 7.375%-8.55% until 2010 or 2011. After these dates, in the event that the reserve capital instruments are not redeemed, they will bear interest at rates fixed periodically in advance, based on London or European interbank rates. These instruments are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after June or December 2010 or 2011. The Bank may elect to defer any payment of interest on the reserve capital instruments for any period of time. Whilst such deferral is continuing, neither the Bank nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares or preference shares.
Issuance of capital notes which bear interest at rates fixed periodically in advance, based on London interbank rates. These notes are repayable in each case, at the option of the Bank, in whole on any interest payment date. The Bank is not obliged to make a payment of interest on its capital notes if, in the preceding six months, a dividend has not been declared or paid on any class of shares of Barclays PLC.
Barclays Annual Report 2008 |
297 |
Barclays Bank PLC data
Notes to the accounts
n Minority interests
2008 £m |
2007 £m |
|||||
At beginning of year |
1,949 | 1,685 | ||||
Share of profit after tax |
403 | 377 | ||||
Dividend and other payments |
(134 | ) | (131 | ) | ||
Equity issued by subsidiaries |
4 | 137 | ||||
Available for sale reserve: net (loss)/gain from changes in fair value |
(1 | ) | 1 | |||
Cash flow hedges: net gain/(loss) from changes in fair value |
76 | (16 | ) | |||
Currency translation differences |
59 | 16 | ||||
Additions |
| 27 | ||||
Disposals |
(11 | ) | (111 | ) | ||
Other |
27 | (36 | ) | |||
At end of year |
2,372 | 1,949 |
o Dividends
2008 £m |
2007 £m | |||
On ordinary shares |
||||
Final dividend |
1,030 | 791 | ||
Interim dividends |
130 | 2,496 | ||
Dividends |
1,160 | 3,287 |
These dividends are paid to enable Barclays PLC to fund its dividends to its shareholders and in 2007, to fund the repurchase by Barclays PLC of ordinary share capital.
Dividends paid on preference shares amounted to £390m (2007: £193m). Dividends paid on other equity instruments as detailed in Note m amounted to £112m (2007: £152m).
p Financial risks
The only significant financial instruments that are held by Barclays Bank PLC and not Barclays PLC are investments in Barclays PLC ordinary shares, dealt with as trading portfolio equity assets, debt securities and available for sale financial investments as appropriate.
There consequently are no significant differences in exposures to market risk, credit risk, liquidity risk and the fair value of financial instruments between Barclays PLC and Barclays Bank PLC, and no differences in the manner in which these financial risks are managed. Therefore the disclosures regarding financial risks appearing in Notes 46 to 49 are in all material respects the same for Barclays Bank PLC and Barclays PLC.
q Capital
The Barclays Bank PLC Groups policies and objectives for managing capital are the same as those for the Barclays PLC Group, disclosed in Note 52.
The table below provides details of the Barclays Bank PLC Group at 31st December 2008 and 2007.
2008 Basel II £m |
2007 Basel I £m |
|||||
Total qualifying Tier 1 capital |
37,101 | 26,534 | ||||
Total qualifying Tier 2 capital |
22,356 | 17,123 | ||||
Total deductions |
(964 | ) | (1,889 | ) | ||
Total net capital resources |
58,493 | 41,768 |
r Segmental reporting
Segmental reporting by Barclays Bank PLC is the same as that presented in Note 53 to the Barclays PLC financial statements, except for:
| the difference in profit before tax of £42m (2007: £31m) between Barclays PLC and Barclays Bank PLC is included in Head office functions and other operations. |
| the difference in total assets of £49m (2007: £222m) is represented by holdings of Barclays PLC shares held by the businesses. |
298 | Barclays Annual Report 2008 |
Financial Data
IFRS | |||||||||||||||
Selected financial statistics | 2008 % |
2007 % |
2006 % |
2005 % |
2004a % |
||||||||||
Attributable profit as a percentage of: |
|||||||||||||||
average total assets |
0.3 | 0.4 | 0.4 | 0.4 | 0.5 | ||||||||||
average shareholders equity |
13.8 | 16.3 | 20.2 | 17.4 | 21.3 | ||||||||||
Average shareholders equity as a percentage of average total assets
|
2.0 | 2.2 | 2.2 | 2.2 | 2.4 | ||||||||||
Selected income statement data
|
£m
|
£m
|
£m
|
£m
|
£m
|
||||||||||
Interest income |
28,010 | 25,308 | 21,805 | 17,232 | 13,880 | ||||||||||
Interest expense |
(16,595 | ) | (15,707 | ) | (12,662 | ) | (9,157 | ) | (7,047 | ) | |||||
Non-interest income |
11,891 | 13,922 | 13,088 | 9,934 | 8,543 | ||||||||||
Operating expenses |
(14,362 | ) | (13,199 | ) | (12,674 | ) | (10,527 | ) | (8,536 | ) | |||||
Impairment charges |
(5,419 | ) | (2,795 | ) | (2,154 | ) | (1,571 | ) | (1,093 | ) | |||||
Share of post-tax results of associates and joint ventures |
14 | 42 | 46 | 45 | 56 | ||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
327 | 28 | 323 | | 45 | ||||||||||
Gains on acquisitions |
2,406 | | | | | ||||||||||
Profit before tax |
6,035 | 7,107 | 7,197 | 5,311 | 4,589 | ||||||||||
Attributable profit
|
4,846 | 4,749 | 4,914 | 3,695 | 3,263 | ||||||||||
Selected balance sheet data
|
£m
|
£m
|
£m
|
£m
|
£m
|
||||||||||
Total shareholders equity |
43,574 | 31,821 | 27,106 | 24,243 | 16,849 | ||||||||||
Subordinated liabilities |
29,842 | 18,150 | 13,786 | 12,463 | 12,277 | ||||||||||
Deposits from banks, customer accounts and debt securities in issue |
603,869 | 506,623 | 447,453 | 417,139 | 412,358 | ||||||||||
Loans and advances to banks and customers |
509,522 | 385,518 | 313,226 | 300,001 | 343,041 | ||||||||||
Total assets
|
2,053,029 | 1,227,583 | 996,503 | 924,170 | 538,300 |
Note
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
Barclays Annual Report 2008 |
299 |
Barclays Bank PLC data
Financial Data
Ratio of earnings to fixed charges Barclays Bank PLC
2008 | 2007 | 2006 | 2005 | 2004a | |||||||||||
(in £m except for ratios) | |||||||||||||||
Ratio of earnings to fixed charges |
|||||||||||||||
IFRS/UK GAAP: |
|||||||||||||||
Fixed charges |
|||||||||||||||
Interest expense |
38,235 | 37,903 | 30,385 | 20,965 | 14,464 | ||||||||||
Rental expense
|
240 | 161 | 137 | 126 | 93 | ||||||||||
Total fixed charges
|
38,475 | 38,064 | 30,522 | 21,091 | 14,557 | ||||||||||
Earnings |
|||||||||||||||
Income before taxes and minority interests |
6,035 | 7,107 | 7,197 | 5,311 | 4,589 | ||||||||||
Less: Unremitted pre-tax income of associated companies and joint ventures
|
(19 | ) | (45 | ) | (41 | ) | (28 | ) | (51 | ) | |||||
6,016 | 7,062 | 7,156 | 5,283 | 4,538 | |||||||||||
Fixed charges
|
38,475 | 38,064 | 30,522 | 21,091 | 14,557 | ||||||||||
Total earnings including fixed charges
|
44,491 | 45,126 | 37,678 | 26,374 | 19,095 | ||||||||||
Ratio of earnings to fixed charges
|
1.16 | 1.19 | 1.23 | 1.25 | 1.31 |
Ratio of earnings to fixed charges and preference shares Barclays Bank PLC
2008 | 2007 | 2006 | 2005 | 2004a | |||||||||||
(in £m except for ratios) | |||||||||||||||
Combined fixed charges, preference share dividends and similar appropriations |
|||||||||||||||
IFRS/UK GAAP: |
|||||||||||||||
Interest expense |
38,235 | 37,903 | 30,385 | 20,965 | 14,464 | ||||||||||
Rental expense
|
240 | 161 | 137 | 126 | 93 | ||||||||||
Fixed charges |
38,475 | 38,064 | 30,522 | 21,091 | 14,557 | ||||||||||
Preference share dividends and similar appropriations
|
583 | 345 | 395 | 304 | 3 | ||||||||||
Total fixed charges
|
39,058 | 38,409 | 30,917 | 21,395 | 14,560 | ||||||||||
Earnings |
|||||||||||||||
Income before taxes and minority interests |
6,035 | 7,107 | 7,197 | 5,311 | 4,589 | ||||||||||
Less: Unremitted pre-tax income of associated companies and joint ventures
|
(19 | ) | (45 | ) | (41 | ) | (28 | ) | (51 | ) | |||||
6,016 | 7,062 | 7,156 | 5,283 | 4,538 | |||||||||||
Fixed charges
|
39,058 | 38,409 | 30,917 | 21,091 | 14,557 | ||||||||||
Total earnings including fixed charges
|
45,074 | 45,471 | 38,073 | 26,374 | 19,095 | ||||||||||
Ratio of earnings to combined fixed charges, preference share dividends and similar appropriations
|
1.15 | 1.18 | 1.23 | 1.23 | 1.31 |
Note
a | Does not reflect the application of IAS 32, IAS 39 and IFRS 4 which became effective from 1st January 2005. |
300 | Barclays Annual Report 2008 |
Dividends on the ordinary shares of Barclays PLC
Barclays PLC has paid dividends on its ordinary shares every year without interruption since its incorporation in 1896.
As announced on 13th October 2008, in the light of the new capital ratios agreed with the FSA and in recognition of the need to maximise capital resources in the current economic climate, the Board has concluded that it would not be appropriate to pay a final dividend for 2008. The Board intends to resume dividend payments in the second half of 2009, at which time it is intended to pay dividends quarterly.
The dividends declared for each of the last five years were:
Pence per 25p ordinary share |
||||||||||
2008 | 2007 | 2006 | 2005 | 2004 | ||||||
Interim |
11.50 | 11.50 | 10.50 | 9.20 | 8.25 | |||||
Final
|
| 22.50 | 20.50 | 17.40 | 15.75 | |||||
Total
|
11.50 | 34.00 | 31.00 | 26.60 | 24.00 | |||||
US Dollars per 25p ordinary share |
||||||||||
2008 | 2007 | 2006 | 2005 | 2004 | ||||||
Interim |
0.20 | 0.23 | 0.20 | 0.16 | 0.15 | |||||
Final
|
| 0.45 | 0.41 | 0.31 | 0.30 | |||||
Total
|
0.20 | 0.68 | 0.61 | 0.47 | 0.45 | |||||
The gross dividends applicable to an American Depositary Share (ADS) representing four ordinary shares, before deduction of withholding tax, are as follows: | ||||||||||
US Dollars per American Depositary Share |
||||||||||
2008 | 2007 | 2006 | 2005 | 2004 | ||||||
Interim |
0.82 | 0.93 | 0.80 | 0.65 | 0.60 | |||||
Final
|
| 1.78 | 1.64 | 1.24 | 1.20 | |||||
Total
|
0.82 | 2.71 | 2.44 | 1.89 | 1.80 |
Dividends expressed in Dollars are translated at the Noon Buying Rates in New York City for cable transfers in Pounds Sterling as certified for customs purposes by the Federal Reserve Bank of New York (the Noon Buying Rate) for the days on which dividends are paid. No representation is made that Pounds Sterling amounts have been, or could have been, or could be, converted into Dollars at these rates.
Trading market for ordinary shares of Barclays PLC
The nominal capital of Barclays PLC is divided into 13,996,000,000 ordinary shares of 25p each (ordinary shares) 0.4 million Sterling preference shares of £100 each, 0.4 million US Dollar preference shares of $100 each, 150 million US Dollar preference shares of $0.25 each, 0.4 million Euro preference shares of 100 each, 0.4 million Yen preference shares of ¥10,000 each and 1 million staff shares of £1 each. At the close of business on 31st December 2008, 8,371,830,617 ordinary shares were outstanding.
The principal trading market for Barclays PLC ordinary shares is the London Stock Exchange. Ordinary share listings were also obtained on the Tokyo Stock Exchange with effect from 1st August 1986 and the New York Stock Exchange (NYSE) with effect from 9th September 1986. During the year, the Company de-listed from the Tokyo Stock Exchange with effect from 28th June 2008.
Trading on the NYSE is in the form of ADSs under the symbol BCS. Each ADS represents four ordinary shares and is evidenced by an American Depositary Receipt (ADR). The ADR depositary is J P Morgan Chase Bank, N.A. Details of trading activity are published in the stock tables of leading daily newspapers in the US.
There were 926 ADR holders and 1,528 recorded holders of ordinary shares with US addresses at 31st December 2008, whose shareholdings represented approximately 4.22% of total outstanding ordinary shares on that date. Since certain of the ordinary shares and ADRs were held by brokers or other nominees, the number of recorded holders in the US may not be representative of the number of beneficial holders or of their country of residence.
302 | Barclays Annual Report 2008 |
The following table shows the high and low sales price for the ordinary shares during the periods indicated, based on mid-market prices at close of business on the London Stock Exchange and the high and low sale price for ADSs as reported on the NYSE composite tape.
25p ordinary shares | American Depositary Shares | |||||||
High p |
Low p |
High US$ |
Low US$ | |||||
2009 |
||||||||
By month: |
||||||||
January |
184.6 | 51.2 | 10.97 | 3.07 | ||||
February |
116.2 | 92.3 | 6.99 | 5.32 | ||||
2008 |
||||||||
By month: |
||||||||
July |
356.5 | 260.5 | 28.2 | 20.76 | ||||
August |
379.5 | 311.0 | 29.52 | 23.62 | ||||
September |
389.0 | 301.0 | 32.5 | 21.48 | ||||
October |
368.0 | 178.9 | 25.9 | 10.73 | ||||
November |
195.9 | 127.7 | 12.68 | 7.37 | ||||
December |
162.0 | 138.2 | 9.81 | 8.45 | ||||
By quarter: |
||||||||
First quarter |
506.42 | 382.25 | 41.39 | 32.27 | ||||
Second quarter |
490.83 | 291.5 | 39.89 | 23.15 | ||||
Third quarter |
389.0 | 260.5 | 32.5 | 20.76 | ||||
Fourth quarter |
368.0 | 127.7 | 25.9 | 7.37 | ||||
2007 |
||||||||
First quarter |
790.0 | 673.5 | 62.46 | 53.35 | ||||
Second quarter |
756.0 | 696.0 | 60.37 | 55.79 | ||||
Third quarter |
738.5 | 580.0 | 60.35 | 46.61 | ||||
Fourth quarter |
665.5 | 474.5 | 54.48 | 39.86 | ||||
2008 |
506.42 | 127.7 | 41.39 | 7.37 | ||||
2007 |
790.0 | 474.5 | 62.46 | 39.86 | ||||
2006 |
737.0 | 586.0 | 61.52 | 41.80 | ||||
2005 |
615.0 | 520.0 | 47.0 | 37.16 | ||||
2004 |
586.0 | 443.0 | 45.99 | 32.78 | ||||
2003 |
527.0 | 311.0 | 36.57 | 20.30 |
This section incorporates information on the prices at which securities of Barclays PLC have traded. It is emphasised that past performance cannot be relied upon as a guide to future performance.
Shareholdings at 31st December 2008a |
||||||||
Number of shareholders |
Percentage of holders |
Shares held (millions) |
Percentage of capital | |||||
Classification of shareholders |
||||||||
Personal holders |
732,093 | 97.10 | 750.24 | 8.97 | ||||
Banks and nominees |
20,516 | 2.72 | 6,522.72 | 77.90 | ||||
Other companies |
1,758 | 0.18 | 1,098.84 | 13.13 | ||||
Insurance companies |
13 | 0.00 | 0.00 | 0.00 | ||||
Pensions funds |
23 | 0.00 | 0.00 | 0.00 | ||||
Totals
|
754,403 | 100 | 8,371.8 | 100 | ||||
Shareholding range |
||||||||
1-100 |
30,074 | 4.02 | 1.27 | 0.02 | ||||
101-250 |
232,523 | 30.8 | 48.9 | 0.58 | ||||
251-500 |
240,892 | 31.9 | 82.3 | 0.98 | ||||
501-1,000 |
117,044 | 15.5 | 82.2 | 0.98 | ||||
1,001-5,000 |
102,416 | 13.6 | 210.1 | 2.51 | ||||
5,001-10,000 |
16,943 | 2.25 | 119.71 | 1.43 | ||||
10,001-25,000 |
10,083 | 1.34 | 152.72 | 1.82 | ||||
25,001-50,000 |
2,318 | 0.31 | 79.4 | 0.96 | ||||
50,001 and over
|
2,110 | 0.28 | 7,595.2 | 90.72 | ||||
Totals
|
754,403 | 100 | 8,371.8 | 100 | ||||
United States holdings |
1,528 | 0.2 | 3.23 | 0.04 |
Note
a | These figures include Barclays Sharestore members. |
Barclays Annual Report 2008 |
303 |
SEC FORM 20-F Other Information
Currency of presentation
In this report, unless otherwise specified, all amounts are expressed in Pounds Sterling. For the months of September through December 2008, the high and low noon buying rates in New York City for cable transfers in Pounds Sterling, as certified for customs purposes by the Federal Reserve Bank of New York (noon buying rate), were as set out in the table below.
Effective January 1, 2009, the Federal Reserve Bank of New York discontinued the publication of noon buying rates. For January and February 2009, the closing spot rates for Pounds Sterling as determined by Bloomberg at 5:00 p.m. (New York time) (the Closing Spot Rate), expressed in US Dollars per Pound Sterling were as set out in the table below.
(US Dollars per Pound Sterling) | ||||||||||||
February | January | December | November | October | September | |||||||
2009 | 2008 | |||||||||||
High |
1.49 | 1.52 | 1.55 | 1.62 | 1.78 | 1.86 | ||||||
Low |
1.42 | 1.38 | 1.44 | 1.48 | 1.55 | 1.75 |
For the years indicated, the averages of the noon buying rates on the last day of each month were:
(US Dollars per Pound Sterling) | ||||||||||
Average |
2008 | 2007 | 2006 | 2005 | 2004 | |||||
1.84 | 2.0 | 1.86 | 1.81 | 1.64 |
On March 20, 2009, the Closing Spot Rate in Pound Sterling was $1.45.
No representation is made that Pounds Sterling amounts have been, or could have been, or could be, converted into US Dollars at any of the above rates. For the purpose of presenting financial information in this report, exchange rates other than those shown above may have been used.
304 | Barclays Annual Report 2008 |
Shareholder information
Barclays Annual Report 2008 |
305 |
306 | Barclays Annual Report 2008 |
Shareholder information
Barclays Annual Report 2008 |
307 |
308 | Barclays Annual Report 2008 |
Barclays Annual Report 2008 |
309 |
310 | Barclays Annual Report 2008 |
Annual Report 2008 index
Barclays Annual Report 2008 |
311 |
312 | Barclays Annual Report 2008 |
Glossary of terms
Term used in Annual Report |
US equivalent or brief description | |
Accounts |
Financial statements | |
Allotted |
Issued | |
Attributable profit |
Net income | |
Called up share capital |
Ordinary shares, issued and fully paid | |
Capital allowances |
Tax term equivalent to US tax depreciation allowances | |
Cash at bank and in hand |
Cash | |
Class of business |
Industry segment | |
Finance lease |
Capital lease | |
Freehold |
Ownership with absolute rights in perpetuity | |
Loans and advances |
Lendings | |
Loan capital |
Long-term debt | |
Net asset value |
Book value | |
Profit |
Income | |
Share capital |
Ordinary shares, capital stock or common stock issued and fully paid | |
Share premium account |
Additional paid-up capital or paid-in surplus (not distributable) | |
Shares in issue |
Shares outstanding | |
Write-offs |
Charge-offs |
Barclays Annual Report 2008 |
313 |
Signatures
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to sign this annual report on its behalf.
Date March 24, 2009 | Barclays PLC (Registrant) | |||
By | /s/ Chris Lucas | |||
Chris Lucas, Group Finance Director |
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to sign this annual report on its behalf.
Date March 24, 2009 | Barclays Bank PLC (Registrant) | |||
By | /s/ Chris Lucas | |||
Chris Lucas, Group Finance Director |
EXHIBIT INDEX
EXHIBIT |
DESCRIPTION | |
1.1 | Memorandum and Articles of Association of Barclays PLC | |
1.2 | Memorandum and Articles of Association of Barclays Bank PLC | |
2.1 | Long term debt instruments | |
4.1 | Rules of the Barclays Group Performance Share Plan (2005) (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.2 | Rules of the Barclays PLC Renewed 1986 Executive Share Option Scheme (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.3 | Rules of the Barclays PLC Approved Incentive Share Option Plan (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.4 | Rules of the Barclays PLC Unapproved Incentive Share Option Plans (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.5 | Rules of the Barclays PLC Executive Share Award Scheme (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.6 | Rules of the Barclays Group Special Award Performance Share Plan (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.7 | Rules of the Barclays Group Incentive Share Plan (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.8 | Rules of Barclays Bank PLC 1999 Directors Deferred Compensation Plan (amended and restated, effective January 1, 2008) (incorporated by reference to Barclays Bank PLCs Registration Statement on Form S-8 (File no. 333-149301) filed on February 19, 2008) |
EXHIBIT |
DESCRIPTION | |
4.9 | Rules of Barclays Bank PLC Senior Management Deferred Compensation Plan (amended and restated, effective January 1, 2008) (incorporated by reference to Barclays Bank PLCs Registration Statement on Form S-8 (File no. 333-149302) filed on February 19, 2008) | |
4.10 | Service Contract John Varley (incorporated by reference to the 2003 Form 20-F filed on March 26th, 2004) | |
4.11 | Service Contract and Subsequent Side Letter to Service Contract Gary Hoffman (incorporated by reference to the 2005 Form 20-F filed on March 29th , 2006) | |
4.12 | Service Contract Robert E. Diamond Jr (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.13 | Employment Contract and Assignment Agreement Frederik Seegers (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.14 | Contract of Employment Christopher Lucas (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.15 | Addendum to contract of employment between Barclays Bank plc and Gary Hoffman (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.16 | Addendum to contract of employment between Barclays Bank plc and John Varley (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.17 | Appointment Letter and Subsequent Amendment to appoint as Senior Independent Director Sir Richard Broadbent (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.18 | Appointment Letter Professor Dame Sandra Dawson (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.19 | Appointment Letter and Subsequent Amendment to appoint as Deputy Chairman Sir Nigel Rudd (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.20 | Appointment Letter Stephen Russell (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.21 | Appointment Letter Leigh Clifford (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.22 | Appointment Letter Sir Andrew Likierman (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) |
EXHIBIT |
DESCRIPTION | |
4.23 | Appointment Letter Dr Daniël Cronjé (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.24 | Appointment Letter John Sunderland (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.25 | Appointment Letter Marcus Agius (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.26 | Appointment Letter Fulvio Conti (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.27 | Appointment Letter David Booth (incorporated by reference to the 2007 20-F filed on March 26th, 2008) | |
4.28 | Appointment Letter Sir Michael Rake (incorporated by reference to the 2007 20-F filed on March 26th, 2008) | |
4.29 | Appointment Letter Patience Wheatcroft (incorporated by reference to the 2007 20-F filed on March 26th, 2008) | |
4.30 | Appointment Letter Simon Fraser | |
4.31 | Indemnity Letter John Varley (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.32 | Indemnity Letter Gary Hoffman (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.33 | Indemnity Letter Robert E. Diamond Jr (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.34 | Indemnity Letter Sir Richard Broadbent (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.35 | Indemnity Letter Professor Dame Sandra Dawson (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) |
EXHIBIT |
DESCRIPTION | |
4.36 | Indemnity Letter Sir Nigel Rudd (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.37 | Indemnity Letter Stephen Russell (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.38 | Indemnity Letter Leigh Clifford (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.39 | Indemnity Letter Sir Andrew Likierman (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.40 | Indemnity Letter Dr Daniël Cronjé (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.41 | Indemnity Letter John Sunderland (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.42 | Term sheet for Barclays PLC Warrants | |
4.43 | Term Sheet for Barclays Bank PLC £4.05 billion Mandatory Convertible Notes (MCNs) | |
7.1 | Ratios of earnings under IFRS to fixed charges | |
7.2 | Ratios of earnings under IFRS to combined fixed charges, preference share dividends and similar appropriations | |
8.1 | List of subsidiaries | |
11.1 | Code of Ethics (incorporated by reference to the 2003 Form 20-F filed on March 26th, 2004) | |
12.1 | Certifications filed pursuant to 17 CFR 240. 13(a)-14(a) | |
13.1 | Certifications filed pursuant to 17 CFR 240. 13(a) and 18 U.S.C 1350(a) and 1350(b) | |
15.1 | Consent of PricewaterhouseCoopers LLP for incorporation by reference of reports in certain securities registration statements of Barclays PLC and Barclays Bank PLC. |